data_2nbg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nbg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -149.26 -179.35 25.06 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 p -117.38 143.12 46.31 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.313 0.578 . . . . 0.0 112.187 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.9 137.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.4 pt -93.18 -38.46 9.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -154.33 147.34 24.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.63 134.36 13.74 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.15 175.75 13.08 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -97.24 146.56 24.98 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -120.24 123.32 42.94 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.526 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.79 -10.03 3.44 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.08 -44.62 0.56 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.023 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -82.81 -25.39 32.74 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 122.859 0.464 . . . . 0.0 110.847 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.15 -166.58 15.48 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.75 116.41 4.09 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 121.84 1.693 . . . . 0.0 110.307 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 482' ' ' THR . 22.5 m -113.05 144.65 20.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-O 121.204 0.526 . . . . 0.0 109.939 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.71 111.98 9.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -85.04 120.9 27.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.0 pp -140.15 173.11 11.84 Favored 'General case' 0 C--N 1.278 -2.516 0 O-C-N 122.281 -0.262 . . . . 0.0 111.521 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.42 107.81 16.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.3 p -67.16 116.69 6.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.49 -15.64 6.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.509 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.31 -17.28 56.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.066 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.6 -107.83 0.33 Allowed Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 96.6 m -131.92 137.48 48.0 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.469 HD21 ' HE3' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.84 127.18 54.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.7 ttpm? -131.71 158.28 41.55 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.8 m -71.19 137.13 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 O-C-N 121.777 -0.577 . . . . 0.0 110.384 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.17 -8.05 60.61 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.604 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 5.8 m-20 -68.5 136.86 90.78 Favored Pre-proline 0 CA--C 1.494 -1.202 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.4 106.43 1.71 Allowed 'Trans proline' 0 N--CA 1.429 -2.29 0 C-N-CA 122.117 1.878 . . . . 0.0 107.544 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 456' ' ' TYR . 2.8 pp -108.23 139.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.175 -170.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.39 113.99 45.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.24 112.0 38.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.08 -97.36 0.65 Allowed Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.85 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.0 t -131.74 3.95 4.18 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 120.963 0.411 . . . . 0.0 110.233 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.443 HG21 ' CB ' ' A' ' 486' ' ' ASP . 96.2 m -116.46 141.64 47.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 44.5 p90 -114.97 151.03 34.84 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -153.81 -164.3 12.59 Favored Glycine 0 C--N 1.296 -1.664 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 448' ' ' ASP . 19.9 ttm180 -134.58 127.43 31.23 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 482' ' ' THR . 60.9 t -58.88 115.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.72 0.638 . . . . 0.0 111.536 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -84.33 -59.27 2.44 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.0 151.22 48.87 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.549 0.739 . . . . 0.0 109.451 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.469 ' HE3' HD21 ' A' ' 444' ' ' LEU . 54.7 tpp -122.49 117.33 25.69 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.3 127.91 75.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -96.45 -176.76 3.73 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.16 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -48.54 -37.06 16.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 126.825 2.05 . . . . 0.0 113.114 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.0 m -88.71 -6.73 57.25 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.33 15.18 48.55 Favored Glycine 0 CA--C 1.496 -1.11 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.13 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.4 135.17 42.26 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.086 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 462' ' ' MET . 6.6 tpt180 -68.89 130.99 44.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 462' ' ' MET . 14.0 m -139.71 -177.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.172 0.295 . . . . 0.0 110.681 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.32 -34.34 7.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -148.13 135.27 20.32 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.641 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . 0.514 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -128.84 144.74 51.25 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 171.11 31.96 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.233 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.448 ' HA ' HG11 ' A' ' 439' ' ' VAL . 30.5 Cg_endo -63.44 156.67 55.02 Favored 'Trans proline' 0 C--O 1.247 0.931 0 C-N-CA 122.969 2.446 . . . . 0.0 112.598 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 44.3 m 71.98 12.32 6.07 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.218 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.0 ttp -118.88 129.73 25.23 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.2 Cg_exo -67.48 127.22 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.694 2.263 . . . . 0.0 111.108 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' A' ' 473' ' ' ALA . 24.5 m -139.85 154.96 24.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 39.4 tt0 -115.7 119.21 35.33 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -98.19 173.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.969 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.2 p -149.38 167.63 25.63 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.62 31.42 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.452 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 53.9 tp -81.22 -30.89 34.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.648 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 61.46 20.58 11.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.351 1.46 . . . . 0.0 111.345 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.443 ' CB ' HG21 ' A' ' 455' ' ' THR . 34.5 t70 -147.81 175.09 11.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.42 114.76 53.83 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 118.983 0.811 . . . . 0.0 112.318 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.75 146.61 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.686 1.59 . . . . 0.0 110.25 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.37 139.58 50.68 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.08 131.6 43.86 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.091 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.38 -0.12 68.05 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.091 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 493' ' ' ARG . 1.6 t0 -85.02 -173.63 4.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.524 ' HD2' ' H ' ' A' ' 493' ' ' ARG . 0.9 OUTLIER -130.0 133.85 47.04 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.485 -175.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 40.5 p90 -127.15 150.23 49.59 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 54.2 ttp -119.98 115.81 24.5 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.822 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 450' ' ' ILE . 26.3 t . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.214 -0.768 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -47.37 -54.15 11.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 112.144 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.47 -34.92 41.05 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.241 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.57 73.04 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 122.006 0.908 . . . . 0.0 108.885 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -61.03 -37.62 83.22 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 125.675 1.59 . . . . 0.0 110.289 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -63.62 -45.32 90.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.798 0.332 . . . . 0.0 110.251 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 80.1 mt -67.67 -34.21 66.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.152 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -177.559 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 CA--C 1.51 -0.576 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -139.63 -178.13 16.36 Favored Glycine 0 C--N 1.295 -1.697 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 26.7 m -124.22 143.8 50.32 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.4 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.045 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.7 pt -91.7 -35.19 6.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -159.21 148.66 18.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.22 130.54 12.06 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 177.46 10.71 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -174.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -94.72 150.12 20.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.84 135.09 50.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.514 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.29 -18.2 59.08 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.834 -174.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -114.82 -36.31 1.28 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.549 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.52 -30.48 19.3 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.418 -0.46 . . . . 0.0 111.796 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.67 -152.28 17.7 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 482' ' ' THR . 14.4 Cg_exo -71.67 116.33 4.66 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.725 1.617 . . . . 0.0 110.017 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.93 124.06 68.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.63 0.729 . . . . 0.0 111.537 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -123.08 112.18 17.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.889 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.472 ' HG1' ' HG2' ' A' ' 480' ' ' GLU . 1.2 m -83.59 115.45 22.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.2 pp -132.21 170.85 14.44 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.898 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' A' ' 440' ' ' GLN . 2.1 tm? -117.03 106.13 13.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -64.64 117.7 5.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-O 121.827 0.823 . . . . 0.0 112.346 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 438' ' ' LEU . 72.1 mt-30 -123.66 -15.46 7.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.698 -175.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.99 59.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.831 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 153.97 -108.05 0.35 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 27.2 m -128.8 142.5 50.96 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.449 HD22 ' HE3' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.13 135.98 53.22 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.582 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.3 ttpt -146.0 150.83 36.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.582 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 33.5 m -70.74 134.23 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.235 0.541 . . . . 0.0 110.707 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 105.2 -21.19 36.11 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.488 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.561 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 43.8 m-20 -79.47 146.44 65.85 Favored Pre-proline 0 C--O 1.251 1.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.8 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.114 1.876 . . . . 0.0 111.179 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.58 152.03 30.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.67 121.9 48.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-O 121.195 0.521 . . . . 0.0 109.64 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 494' ' ' PHE . 2.5 p -143.78 133.45 20.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.644 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.75 33.82 88.26 Favored Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.261 26.7 p 62.05 1.76 0.71 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.928 1.691 . . . . 0.0 114.306 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.444 HG23 ' CB ' ' A' ' 486' ' ' ASP . 39.0 m -98.38 141.15 31.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -120.18 151.37 39.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.171 -1.011 . . . . 0.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.25 14.04 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -127.76 146.65 50.52 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 45.9 t -74.08 120.17 22.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -92.63 -45.16 8.21 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.782 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -144.04 152.56 41.17 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.449 ' HE3' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -122.47 117.59 26.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.94 133.81 65.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.423 HD22 ' HB2' ' A' ' 468' ' ' ARG . 4.7 p30 -101.63 172.77 6.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.816 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.67 -26.1 61.2 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.335 1.054 . . . . 0.0 113.061 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.7 m -86.02 -2.22 58.1 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 122.099 -0.375 . . . . 0.0 111.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 93.92 1.98 64.98 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.413 170.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.423 ' HB2' HD22 ' A' ' 464' ' ' ASN . 11.8 mpt_? -86.35 131.83 34.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.597 -0.301 . . . . 0.0 110.439 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -77.85 129.63 35.64 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.08 176.04 9.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 -8.35 10.38 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.736 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -151.65 139.4 19.81 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.55 131.55 29.73 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.74 166.9 31.73 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.439 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.472 ' HA ' HG13 ' A' ' 439' ' ' VAL . 17.7 Cg_endo -58.05 149.81 68.86 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 123.252 2.635 . . . . 0.0 112.175 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 43.4 t 77.55 6.44 2.92 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.917 0.887 . . . . 0.0 112.133 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 39.5 ttp -110.26 127.09 27.62 Favored Pre-proline 0 N--CA 1.439 -0.993 0 O-C-N 121.403 -0.811 . . . . 0.0 111.417 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.8 Cg_endo -74.15 126.59 10.62 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.627 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 152.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.327 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.472 ' HG2' ' HG1' ' A' ' 436' ' ' THR . 35.4 mt-10 -99.62 123.1 43.57 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.5 pt -97.58 164.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 4.1 p -145.77 158.38 43.86 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 100.9 12.48 36.96 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.919 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.31 -36.58 71.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 67.33 21.43 9.81 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.731 1.612 . . . . 0.0 109.873 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.444 ' CB ' HG23 ' A' ' 455' ' ' THR . 6.7 t70 -145.63 -179.05 6.42 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.29 110.05 48.36 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 123.405 0.441 . . . . 0.0 110.982 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -82.73 148.49 13.98 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.931 1.754 . . . . 0.0 110.561 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -111.29 135.98 51.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.024 0.44 . . . . 0.0 111.958 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.87 127.26 32.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.99 -0.24 66.69 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.866 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.557 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.2 t70 -88.41 -172.13 3.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.557 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.0 OUTLIER -128.31 139.0 52.65 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -171.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 46.7 p90 -127.63 159.69 33.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.01 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 28.1 ttt -132.44 130.68 40.88 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.426 -1.657 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.256 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 . . . . . 0 C--O 1.199 -1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -62.27 -52.97 61.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.903 -170.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.22 -40.72 95.05 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.282 0.363 . . . . 0.0 110.257 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.05 60.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.104 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -60.29 -38.11 82.61 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.961 0.904 . . . . 0.0 110.928 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -69.84 -34.62 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.645 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.65 -23.21 14.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.655 0.741 . . . . 0.0 110.116 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.086 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -177.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 30.4 m . . . . . 0 CA--C 1.498 -1.041 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.99 162.02 13.29 Favored Glycine 0 C--N 1.279 -2.62 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 m -117.01 138.76 51.36 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.88 139.45 17.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 18.2 pt -99.3 -39.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 490' ' ' ALA . 8.5 pt-20 -153.39 152.29 30.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.22 134.34 29.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.69 177.39 10.91 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.311 0.577 . . . . 0.0 111.185 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.97 145.08 26.19 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.771 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 10.4 t70 -128.02 129.16 46.25 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.525 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -75.55 -11.23 59.98 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -175.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -119.34 -35.64 0.92 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.478 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.0 mtp180 -94.08 -15.22 24.94 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.844 0.458 . . . . 0.0 111.028 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 88.15 -154.1 25.08 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -60.27 116.16 3.13 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.108 1.872 . . . . 0.0 111.173 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.8 137.18 53.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.434 0.635 . . . . 0.0 110.377 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -131.4 114.62 15.19 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.104 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -83.39 119.44 24.64 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.481 HD22 ' CE1' ' A' ' 494' ' ' PHE . 1.6 pp -135.73 173.07 12.12 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -120.01 112.41 19.12 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -75.77 125.2 35.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.526 0.679 . . . . 0.0 111.799 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 72.6 mt-30 -124.03 -15.11 6.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.937 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.423 ' HB3' HG13 ' A' ' 496' ' ' VAL . . . -97.3 6.31 48.55 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 147.62 -125.77 2.22 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.15 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.7 m -116.39 141.63 47.92 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.489 HD21 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.77 119.25 36.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.561 ' HZ2' ' HB3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -130.02 155.14 46.61 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.467 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.0 m -67.06 132.16 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.84 -7.09 48.76 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.916 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.88 135.02 77.68 Favored Pre-proline 0 C--O 1.25 1.089 0 CA-C-N 117.555 0.678 . . . . 0.0 111.932 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.32 119.15 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.629 2.219 . . . . 0.0 109.306 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.07 159.81 29.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.73 115.59 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 16.6 t -128.38 124.17 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 56.98 42.35 92.78 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.264 6.6 t 60.39 4.09 0.65 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.549 2.34 . . . . 0.0 113.436 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.445 HG21 ' CB ' ' A' ' 486' ' ' ASP . 22.4 m -96.53 135.62 38.18 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -111.5 151.65 28.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.604 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.95 -163.97 19.29 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -134.62 137.21 43.48 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.69 119.36 11.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.184 0.516 . . . . 0.0 112.097 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -81.54 -60.59 2.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.92 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -136.2 152.05 50.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.489 ' HE2' HD21 ' A' ' 444' ' ' LEU . 41.2 tpp -115.23 117.07 29.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.88 126.49 73.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -92.81 174.77 7.08 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.625 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.21 -27.82 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.949 0.9 . . . . 0.0 113.144 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.5 m -78.81 -12.1 60.01 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.756 0.312 . . . . 0.0 111.0 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 98.41 8.32 54.95 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.93 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -97.0 128.81 44.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -84.77 124.33 31.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.43 -174.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -99.31 -31.85 11.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.11 156.67 40.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.304 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.53 42.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -100.58 177.04 28.0 Favored Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.44 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 439' ' ' VAL . 18.7 Cg_endo -59.76 155.37 43.6 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.971 2.447 . . . . 0.0 112.641 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 47.6 m 70.81 16.94 6.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.955 0.902 . . . . 0.0 112.144 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 45.5 ttm -117.81 136.68 23.8 Favored Pre-proline 0 C--N 1.316 -0.861 0 O-C-N 122.007 -0.433 . . . . 0.0 111.185 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.1 Cg_endo -82.57 125.85 4.5 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.234 1.956 . . . . 0.0 110.884 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.22 156.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.0 mt-10 -105.0 126.55 52.18 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 50.0 pt -97.95 170.4 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 1.2 p -150.42 167.46 27.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.75 13.89 62.05 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.914 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.63 -32.54 64.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.9 t60 67.45 19.85 9.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.076 1.75 . . . . 0.0 109.788 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.445 ' CB ' HG21 ' A' ' 455' ' ' THR . 7.3 t70 -148.39 -179.98 7.36 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.9 t -120.42 113.41 33.68 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.46 175.38 10.24 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.773 2.315 . . . . 0.0 111.509 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -111.03 148.0 33.54 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 424' ' ' GLU . . . -70.22 138.84 52.05 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.255 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.85 -0.23 86.26 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.18 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.598 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 4.5 t70 -83.96 -165.34 1.11 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.598 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -138.59 148.98 44.78 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.688 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.481 ' CE1' HD22 ' A' ' 437' ' ' LEU . 15.0 p90 -139.56 156.19 47.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.833 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.1 ttt -118.86 127.39 53.46 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 441' ' ' ALA . 4.8 p . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.096 0.474 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -72.53 -38.63 67.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.607 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.49 -46.78 88.84 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.611 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.94 -45.03 94.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -58.94 -36.03 74.1 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 125.374 1.469 . . . . 0.0 111.757 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -34.14 59.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.9 mm -80.18 -54.06 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.316 0 C-N-CA 118.695 -1.717 . . . . 0.0 115.052 -178.378 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.503 -0.85 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -129.47 178.37 17.43 Favored Glycine 0 C--N 1.298 -1.554 0 C-N-CA 119.233 -1.46 . . . . 0.0 112.542 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.84 145.16 45.89 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 123.335 0.654 . . . . 0.0 111.107 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 30.0 t -86.55 134.06 28.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -94.26 -33.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.31 149.13 20.56 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.58 131.27 18.93 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.78 177.98 4.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.89 152.85 21.77 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -126.62 119.32 26.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -58.11 -19.55 33.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -112.53 -38.78 1.28 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.784 -1.198 . . . . 0.0 112.839 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.57 -32.59 19.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.37 -155.53 16.17 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.56 116.38 4.38 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.075 1.85 . . . . 0.0 110.068 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 32.4 m -116.3 143.94 25.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.793 0.806 . . . . 0.0 111.684 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -133.17 112.03 11.4 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.488 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.7 m -87.55 115.36 24.92 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.628 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.4 pp -132.86 171.37 14.0 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -113.33 106.38 14.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -70.3 108.84 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.352 1.072 . . . . 0.0 111.928 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -115.0 -15.94 11.71 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.18 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -77.64 -4.12 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.906 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.31 -95.67 0.19 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.218 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.9 m -142.05 139.61 32.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.452 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -114.47 135.57 53.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.571 ' HZ3' ' HB3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -147.75 164.3 34.01 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 28.6 m -70.62 138.12 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 121.734 0.778 . . . . 0.0 112.134 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.28 -10.62 65.4 Favored Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.207 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 51.1 m-20 -76.66 131.76 73.37 Favored Pre-proline 0 C--O 1.245 0.848 0 CA-C-N 117.651 0.725 . . . . 0.0 111.536 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.42 107.68 2.44 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.681 2.254 . . . . 0.0 109.26 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.48 161.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.898 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.56 114.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.34 112.42 36.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.55 -115.61 7.52 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.8 p -107.34 7.02 28.94 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.997 0.427 . . . . 0.0 111.259 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 486' ' ' ASP . 90.0 m -121.59 129.53 52.9 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.781 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -111.31 151.99 27.74 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.66 -164.27 20.77 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 56.7 ttp180 -131.91 128.72 39.15 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 482' ' ' THR . 40.1 t -61.28 122.86 12.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 123.859 0.724 . . . . 0.0 111.767 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -95.71 -56.93 2.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.31 52.28 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.452 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.6 tpp -115.37 117.68 31.09 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 16.8 t -116.36 139.6 42.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -105.43 171.97 7.04 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.095 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.6 -25.89 54.02 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 41.2 m -77.09 -11.71 59.85 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.011 -0.43 . . . . 0.0 110.954 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.74 -4.64 56.41 Favored Glycine 0 CA--C 1.496 -1.12 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.484 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -91.89 140.26 29.85 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 4.4 tmm_? -86.44 138.01 32.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 16.7 m -136.17 -173.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 124.41 1.084 . . . . 0.0 108.493 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -119.34 -17.07 8.91 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.113 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -149.19 152.25 35.72 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.44 135.36 30.25 Favored 'General case' 0 C--O 1.25 1.11 0 O-C-N 123.536 0.522 . . . . 0.0 110.876 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -86.45 168.43 40.19 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.641 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.422 ' HA ' HG12 ' A' ' 439' ' ' VAL . 37.0 Cg_endo -64.26 154.99 68.0 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 122.941 2.427 . . . . 0.0 113.729 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 34.1 m 70.17 16.55 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.016 1.326 . . . . 0.0 112.19 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.6 ttp -117.0 130.07 24.87 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.475 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 11.2 Cg_endo -72.68 126.12 11.16 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.27 1.98 . . . . 0.0 111.788 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.72 155.05 22.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.672 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.64 113.63 26.78 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 124.516 1.127 . . . . 0.0 108.575 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.8 pt -98.13 172.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.805 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.6 p -146.45 163.03 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 107.29 11.56 25.34 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.972 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.4 mt -83.71 -27.29 29.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.706 0.289 . . . . 0.0 111.749 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 60.27 19.26 8.73 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.61 1.164 . . . . 0.0 110.518 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.463 ' HB3' HG21 ' A' ' 455' ' ' THR . 34.4 t70 -149.26 174.39 12.44 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.22 112.26 52.37 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.92 2.413 . . . . 0.0 111.37 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -105.31 132.43 51.51 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.484 0.659 . . . . 0.0 111.656 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.03 28.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 101.63 -5.11 54.16 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.24 -177.48 6.25 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.09 143.66 44.41 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.656 0.782 . . . . 0.0 110.758 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 50.1 p90 -136.83 163.16 31.3 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.5 ttm -130.17 115.88 17.65 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.851 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.218 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 49.3 mt-10 . . . . . 0 C--O 1.182 -2.458 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -62.42 -39.12 92.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.74 0.781 . . . . 0.0 111.141 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.12 -41.2 86.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.914 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.65 -25.92 41.22 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.159 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 28.7 ttt180 -70.76 -29.06 65.17 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.74 1.216 . . . . 0.0 110.014 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.2 -34.52 78.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.033 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 70.9 mt -79.08 -35.02 17.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.437 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.272 177.256 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -147.8 -175.35 20.46 Favored Glycine 0 C--N 1.299 -1.508 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 6.6 m -123.76 141.96 51.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.098 0.449 . . . . 0.0 109.891 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.87 138.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.4 pt -94.19 -42.22 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.779 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.77 146.72 27.34 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.71 19.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 177.44 4.34 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.98 150.78 20.05 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.043 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -127.46 129.84 48.18 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.416 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -67.21 -16.87 64.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.7 -53.78 0.55 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.93 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.72 -29.25 64.33 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.49 0.662 . . . . 0.0 110.15 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 434' ' ' VAL . . . 104.16 -179.42 24.89 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 486' ' ' ASP . 35.6 Cg_exo -49.73 119.55 4.87 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.341 2.027 . . . . 0.0 111.179 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 432' ' ' GLY . 21.0 m -117.98 158.81 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.444 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -150.76 113.38 4.69 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.095 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 m -90.47 119.84 31.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -134.63 173.3 11.82 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.54 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.07 106.16 13.06 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.71 123.41 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.415 0.626 . . . . 0.0 112.506 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -124.09 -16.31 6.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.403 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -63.82 -16.99 62.64 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.541 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.89 -92.79 0.11 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.433 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.3 m -148.1 141.86 25.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.467 ' CD1' HD13 ' A' ' 437' ' ' LEU . 0.5 OUTLIER -109.22 117.76 34.94 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.496 ' HZ1' ' HB3' ' A' ' 445' ' ' LYS . 1.8 ttpm? -125.62 153.46 43.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.2 m -71.02 139.02 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.775 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 101.75 -10.23 57.3 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.405 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 66.1 m-20 -82.08 138.19 46.01 Favored Pre-proline 0 C--O 1.244 0.789 0 CA-C-N 117.271 0.535 . . . . 0.0 111.846 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -83.68 106.87 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.542 2.161 . . . . 0.0 110.161 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -108.4 162.98 6.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.034 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 6.9 p -133.18 125.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.67 125.5 70.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.64 -103.12 1.13 Allowed Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 19.6 m -126.33 0.24 7.02 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.739 0.78 . . . . 0.0 109.662 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.442 HG21 ' CB ' ' A' ' 486' ' ' ASP . 74.7 m -116.23 146.01 42.68 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.491 -0.755 . . . . 0.0 111.158 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -119.24 159.89 23.23 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.81 -164.44 20.14 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 35.3 ttm-85 -135.43 130.03 34.16 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 482' ' ' THR . 38.2 t -64.46 120.78 12.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.69 0.757 . . . . 0.0 112.858 -172.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -85.33 -60.28 2.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.812 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.8 160.75 37.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.921 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.44 ' HE2' HD21 ' A' ' 444' ' ' LEU . 36.7 tpp -130.69 117.51 19.56 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.16 138.78 53.72 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.62 176.48 5.14 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.932 -173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -51.33 -38.39 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.517 1.136 . . . . 0.0 111.783 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.0 m -76.74 -5.9 49.98 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.01 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.44 2.64 63.5 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.38 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -88.67 128.63 35.6 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.755 0.312 . . . . 0.0 110.365 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -84.31 134.15 34.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.1 176.15 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -96.52 -35.51 11.09 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.962 0.411 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.75 151.43 28.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.304 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.91 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.135 0.574 . . . . 0.0 109.755 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.77 179.29 42.87 Favored Glycine 0 N--CA 1.439 -1.148 0 O-C-N 123.534 0.521 . . . . 0.0 112.327 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.72 161.01 46.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.696 2.264 . . . . 0.0 112.689 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.7 m 67.25 23.14 9.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.406 1.082 . . . . 0.0 110.591 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 26.0 ttt -125.86 137.62 30.43 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.884 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 5.7 Cg_exo -83.21 125.75 4.1 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.69 151.66 17.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.248 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.7 tt0 -108.63 119.05 38.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.5 pt -98.15 172.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.262 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.6 p -148.9 157.24 43.28 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.823 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.49 4.96 Favored Glycine 0 C--N 1.308 -0.988 0 O-C-N 123.566 0.541 . . . . 0.0 112.379 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.27 -31.65 11.95 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.76 21.16 11.22 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.992 1.317 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.442 ' CB ' HG21 ' A' ' 455' ' ' THR . 38.1 t70 -147.78 167.43 24.72 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.75 115.93 65.85 Favored Pre-proline 0 C--N 1.287 -2.117 0 CA-C-O 121.035 0.445 . . . . 0.0 110.762 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -84.97 173.7 7.88 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.617 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -122.47 136.63 54.93 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.962 0.411 . . . . 0.0 111.383 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.85 140.6 51.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.922 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.51 89.38 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.585 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.84 -176.4 4.43 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 6.3 mpt_? -113.14 150.4 32.26 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.241 0.543 . . . . 0.0 110.196 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.616 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.2 p90 -139.54 165.13 28.07 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.14 131.99 45.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.682 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.968 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 505' ' ' GLN . 6.7 mmmm -56.36 -42.48 77.87 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.277 0.361 . . . . 0.0 110.363 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -80.82 -37.38 30.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.64 -56.6 17.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.23 0.612 . . . . 0.0 111.425 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -72.73 -19.49 61.37 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.394 0.616 . . . . 0.0 111.296 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 501' ' ' LYS . 7.9 tt0 -81.21 -31.05 34.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.01 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 83.3 mt -87.29 -53.89 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.607 0 C-N-CA 119.237 -1.459 . . . . 0.0 114.173 179.278 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.504 -0.791 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -141.84 -178.35 17.87 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.3 m -124.21 138.97 54.34 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.64 138.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.7 pt -89.13 -44.3 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.045 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.45 157.42 36.95 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.05 136.98 32.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 177.74 5.54 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.18 152.48 21.08 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.344 0.593 . . . . 0.0 110.047 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -122.76 118.28 27.68 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.472 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.2 -19.37 13.44 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.31 -41.32 1.79 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.642 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.55 -37.25 19.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 110.817 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.63 -146.42 18.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.53 116.51 4.27 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.507 2.138 . . . . 0.0 111.331 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.419 HG12 ' CG2' ' A' ' 482' ' ' THR . 27.4 m -119.81 158.6 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.2 121.77 13.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.403 HG21 ' HG2' ' A' ' 480' ' ' GLU . 1.6 m -92.55 117.65 30.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.599 HD23 ' CZ ' ' A' ' 494' ' ' PHE . 0.0 OUTLIER -133.75 168.87 17.92 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.506 -177.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.86 106.35 14.07 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -72.72 117.08 15.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.779 0.799 . . . . 0.0 112.494 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.41 -15.96 9.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.123 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.68 60.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.802 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 155.63 -106.92 0.3 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 90.1 m -134.74 133.69 40.2 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.47 HD22 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -101.9 126.02 48.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.591 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.1 ttpt -140.09 145.71 37.98 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.591 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -64.93 145.58 13.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.368 0.604 . . . . 0.0 112.449 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 -21.87 42.52 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.419 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.7 144.03 27.21 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 26.1 Cg_exo -66.55 136.69 43.7 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.914 2.409 . . . . 0.0 111.346 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 161.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.262 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.22 116.19 47.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 85.0 t -128.58 122.62 57.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . 0.497 ' HA2' ' OD1' ' A' ' 492' ' ' ASP . . . 60.89 36.63 92.39 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 121.18 -0.534 . . . . 0.0 111.966 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.295 8.3 p 60.97 8.93 2.08 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.488 HG22 ' CB ' ' A' ' 486' ' ' ASP . 87.0 m -102.81 139.41 38.42 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -111.65 146.77 36.87 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.493 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -152.6 -167.86 15.94 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.67 135.92 47.27 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.73 117.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 123.404 0.44 . . . . 0.0 110.292 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.97 -56.22 3.42 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -130.63 153.76 48.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.47 ' HE2' HD22 ' A' ' 444' ' ' LEU . 39.5 tpp -121.09 120.02 34.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.87 139.13 51.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 5.5 p30 -97.02 174.53 6.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.12 -25.88 67.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 44.0 m -78.83 -19.8 51.21 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.189 0.519 . . . . 0.0 111.102 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.88 2.21 Favored Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.191 165.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.462 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 25.8 ttm180 -120.27 136.5 54.65 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.021 -1.59 . . . . 0.0 109.941 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -79.77 132.05 36.06 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.16 0.913 . . . . 0.0 110.728 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.29 -32.0 8.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.138 0.494 . . . . 0.0 110.284 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.04 163.95 37.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.388 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.64 38.45 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.09 172.31 38.19 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.555 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 439' ' ' VAL . 35.6 Cg_endo -65.79 158.55 53.11 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 21.9 m 70.54 16.83 6.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.598 1.159 . . . . 0.0 111.362 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 25.1 ttt -117.04 137.53 23.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.677 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.06 126.15 4.93 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.417 2.078 . . . . 0.0 111.298 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.57 158.0 16.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.334 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 37.8 mt-10 -111.62 121.24 44.61 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.7 pt -98.44 172.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.773 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.419 ' CG2' HG12 ' A' ' 434' ' ' VAL . 3.1 p -147.43 163.19 37.29 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.65 7.73 58.79 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.159 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.89 -39.05 64.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.22 30.41 19.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.003 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.488 ' CB ' HG22 ' A' ' 455' ' ' THR . 35.2 t70 -140.77 179.67 6.57 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.58 109.73 47.27 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 118.317 0.508 . . . . 0.0 109.939 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 1.2 Cg_endo -80.58 164.19 21.15 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 121.602 1.535 . . . . 0.0 109.73 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -131.4 140.06 49.57 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-O 121.318 0.58 . . . . 0.0 110.458 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.11 132.08 44.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.285 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 88.24 0.61 82.57 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.968 -1.111 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.582 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.6 t70 -88.41 -173.26 4.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.582 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -128.4 153.54 46.96 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.156 0.503 . . . . 0.0 111.0 -171.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 437' ' ' LEU . 44.2 p90 -145.65 165.7 27.96 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.105 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.3 ttt -133.15 123.44 25.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.217 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 7.1 pt-20 . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.491 0.662 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 61.6 mtpt -66.49 -37.7 85.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.562 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 506' ' ' ILE . 87.8 tttt -77.79 -40.0 42.09 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.035 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.22 86.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.481 0.657 . . . . 0.0 110.924 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -58.5 -38.83 78.47 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.835 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -74.32 -35.43 63.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.534 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 502' ' ' LYS . 75.7 mt -64.68 -38.42 82.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.724 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.31 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.117 -179.423 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -126.41 171.07 18.17 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.1 m -121.86 139.94 53.01 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 34.1 t -84.61 134.78 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.93 -38.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.196 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.33 132.05 12.32 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -166.33 175.48 8.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -82.62 142.75 31.5 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.992 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.46 122.56 48.05 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.519 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.21 -16.33 43.88 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.09 -36.15 1.05 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.508 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -93.76 -15.25 25.37 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 94.13 -167.56 27.91 Favored Glycine 0 C--O 1.206 -1.597 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.32 116.46 3.2 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.207 1.938 . . . . 0.0 111.06 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.75 145.36 21.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-O 121.292 0.568 . . . . 0.0 111.043 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.79 114.92 8.32 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.36 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.426 ' HG1' ' HG2' ' A' ' 480' ' ' GLU . 6.7 m -87.04 127.56 35.1 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -141.6 169.87 16.79 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.543 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -118.44 109.48 16.29 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -78.06 122.51 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.572 0.701 . . . . 0.0 112.293 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -123.92 -13.4 7.37 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.38 -19.82 41.84 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.03 -171.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 167.53 -118.32 0.78 Allowed Glycine 0 N--CA 1.414 -2.77 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.024 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.3 m -130.85 120.82 24.23 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.44 HD21 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -98.18 123.19 42.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.586 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 24.6 ttpt -137.87 153.12 49.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.586 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -70.78 141.25 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.372 0.606 . . . . 0.0 112.554 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.39 87.14 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.403 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.32 139.63 21.66 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.16 134.7 47.0 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.085 2.523 . . . . 0.0 113.192 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.22 162.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.651 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 121.42 49.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.45 119.25 49.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.99 96.9 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 123.474 0.484 . . . . 0.0 112.069 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.304 35.0 p 66.82 -6.34 0.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.83 1.652 . . . . 0.0 115.027 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.471 HG23 ' CB ' ' A' ' 486' ' ' ASP . 91.0 m -90.94 140.92 29.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -110.78 155.48 22.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.688 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -161.47 -164.33 16.15 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 40.9 ttm180 -135.7 131.66 35.94 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 446' ' ' VAL . 35.2 t -67.96 114.06 4.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -79.22 -56.55 4.27 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.732 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.65 148.93 46.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.44 ' HE2' HD21 ' A' ' 444' ' ' LEU . 44.9 tpp -114.69 116.97 29.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.4 136.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.43 178.01 5.01 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.792 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.14 -34.76 58.18 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.157 0.983 . . . . 0.0 112.375 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.6 m -83.88 -4.03 58.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.53 62.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.97 171.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.46 136.9 37.72 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 1.9 tmm_? -90.07 128.65 36.35 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 27.5 m -125.46 -175.37 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.428 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.53 -36.26 6.25 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.79 148.3 35.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.631 -174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.39 142.15 39.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.51 176.26 36.62 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.403 ' HA ' HG11 ' A' ' 439' ' ' VAL . 36.5 Cg_endo -64.28 155.44 65.47 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 70.8 m 70.23 22.04 5.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.383 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 26.8 ttt -120.52 133.74 24.08 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.244 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.2 126.5 7.01 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.866 2.377 . . . . 0.0 110.718 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.48 155.01 14.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.49 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.426 ' HG2' ' HG1' ' A' ' 436' ' ' THR . 33.4 mt-10 -106.72 116.63 32.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -98.19 168.25 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.2 p -147.77 165.81 29.42 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 98.93 13.49 39.77 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.597 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.56 -28.3 33.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 58.11 25.48 12.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.141 1.376 . . . . 0.0 110.944 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.471 ' CB ' HG23 ' A' ' 455' ' ' THR . 11.2 t70 -147.53 -179.61 6.99 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.21 105.1 51.32 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.69 170.88 19.29 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.939 1.759 . . . . 0.0 111.144 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -111.92 141.01 46.1 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.76 21.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.03 59.25 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.905 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.44 174.62 10.48 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 141.93 43.31 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.394 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -133.77 158.33 43.61 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.9 ttt -132.37 131.27 41.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.159 0.504 . . . . 0.0 109.801 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . 0.564 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 86.7 mttt -62.84 -47.04 85.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.815 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -79.97 -29.01 39.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.036 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.1 -47.03 86.45 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -57.22 -39.55 75.69 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.957 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 81.5 mm-40 -64.32 -44.82 90.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.239 0.337 . . . . 0.0 110.633 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.96 -38.84 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.612 0.72 . . . . 0.0 110.345 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.334 -177.581 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.508 -0.665 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.72 -179.04 19.19 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 61.1 m -126.36 144.34 50.85 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.324 0.583 . . . . 0.0 110.535 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.13 132.87 30.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.9 pt -86.7 -39.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.65 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.51 146.42 22.37 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.86 146.51 27.15 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -173.85 177.15 2.49 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.3 pt? -85.39 148.73 25.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.98 131.1 51.13 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.982 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -15.7 60.96 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.625 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -91.3 -58.53 1.45 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.935 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -95.81 -42.47 8.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.144 0.472 . . . . 0.0 112.056 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 135.35 -135.89 8.16 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.53 116.05 4.38 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.971 1.78 . . . . 0.0 110.708 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.47 142.63 33.9 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 CA-C-O 121.38 0.609 . . . . 0.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -139.94 113.42 8.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.871 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.64 120.82 27.49 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -135.88 173.44 11.71 Favored 'General case' 0 C--N 1.273 -2.743 0 O-C-N 122.188 -0.32 . . . . 0.0 111.756 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -121.39 106.3 11.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.35 121.85 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.634 0.73 . . . . 0.0 112.891 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -125.38 -15.97 6.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.772 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 496' ' ' VAL . . . -73.24 -9.51 58.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.407 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.02 -97.01 0.16 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.887 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.3 m -144.51 139.64 28.36 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.446 ' CD1' HD11 ' A' ' 437' ' ' LEU . 0.6 OUTLIER -111.05 115.52 29.59 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.487 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -131.75 154.22 49.28 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -70.46 146.14 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.778 0.799 . . . . 0.0 112.774 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 502' ' ' LYS . . . 97.23 -10.61 65.49 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.577 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.56 153.43 38.82 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.04 134.64 6.17 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 C-N-CA 122.401 2.068 . . . . 0.0 112.501 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.2 150.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.28 122.49 67.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.43 108.75 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.91 -90.96 0.22 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.233 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.7 t -118.25 -19.78 8.83 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.887 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 486' ' ' ASP . 29.6 m -105.68 137.92 42.74 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.364 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -114.82 148.5 38.41 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.066 0.46 . . . . 0.0 110.858 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -155.73 -164.93 13.71 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -126.6 143.13 51.32 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 32.6 t -73.21 113.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.492 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -88.69 -59.28 2.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.98 148.43 50.09 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 470' ' ' VAL . 40.0 tpp -114.74 117.78 31.75 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.97 157.65 22.25 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.421 HD22 ' HB2' ' A' ' 468' ' ' ARG . 44.4 p30 -108.18 -176.68 3.12 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.548 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.1 -25.29 61.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.375 0.607 . . . . 0.0 110.251 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.1 m -81.89 -13.27 57.8 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.36 6.61 50.61 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.421 ' HB2' HD22 ' A' ' 464' ' ' ASN . 10.8 mpt_? -88.97 140.78 29.08 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -101.58 126.58 48.42 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 462' ' ' MET . 31.0 m -131.54 -175.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.63 -23.13 8.87 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -154.17 137.28 15.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.13 147.67 32.76 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.658 0.383 . . . . 0.0 110.694 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -95.3 179.82 36.45 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.44 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.56 160.51 49.03 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.921 2.414 . . . . 0.0 113.463 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 36.8 m 65.4 29.64 11.31 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.236 1.017 . . . . 0.0 110.704 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.2 ttt -131.59 131.01 22.57 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.502 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.03 125.17 7.09 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.653 1.569 . . . . 0.0 111.884 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.4 m -137.66 158.48 34.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.585 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 33.3 tt0 -121.48 114.78 21.73 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.7 pt -97.74 170.78 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.561 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 5.3 p -147.96 160.44 42.82 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.85 7.51 38.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.096 -1.05 . . . . 0.0 114.332 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.47 -30.91 64.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.182 0.491 . . . . 0.0 109.938 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 23.5 t60 64.3 21.45 12.52 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.959 1.304 . . . . 0.0 110.73 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.422 ' CB ' HG22 ' A' ' 455' ' ' THR . 14.8 t70 -147.68 179.6 7.58 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.61 111.15 64.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-O 121.645 0.736 . . . . 0.0 111.251 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.11 161.43 18.0 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.203 1.936 . . . . 0.0 111.193 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -114.93 148.03 39.21 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-O 121.284 0.564 . . . . 0.0 109.487 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.07 128.55 36.32 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.626 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.4 64.05 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.002 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.76 178.63 7.21 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -122.91 130.52 52.95 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 44.8 p90 -122.99 151.77 41.53 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 121.26 0.552 . . . . 0.0 110.235 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.7 ttm -121.62 116.67 25.02 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 441' ' ' ALA . 92.7 t . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 6.9 pt-20 . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 48.3 mmtm -64.12 -49.66 71.31 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.346 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 447' ' ' GLY . 61.9 mttp -68.25 -35.24 77.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.81 -57.07 12.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.784 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -58.69 -40.2 82.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 111.861 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.09 -25.23 65.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.28 . . . . 0.0 111.705 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 502' ' ' LYS . 42.0 mm -78.36 -51.47 17.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.202 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.654 -179.31 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.434 -1.225 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.03 -178.29 18.27 Favored Glycine 0 C--N 1.289 -2.04 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.9 m -120.69 141.69 50.17 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 117.812 0.806 . . . . 0.0 109.507 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.23 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.8 pt -94.35 -34.7 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.318 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.4 147.85 21.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.48 17.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 178.15 2.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.14 151.97 29.5 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.728 0.775 . . . . 0.0 111.445 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -17.7 59.53 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.27 -36.35 2.71 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.058 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -95.81 -29.01 14.46 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.065 0.459 . . . . 0.0 110.891 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 110.28 -149.33 17.54 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.461 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 13.8 Cg_exo -68.85 115.65 4.06 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.809 1.673 . . . . 0.0 109.217 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.98 137.53 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 122.309 1.052 . . . . 0.0 112.621 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.91 15.23 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.3 m -88.72 123.09 32.82 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -140.36 170.99 14.78 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.474 -173.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 106.42 12.47 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.63 121.95 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.631 . . . . 0.0 112.229 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -120.84 -15.12 8.4 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.689 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.8 -7.54 59.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.659 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.73 -110.79 0.46 Allowed Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.348 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.4 m -139.9 139.78 36.29 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.469 HD21 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -112.7 126.41 55.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -174.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 8.2 ttpt -136.83 150.83 48.54 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 110.223 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.46 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.2 m -68.5 146.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.471 0.653 . . . . 0.0 112.193 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.7 -3.44 84.97 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.768 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.46 139.31 19.99 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.39 133.56 19.37 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.449 2.099 . . . . 0.0 113.281 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 14.3 pt -126.25 172.46 13.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.22 122.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 494' ' ' PHE . 44.4 t -122.8 105.29 15.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.61 -118.92 14.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.4 p -102.38 -3.5 26.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 87.1 m -104.07 129.52 51.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -123.53 167.39 13.96 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 122.032 -0.417 . . . . 0.0 109.88 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.26 -164.61 37.07 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -115.07 143.33 45.37 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.36 124.43 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.446 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.1 tmt_? -93.79 -58.89 2.13 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.19 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.89 148.47 50.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.469 ' HE2' HD21 ' A' ' 444' ' ' LEU . 50.4 tpp -119.15 117.25 28.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.82 125.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 468' ' ' ARG . 5.1 p30 -95.1 176.26 6.31 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.325 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.44 -23.17 62.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 113.083 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.4 m -77.83 -16.34 58.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.04 32.37 8.47 Favored Glycine 0 CA--C 1.486 -1.743 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.562 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.4 ' HB2' ' ND2' ' A' ' 464' ' ' ASN . 80.9 mtt180 -116.9 126.65 53.3 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -81.45 123.45 28.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.61 -174.46 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -98.68 -34.06 10.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.892 0.377 . . . . 0.0 109.986 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.67 166.1 31.39 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.941 0.401 . . . . 0.0 111.38 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.69 150.51 34.46 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.745 0.818 . . . . 0.0 109.089 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -96.39 -179.96 35.04 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.166 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.401 ' HA ' HG12 ' A' ' 439' ' ' VAL . 51.4 Cg_endo -67.06 161.9 40.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.814 2.343 . . . . 0.0 112.066 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . 0.258 51.9 p 66.47 6.79 4.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.775 1.63 . . . . 0.0 113.516 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 40.0 ttm -107.98 136.92 19.7 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.232 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.34 126.62 4.9 Favored 'Trans proline' 0 C--O 1.252 1.187 0 C-N-CA 122.46 2.107 . . . . 0.0 110.6 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 473' ' ' ALA . 20.0 m -137.33 155.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.194 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.09 115.74 30.7 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.7 pt -97.93 167.95 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 7.8 p -150.1 166.49 29.63 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.43 -15.68 19.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.877 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.76 -40.32 91.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.998 0.427 . . . . 0.0 110.802 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 72.1 t60 61.83 20.12 11.17 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.578 1.551 . . . . 0.0 110.627 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -142.38 167.21 22.63 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.6 p -110.05 119.76 46.41 Favored Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.882 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.73 176.52 7.69 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.194 2.596 . . . . 0.0 110.604 175.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -102.05 140.15 36.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.36 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -67.18 124.53 23.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.7 -0.36 57.94 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.478 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.39 176.93 8.73 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.45 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 1.4 mpt_? -118.77 124.83 48.22 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.387 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 31.8 p90 -119.96 148.84 43.04 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 53.2 ttp -118.51 127.01 53.23 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.433 -1.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.245 -178.732 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -77.91 -39.06 44.2 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.42 -47.94 82.29 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.98 88.06 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.804 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.82 -43.11 90.55 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.738 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -75.13 -35.36 61.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.89 -30.52 14.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.472 0.653 . . . . 0.0 109.907 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.561 -179.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 4.8 m . . . . . 0 CA--C 1.476 -1.878 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -114.89 172.2 14.09 Favored Glycine 1 N--CA 1.385 -4.705 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.2 p -131.18 141.99 50.15 Favored 'General case' 0 C--N 1.245 -3.937 0 O-C-N 124.225 0.603 . . . . 0.0 110.903 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 53.7 t -89.13 130.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.8 -38.82 11.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.698 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -154.74 154.45 32.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -139.99 139.19 35.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.35 177.92 3.94 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.514 0.673 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -88.24 149.45 23.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.875 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.6 129.9 46.56 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 173.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -20.85 64.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -104.66 -40.6 2.15 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.723 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.454 ' HB3' HG21 ' A' ' 482' ' ' THR . 91.8 mtm180 -94.94 -22.76 17.77 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.5 -159.69 21.11 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.64 116.4 3.17 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.28 1.987 . . . . 0.0 111.095 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.428 HG13 ' CG2' ' A' ' 482' ' ' THR . 34.6 m -118.17 154.39 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -136.8 116.34 12.86 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.419 ' HG1' ' HG2' ' A' ' 480' ' ' GLU . 2.2 m -85.3 116.69 23.79 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 0.9 OUTLIER -134.18 170.91 14.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.23 108.03 12.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.56 122.05 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.398 0.618 . . . . 0.0 110.913 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 45.7 mt-30 -120.28 -21.42 6.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -97.1 -8.9 29.12 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 113.956 -3.098 . . . . 0.0 114.666 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . -164.94 -110.09 0.23 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 118.255 -1.926 . . . . 0.0 113.299 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.1 m -147.94 138.08 22.78 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.448 HD21 ' HE3' ' A' ' 462' ' ' MET . 0.6 OUTLIER -108.23 130.91 55.13 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.0 ttpt -146.02 151.74 38.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.508 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 26.9 m -67.22 146.96 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.91 -17.21 59.12 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.55 -1.204 . . . . 0.0 114.117 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -111.09 152.9 44.02 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.167 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 33.0 Cg_endo -64.15 147.47 91.37 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.342 2.695 . . . . 0.0 113.689 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.55 158.86 16.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 124.969 1.308 . . . . 0.0 108.455 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.51 118.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.66 107.66 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.1 -111.28 3.83 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.063 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.4 p -104.4 -4.14 23.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.148 0.579 . . . . 0.0 111.672 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 486' ' ' ASP . 65.1 m -125.92 141.89 51.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 120.945 0.403 . . . . 0.0 110.943 -175.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -118.05 154.48 31.97 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -160.56 -164.22 15.17 Favored Glycine 0 C--N 1.282 -2.427 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . 0.402 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 35.1 ttm180 -126.71 136.67 52.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 482' ' ' THR . 26.2 t -73.69 111.69 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.532 0.52 . . . . 0.0 110.612 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -83.36 -50.51 8.27 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.855 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.31 144.92 42.86 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.448 ' HE3' HD21 ' A' ' 444' ' ' LEU . 41.5 tpp -115.06 117.2 29.89 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.05 126.73 68.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 6.2 p30 -87.13 177.86 7.07 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.831 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.01 -30.62 36.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.1 m -76.16 -26.17 55.99 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.899 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.12 38.64 3.28 Favored Glycine 0 CA--C 1.475 -2.46 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.628 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 69.7 ttt180 -119.63 127.37 52.86 Favored 'General case' 0 N--CA 1.404 -2.748 0 CA-C-N 112.171 -2.015 . . . . 0.0 105.977 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -81.32 129.83 34.78 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.93 -178.72 2.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -111.45 -28.56 8.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.878 0.371 . . . . 0.0 111.368 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -150.67 168.22 25.0 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -147.45 134.33 20.18 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.57 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.85 176.6 53.34 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.2 156.22 66.55 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.028 1.819 . . . . 0.0 112.754 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.8 t 77.85 -0.34 2.72 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.15 1.38 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 33.6 ttm -98.93 133.66 22.1 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -84.92 126.0 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.374 2.05 . . . . 0.0 112.083 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.74 155.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.419 ' HG2' ' HG1' ' A' ' 436' ' ' THR . 37.4 mt-10 -107.3 118.96 38.09 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 45.4 pt -98.02 170.01 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.083 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 431' ' ' ARG . 3.0 p -146.3 156.57 43.45 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 109.26 22.17 6.95 Favored Glycine 0 N--CA 1.427 -1.964 0 O-C-N 124.081 0.863 . . . . 0.0 113.807 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.95 -38.31 16.77 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 60.09 21.97 11.2 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.279 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.7 t0 -139.33 179.96 6.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 5.9 p -90.19 114.69 61.87 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-O 121.304 0.573 . . . . 0.0 111.487 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.68 168.43 8.33 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -129.48 131.93 46.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.773 0.321 . . . . 0.0 111.36 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.46 134.91 46.92 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.97 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 91.01 -5.0 81.88 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.24 -179.09 7.13 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -109.82 141.35 42.61 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 8.7 p90 -128.84 153.3 47.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.86 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 44.0 ttp -122.5 117.0 24.9 Favored 'General case' 0 C--N 1.248 -3.821 0 C-N-CA 125.399 1.48 . . . . 0.0 110.582 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.43 -1.459 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.316 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.202 -1.398 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 504' ' ' ARG . 7.2 tppt? -57.65 -34.46 69.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.369 0.668 . . . . 0.0 111.135 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 506' ' ' ILE . 13.1 mmmm -60.89 -51.59 68.64 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.683 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.31 99.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.9 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 501' ' ' LYS . 21.9 tpp180 -50.2 -54.22 22.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.456 1.502 . . . . 0.0 109.239 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.62 -39.86 89.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.901 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 502' ' ' LYS . 50.9 mm -75.68 -53.9 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.598 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.013 0 C-N-CA 118.931 -1.604 . . . . 0.0 115.794 -176.605 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.8 m . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -138.08 176.31 20.8 Favored Glycine 0 C--N 1.293 -1.856 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.722 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 19.2 m -120.82 141.99 50.03 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.6 138.57 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.41 -39.02 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.62 148.86 26.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.79 131.4 12.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.5 178.46 1.96 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.95 149.23 29.46 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.234 0.54 . . . . 0.0 110.151 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -126.7 122.56 35.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.571 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.4 -17.09 52.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -178.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.26 -42.88 1.13 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -84.51 -31.63 24.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.68 -158.08 14.56 Favored Glycine 0 C--N 1.314 -0.639 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.56 116.25 4.14 Favored 'Trans proline' 0 C--O 1.244 0.8 0 CA-C-N 120.047 1.924 . . . . 0.0 108.949 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.44 150.94 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.943 0.878 . . . . 0.0 112.386 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -141.56 111.52 6.71 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.519 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -88.22 122.86 32.25 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.55 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -139.21 173.2 11.8 Favored 'General case' 0 C--N 1.272 -2.77 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.425 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -117.24 106.01 12.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -73.48 119.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 112.143 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 77.6 mt-30 -124.28 -15.03 6.84 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.865 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.24 -15.57 60.0 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.189 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 166.98 -100.93 0.17 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.3 m -144.93 144.15 30.92 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.464 ' CD1' HD12 ' A' ' 437' ' ' LEU . 0.5 OUTLIER -108.65 129.75 55.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 448' ' ' ASP . 18.0 ttpt -138.81 148.39 43.71 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.417 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.8 m -70.76 141.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.21 0.529 . . . . 0.0 111.058 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.14 83.8 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.601 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.427 ' HB2' ' HE2' ' A' ' 445' ' ' LYS . 1.2 t70 -94.9 130.71 32.11 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.57 123.22 10.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.284 1.989 . . . . 0.0 109.755 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.45 162.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 122.639 0.376 . . . . 0.0 110.498 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.35 122.56 56.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.25 125.33 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.14 97.29 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.999 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 2.3 m 65.07 9.51 5.56 Favored 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 124.905 1.282 . . . . 0.0 112.758 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 59.7 m -113.23 137.48 51.42 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -111.55 150.87 29.39 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -157.15 -164.11 13.26 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -134.06 129.53 36.18 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 482' ' ' THR . 47.5 t -62.16 114.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.432 0.458 . . . . 0.0 111.58 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -81.3 -55.19 4.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.259 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.51 152.64 51.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.456 ' HE2' HD21 ' A' ' 444' ' ' LEU . 51.1 tpp -115.01 117.57 30.98 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.74 136.52 53.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.38 -179.22 4.15 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.463 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.08 -29.57 60.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.8 m -74.86 -25.29 58.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.028 0.442 . . . . 0.0 110.378 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.75 30.02 6.3 Favored Glycine 0 CA--C 1.5 -0.899 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.588 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -115.77 144.45 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -76.58 129.79 36.94 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 124.239 0.962 . . . . 0.0 110.329 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.8 m -135.87 -178.25 2.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -115.72 -23.74 8.55 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.08 143.77 19.48 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -173.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.48 146.82 32.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.78 177.35 40.21 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.678 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.41 ' HA ' HG11 ' A' ' 439' ' ' VAL . 54.7 Cg_endo -65.07 161.26 37.81 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 123.167 2.578 . . . . 0.0 113.666 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 20.4 t 67.74 16.77 9.78 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 125.124 1.37 . . . . 0.0 111.076 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 23.8 ttt -120.16 133.92 24.0 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -72.73 125.88 10.92 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.559 2.172 . . . . 0.0 112.129 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 8.3 m -141.81 159.38 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.64 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -122.35 115.81 22.94 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.8 172.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.655 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.6 p -149.08 167.16 26.61 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.23 33.37 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.779 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.36 -33.37 25.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 70.6 t60 64.93 21.31 12.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.859 1.663 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -145.91 179.6 7.35 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.7 t -121.67 109.65 34.18 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 118.389 0.541 . . . . 0.0 109.544 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.0 175.57 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.894 2.396 . . . . 0.0 110.952 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -118.59 148.32 42.8 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.25 0.547 . . . . 0.0 112.052 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.95 141.93 54.83 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.829 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.38 0.03 89.88 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.091 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -92.56 -179.21 5.12 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.34 145.2 43.39 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.308 0.575 . . . . 0.0 110.653 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -132.14 159.15 39.78 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.6 ttt -132.15 118.03 19.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.235 0.54 . . . . 0.0 109.814 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 C--N 1.3 -1.557 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.118 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.305 0.574 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -62.49 -51.36 67.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . 0.552 ' HZ2' ' HB2' ' A' ' 502' ' ' LYS . 10.3 mtmp? -64.2 -40.74 96.72 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.519 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.21 40.41 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 123.379 0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.01 -39.75 86.89 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.68 -46.74 71.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.786 0.327 . . . . 0.0 111.558 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.85 -32.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.292 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.35 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -177.847 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 16.4 m . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.49 169.22 25.57 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.3 m -119.06 141.93 48.3 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.59 137.13 22.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.1 pt -89.53 -39.83 12.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.844 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.39 148.52 18.23 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.3 144.2 33.15 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -170.07 176.02 4.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.9 pt? -84.46 142.06 30.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.55 120.45 37.53 Favored 'General case' 0 C--N 1.255 -3.51 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.43 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.59 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.35 -17.08 6.74 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.26 -40.85 0.85 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.355 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -88.4 -16.05 33.91 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 90.86 -158.92 26.34 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -59.79 116.45 3.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 121.894 1.729 . . . . 0.0 110.363 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 482' ' ' THR . 33.3 m -122.54 163.86 20.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -147.76 112.2 5.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.323 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.87 117.28 24.63 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.678 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.8 pp -132.92 173.14 11.71 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -173.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -119.48 105.72 11.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.56 121.57 27.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.636 0.731 . . . . 0.0 112.189 -175.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 37.8 mt-30 -124.04 -14.26 7.13 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.401 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.47 61.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.187 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 152.04 -104.71 0.27 Allowed Glycine 0 N--CA 1.411 -2.981 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.823 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 6.8 m -130.82 136.5 48.74 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.489 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -111.39 124.06 51.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.5 ' HB3' ' HZ2' ' A' ' 445' ' ' LYS . 2.4 ttpm? -134.07 157.24 46.64 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.492 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.7 m -67.64 126.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.24 0.543 . . . . 0.0 109.987 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 110.91 -11.1 29.63 Favored Glycine 0 C--N 1.306 -1.137 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 445' ' ' LYS . 1.0 OUTLIER -71.0 131.2 87.45 Favored Pre-proline 0 C--O 1.247 0.938 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -79.44 112.38 2.97 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 122.239 1.959 . . . . 0.0 108.935 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.24 149.28 14.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.216 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 40.5 t -122.85 115.03 44.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.525 HG11 ' CB ' ' A' ' 494' ' ' PHE . 30.0 m -120.31 116.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.11 0.481 . . . . 0.0 109.723 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.94 -96.62 0.16 Allowed Glycine 0 C--N 1.307 -1.068 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.345 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 30.9 p -118.26 -7.21 10.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 122.734 0.413 . . . . 0.0 111.205 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.493 HG22 ' CB ' ' A' ' 486' ' ' ASP . 21.1 m -113.67 145.84 40.71 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.201 -0.312 . . . . 0.0 110.899 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -120.72 156.25 32.19 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.22 -168.51 27.49 Favored Glycine 0 C--N 1.295 -1.733 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.305 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -127.66 132.6 49.68 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 444' ' ' LEU . 51.1 t -65.75 121.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.586 0.554 . . . . 0.0 110.735 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -91.4 -52.26 4.88 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.672 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.15 150.37 50.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.489 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.1 tpp -115.1 117.11 29.64 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 9.4 t -120.35 141.42 40.72 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.63 175.06 5.6 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.193 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.71 -25.86 55.47 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.075 0.95 . . . . 0.0 113.087 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.3 t -78.19 -10.66 59.74 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.222 0.534 . . . . 0.0 110.097 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.99 8.16 61.94 Favored Glycine 0 CA--C 1.491 -1.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.83 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -96.79 129.69 44.17 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.558 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.0 tmm_? -86.65 129.99 34.66 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 19.3 m -135.12 -174.21 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.236 0.614 . . . . 0.0 109.907 -174.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -98.04 -36.12 10.21 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 122.96 0.504 . . . . 0.0 111.404 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -156.0 151.74 27.29 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.535 -172.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -142.91 150.23 39.5 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 123.924 0.765 . . . . 0.0 109.549 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.11 179.53 39.46 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.352 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.83 161.42 46.13 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 123.052 2.501 . . . . 0.0 113.888 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.2 m 68.83 18.63 8.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.834 1.254 . . . . 0.0 111.116 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.4 ttt -122.23 133.98 24.6 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.561 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 46.5 Cg_endo -77.55 125.9 7.9 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 122.293 1.995 . . . . 0.0 112.577 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.11 157.83 22.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.19 117.51 29.77 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -97.68 168.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.859 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 434' ' ' VAL . 6.0 p -146.74 165.66 28.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.574 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.45 20.53 22.24 Favored Glycine 0 C--N 1.296 -1.684 0 O-C-N 123.929 0.768 . . . . 0.0 112.576 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 41.6 tp -85.34 -39.35 17.75 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 64.41 21.44 12.48 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.776 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.493 ' CB ' HG22 ' A' ' 455' ' ' THR . 15.0 t70 -138.92 179.24 6.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 38.0 t -111.47 107.08 57.04 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 118.214 0.461 . . . . 0.0 111.175 -173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -85.84 174.7 6.36 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.556 2.171 . . . . 0.0 111.61 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.71 145.53 50.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.922 0.392 . . . . 0.0 110.701 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -66.69 128.62 36.95 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.571 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.28 60.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.123 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.48 179.18 6.06 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.333 0.587 . . . . 0.0 110.591 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 0.4 OUTLIER -114.73 129.2 56.65 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.678 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 45.8 p90 -131.87 158.95 40.0 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.671 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.0 ttt -131.44 134.45 46.22 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.311 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.655 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--O 1.218 -0.589 0 CA-C-O 120.573 0.225 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.3 -43.66 73.34 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -61.22 -46.22 91.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.93 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.8 92.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.727 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -63.74 -34.72 78.51 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.781 0.832 . . . . 0.0 111.24 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.7 -38.77 91.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.75 -42.95 77.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.503 179.329 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.4 m . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -124.22 169.75 16.33 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.8 m -115.99 139.54 50.16 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.24 133.91 28.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 12.6 pt -91.94 -39.8 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.884 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.87 153.76 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.42 29.95 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -165.63 176.34 8.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.478 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.6 pt? -94.83 148.23 22.51 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.44 121.94 32.16 Favored 'General case' 0 N--CA 1.391 -3.412 0 C-N-CA 116.929 -1.908 . . . . 0.0 109.697 167.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.9 -22.58 62.57 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.026 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.8 -51.99 0.82 Allowed Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.702 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.68 -26.56 57.74 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 122.935 0.494 . . . . 0.0 111.379 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 107.79 -163.74 12.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -69.21 115.56 4.07 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 121.914 1.743 . . . . 0.0 108.215 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.435 ' HB ' ' CG ' ' A' ' 480' ' ' GLU . 28.3 m -124.46 162.79 25.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -154.39 114.82 3.92 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.603 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 119.64 25.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.54 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.0 OUTLIER -136.24 173.48 11.66 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 476' ' ' SER . 1.2 tm? -122.61 107.98 12.59 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 475' ' ' PRO . 6.4 p -73.98 119.85 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 111.751 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 40.5 mt-30 -123.59 -15.81 6.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.794 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.434 ' HB3' HG13 ' A' ' 496' ' ' VAL . . . -92.23 2.17 56.77 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 158.87 -125.67 1.55 Allowed Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.185 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.3 m -129.83 134.19 47.39 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.491 HD22 ' HE2' ' A' ' 462' ' ' MET . 0.6 OUTLIER -104.6 133.2 49.86 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.557 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 2.1 ttpm? -148.29 159.66 43.76 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.557 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -68.06 136.27 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.159 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.59 -2.83 60.8 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.403 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.76 132.77 30.51 Favored Pre-proline 0 C--O 1.25 1.115 0 CA-C-N 117.317 0.559 . . . . 0.0 110.003 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.35 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.08 1.853 . . . . 0.0 111.762 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.92 172.65 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.25 124.29 18.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.178 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.4 111.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.32 11.13 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.1 m -99.15 -4.45 32.15 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.32 0.581 . . . . 0.0 110.3 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 48.9 m -102.86 136.32 42.9 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.602 -0.686 . . . . 0.0 112.053 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.75 161.88 16.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -177.3 -169.33 38.31 Favored Glycine 0 CA--C 1.475 -2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . 0.479 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 55.2 ttp180 -130.6 137.71 49.77 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.99 116.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.04 0.448 . . . . 0.0 111.824 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -79.43 -60.07 2.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -143.49 160.25 40.93 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.491 ' HE2' HD22 ' A' ' 444' ' ' LEU . 35.6 tpp -121.48 134.65 55.07 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 480' ' ' GLU . 6.1 t -117.24 142.09 32.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -103.62 179.73 4.19 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.178 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.42 -29.25 48.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.612 1.165 . . . . 0.0 112.94 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 -6.85 58.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.0 4.13 63.38 Favored Glycine 0 N--CA 1.466 0.654 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.255 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -93.09 156.93 16.56 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.4 ' NH1' HG22 ' A' ' 463' ' ' VAL . 20.2 tpp180 -75.41 132.88 41.17 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.824 0.85 . . . . 0.0 110.97 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.3 175.59 5.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.76 -28.89 3.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.719 0.295 . . . . 0.0 111.673 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.465 ' HG2' ' HG3' ' A' ' 445' ' ' LYS . 30.7 mt-10 -123.6 141.17 52.27 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.44 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . 0.424 ' CB ' HG13 ' A' ' 479' ' ' VAL . . . -139.29 126.01 20.73 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.54 161.36 40.61 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' A' ' 439' ' ' VAL . 19.3 Cg_endo -59.67 150.75 74.72 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.931 2.421 . . . . 0.0 113.031 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 438' ' ' LEU . 22.2 m 75.77 4.45 3.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.351 1.46 . . . . 0.0 112.268 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 47.0 ttp -103.86 136.11 19.25 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 122.275 -0.266 . . . . 0.0 110.953 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.77 126.2 8.67 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.423 2.082 . . . . 0.0 111.326 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 473' ' ' ALA . 12.7 m -142.06 159.02 20.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 463' ' ' VAL . 37.7 tt0 -117.56 124.94 49.91 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.45 172.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.725 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.9 p -151.22 161.99 41.7 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 112.73 8.11 21.13 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.941 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 58.2 mt -89.95 -40.33 12.43 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.478 -0.425 . . . . 0.0 110.166 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 58.17 21.29 7.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 111.07 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 488' ' ' PRO . 5.4 t70 -126.74 -178.89 4.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.27 110.09 46.37 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 4.6 Cg_endo -84.24 156.42 12.84 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.178 1.919 . . . . 0.0 109.988 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -121.29 134.8 55.17 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -69.17 124.5 23.98 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.141 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.04 -0.37 56.19 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.62 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.01 178.51 8.12 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.859 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -110.44 130.07 55.63 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 32.5 p90 -125.86 154.86 42.08 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.123 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 59.6 ttp -119.28 127.13 52.94 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 441' ' ' ALA . 10.6 p . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.4 -44.76 70.78 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.501 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 506' ' ' ILE . 60.4 mttp -79.96 -30.57 39.83 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.141 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.7 88.98 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -59.36 -41.88 90.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.488 0.661 . . . . 0.0 109.983 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -68.8 -29.86 68.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.6 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 502' ' ' LYS . 85.1 mt -83.5 -52.16 13.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.895 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 C-N-CA 119.411 -1.376 . . . . 0.0 113.552 -173.566 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.497 -1.096 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -140.16 -175.16 14.23 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.055 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.7 p -125.57 145.13 50.26 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 124.156 0.983 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 37.7 t -87.73 134.01 28.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.76 -39.69 12.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.506 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 490' ' ' ALA . 8.5 pt-20 -158.31 149.43 20.84 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.35 149.13 34.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.491 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -172.65 177.1 3.02 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -95.26 146.72 24.15 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -123.38 120.57 33.41 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.551 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -55.84 -18.77 9.5 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -107.62 -42.57 1.44 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.403 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -81.2 -34.25 32.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.728 0.299 . . . . 0.0 111.489 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.09 -145.85 17.98 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.32 115.99 4.24 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 121.86 1.706 . . . . 0.0 108.648 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.491 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 18.1 m -116.09 153.53 17.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.259 0.552 . . . . 0.0 111.134 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -144.91 112.74 6.32 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.482 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.62 114.91 22.98 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.9 pp -132.95 173.27 11.58 Favored 'General case' 0 C--N 1.266 -3.022 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.007 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.92 106.78 14.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -65.94 114.85 3.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.421 1.105 . . . . 0.0 111.943 -176.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.63 -14.33 7.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.08 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -85.24 0.29 52.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.829 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 140.85 -115.27 1.02 Allowed Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 144.53 49.35 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.498 ' CD1' HD12 ' A' ' 437' ' ' LEU . 0.9 OUTLIER -125.82 120.23 29.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.563 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.2 ttpm? -138.38 161.71 36.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.563 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.6 m -66.09 130.67 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.557 0.694 . . . . 0.0 111.443 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.12 50.98 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.851 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 67.5 m-20 -88.32 147.17 39.5 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.959 0.379 . . . . 0.0 110.788 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -81.74 131.86 7.38 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.391 2.061 . . . . 0.0 110.731 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.79 140.46 48.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.478 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.84 111.62 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.41 138.22 26.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.74 26.09 74.73 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.33 -0.938 . . . . 0.0 110.875 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 65.0 p 63.68 7.05 2.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.166 1.786 . . . . 0.0 113.036 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.433 HG22 ' CB ' ' A' ' 486' ' ' ASP . 88.2 m -107.34 146.36 31.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -122.68 151.86 41.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.633 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -154.09 -164.3 12.66 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . 0.524 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 47.7 ttp180 -131.49 137.15 48.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.153 0.477 . . . . 0.0 110.005 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 482' ' ' THR . 28.3 t -67.9 123.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 122.688 0.395 . . . . 0.0 111.314 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . 0.404 ' HD3' ' C ' ' A' ' 460' ' ' ARG . 1.2 tmt_? -98.81 -51.04 4.01 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.767 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.81 153.86 51.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.444 ' HE3' HD22 ' A' ' 444' ' ' LEU . 42.1 tpp -122.5 121.47 36.64 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.85 148.6 32.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 468' ' ' ARG . 5.9 p30 -109.27 179.46 4.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.736 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -58.97 -32.19 69.42 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.7 t -78.61 -9.12 59.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.311 0.577 . . . . 0.0 110.401 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.41 63.04 Favored Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.787 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.433 ' HB2' HD22 ' A' ' 464' ' ' ASN . 11.2 mpt_? -73.38 116.86 14.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 4.0 tmm_? -81.09 133.48 35.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.0 m -136.11 -173.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 123.844 0.858 . . . . 0.0 108.791 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -117.39 -20.46 9.1 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.147 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.37 147.35 33.3 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.68 139.14 26.34 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.208 0.603 . . . . 0.0 110.169 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -97.92 167.1 22.75 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.463 ' HA ' HG11 ' A' ' 439' ' ' VAL . 18.9 Cg_endo -58.63 150.66 68.26 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.09 2.527 . . . . 0.0 112.878 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 32.6 m 75.32 17.83 2.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.431 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.5 ttt -117.16 136.36 23.36 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.12 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 3.6 Cg_exo -80.55 126.77 6.17 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.201 1.934 . . . . 0.0 110.933 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.36 149.87 19.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.005 0.431 . . . . 0.0 110.865 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.4 tt0 -108.67 112.56 24.95 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 434' ' ' VAL . 48.6 pt -99.84 172.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.576 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 5.5 p -145.33 157.55 44.02 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 113.23 4.44 23.83 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.16 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 51.2 tp -73.3 -37.58 66.16 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.483 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 64.62 24.14 12.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.278 1.431 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' A' ' 455' ' ' THR . 37.5 t70 -144.93 171.62 14.19 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.85 109.23 47.64 Favored Pre-proline 0 C--N 1.291 -1.956 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.44 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.02 174.52 4.56 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.595 2.197 . . . . 0.0 111.783 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -129.94 150.78 51.08 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.116 0.484 . . . . 0.0 111.327 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 424' ' ' GLU . . . -63.74 130.03 42.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.346 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.28 58.83 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.749 -1.215 . . . . 0.0 111.588 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 493' ' ' ARG . 7.3 t70 -86.29 -166.63 1.6 Allowed 'General case' 0 C--O 1.248 0.974 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.465 ' H ' ' CG ' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -131.24 136.89 48.61 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.295 -169.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 38.4 p90 -136.74 158.53 44.23 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.824 0.821 . . . . 0.0 111.758 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.2 ttp -134.05 119.53 19.08 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.862 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 83.1 t . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.21 -1.008 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -70.19 -47.0 63.45 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -61.33 -37.71 84.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.207 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.58 64.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.901 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -55.44 -40.29 71.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 123.891 0.876 . . . . 0.0 112.274 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.01 -31.8 69.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.967 0.792 . . . . 0.0 111.147 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.63 -9.0 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.451 0.7 . . . . 0.0 110.219 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.342 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.315 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 9.7 m . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 120.511 0.196 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -151.43 -174.68 22.48 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 18.8 m -127.89 143.87 51.1 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 117.049 0.424 . . . . 0.0 110.558 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.64 136.38 22.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.0 pt -89.77 -43.21 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.687 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.01 155.75 37.51 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.093 0.473 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -134.2 129.83 36.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.497 ' HG2' ' N ' ' A' ' 427' ' ' LEU . 0.3 OUTLIER -134.8 159.53 41.06 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -170.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.497 ' N ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -94.68 139.64 30.95 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.472 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 9.9 t70 -127.66 117.62 22.31 Favored 'General case' 0 C--N 1.261 -3.25 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.465 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.69 -26.15 65.34 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.24 -37.95 1.73 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.9 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.472 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.1 mtp180 -86.51 -24.37 25.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.14 -166.91 19.09 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -58.11 116.11 3.01 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.529 2.153 . . . . 0.0 111.049 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 20.1 m -114.94 136.62 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.341 0.591 . . . . 0.0 110.508 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -126.75 124.66 40.24 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.381 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 479' ' ' VAL . 2.0 m -98.7 118.78 36.2 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 170.14 15.31 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.44 105.29 11.53 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 475' ' ' PRO . 3.3 p -71.14 118.6 16.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.708 0.766 . . . . 0.0 112.197 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 47.0 mt-30 -123.3 -16.22 6.96 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.468 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.4 31.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.957 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 145.81 -89.89 0.16 Allowed Glycine 0 C--O 1.212 -1.244 0 C-N-CA 119.019 -1.562 . . . . 0.0 113.219 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 56.3 m -146.64 146.89 30.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.451 HD22 ' HE1' ' A' ' 462' ' ' MET . 2.2 tt -128.23 115.58 18.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 0.0 OUTLIER -135.81 158.9 43.26 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 120.708 0.29 . . . . 0.0 110.847 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.7 m -61.81 133.71 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.89 0.376 . . . . 0.0 110.119 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.82 4.04 56.95 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.259 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.36 127.91 59.29 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.997 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 5.5 Cg_exo -77.18 106.65 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.814 1.676 . . . . 0.0 108.073 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -104.9 140.84 21.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.035 -172.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.34 119.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 494' ' ' PHE . 8.5 m -125.27 133.94 68.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . 0.438 ' HA2' ' NH1' ' A' ' 493' ' ' ARG . . . 57.97 -100.17 0.14 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.515 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 7.0 p -131.54 10.86 4.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.639 0.776 . . . . 0.0 110.895 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.504 HG22 ' CB ' ' A' ' 486' ' ' ASP . 89.3 m -119.7 144.8 47.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.777 0.322 . . . . 0.0 110.282 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -120.5 150.85 40.18 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -150.36 -170.68 17.86 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -134.82 127.89 31.68 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.73 118.23 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.15 -52.82 3.87 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.1 35.86 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.451 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -133.18 117.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.78 131.43 72.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.88 177.74 5.8 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.369 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.73 -30.55 33.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.37 1.068 . . . . 0.0 113.148 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.2 t -76.95 -16.14 59.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.078 0.466 . . . . 0.0 110.483 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.64 15.09 47.8 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.23 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -99.87 133.82 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.541 -0.33 . . . . 0.0 110.184 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.4 tpt85 -73.16 126.06 29.16 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.181 0.926 . . . . 0.0 108.981 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 462' ' ' MET . 30.6 m -135.66 -177.2 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 471' ' ' LYS . 0.0 OUTLIER -120.9 -12.71 8.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.947 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.68 152.18 33.58 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.04 145.96 31.68 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 123.719 0.637 . . . . 0.0 109.866 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -94.84 173.91 32.48 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.426 ' HA ' HG13 ' A' ' 439' ' ' VAL . 58.5 Cg_endo -69.57 156.66 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.637 2.224 . . . . 0.0 113.378 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.1 t 72.08 16.51 5.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.022 1.329 . . . . 0.0 110.892 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 34.8 ttp -119.76 129.53 25.31 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.638 -0.664 . . . . 0.0 112.069 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.77 125.93 12.71 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.777 2.318 . . . . 0.0 112.345 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 436' ' ' THR . 6.0 m -140.41 151.74 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.163 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 40.8 tt0 -112.42 112.78 24.58 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . 0.416 ' C ' ' HG1' ' A' ' 482' ' ' THR . 48.3 pt -98.23 170.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.699 -177.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.416 ' HG1' ' C ' ' A' ' 481' ' ' ILE . 0.2 OUTLIER -150.72 150.1 30.63 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 109.72 31.94 3.04 Favored Glycine 0 C--N 1.304 -1.25 0 O-C-N 123.742 0.651 . . . . 0.0 113.295 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 54.9 tp -82.94 -35.84 25.68 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.0 t60 65.4 27.72 11.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.185 1.394 . . . . 0.0 109.404 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.504 ' CB ' HG22 ' A' ' 455' ' ' THR . 8.3 t0 -148.01 -179.95 7.29 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.91 108.97 44.06 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.77 158.1 56.59 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.902 1.735 . . . . 0.0 110.733 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -126.48 131.35 51.66 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.391 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -72.48 135.66 45.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.295 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.44 89.35 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.664 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.45 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 1.6 t70 -84.7 -172.69 4.31 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.45 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -129.16 150.92 50.34 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.742 -173.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.458 ' CB ' HG11 ' A' ' 452' ' ' VAL . 40.7 p90 -140.28 168.68 19.25 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 52.3 ttp -134.02 115.98 14.97 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 494' ' ' PHE . 61.7 t . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.48 -38.97 68.06 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.486 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -70.88 -26.64 63.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.855 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.67 50.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.39 -45.76 55.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.579 1.552 . . . . 0.0 110.32 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.62 -36.21 75.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.2 -10.96 11.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.432 0.634 . . . . 0.0 109.838 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.417 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.893 -178.643 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -117.74 178.59 17.01 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.6 m -122.02 139.09 54.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 52.1 t -82.51 135.07 25.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 11.3 pt -93.73 -37.05 7.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.905 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 490' ' ' ALA . 12.6 pt-20 -156.7 148.14 22.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.46 136.76 17.6 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 176.43 8.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.44 145.92 24.23 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.69 122.81 33.91 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.542 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.13 -13.4 58.01 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -109.67 -46.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.401 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.49 -40.59 42.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 109.605 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 121.7 -176.45 16.38 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.45 116.13 3.07 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.141 1.894 . . . . 0.0 109.445 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.406 HG11 ' CG2' ' A' ' 482' ' ' THR . 29.1 m -121.94 146.56 26.88 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.391 0.615 . . . . 0.0 112.229 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -137.53 119.14 14.95 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.3 m -88.22 125.06 34.44 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.91 168.05 20.67 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.399 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.83 105.9 12.43 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 475' ' ' PRO . 4.3 p -70.84 121.21 20.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.836 0.827 . . . . 0.0 111.529 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -121.84 -20.5 6.38 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.63 -11.41 59.12 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 165.13 -111.38 0.46 Allowed Glycine 0 N--CA 1.416 -2.663 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.86 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 24.7 m -137.16 133.75 35.59 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.449 HD21 ' HE1' ' A' ' 462' ' ' MET . 0.7 OUTLIER -101.28 115.79 31.32 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.0 OUTLIER -129.04 150.99 50.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.446 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.4 m -71.0 141.32 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.257 0.551 . . . . 0.0 111.297 177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.38 8.6 70.91 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.792 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -101.07 128.17 30.15 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 6.8 Cg_exo -72.38 120.81 6.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 18.9 pt -114.36 160.63 13.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.404 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.44 127.25 59.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.466 HG11 ' CB ' ' A' ' 494' ' ' PHE . 3.0 m -127.22 128.19 70.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 55.47 -97.09 0.04 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 121.597 -0.335 . . . . 0.0 113.595 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 8.9 t -127.84 11.33 6.63 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.072 0.463 . . . . 0.0 110.623 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.464 HG22 ' CB ' ' A' ' 486' ' ' ASP . 91.2 m -124.21 150.12 45.61 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -127.92 162.1 27.53 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -173.91 -165.09 30.06 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -135.61 134.77 39.66 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 482' ' ' THR . 31.0 t -70.2 122.58 22.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 123.369 0.418 . . . . 0.0 110.352 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -93.09 -56.74 2.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.651 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.45 146.62 50.02 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.449 ' HE1' HD21 ' A' ' 444' ' ' LEU . 42.5 tpp -121.8 117.47 26.62 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.17 136.74 49.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.87 174.18 5.99 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.046 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.53 -29.82 38.55 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.602 1.161 . . . . 0.0 113.491 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 68.7 m -77.17 -11.81 59.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.821 -0.55 . . . . 0.0 111.33 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.77 -11.56 59.25 Favored Glycine 0 CA--C 1.494 -1.273 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.785 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -77.7 137.09 38.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.006 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.16 127.48 34.29 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.39 174.52 10.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.558 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -102.74 -35.24 8.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 151.25 37.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.483 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -139.17 145.22 39.09 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.43 174.14 37.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.994 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 439' ' ' VAL . 36.2 Cg_endo -64.51 158.6 48.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 38.6 m 68.67 17.0 8.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.521 0.728 . . . . 0.0 112.39 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.5 ttp -122.6 127.14 25.91 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.156 -0.34 . . . . 0.0 110.927 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.79 126.38 13.88 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 121.99 1.793 . . . . 0.0 111.72 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 473' ' ' ALA . 17.6 m -139.12 167.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.514 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 34.4 tt0 -125.33 118.3 25.64 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -98.52 173.02 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.472 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.1 p -152.77 155.04 36.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.399 1.08 . . . . 0.0 108.352 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.18 8.15 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 172.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.21 -31.14 38.69 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 63.51 21.36 12.71 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.823 1.249 . . . . 0.0 109.263 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.464 ' CB ' HG22 ' A' ' 455' ' ' THR . 5.4 t70 -140.79 -179.77 6.24 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.67 107.63 58.7 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-O 121.538 0.685 . . . . 0.0 111.779 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.45 167.92 14.98 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.019 1.812 . . . . 0.0 110.059 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 492' ' ' ASP . 21.9 mt-30 -134.8 154.2 51.71 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.109 -0.369 . . . . 0.0 110.356 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 424' ' ' GLU . . . -70.97 133.42 46.36 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.2 -11.39 63.73 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.116 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 489' ' ' GLN . 4.3 m-20 -79.5 164.61 23.78 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.779 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 5.9 mpt_? -113.11 128.75 56.58 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.466 ' CB ' HG11 ' A' ' 452' ' ' VAL . 53.9 p90 -118.94 155.73 30.81 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.3 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 51.6 ttm -121.03 116.29 24.77 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.172 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.313 -0.995 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 172.256 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.197 -1.682 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 0.1 OUTLIER -63.86 -54.11 40.07 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.633 0.652 . . . . 0.0 110.899 -174.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . 0.485 ' O ' HG12 ' A' ' 506' ' ' ILE . 10.8 ptpp? -65.28 -35.35 80.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.074 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.55 77.64 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.848 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -55.61 -50.17 70.85 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.127 1.371 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 12.0 mm100 -70.08 -26.31 63.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.926 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 502' ' ' LYS . 44.6 mm -74.06 -41.65 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.558 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.827 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.54 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 17.5 m . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.35 176.48 17.88 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.0 m -127.2 139.6 52.83 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 42.7 t -83.58 137.29 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -97.54 -37.55 6.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.232 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.35 166.07 33.0 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.39 128.59 17.72 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.485 ' HZ2' ' HB3' ' A' ' 426' ' ' LYS . 0.0 OUTLIER -146.54 146.85 30.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.67 144.71 26.51 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.299 0.571 . . . . 0.0 109.885 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.24 129.48 50.86 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.51 ' H ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -64.0 -19.98 65.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -111.61 -48.42 0.69 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.878 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -74.68 -26.94 60.18 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 123.594 0.758 . . . . 0.0 110.59 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 98.98 -158.91 20.14 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.25 116.46 3.51 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.567 2.178 . . . . 0.0 111.084 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 482' ' ' THR . 15.1 m -121.33 157.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -148.26 120.37 8.29 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 480' ' ' GLU . 3.4 m -82.74 123.67 29.53 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 478' ' ' PRO . 1.3 pp -133.03 173.3 11.57 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -119.44 110.99 17.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -75.5 122.58 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.763 0.792 . . . . 0.0 111.24 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 18.8 mt-30 -123.83 -14.45 7.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.095 -174.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -96.36 8.42 44.02 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.049 0.452 . . . . 0.0 110.133 -173.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.62 -126.55 2.92 Favored Glycine 0 N--CA 1.403 -3.513 0 C-N-CA 120.033 -1.08 . . . . 0.0 111.347 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.3 m -115.62 142.7 46.38 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.457 HD21 ' HE3' ' A' ' 462' ' ' MET . 0.4 OUTLIER -111.45 117.69 33.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.535 ' HB3' ' OD2' ' A' ' 448' ' ' ASP . 12.3 ttpt -122.86 148.36 45.51 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.02 123.88 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.413 0.625 . . . . 0.0 109.768 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 109.5 -8.51 32.52 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.125 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.535 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 42.7 m-20 -90.32 146.02 33.82 Favored Pre-proline 0 C--O 1.25 1.081 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.448 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.03 145.37 24.71 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.536 2.157 . . . . 0.0 111.391 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 13.8 pt -136.44 156.88 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.345 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.74 115.34 44.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.0 115.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.38 -102.56 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 12.6 t -127.9 8.23 6.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.476 HG23 ' CB ' ' A' ' 486' ' ' ASP . 26.6 m -115.76 145.02 43.16 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.618 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -127.95 158.77 36.93 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -173.05 -164.3 28.2 Favored Glycine 0 C--N 1.29 -2.015 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -125.48 134.68 51.97 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.444 HG23 ' CD2' ' A' ' 444' ' ' LEU . 41.6 t -72.15 123.47 26.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -95.79 -50.38 4.93 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.693 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.05 159.66 32.19 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.457 ' HE3' HD21 ' A' ' 444' ' ' LEU . 39.9 tpp -130.8 117.33 19.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.79 128.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' A' ' 468' ' ' ARG . 8.8 p30 -92.9 -175.71 3.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.227 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.94 -20.26 66.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 112.402 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 31.5 t -84.21 -20.31 32.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.71 40.62 5.26 Favored Glycine 0 CA--C 1.488 -1.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.706 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 464' ' ' ASN . 85.2 mtt180 -118.34 129.88 55.69 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 2.3 tmm_? -80.17 129.51 34.55 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.4 m -130.55 -179.23 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 120.583 0.23 . . . . 0.0 110.385 -176.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -98.97 -35.98 9.89 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.231 0.612 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -157.74 147.59 20.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.017 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -134.7 142.99 46.95 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.059 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.04 173.85 45.18 Favored Glycine 0 N--CA 1.442 -0.928 0 O-C-N 123.717 0.636 . . . . 0.0 112.304 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.423 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.9 Cg_endo -64.98 156.52 62.07 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.551 2.168 . . . . 0.0 113.23 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 28.3 m 72.54 10.85 5.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.439 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' MET . . . . . 0.452 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.1 ttt -111.08 138.26 21.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 4.5 Cg_exo -83.91 126.34 3.88 Favored 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.925 2.416 . . . . 0.0 112.001 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.7 151.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.171 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.7 mt-10 -96.82 129.19 44.29 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -100.87 170.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.467 ' CG2' HG11 ' A' ' 434' ' ' VAL . 1.7 p -151.07 158.86 44.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 124.237 1.015 . . . . 0.0 108.503 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.12 8.15 Favored Glycine 0 N--CA 1.422 -2.277 0 O-C-N 124.059 0.849 . . . . 0.0 114.428 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.57 -36.39 13.72 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.1 t60 64.62 20.95 12.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.357 1.463 . . . . 0.0 108.423 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.476 ' CB ' HG23 ' A' ' 455' ' ' THR . 30.9 t70 -135.9 173.52 11.62 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.12 103.6 36.06 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 118.094 0.406 . . . . 0.0 110.008 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.61 174.97 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.814 2.343 . . . . 0.0 111.124 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -111.17 145.56 38.43 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.308 0.575 . . . . 0.0 111.365 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -64.02 127.62 32.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.185 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.67 -3.48 56.15 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.609 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.18 178.11 8.44 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.751 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.61 140.73 48.91 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 124.105 0.962 . . . . 0.0 108.779 -175.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.05 155.18 49.68 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.998 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 49.7 ttp -122.02 120.34 34.09 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' A' ' 441' ' ' ALA . 7.0 p . . . . . 0 C--N 1.307 -1.26 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -68.88 -49.24 59.93 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -69.2 -40.6 77.92 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.572 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.92 88.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -73.71 -16.1 61.2 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.878 0.471 . . . . 0.0 111.033 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.6 -28.65 61.0 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 2.4 mp -86.93 -34.96 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.466 176.366 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' A' ' 441' ' ' ALA . 15.9 m . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.52 166.11 12.82 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.12 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.6 m -114.2 143.01 45.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.11 131.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.1 pt -88.75 -36.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.747 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -160.11 153.36 21.99 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.38 143.33 23.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -163.49 175.73 10.44 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.2 pt? -85.07 143.38 28.91 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -126.41 129.77 49.41 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.04 -24.68 67.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.743 -178.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -97.32 -47.63 2.16 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.723 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -91.4 -33.43 15.25 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.24 -134.56 12.23 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.83 115.96 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.679 1.74 . . . . 0.0 110.782 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.445 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 25.3 m -118.2 148.26 21.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -143.54 114.24 7.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.2 m -85.58 116.91 24.15 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.4 pp -132.89 171.54 13.79 Favored 'General case' 0 C--N 1.279 -2.476 0 O-C-N 122.205 -0.309 . . . . 0.0 111.795 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.51 106.37 11.73 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.83 123.89 36.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.241 0.544 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -124.72 -15.88 6.38 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 419' ' ' VAL . . . -77.84 -15.29 59.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.03 -0.987 . . . . 0.0 113.34 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 169.97 -102.26 0.18 Allowed Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.051 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 32.5 m -148.04 131.94 17.11 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.48 HD22 ' HE1' ' A' ' 462' ' ' MET . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.608 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.1 ttpt -148.3 153.23 38.39 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.608 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 28.2 m -71.24 134.7 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.25 0.547 . . . . 0.0 110.746 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.05 8.44 72.24 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.79 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.8 132.86 20.51 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 123.92 11.77 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.779 2.32 . . . . 0.0 111.495 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.73 151.7 26.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.452 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.95 123.12 70.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.424 HG11 ' CB ' ' A' ' 494' ' ' PHE . 4.1 m -128.0 135.13 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 54.89 -100.44 0.08 OUTLIER Glycine 0 CA--C 1.533 1.164 0 N-CA-C 114.221 0.448 . . . . 0.0 114.221 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 42.2 p -121.94 4.54 9.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 122.652 0.381 . . . . 0.0 111.239 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.521 HG22 ' CB ' ' A' ' 486' ' ' ASP . 44.3 m -125.36 145.62 49.96 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.835 0.35 . . . . 0.0 111.419 -173.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.0 144.38 48.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -149.74 -175.54 22.07 Favored Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -124.77 126.9 46.38 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 482' ' ' THR . 48.3 t -63.62 132.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.938 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -97.62 -59.42 1.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -122.6 167.79 12.97 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.48 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.8 tpp -143.23 117.14 9.36 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.74 132.03 72.03 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -98.71 -179.77 4.41 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.006 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.38 -30.15 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.065 0.946 . . . . 0.0 112.539 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 28.3 m -80.7 -13.18 59.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.188 -0.32 . . . . 0.0 111.445 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 95.95 7.96 58.31 Favored Glycine 0 CA--C 1.501 -0.795 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.206 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -91.72 138.94 31.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.567 -0.317 . . . . 0.0 110.336 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 462' ' ' MET . 9.2 tpt180 -74.22 131.33 41.12 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.39 174.49 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.9 -36.16 8.74 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.086 0.469 . . . . 0.0 110.02 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.83 151.98 49.75 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.851 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -137.81 137.48 38.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.022 0.529 . . . . 0.0 109.597 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 169.17 30.19 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.89 151.93 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 31.1 t 75.44 15.71 2.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.139 1.376 . . . . 0.0 110.637 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 44.1 ttm -113.71 135.11 21.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.062 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.7 Cg_exo -79.53 126.23 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.394 2.063 . . . . 0.0 110.427 173.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 10.2 m -141.71 146.67 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 123.068 0.547 . . . . 0.0 110.07 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.9 tt0 -105.67 118.63 37.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.8 172.0 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.82 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.1 p -148.49 166.07 29.31 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 87.51 22.81 42.16 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.158 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 50.3 tp -72.98 -28.64 62.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.139 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 64.23 20.01 12.01 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.279 1.031 . . . . 0.0 110.213 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.521 ' CB ' HG22 ' A' ' 455' ' ' THR . 33.2 t70 -149.03 179.39 7.91 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.47 114.9 65.8 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 118.415 0.552 . . . . 0.0 110.395 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.21 157.63 23.08 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.05 1.833 . . . . 0.0 111.091 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -124.6 137.91 54.35 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-O 121.529 0.681 . . . . 0.0 110.59 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.32 139.83 50.05 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.944 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.81 89.46 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . 0.463 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 2.5 t70 -85.13 -170.87 3.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.463 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.3 OUTLIER -137.75 148.87 45.97 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.09 0.471 . . . . 0.0 109.903 -174.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.606 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.7 p90 -139.4 162.7 34.39 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.356 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.09 116.06 16.56 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.115 0.483 . . . . 0.0 109.87 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 172.8 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 121.689 0.757 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -63.1 -41.21 99.32 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.649 1.18 . . . . 0.0 109.553 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -75.45 -19.8 59.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.655 0.741 . . . . 0.0 110.496 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.54 -44.07 21.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 108.877 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -70.56 -19.74 62.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.538 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . 0.46 ' OE1' ' HD3' ' A' ' 445' ' ' LYS . 45.0 tp60 -64.17 -40.67 96.62 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.613 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 40.0 mm -76.23 -35.27 27.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 CA-C-N 115.078 -0.964 . . . . 0.0 113.325 175.914 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 441' ' ' ALA . 18.7 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.2 162.75 12.31 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.24 140.22 41.8 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.13 139.61 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.26 -39.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.27 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.22 158.45 44.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.62 135.32 14.45 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 177.52 8.36 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 123.582 0.551 . . . . 0.0 109.84 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.8 149.0 22.16 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.094 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.04 127.95 45.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -32.97 74.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.21 -39.27 2.3 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.641 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -87.85 -20.2 26.37 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.697 0.284 . . . . 0.0 111.717 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.24 -166.48 23.22 Favored Glycine 0 C--O 1.222 -0.633 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.84 117.01 3.66 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.589 2.193 . . . . 0.0 111.063 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.57 153.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.467 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -147.88 123.95 10.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.926 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 5.9 m -96.32 126.39 41.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.408 HD23 ' CD1' ' A' ' 444' ' ' LEU . 0.0 OUTLIER -134.97 173.43 11.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 121.04 0.448 . . . . 0.0 111.208 -177.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.7 tm? -116.52 107.58 14.93 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -74.69 119.58 22.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.274 0.559 . . . . 0.0 112.063 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -124.39 -16.65 6.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 419' ' ' VAL . . . -69.21 -28.0 65.98 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.673 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 175.01 -96.07 0.1 Allowed Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.103 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 40.2 m -149.2 143.92 26.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.46 ' CD2' HG21 ' A' ' 459' ' ' VAL . 0.5 OUTLIER -109.79 136.24 49.43 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.631 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 25.7 ttpt -147.23 150.57 35.13 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.631 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 34.1 m -69.69 131.04 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.167 0.508 . . . . 0.0 110.042 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.48 -10.46 61.18 Favored Glycine 0 N--CA 1.417 -2.586 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.415 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 445' ' ' LYS . 17.2 m-20 -89.19 146.2 35.77 Favored Pre-proline 0 C--O 1.252 1.191 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.085 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.36 148.27 33.72 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.33 2.02 . . . . 0.0 111.702 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.27 153.45 37.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.682 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.07 107.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.88 162.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . -39.85 108.7 0.1 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.263 0.483 . . . . 0.0 113.191 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.3 m 70.78 -25.34 0.16 Allowed 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 126.523 1.929 . . . . 0.0 115.198 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.403 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.1 m -119.6 132.82 55.8 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 120.955 -1.091 . . . . 0.0 112.295 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -111.46 165.44 11.98 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -169.8 -164.04 24.85 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -137.89 135.84 36.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 444' ' ' LEU . 38.6 t -69.99 118.48 14.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 120.905 0.383 . . . . 0.0 111.548 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -88.29 -54.86 3.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.149 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -133.19 146.37 51.45 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.444 ' HE3' HD21 ' A' ' 444' ' ' LEU . 49.6 tpp -115.54 116.69 28.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.24 132.13 60.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -103.7 178.22 4.62 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.945 -174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.27 -29.83 25.01 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.323 1.449 . . . . 0.0 112.985 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 47.6 t -78.52 -17.2 56.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.034 0.445 . . . . 0.0 110.494 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.74 56.69 Favored Glycine 0 CA--C 1.501 -0.814 0 O-C-N 122.013 -0.43 . . . . 0.0 112.157 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -92.08 149.19 21.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 120.722 0.296 . . . . 0.0 111.607 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -75.33 129.78 37.95 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.763 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.33 -176.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -111.54 -24.68 9.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.129 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -149.02 157.57 43.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . 0.442 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.84 136.01 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 122.979 0.512 . . . . 0.0 110.189 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.0 167.86 38.48 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 439' ' ' VAL . 38.6 Cg_endo -63.04 153.02 76.41 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.02 2.48 . . . . 0.0 112.925 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' SER . . . . . 0.416 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.1 m 71.61 21.63 4.33 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.649 1.18 . . . . 0.0 111.714 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.9 ttt -121.0 137.07 26.13 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.84 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.61 126.84 7.66 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.84 2.36 . . . . 0.0 111.64 176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 473' ' ' ALA . 13.4 m -143.78 155.93 16.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 122.516 0.326 . . . . 0.0 110.536 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.3 tt0 -116.11 115.43 26.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.32 177.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.035 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.0 p -152.44 166.68 31.2 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.91 20.35 24.1 Favored Glycine 0 C--N 1.294 -1.797 0 O-C-N 123.823 0.702 . . . . 0.0 114.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 43.3 tp -85.18 -33.37 22.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 7.6 t60 60.82 23.59 13.57 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.346 1.459 . . . . 0.0 110.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.403 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.2 t70 -144.82 -179.91 6.9 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.18 112.49 56.48 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -78.19 166.2 24.88 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.961 1.774 . . . . 0.0 110.41 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -120.09 132.81 55.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.785 0.802 . . . . 0.0 110.587 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.53 121.46 18.74 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.032 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.45 -0.25 59.76 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -80.28 -167.43 1.32 Allowed 'General case' 0 C--O 1.247 0.93 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . 0.489 ' HD3' ' N ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -137.76 129.71 28.76 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.385 0.612 . . . . 0.0 110.422 -172.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.33 158.95 29.9 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.715 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.8 ttt -118.4 123.23 44.75 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.299 -1.593 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 504' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.188 -2.156 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.97 -45.32 93.0 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.297 0.57 . . . . 0.0 112.174 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -74.82 -27.51 60.32 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.75 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.13 31.75 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 500' ' ' GLU . 3.9 ptp180 -64.66 -23.22 67.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.87 -32.79 72.22 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.208 1.004 . . . . 0.0 109.028 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 60.6 mt -87.31 -44.89 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.564 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.269 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.151 178.893 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -125.72 170.86 17.58 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.8 m -114.65 139.74 49.4 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.37 127.91 38.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.07 -37.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.83 154.96 26.97 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.58 139.13 25.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.415 ' CD ' HG22 ' A' ' 434' ' ' VAL . 0.0 OUTLIER -156.99 176.85 12.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.41 150.09 22.98 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.88 119.48 32.76 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.555 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -50.85 -25.46 4.54 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.24 -36.28 1.23 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.119 -1.038 . . . . 0.0 113.646 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -90.08 -15.09 32.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 122.398 -0.472 . . . . 0.0 111.333 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 91.68 -144.93 17.45 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.02 116.42 4.14 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.388 2.059 . . . . 0.0 111.879 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.415 HG22 ' CD ' ' A' ' 426' ' ' LYS . 2.9 m -121.14 123.92 71.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 124.532 1.133 . . . . 0.0 108.943 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -130.18 125.22 34.45 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.175 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.11 122.2 40.96 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.5 pp -132.3 173.18 11.54 Favored 'General case' 0 C--N 1.257 -3.417 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 476' ' ' SER . 4.5 tt -124.17 110.63 14.92 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -69.12 121.63 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.806 0.812 . . . . 0.0 111.761 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -122.2 -16.03 7.55 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.655 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.0 -3.83 55.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.61 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 149.84 -103.56 0.25 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 119.943 -1.123 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.8 m -142.51 130.44 21.77 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.466 ' CD1' HD12 ' A' ' 437' ' ' LEU . 2.9 tt -107.26 138.47 43.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -145.94 151.94 38.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.866 0.757 . . . . 0.0 110.946 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . 0.536 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.9 m -62.77 128.29 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.331 0.586 . . . . 0.0 111.123 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.59 54.0 Favored Glycine 0 N--CA 1.428 -1.865 0 C-N-CA 119.845 -1.169 . . . . 0.0 114.219 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 445' ' ' LYS 0.254 2.2 p30 -101.17 149.58 36.4 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 118.904 1.352 . . . . 0.0 112.55 177.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.37 124.83 6.67 Favored 'Trans proline' 0 C--N 1.364 1.393 0 C-N-CA 122.881 2.387 . . . . 0.0 113.04 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.39 151.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.364 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.03 120.61 65.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.24 111.36 26.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.68 -113.83 6.23 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.235 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 17.5 p -104.06 2.92 32.68 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.889 0.376 . . . . 0.0 111.53 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.441 HG22 ' CB ' ' A' ' 486' ' ' ASP . 25.3 m -124.78 151.33 45.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.685 0.278 . . . . 0.0 110.692 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -127.56 144.34 51.08 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -147.26 -164.36 11.12 Favored Glycine 0 C--N 1.287 -2.149 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -135.39 134.67 39.95 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.67 121.58 16.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -86.88 -61.24 1.77 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.005 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.13 155.25 51.03 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 123.892 0.877 . . . . 0.0 109.091 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.438 ' HE3' HD21 ' A' ' 444' ' ' LEU . 36.4 tpp -123.68 117.83 25.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.27 132.01 70.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -96.65 175.03 6.53 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.617 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.16 -27.35 61.83 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.53 0.732 . . . . 0.0 112.884 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.8 t -79.42 -11.03 59.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 96.55 6.0 58.69 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.134 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -87.75 130.79 34.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.625 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.39 127.27 32.59 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.46 178.57 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -103.34 -35.4 8.42 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.647 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.65 162.16 33.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.905 0.383 . . . . 0.0 111.434 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -129.65 129.49 44.36 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.213 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.25 163.99 34.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 439' ' ' VAL . 36.4 Cg_endo -65.26 152.37 82.36 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.402 2.068 . . . . 0.0 112.409 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' SER . . . . . 0.463 ' HA ' HD23 ' A' ' 438' ' ' LEU . 23.0 t 74.43 15.34 3.47 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.415 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.1 ttm -113.14 134.81 21.77 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.21 126.09 5.45 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.675 2.25 . . . . 0.0 110.882 173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.86 142.49 35.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.216 0.532 . . . . 0.0 112.221 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -91.25 112.2 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.47 167.37 2.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.17 0.51 . . . . 0.0 109.652 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.3 29.37 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.27 12.87 55.67 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.512 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.05 -31.85 61.39 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t60 61.73 20.52 11.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 111.499 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ASP . . . . . 0.441 ' CB ' HG22 ' A' ' 455' ' ' THR . 4.1 t70 -149.26 -179.54 7.13 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.15 120.4 69.2 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-O 121.003 0.43 . . . . 0.0 110.369 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.01 172.05 5.49 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.064 1.843 . . . . 0.0 111.425 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -128.53 131.07 48.25 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.71 33.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.85 -0.4 59.21 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.383 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -89.36 -178.35 5.59 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 152.55 24.17 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' PHE . . . . . 0.635 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.6 p90 -141.59 154.54 45.49 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.0 ttp -126.26 121.41 32.6 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 C--N 1.301 -1.54 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.35 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.213 -0.863 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -68.77 -39.59 80.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.106 0.479 . . . . 0.0 111.374 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -80.24 -39.57 28.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.57 -52.44 61.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -67.84 -15.79 63.79 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.389 0.676 . . . . 0.0 111.591 -174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -80.95 -33.87 33.62 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.411 0.624 . . . . 0.0 109.375 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.83 -54.73 7.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.351 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.447 -179.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.993 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.9 m -89.11 89.46 7.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 69.64 -63.39 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.808 1.243 . . . . 0.0 112.606 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 60.2 mtt 73.51 100.32 0.07 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.033 1.333 . . . . 0.0 109.649 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.13 123.66 21.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.868 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.54 119.29 19.4 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -148.37 -71.18 0.21 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 125.006 1.322 . . . . 0.0 107.742 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -176.48 100.03 0.06 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 62.7 tp -107.38 107.91 19.02 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.4 121.38 14.73 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 123.532 0.52 . . . . 0.0 110.047 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' MET . . . . . 0.581 ' HB2' ' CD ' ' A' ' 498' ' ' GLU . 25.8 ptt? -163.05 133.3 4.48 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.424 ' HA ' ' HE3' ' A' ' 445' ' ' LYS . 54.4 mt -143.14 -66.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.68 162.1 27.35 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.12 174.9 10.16 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 123.269 0.356 . . . . 0.0 110.976 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 33.7 t -119.82 -75.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.998 0.427 . . . . 0.0 110.478 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 3.3 m -142.86 96.98 3.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 497' ' ' PHE . 28.3 mm-40 -98.14 114.21 26.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -142.0 22.23 2.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.039 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.02 151.39 23.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.03 117.16 28.89 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.589 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.51 -35.04 21.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 68.42 95.59 0.07 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 125.737 1.615 . . . . 0.0 110.95 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -146.59 -44.21 0.19 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.054 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -125.25 146.59 54.58 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.8 -27.55 21.35 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.643 2.229 . . . . 0.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.11 -61.66 2.39 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.392 0.615 . . . . 0.0 109.815 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -134.23 150.04 51.01 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -82.11 25.23 0.6 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 495' ' ' MET . . . -169.43 82.54 0.13 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.315 1.046 . . . . 0.0 109.193 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.9 m -154.89 175.92 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 C-N-CA 124.047 0.939 . . . . 0.0 108.982 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -149.26 -179.35 25.06 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 p -117.38 143.12 46.31 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.313 0.578 . . . . 0.0 112.187 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.9 137.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.4 pt -93.18 -38.46 9.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -154.33 147.34 24.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.63 134.36 13.74 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.15 175.75 13.08 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -97.24 146.56 24.98 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -120.24 123.32 42.94 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.526 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.79 -10.03 3.44 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.08 -44.62 0.56 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.023 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -82.81 -25.39 32.74 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 122.859 0.464 . . . . 0.0 110.847 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.15 -166.58 15.48 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.75 116.41 4.09 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 121.84 1.693 . . . . 0.0 110.307 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 482' ' ' THR . 22.5 m -113.05 144.65 20.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-O 121.204 0.526 . . . . 0.0 109.939 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.71 111.98 9.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -85.04 120.9 27.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.0 pp -140.15 173.11 11.84 Favored 'General case' 0 C--N 1.278 -2.516 0 O-C-N 122.281 -0.262 . . . . 0.0 111.521 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.42 107.81 16.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.3 p -67.16 116.69 6.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.49 -15.64 6.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.509 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.31 -17.28 56.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.066 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.6 -107.83 0.33 Allowed Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 96.6 m -131.92 137.48 48.0 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.469 HD21 ' HE3' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.84 127.18 54.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.7 ttpm? -131.71 158.28 41.55 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.8 m -71.19 137.13 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 O-C-N 121.777 -0.577 . . . . 0.0 110.384 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.17 -8.05 60.61 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.604 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 5.8 m-20 -68.5 136.86 90.78 Favored Pre-proline 0 CA--C 1.494 -1.202 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.4 106.43 1.71 Allowed 'Trans proline' 0 N--CA 1.429 -2.29 0 C-N-CA 122.117 1.878 . . . . 0.0 107.544 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 456' ' ' TYR . 2.8 pp -108.23 139.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.175 -170.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.39 113.99 45.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.24 112.0 38.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.08 -97.36 0.65 Allowed Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.85 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.0 t -131.74 3.95 4.18 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 120.963 0.411 . . . . 0.0 110.233 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.443 HG21 ' CB ' ' A' ' 486' ' ' ASP . 96.2 m -116.46 141.64 47.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 44.5 p90 -114.97 151.03 34.84 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -153.81 -164.3 12.59 Favored Glycine 0 C--N 1.296 -1.664 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 448' ' ' ASP . 19.9 ttm180 -134.58 127.43 31.23 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 482' ' ' THR . 60.9 t -58.88 115.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.72 0.638 . . . . 0.0 111.536 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -84.33 -59.27 2.44 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.0 151.22 48.87 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.549 0.739 . . . . 0.0 109.451 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.469 ' HE3' HD21 ' A' ' 444' ' ' LEU . 54.7 tpp -122.49 117.33 25.69 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.3 127.91 75.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -96.45 -176.76 3.73 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.16 -173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -48.54 -37.06 16.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 126.825 2.05 . . . . 0.0 113.114 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.0 m -88.71 -6.73 57.25 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.33 15.18 48.55 Favored Glycine 0 CA--C 1.496 -1.11 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.13 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.4 135.17 42.26 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.086 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 462' ' ' MET . 6.6 tpt180 -68.89 130.99 44.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 462' ' ' MET . 14.0 m -139.71 -177.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.172 0.295 . . . . 0.0 110.681 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.32 -34.34 7.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -148.13 135.27 20.32 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.641 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . 0.514 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -128.84 144.74 51.25 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 171.11 31.96 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.233 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.448 ' HA ' HG11 ' A' ' 439' ' ' VAL . 30.5 Cg_endo -63.44 156.67 55.02 Favored 'Trans proline' 0 C--O 1.247 0.931 0 C-N-CA 122.969 2.446 . . . . 0.0 112.598 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 44.3 m 71.98 12.32 6.07 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.218 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.0 ttp -118.88 129.73 25.23 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.2 Cg_exo -67.48 127.22 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.694 2.263 . . . . 0.0 111.108 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' A' ' 473' ' ' ALA . 24.5 m -139.85 154.96 24.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 39.4 tt0 -115.7 119.21 35.33 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -98.19 173.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.969 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.2 p -149.38 167.63 25.63 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.62 31.42 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.452 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 53.9 tp -81.22 -30.89 34.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.648 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 61.46 20.58 11.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.351 1.46 . . . . 0.0 111.345 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.443 ' CB ' HG21 ' A' ' 455' ' ' THR . 34.5 t70 -147.81 175.09 11.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.42 114.76 53.83 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 118.983 0.811 . . . . 0.0 112.318 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.75 146.61 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.686 1.59 . . . . 0.0 110.25 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.37 139.58 50.68 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.08 131.6 43.86 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.091 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.38 -0.12 68.05 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.091 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 493' ' ' ARG . 1.6 t0 -85.02 -173.63 4.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.524 ' HD2' ' H ' ' A' ' 493' ' ' ARG . 0.9 OUTLIER -130.0 133.85 47.04 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.485 -175.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 40.5 p90 -127.15 150.23 49.59 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 418' ' ' ALA . 54.2 ttp -119.98 115.81 24.5 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.822 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 450' ' ' ILE . 26.3 t -137.04 104.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 406' ' ' GLU . 14.9 p90 -153.95 124.29 7.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.581 ' CD ' ' HB2' ' A' ' 400' ' ' MET . 15.5 pt-20 -138.04 -57.02 0.66 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 163.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.419 ' N ' ' HG3' ' A' ' 498' ' ' GLU . 15.0 t70 47.94 -92.94 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.116 1.766 . . . . 0.0 114.406 168.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.91 -10.66 59.69 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 122.12 -0.363 . . . . 0.0 111.872 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -47.37 -54.15 11.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 112.144 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.47 -34.92 41.05 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.241 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.57 73.04 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 122.006 0.908 . . . . 0.0 108.885 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -61.03 -37.62 83.22 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 125.675 1.59 . . . . 0.0 110.289 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -63.62 -45.32 90.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.798 0.332 . . . . 0.0 110.251 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 80.1 mt -67.67 -34.21 66.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.06 22.72 6.74 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -85.69 -44.29 12.69 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.402 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -93.61 -175.73 3.86 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -72.76 123.61 23.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -146.98 -77.64 0.17 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 170.34 93.85 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.91 1.284 . . . . 0.0 108.228 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -82.21 145.88 29.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 . . . . . 0 C--N 1.276 -2.609 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.389 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 23.1 t 68.48 -176.44 0.2 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.278 1.031 . . . . 0.0 109.623 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.424 ' O ' ' HG2' ' A' ' 393' ' ' MET . 71.6 m-70 73.25 -57.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.14 1.376 . . . . 0.0 111.402 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 392' ' ' HIS . 21.0 ptp 64.8 -26.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 128.022 2.529 . . . . 0.0 114.49 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 392' ' ' HIS . 84.8 mt -81.74 -10.2 59.43 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.121 0.486 . . . . 0.0 109.964 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -88.44 135.44 33.47 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -136.13 170.77 15.49 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.27 107.54 18.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 95.9 mt 71.68 98.35 0.07 Allowed 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.607 1.192 . . . . 0.0 111.247 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.44 -5.34 52.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.807 0.813 . . . . 0.0 109.232 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -152.44 168.86 24.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 26.1 pt -73.43 157.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.91 -47.71 50.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.639 0.733 . . . . 0.0 111.246 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.61 162.69 18.73 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.345 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.08 -69.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 22.7 t -178.63 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.52 104.08 4.86 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.702 0.763 . . . . 0.0 111.181 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -166.11 106.01 0.68 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -118.81 140.6 49.69 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.189 0.519 . . . . 0.0 111.732 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -150.66 132.17 14.77 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.69 -18.35 21.39 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -170.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.98 75.09 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.127 0.892 . . . . 0.0 109.05 -174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -137.59 26.16 2.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.357 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -142.56 109.95 5.72 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.632 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.66 -20.1 18.06 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.557 2.171 . . . . 0.0 113.334 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.83 98.66 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' A' ' 416' ' ' ARG . 4.5 mmp_? -96.17 79.62 3.19 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.661 0.744 . . . . 0.0 112.628 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -133.72 -86.32 0.43 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -155.14 79.31 1.05 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 10.9 m -155.39 164.17 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 124.72 1.208 . . . . 0.0 108.04 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -139.63 -178.13 16.36 Favored Glycine 0 C--N 1.295 -1.697 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 26.7 m -124.22 143.8 50.32 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.4 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.045 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.7 pt -91.7 -35.19 6.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -159.21 148.66 18.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.22 130.54 12.06 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 177.46 10.71 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -174.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -94.72 150.12 20.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.84 135.09 50.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.514 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.29 -18.2 59.08 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.834 -174.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -114.82 -36.31 1.28 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.549 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.52 -30.48 19.3 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.418 -0.46 . . . . 0.0 111.796 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.67 -152.28 17.7 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 482' ' ' THR . 14.4 Cg_exo -71.67 116.33 4.66 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.725 1.617 . . . . 0.0 110.017 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.93 124.06 68.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.63 0.729 . . . . 0.0 111.537 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -123.08 112.18 17.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.889 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.472 ' HG1' ' HG2' ' A' ' 480' ' ' GLU . 1.2 m -83.59 115.45 22.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.2 pp -132.21 170.85 14.44 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.898 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' A' ' 440' ' ' GLN . 2.1 tm? -117.03 106.13 13.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -64.64 117.7 5.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-O 121.827 0.823 . . . . 0.0 112.346 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 438' ' ' LEU . 72.1 mt-30 -123.66 -15.46 7.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.698 -175.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.28 -14.99 59.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.831 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 153.97 -108.05 0.35 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 27.2 m -128.8 142.5 50.96 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.449 HD22 ' HE3' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.13 135.98 53.22 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.582 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.3 ttpt -146.0 150.83 36.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.582 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 33.5 m -70.74 134.23 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.235 0.541 . . . . 0.0 110.707 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 105.2 -21.19 36.11 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.488 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.561 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 43.8 m-20 -79.47 146.44 65.85 Favored Pre-proline 0 C--O 1.251 1.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -77.8 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.114 1.876 . . . . 0.0 111.179 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.58 152.03 30.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.67 121.9 48.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-O 121.195 0.521 . . . . 0.0 109.64 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 494' ' ' PHE . 2.5 p -143.78 133.45 20.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.644 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.75 33.82 88.26 Favored Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.261 26.7 p 62.05 1.76 0.71 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.928 1.691 . . . . 0.0 114.306 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.444 HG23 ' CB ' ' A' ' 486' ' ' ASP . 39.0 m -98.38 141.15 31.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -120.18 151.37 39.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.171 -1.011 . . . . 0.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.25 14.04 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -127.76 146.65 50.52 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 45.9 t -74.08 120.17 22.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -92.63 -45.16 8.21 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.782 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -144.04 152.56 41.17 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.449 ' HE3' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -122.47 117.59 26.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.94 133.81 65.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.423 HD22 ' HB2' ' A' ' 468' ' ' ARG . 4.7 p30 -101.63 172.77 6.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.816 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.67 -26.1 61.2 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.335 1.054 . . . . 0.0 113.061 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.7 m -86.02 -2.22 58.1 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 122.099 -0.375 . . . . 0.0 111.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 93.92 1.98 64.98 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.413 170.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.423 ' HB2' HD22 ' A' ' 464' ' ' ASN . 11.8 mpt_? -86.35 131.83 34.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.597 -0.301 . . . . 0.0 110.439 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -77.85 129.63 35.64 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.08 176.04 9.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 -8.35 10.38 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.736 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -151.65 139.4 19.81 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.55 131.55 29.73 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.74 166.9 31.73 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.439 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.472 ' HA ' HG13 ' A' ' 439' ' ' VAL . 17.7 Cg_endo -58.05 149.81 68.86 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 123.252 2.635 . . . . 0.0 112.175 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 43.4 t 77.55 6.44 2.92 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.917 0.887 . . . . 0.0 112.133 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 39.5 ttp -110.26 127.09 27.62 Favored Pre-proline 0 N--CA 1.439 -0.993 0 O-C-N 121.403 -0.811 . . . . 0.0 111.417 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.8 Cg_endo -74.15 126.59 10.62 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.627 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.17 152.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.327 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.472 ' HG2' ' HG1' ' A' ' 436' ' ' THR . 35.4 mt-10 -99.62 123.1 43.57 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.5 pt -97.58 164.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 4.1 p -145.77 158.38 43.86 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 100.9 12.48 36.96 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.919 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.31 -36.58 71.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 67.33 21.43 9.81 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.731 1.612 . . . . 0.0 109.873 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.444 ' CB ' HG23 ' A' ' 455' ' ' THR . 6.7 t70 -145.63 -179.05 6.42 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.29 110.05 48.36 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 123.405 0.441 . . . . 0.0 110.982 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -82.73 148.49 13.98 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.931 1.754 . . . . 0.0 110.561 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -111.29 135.98 51.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.024 0.44 . . . . 0.0 111.958 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.87 127.26 32.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.99 -0.24 66.69 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.866 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.557 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.2 t70 -88.41 -172.13 3.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.557 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.0 OUTLIER -128.31 139.0 52.65 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -171.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 46.7 p90 -127.63 159.69 33.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.01 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 28.1 ttt -132.44 130.68 40.88 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 4.0 p -87.42 138.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -93.86 122.02 35.91 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.579 ' HG3' ' H ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -91.51 -83.47 0.28 Allowed 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.516 -173.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.579 ' H ' ' HG3' ' A' ' 498' ' ' GLU . 34.0 t70 67.45 -55.61 0.46 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 127.133 2.173 . . . . 0.0 114.625 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -65.78 -35.82 81.79 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -62.27 -52.97 61.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.903 -170.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 499' ' ' ASP . 21.9 pttp -61.22 -40.72 95.05 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.282 0.363 . . . . 0.0 110.257 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.05 60.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.104 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -60.29 -38.11 82.61 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.961 0.904 . . . . 0.0 110.928 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -69.84 -34.62 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.645 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.65 -23.21 14.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.655 0.741 . . . . 0.0 110.116 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.74 29.4 9.27 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -95.18 -50.39 5.07 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.728 0.811 . . . . 0.0 109.045 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -82.47 101.02 10.41 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -106.2 -47.32 3.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.864 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 512' ' ' GLN . . . 72.02 116.98 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.659 1.225 . . . . 0.0 108.971 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 511' ' ' ALA . 1.5 pt20 68.64 168.06 0.27 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 127.102 2.161 . . . . 0.0 111.095 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -109.39 164.29 12.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.568 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 40.0 m -85.31 15.82 4.09 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 117.432 0.616 . . . . 0.0 111.849 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 31.8 m170 63.57 46.67 4.1 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.328 1.061 . . . . 0.0 109.986 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 59.5 ttp -92.12 96.82 10.54 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.546 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 394' ' ' LEU . 2.3 pt? -111.68 139.32 47.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.27 -164.13 0.23 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.746 0.654 . . . . 0.0 110.353 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -114.76 99.5 7.55 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.87 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 61.8 tp 68.52 109.78 0.05 OUTLIER 'General case' 0 C--O 1.245 0.822 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.89 114.47 27.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.58 -32.43 62.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.06 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 93.1 mmm 64.98 82.21 0.19 Allowed 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 110.929 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 10.9 tp -113.6 142.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.55 -93.31 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.145 0.578 . . . . 0.0 111.332 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 95.6 mt -151.07 -57.45 0.16 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 124.228 1.011 . . . . 0.0 108.882 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 81.0 t 71.8 -63.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.194 1.798 . . . . 0.0 111.106 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 74.3 m -128.44 -1.15 5.6 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.01 105.45 15.78 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 22.8 mmt -95.57 -16.99 21.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.309 0.576 . . . . 0.0 110.178 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.35 117.91 13.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.037 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . 0.25 6.1 pt-20 -157.72 85.32 0.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.295 1.045 . . . . 0.0 111.439 171.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 411' ' ' LYS . 4.3 pp -92.99 -38.83 11.45 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.504 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.462 ' N ' HD11 ' A' ' 410' ' ' LEU . 82.3 mttt 69.5 -67.82 0.21 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 126.343 1.857 . . . . 0.0 110.648 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.492 ' O ' ' HD3' ' A' ' 414' ' ' PRO . . . -176.18 93.51 0.05 Allowed 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -108.67 93.16 11.48 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 412' ' ' ALA . 26.4 Cg_endo -103.34 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.859 3.039 . . . . 0.0 115.028 -170.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -75.47 110.13 9.59 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 72.51 -64.1 0.41 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.693 1.597 . . . . 0.0 109.046 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -168.34 -39.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -165.42 139.18 4.63 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 30.4 m -143.77 172.96 5.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.99 162.02 13.29 Favored Glycine 0 C--N 1.279 -2.62 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 m -117.01 138.76 51.36 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.88 139.45 17.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 18.2 pt -99.3 -39.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 490' ' ' ALA . 8.5 pt-20 -153.39 152.29 30.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.22 134.34 29.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.69 177.39 10.91 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.311 0.577 . . . . 0.0 111.185 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.97 145.08 26.19 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.771 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 10.4 t70 -128.02 129.16 46.25 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.525 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -75.55 -11.23 59.98 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -175.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -119.34 -35.64 0.92 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.478 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.0 mtp180 -94.08 -15.22 24.94 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.844 0.458 . . . . 0.0 111.028 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 88.15 -154.1 25.08 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -60.27 116.16 3.13 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.108 1.872 . . . . 0.0 111.173 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.8 137.18 53.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.434 0.635 . . . . 0.0 110.377 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -131.4 114.62 15.19 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.104 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -83.39 119.44 24.64 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.481 HD22 ' CE1' ' A' ' 494' ' ' PHE . 1.6 pp -135.73 173.07 12.12 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -120.01 112.41 19.12 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -75.77 125.2 35.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.526 0.679 . . . . 0.0 111.799 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.579 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 72.6 mt-30 -124.03 -15.11 6.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.937 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.423 ' HB3' HG13 ' A' ' 496' ' ' VAL . . . -97.3 6.31 48.55 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 147.62 -125.77 2.22 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.15 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.7 m -116.39 141.63 47.92 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.489 HD21 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.77 119.25 36.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.561 ' HB3' ' HZ2' ' A' ' 445' ' ' LYS . 1.4 ttpm? -130.02 155.14 46.61 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.467 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.0 m -67.06 132.16 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.84 -7.09 48.76 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.916 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 498' ' ' GLU . 13.7 m-20 -73.88 135.02 77.68 Favored Pre-proline 0 C--O 1.25 1.089 0 CA-C-N 117.555 0.678 . . . . 0.0 111.932 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.32 119.15 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.629 2.219 . . . . 0.0 109.306 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.07 159.81 29.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.73 115.59 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 16.6 t -128.38 124.17 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 56.98 42.35 92.78 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.264 6.6 t 60.39 4.09 0.65 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.549 2.34 . . . . 0.0 113.436 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.445 HG21 ' CB ' ' A' ' 486' ' ' ASP . 22.4 m -96.53 135.62 38.18 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -111.5 151.65 28.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.604 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.95 -163.97 19.29 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -134.62 137.21 43.48 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.69 119.36 11.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.184 0.516 . . . . 0.0 112.097 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -81.54 -60.59 2.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.92 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -136.2 152.05 50.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.489 ' HE2' HD21 ' A' ' 444' ' ' LEU . 41.2 tpp -115.23 117.07 29.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 11.9 t -122.88 126.49 73.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -92.81 174.77 7.08 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.625 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.21 -27.82 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.949 0.9 . . . . 0.0 113.144 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.5 m -78.81 -12.1 60.01 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.756 0.312 . . . . 0.0 111.0 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 98.41 8.32 54.95 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.93 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -97.0 128.81 44.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -84.77 124.33 31.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.43 -174.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -99.31 -31.85 11.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.11 156.67 40.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.304 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.53 42.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -100.58 177.04 28.0 Favored Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.44 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 439' ' ' VAL . 18.7 Cg_endo -59.76 155.37 43.6 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.971 2.447 . . . . 0.0 112.641 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 47.6 m 70.81 16.94 6.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.955 0.902 . . . . 0.0 112.144 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 45.5 ttm -117.81 136.68 23.8 Favored Pre-proline 0 C--N 1.316 -0.861 0 O-C-N 122.007 -0.433 . . . . 0.0 111.185 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.1 Cg_endo -82.57 125.85 4.5 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.234 1.956 . . . . 0.0 110.884 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.22 156.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.0 mt-10 -105.0 126.55 52.18 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 50.0 pt -97.95 170.4 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 1.2 p -150.42 167.46 27.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.75 13.89 62.05 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.914 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.63 -32.54 64.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.9 t60 67.45 19.85 9.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.076 1.75 . . . . 0.0 109.788 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.445 ' CB ' HG21 ' A' ' 455' ' ' THR . 7.3 t70 -148.39 -179.98 7.36 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.9 t -120.42 113.41 33.68 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.46 175.38 10.24 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.773 2.315 . . . . 0.0 111.509 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -111.03 148.0 33.54 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 424' ' ' GLU . . . -70.22 138.84 52.05 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.255 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.85 -0.23 86.26 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.18 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.598 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 4.5 t70 -83.96 -165.34 1.11 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.598 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -138.59 148.98 44.78 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.688 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.481 ' CE1' HD22 ' A' ' 437' ' ' LEU . 15.0 p90 -139.56 156.19 47.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.833 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.1 ttt -118.86 127.39 53.46 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 441' ' ' ALA . 4.8 p -101.65 136.44 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -150.65 133.47 15.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.443 ' HA ' ' OD1' ' A' ' 448' ' ' ASP . 8.2 tp10 -76.42 148.07 37.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.893 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.46 -55.06 38.06 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 124.217 1.007 . . . . 0.0 110.882 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.56 -34.55 78.51 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.563 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -72.53 -38.63 67.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.607 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.49 -46.78 88.84 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.611 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.94 -45.03 94.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 509' ' ' ALA . 37.2 ttm180 -58.94 -36.03 74.1 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 125.374 1.469 . . . . 0.0 111.757 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -34.14 59.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.9 mm -80.18 -54.06 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -171.83 9.55 0.04 OUTLIER Glycine 0 C--N 1.32 -0.316 0 C-N-CA 118.695 -1.717 . . . . 0.0 115.052 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 504' ' ' ARG . 5.4 tp10 -83.04 -29.09 29.12 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.84 -0.744 . . . . 0.0 108.998 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 504' ' ' ARG . . . 59.68 -163.17 0.24 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.552 0.741 . . . . 0.0 109.557 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -74.96 -29.93 61.06 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.204 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . 65.22 74.55 0.38 Allowed 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.487 1.115 . . . . 0.0 112.661 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -160.56 162.08 32.81 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -169.83 105.8 0.34 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.76 0.79 . . . . 0.0 109.568 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.252 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.5 m -78.26 91.99 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -128.73 86.01 2.4 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.563 0.697 . . . . 0.0 110.876 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -94.41 3.96 54.48 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.166 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.19 13.74 1.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.436 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.95 105.58 17.67 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -101.71 13.14 35.77 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.355 0.598 . . . . 0.0 111.288 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.36 -36.2 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.0 tp 72.71 -76.78 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.606 1.163 . . . . 0.0 111.983 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 52.24 70.52 0.55 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.742 0.817 . . . . 0.0 109.0 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 52.8 ttm -77.86 89.13 4.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.716 0.77 . . . . 0.0 112.06 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 50.0 mm -95.69 -65.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 84.3 mt 61.97 177.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.165 1.386 . . . . 0.0 112.622 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 95.2 mt 63.97 89.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.409 1.084 . . . . 0.0 111.811 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.75 1.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 50.8 m -111.6 -8.18 14.24 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.454 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -145.46 64.78 1.25 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.773 0.797 . . . . 0.0 111.466 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.7 170.32 8.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.05 117.79 30.18 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.493 ' OE2' ' HG2' ' A' ' 411' ' ' LYS . 7.8 tp10 -97.54 106.16 18.43 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 413' ' ' ASN . 2.2 pt? -131.03 3.36 4.38 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.757 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.493 ' HG2' ' OE2' ' A' ' 409' ' ' GLU . 23.5 pttm -102.02 -35.51 8.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.411 0.624 . . . . 0.0 109.807 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -104.23 -23.47 13.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.046 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 410' ' ' LEU . 12.8 m120 -123.31 121.83 26.88 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.952 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.92 -12.85 10.68 Favored 'Trans proline' 0 C--N 1.329 -0.456 0 C-N-CA 122.084 1.856 . . . . 0.0 112.921 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' A' ' 419' ' ' VAL . 11.3 m120 -81.41 -7.78 59.63 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.823 -172.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.91 176.58 0.26 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 52.42 -112.91 0.71 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.328 1.451 . . . . 0.0 112.933 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -127.17 104.48 7.99 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 415' ' ' ASN . 2.5 m -149.18 162.78 4.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -129.47 178.37 17.43 Favored Glycine 0 C--N 1.298 -1.554 0 C-N-CA 119.233 -1.46 . . . . 0.0 112.542 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.84 145.16 45.89 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 123.335 0.654 . . . . 0.0 111.107 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 30.0 t -86.55 134.06 28.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -94.26 -33.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.31 149.13 20.56 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.58 131.27 18.93 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.78 177.98 4.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.89 152.85 21.77 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -126.62 119.32 26.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.551 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -58.11 -19.55 33.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -112.53 -38.78 1.28 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.784 -1.198 . . . . 0.0 112.839 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.57 -32.59 19.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.37 -155.53 16.17 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.56 116.38 4.38 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.075 1.85 . . . . 0.0 110.068 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 32.4 m -116.3 143.94 25.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.793 0.806 . . . . 0.0 111.684 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -133.17 112.03 11.4 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.488 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.7 m -87.55 115.36 24.92 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.628 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.4 pp -132.86 171.37 14.0 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -113.33 106.38 14.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -70.3 108.84 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.352 1.072 . . . . 0.0 111.928 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -115.0 -15.94 11.71 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.18 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -77.64 -4.12 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.906 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.31 -95.67 0.19 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.218 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.9 m -142.05 139.61 32.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.452 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -114.47 135.57 53.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.571 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -147.75 164.3 34.01 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 28.6 m -70.62 138.12 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 121.734 0.778 . . . . 0.0 112.134 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.28 -10.62 65.4 Favored Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.207 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 51.1 m-20 -76.66 131.76 73.37 Favored Pre-proline 0 C--O 1.245 0.848 0 CA-C-N 117.651 0.725 . . . . 0.0 111.536 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.42 107.68 2.44 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.681 2.254 . . . . 0.0 109.26 171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.48 161.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.898 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.56 114.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 61.7 t -120.34 112.42 36.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.55 -115.61 7.52 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.8 p -107.34 7.02 28.94 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.997 0.427 . . . . 0.0 111.259 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 486' ' ' ASP . 90.0 m -121.59 129.53 52.9 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.781 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -111.31 151.99 27.74 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.66 -164.27 20.77 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 56.7 ttp180 -131.91 128.72 39.15 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 482' ' ' THR . 40.1 t -61.28 122.86 12.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 123.859 0.724 . . . . 0.0 111.767 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -95.71 -56.93 2.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.31 52.28 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.452 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.6 tpp -115.37 117.68 31.09 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 16.8 t -116.36 139.6 42.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -105.43 171.97 7.04 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.095 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.6 -25.89 54.02 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 41.2 m -77.09 -11.71 59.85 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.011 -0.43 . . . . 0.0 110.954 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.74 -4.64 56.41 Favored Glycine 0 CA--C 1.496 -1.12 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.484 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -91.89 140.26 29.85 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 4.4 tmm_? -86.44 138.01 32.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 16.7 m -136.17 -173.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 124.41 1.084 . . . . 0.0 108.493 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -119.34 -17.07 8.91 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.113 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -149.19 152.25 35.72 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.44 135.36 30.25 Favored 'General case' 0 C--O 1.25 1.11 0 O-C-N 123.536 0.522 . . . . 0.0 110.876 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -86.45 168.43 40.19 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.641 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.422 ' HA ' HG12 ' A' ' 439' ' ' VAL . 37.0 Cg_endo -64.26 154.99 68.0 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 122.941 2.427 . . . . 0.0 113.729 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 34.1 m 70.17 16.55 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.016 1.326 . . . . 0.0 112.19 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.6 ttp -117.0 130.07 24.87 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.475 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 11.2 Cg_endo -72.68 126.12 11.16 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.27 1.98 . . . . 0.0 111.788 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.72 155.05 22.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.672 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.64 113.63 26.78 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 124.516 1.127 . . . . 0.0 108.575 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.8 pt -98.13 172.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.805 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.6 p -146.45 163.03 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 107.29 11.56 25.34 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.972 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.4 mt -83.71 -27.29 29.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.706 0.289 . . . . 0.0 111.749 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 60.27 19.26 8.73 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.61 1.164 . . . . 0.0 110.518 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.463 ' HB3' HG21 ' A' ' 455' ' ' THR . 34.4 t70 -149.26 174.39 12.44 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.22 112.26 52.37 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.92 2.413 . . . . 0.0 111.37 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -105.31 132.43 51.51 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.484 0.659 . . . . 0.0 111.656 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.03 28.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 101.63 -5.11 54.16 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.24 -177.48 6.25 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.429 ' HG3' ' ND2' ' A' ' 413' ' ' ASN . 6.4 mpt_? -114.09 143.66 44.41 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.656 0.782 . . . . 0.0 110.758 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 50.1 p90 -136.83 163.16 31.3 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.5 ttm -130.17 115.88 17.65 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.851 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 74.6 t -101.05 106.88 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -151.39 123.05 7.97 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.836 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -179.25 4.89 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 167.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -158.75 -52.43 0.06 Allowed 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.651 0.738 . . . . 0.0 109.921 -165.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 49.3 mt-10 -71.68 -33.69 69.04 Favored 'General case' 0 C--O 1.182 -2.458 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.401 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -62.42 -39.12 92.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.74 0.781 . . . . 0.0 111.141 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.12 -41.2 86.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.914 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.65 -25.92 41.22 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.159 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 28.7 ttt180 -70.76 -29.06 65.17 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.74 1.216 . . . . 0.0 110.014 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.2 -34.52 78.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.033 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 70.9 mt -79.08 -35.02 17.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 108.11 28.06 4.83 Favored Glycine 0 N--CA 1.419 -2.437 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.272 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.68 -32.04 5.97 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.566 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 64.44 -74.52 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.116 1.366 . . . . 0.0 113.084 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -72.56 93.37 1.58 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -89.15 92.47 9.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -101.87 132.78 47.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.305 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -147.18 134.32 20.46 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.015 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 66.0 m 70.05 135.74 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.463 1.105 . . . . 0.0 112.493 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -115.22 134.91 54.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.323 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -114.57 -49.38 2.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.599 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 63.97 -175.06 0.16 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 124.226 0.954 . . . . 0.0 111.858 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.4 t70 68.52 -82.49 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.436 1.494 . . . . 0.0 111.745 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -87.82 95.41 10.08 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 74.68 153.03 0.14 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.414 1.085 . . . . 0.0 111.605 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.23 152.08 35.57 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -77.26 131.03 37.97 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 50.5 ttm -79.4 -38.85 33.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 109.814 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.4 111.34 23.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.66 172.16 10.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 tp 72.7 -62.7 0.46 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.152 1.381 . . . . 0.0 111.065 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 7.5 p -178.92 -47.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 124.645 1.178 . . . . 0.0 108.275 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 50.7 m -163.76 155.08 16.45 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.39 102.93 6.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 96.1 mmm -61.14 -35.82 78.12 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.893 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -135.88 118.55 16.03 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.71 139.75 26.75 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.054 0.454 . . . . 0.0 110.66 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 5.55 37.24 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -80.86 -11.05 59.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.621 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -87.55 5.34 39.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.725 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 75.21 126.19 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.038 1.335 . . . . 0.0 110.424 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.44 -13.46 37.58 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.08 2.52 . . . . 0.0 113.731 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -86.93 -170.01 2.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -72.29 175.02 6.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -85.0 8.25 18.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.241 0.544 . . . . 0.0 111.017 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -82.85 6.24 19.05 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.204 0.526 . . . . 0.0 110.547 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.01 179.93 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 123.887 0.875 . . . . 0.0 108.807 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -147.8 -175.35 20.46 Favored Glycine 0 C--N 1.299 -1.508 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 6.6 m -123.76 141.96 51.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.098 0.449 . . . . 0.0 109.891 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.87 138.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.4 pt -94.19 -42.22 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.779 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.77 146.72 27.34 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.71 19.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 177.44 4.34 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.98 150.78 20.05 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.043 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -127.46 129.84 48.18 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.416 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -67.21 -16.87 64.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.7 -53.78 0.55 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.93 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.72 -29.25 64.33 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.49 0.662 . . . . 0.0 110.15 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 434' ' ' VAL . . . 104.16 -179.42 24.89 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 486' ' ' ASP . 35.6 Cg_exo -49.73 119.55 4.87 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.341 2.027 . . . . 0.0 111.179 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 432' ' ' GLY . 21.0 m -117.98 158.81 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.444 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -150.76 113.38 4.69 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.095 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 m -90.47 119.84 31.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -134.63 173.3 11.82 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.54 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.07 106.16 13.06 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.71 123.41 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.415 0.626 . . . . 0.0 112.506 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -124.09 -16.31 6.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.403 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -63.82 -16.99 62.64 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.541 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.89 -92.79 0.11 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.433 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.3 m -148.1 141.86 25.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.467 ' CD1' HD13 ' A' ' 437' ' ' LEU . 0.5 OUTLIER -109.22 117.76 34.94 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.496 ' HZ1' ' HB3' ' A' ' 445' ' ' LYS . 1.8 ttpm? -125.62 153.46 43.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.2 m -71.02 139.02 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.775 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 101.75 -10.23 57.3 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.405 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 66.1 m-20 -82.08 138.19 46.01 Favored Pre-proline 0 C--O 1.244 0.789 0 CA-C-N 117.271 0.535 . . . . 0.0 111.846 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -83.68 106.87 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.542 2.161 . . . . 0.0 110.161 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -108.4 162.98 6.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.034 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 6.9 p -133.18 125.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.67 125.5 70.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.64 -103.12 1.13 Allowed Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 19.6 m -126.33 0.24 7.02 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.739 0.78 . . . . 0.0 109.662 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.442 HG21 ' CB ' ' A' ' 486' ' ' ASP . 74.7 m -116.23 146.01 42.68 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.491 -0.755 . . . . 0.0 111.158 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -119.24 159.89 23.23 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.81 -164.44 20.14 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 35.3 ttm-85 -135.43 130.03 34.16 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 482' ' ' THR . 38.2 t -64.46 120.78 12.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.69 0.757 . . . . 0.0 112.858 -172.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -85.33 -60.28 2.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.812 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.8 160.75 37.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.921 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.44 ' HE2' HD21 ' A' ' 444' ' ' LEU . 36.7 tpp -130.69 117.51 19.56 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.16 138.78 53.72 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -103.62 176.48 5.14 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.932 -173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -51.33 -38.39 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.517 1.136 . . . . 0.0 111.783 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.0 m -76.74 -5.9 49.98 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.01 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.44 2.64 63.5 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.38 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -88.67 128.63 35.6 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.755 0.312 . . . . 0.0 110.365 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -84.31 134.15 34.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.1 176.15 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -96.52 -35.51 11.09 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.962 0.411 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.75 151.43 28.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.304 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.91 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.135 0.574 . . . . 0.0 109.755 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.77 179.29 42.87 Favored Glycine 0 N--CA 1.439 -1.148 0 O-C-N 123.534 0.521 . . . . 0.0 112.327 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.72 161.01 46.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.696 2.264 . . . . 0.0 112.689 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.7 m 67.25 23.14 9.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.406 1.082 . . . . 0.0 110.591 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 26.0 ttt -125.86 137.62 30.43 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.884 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 5.7 Cg_exo -83.21 125.75 4.1 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.69 151.66 17.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.248 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.7 tt0 -108.63 119.05 38.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.5 pt -98.15 172.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.262 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.6 p -148.9 157.24 43.28 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.823 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.49 4.96 Favored Glycine 0 C--N 1.308 -0.988 0 O-C-N 123.566 0.541 . . . . 0.0 112.379 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.27 -31.65 11.95 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.76 21.16 11.22 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.992 1.317 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.442 ' CB ' HG21 ' A' ' 455' ' ' THR . 38.1 t70 -147.78 167.43 24.72 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.75 115.93 65.85 Favored Pre-proline 0 C--N 1.287 -2.117 0 CA-C-O 121.035 0.445 . . . . 0.0 110.762 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -84.97 173.7 7.88 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.617 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -122.47 136.63 54.93 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.962 0.411 . . . . 0.0 111.383 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.85 140.6 51.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.922 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.51 89.38 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.585 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.84 -176.4 4.43 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 6.3 mpt_? -113.14 150.4 32.26 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.241 0.543 . . . . 0.0 110.196 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.616 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.2 p90 -139.54 165.13 28.07 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.14 131.99 45.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 84.5 t -129.08 138.14 55.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -133.92 123.2 24.27 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -92.94 -41.86 9.79 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.785 0.802 . . . . 0.0 109.387 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.576 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 15.2 t70 73.36 -76.87 0.06 Allowed 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 126.505 1.922 . . . . 0.0 112.79 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -27.24 60.5 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -165.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.429 ' HB2' ' HG3' ' A' ' 498' ' ' GLU . 6.7 mmmm -56.36 -42.48 77.87 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.277 0.361 . . . . 0.0 110.363 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -80.82 -37.38 30.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.64 -56.6 17.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.23 0.612 . . . . 0.0 111.425 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -72.73 -19.49 61.37 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.394 0.616 . . . . 0.0 111.296 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 501' ' ' LYS . 7.9 tt0 -81.21 -31.05 34.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.01 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 83.3 mt -87.29 -53.89 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 151.79 32.56 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.237 -1.459 . . . . 0.0 114.173 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -66.42 -38.83 88.32 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -131.57 115.86 16.66 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -104.0 -56.52 2.18 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.645 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -86.45 -40.7 15.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -172.49 170.73 4.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -89.99 -20.38 23.35 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.208 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 124.564 1.146 . . . . 0.0 109.845 -176.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.492 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 25.5 m -127.43 -61.15 1.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -94.5 74.66 3.81 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 56.9 ttp -100.92 106.82 18.19 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.287 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 94.3 mt -98.45 157.77 16.0 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.68 -23.99 45.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -85.61 105.19 16.0 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.527 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 98.0 mt -126.49 118.13 24.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.71 -25.51 44.67 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 66.67 102.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.87 1.268 . . . . 0.0 112.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 64.4 mtt -116.81 142.82 46.43 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.906 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 52.6 mt 60.75 79.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.274 1.03 . . . . 0.0 110.152 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.16 88.38 4.19 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.9 99.46 3.26 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.91 -13.19 8.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.724 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 13.8 m -82.86 95.67 8.01 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.589 0.709 . . . . 0.0 110.57 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.42 -64.76 1.04 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.278 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 16.6 tpt 71.97 -14.12 0.54 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.334 1.454 . . . . 0.0 112.312 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.98 123.28 26.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 111.54 22.2 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.2 tp -132.69 14.21 4.42 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.958 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 61.37 85.43 0.12 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.828 -173.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -75.15 97.3 3.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -45.49 123.45 5.74 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 124.671 1.188 . . . . 0.0 111.766 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.83 -49.82 7.68 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 111.258 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 418' ' ' ALA . 14.7 m120 -90.72 74.57 6.62 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.0 117.48 5.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.396 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 75.39 7.83 3.95 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.674 1.59 . . . . 0.0 112.206 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.518 ' HA ' ' HZ3' ' A' ' 501' ' ' LYS . . . -111.46 -6.76 14.4 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.915 -0.491 . . . . 0.0 110.469 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 415' ' ' ASN . 30.3 m -147.99 175.28 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -141.84 -178.35 17.87 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.3 m -124.21 138.97 54.34 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.64 138.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.7 pt -89.13 -44.3 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.045 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.45 157.42 36.95 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.05 136.98 32.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 177.74 5.54 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.18 152.48 21.08 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.344 0.593 . . . . 0.0 110.047 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -122.76 118.28 27.68 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.472 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.2 -19.37 13.44 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.31 -41.32 1.79 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.642 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.55 -37.25 19.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 110.817 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.63 -146.42 18.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.53 116.51 4.27 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.507 2.138 . . . . 0.0 111.331 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.419 HG12 ' CG2' ' A' ' 482' ' ' THR . 27.4 m -119.81 158.6 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.2 121.77 13.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.403 HG21 ' HG2' ' A' ' 480' ' ' GLU . 1.6 m -92.55 117.65 30.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.599 HD23 ' CZ ' ' A' ' 494' ' ' PHE . 0.0 OUTLIER -133.75 168.87 17.92 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.506 -177.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.86 106.35 14.07 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -72.72 117.08 15.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.779 0.799 . . . . 0.0 112.494 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.41 -15.96 9.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.123 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.68 60.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.802 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 155.63 -106.92 0.3 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 90.1 m -134.74 133.69 40.2 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.47 HD22 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -101.9 126.02 48.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.591 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.1 ttpt -140.09 145.71 37.98 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.591 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -64.93 145.58 13.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.368 0.604 . . . . 0.0 112.449 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 -21.87 42.52 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.419 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.7 144.03 27.21 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 26.1 Cg_exo -66.55 136.69 43.7 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.914 2.409 . . . . 0.0 111.346 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 161.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.262 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.22 116.19 47.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 85.0 t -128.58 122.62 57.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . 0.497 ' HA2' ' OD1' ' A' ' 492' ' ' ASP . . . 60.89 36.63 92.39 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 121.18 -0.534 . . . . 0.0 111.966 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.295 8.3 p 60.97 8.93 2.08 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.488 HG22 ' CB ' ' A' ' 486' ' ' ASP . 87.0 m -102.81 139.41 38.42 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -111.65 146.77 36.87 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.493 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -152.6 -167.86 15.94 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.67 135.92 47.27 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.73 117.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 123.404 0.44 . . . . 0.0 110.292 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.97 -56.22 3.42 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -130.63 153.76 48.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.47 ' HE2' HD22 ' A' ' 444' ' ' LEU . 39.5 tpp -121.09 120.02 34.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.87 139.13 51.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 5.5 p30 -97.02 174.53 6.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.12 -25.88 67.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 44.0 m -78.83 -19.8 51.21 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.189 0.519 . . . . 0.0 111.102 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.88 2.21 Favored Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.191 165.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.462 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 25.8 ttm180 -120.27 136.5 54.65 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.021 -1.59 . . . . 0.0 109.941 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -79.77 132.05 36.06 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.16 0.913 . . . . 0.0 110.728 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.29 -32.0 8.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.138 0.494 . . . . 0.0 110.284 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.04 163.95 37.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.388 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.64 38.45 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.09 172.31 38.19 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.555 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 439' ' ' VAL . 35.6 Cg_endo -65.79 158.55 53.11 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 21.9 m 70.54 16.83 6.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.598 1.159 . . . . 0.0 111.362 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 25.1 ttt -117.04 137.53 23.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.677 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.06 126.15 4.93 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.417 2.078 . . . . 0.0 111.298 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.57 158.0 16.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.334 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 37.8 mt-10 -111.62 121.24 44.61 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.7 pt -98.44 172.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.773 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.419 ' CG2' HG12 ' A' ' 434' ' ' VAL . 3.1 p -147.43 163.19 37.29 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.65 7.73 58.79 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.159 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.89 -39.05 64.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.22 30.41 19.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.003 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.488 ' CB ' HG22 ' A' ' 455' ' ' THR . 35.2 t70 -140.77 179.67 6.57 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.58 109.73 47.27 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 118.317 0.508 . . . . 0.0 109.939 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 1.2 Cg_endo -80.58 164.19 21.15 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 121.602 1.535 . . . . 0.0 109.73 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -131.4 140.06 49.57 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-O 121.318 0.58 . . . . 0.0 110.458 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.11 132.08 44.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.285 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 88.24 0.61 82.57 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.968 -1.111 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.582 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.6 t70 -88.41 -173.26 4.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.582 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -128.4 153.54 46.96 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.156 0.503 . . . . 0.0 111.0 -171.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 437' ' ' LEU . 44.2 p90 -145.65 165.7 27.96 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.105 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.3 ttt -133.15 123.44 25.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.0 136.72 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.47 122.55 32.07 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.544 0.688 . . . . 0.0 112.072 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.77 155.85 17.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.49 -65.73 0.51 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 7.1 pt-20 -66.39 -36.1 82.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.491 0.662 . . . . 0.0 110.984 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.518 ' HZ3' ' HA ' ' A' ' 418' ' ' ALA . 61.6 mtpt -66.49 -37.7 85.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.562 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 506' ' ' ILE . 87.8 tttt -77.79 -40.0 42.09 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.035 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.22 86.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.481 0.657 . . . . 0.0 110.924 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 508' ' ' GLU . 28.3 ttm180 -58.5 -38.83 78.47 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.835 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -74.32 -35.43 63.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.534 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 502' ' ' LYS . 75.7 mt -64.68 -38.42 82.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.724 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 157.48 -11.56 0.25 Allowed Glycine 0 N--CA 1.421 -2.31 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.117 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 504' ' ' ARG . 29.8 tt0 -88.14 63.95 7.49 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.682 1.23 . . . . 0.0 108.796 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.6 15.24 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.981 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -110.99 -173.26 2.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -84.23 25.01 0.89 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.012 0.434 . . . . 0.0 111.729 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -132.02 109.17 9.83 Favored 'General case' 0 CA--C 1.491 -1.294 0 C-N-CA 123.583 0.753 . . . . 0.0 110.864 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -127.54 21.23 6.58 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.614 1.197 . . . . 0.0 108.118 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 N--CA 1.422 -1.84 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.126 -179.603 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.475 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 45.6 m -150.2 163.73 37.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -113.77 98.06 6.79 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.407 0.622 . . . . 0.0 111.915 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 97.0 mmm -120.83 32.18 6.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.849 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 32.3 tp 66.94 20.48 10.49 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.319 1.048 . . . . 0.0 111.176 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -80.35 -40.24 27.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.624 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -63.26 -59.83 4.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.14 150.71 52.03 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.27 -45.34 5.91 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 56.04 -103.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.238 1.415 . . . . 0.0 111.652 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 70.8 mtm -147.25 114.0 6.07 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.75 103.73 14.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 80.2 mt -87.5 129.78 34.95 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.176 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.02 110.03 13.68 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.62 -3.28 10.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.241 0.544 . . . . 0.0 109.902 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.9 m -91.83 120.05 32.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.746 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -55.33 125.34 20.36 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.139 0.976 . . . . 0.0 111.416 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 407' ' ' MET . 1.9 mmt -73.92 146.32 44.07 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.083 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.54 117.15 24.42 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.05 86.52 6.6 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.359 1.076 . . . . 0.0 110.571 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -169.32 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 476' ' ' SER . 23.4 pttm -140.37 113.14 8.13 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.365 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -170.86 159.57 6.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -155.5 100.87 2.23 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.97 -68.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.071 1.847 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 57.64 -71.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.782 1.633 . . . . 0.0 111.189 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.428 ' C ' ' HD3' ' A' ' 417' ' ' ARG . 89.1 mtt180 -111.54 -92.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 416' ' ' ARG . 0.0 OUTLIER -137.84 93.39 2.77 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . 61.45 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.854 1.346 . . . . 0.0 113.655 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.38 175.62 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -126.41 171.07 18.17 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.1 m -121.86 139.94 53.01 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 34.1 t -84.61 134.78 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.93 -38.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.196 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.33 132.05 12.32 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -166.33 175.48 8.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -82.62 142.75 31.5 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.992 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.46 122.56 48.05 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.519 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.21 -16.33 43.88 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.09 -36.15 1.05 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.508 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -93.76 -15.25 25.37 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 94.13 -167.56 27.91 Favored Glycine 0 C--O 1.206 -1.597 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.32 116.46 3.2 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.207 1.938 . . . . 0.0 111.06 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.75 145.36 21.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-O 121.292 0.568 . . . . 0.0 111.043 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.79 114.92 8.32 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.36 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.426 ' HG1' ' HG2' ' A' ' 480' ' ' GLU . 6.7 m -87.04 127.56 35.1 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -141.6 169.87 16.79 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.543 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -118.44 109.48 16.29 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -78.06 122.51 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.572 0.701 . . . . 0.0 112.293 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -123.92 -13.4 7.37 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.38 -19.82 41.84 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.03 -171.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 167.53 -118.32 0.78 Allowed Glycine 0 N--CA 1.414 -2.77 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.024 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.3 m -130.85 120.82 24.23 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.44 HD21 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -98.18 123.19 42.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.586 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 24.6 ttpt -137.87 153.12 49.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.586 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -70.78 141.25 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.372 0.606 . . . . 0.0 112.554 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.39 87.14 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.403 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.32 139.63 21.66 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.16 134.7 47.0 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.085 2.523 . . . . 0.0 113.192 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.22 162.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.651 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 121.42 49.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.45 119.25 49.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.99 96.9 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 123.474 0.484 . . . . 0.0 112.069 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.304 35.0 p 66.82 -6.34 0.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.83 1.652 . . . . 0.0 115.027 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.471 HG23 ' CB ' ' A' ' 486' ' ' ASP . 91.0 m -90.94 140.92 29.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -110.78 155.48 22.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.688 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -161.47 -164.33 16.15 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 40.9 ttm180 -135.7 131.66 35.94 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 446' ' ' VAL . 35.2 t -67.96 114.06 4.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -79.22 -56.55 4.27 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.732 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.65 148.93 46.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.44 ' HE2' HD21 ' A' ' 444' ' ' LEU . 44.9 tpp -114.69 116.97 29.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.4 136.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.43 178.01 5.01 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.792 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.14 -34.76 58.18 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.157 0.983 . . . . 0.0 112.375 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.6 m -83.88 -4.03 58.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.53 62.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.97 171.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.46 136.9 37.72 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 1.9 tmm_? -90.07 128.65 36.35 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 27.5 m -125.46 -175.37 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.428 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.53 -36.26 6.25 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.79 148.3 35.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.631 -174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.39 142.15 39.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.51 176.26 36.62 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.403 ' HA ' HG11 ' A' ' 439' ' ' VAL . 36.5 Cg_endo -64.28 155.44 65.47 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.438 ' HB3' ' HE3' ' A' ' 411' ' ' LYS . 70.8 m 70.23 22.04 5.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.383 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 26.8 ttt -120.52 133.74 24.08 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.244 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.2 126.5 7.01 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.866 2.377 . . . . 0.0 110.718 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.48 155.01 14.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.49 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.426 ' HG2' ' HG1' ' A' ' 436' ' ' THR . 33.4 mt-10 -106.72 116.63 32.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -98.19 168.25 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.2 p -147.77 165.81 29.42 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 98.93 13.49 39.77 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.597 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.56 -28.3 33.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 58.11 25.48 12.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.141 1.376 . . . . 0.0 110.944 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.471 ' CB ' HG23 ' A' ' 455' ' ' THR . 11.2 t70 -147.53 -179.61 6.99 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.21 105.1 51.32 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.69 170.88 19.29 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.939 1.759 . . . . 0.0 111.144 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -111.92 141.01 46.1 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.76 21.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.03 59.25 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.905 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.44 174.62 10.48 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 141.93 43.31 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.394 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -133.77 158.33 43.61 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.9 ttt -132.37 131.27 41.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.159 0.504 . . . . 0.0 109.801 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 99.3 t -123.84 107.48 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -125.99 121.95 34.52 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.597 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.9 OUTLIER -121.86 -42.08 2.42 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.826 -175.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.597 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 21.6 t70 50.13 -87.09 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 127.928 2.491 . . . . 0.0 112.764 -174.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -49.15 -42.66 40.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.392 1.877 . . . . 0.0 111.964 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.564 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 86.7 mttt -62.84 -47.04 85.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.815 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -79.97 -29.01 39.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.036 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.1 -47.03 86.45 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -57.22 -39.55 75.69 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.957 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 81.5 mm-40 -64.32 -44.82 90.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.239 0.337 . . . . 0.0 110.633 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.96 -38.84 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.612 0.72 . . . . 0.0 110.345 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 114.89 23.25 4.7 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.334 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -88.52 -44.41 10.7 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.578 0.704 . . . . 0.0 109.556 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -124.86 93.86 4.02 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-O 121.432 0.634 . . . . 0.0 109.425 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -116.43 -60.76 1.82 Allowed 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -156.35 127.46 6.97 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.11 138.6 58.53 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -133.41 151.52 51.83 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 C--N 1.286 -2.164 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.306 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.977 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 53.3 p -90.81 -19.28 23.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.245 1.022 . . . . 0.0 111.353 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -83.47 68.58 9.81 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.896 0.855 . . . . 0.0 110.373 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 26.7 ptm -173.23 26.59 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.633 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.0 -56.15 2.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.093 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.66 111.69 18.17 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 60.88 72.12 0.53 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.941 0.877 . . . . 0.0 109.217 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.45 4.32 54.16 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.863 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.76 -67.38 0.43 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.2 -176.54 5.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 23.4 ptp -111.34 145.2 39.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.631 0.253 . . . . 0.0 111.549 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 11.1 tt -69.78 144.56 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.264 0.626 . . . . 0.0 110.518 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.03 -177.14 4.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.08 0.466 . . . . 0.0 110.666 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.0 mt -85.1 160.42 19.97 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.71 12.04 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 26.0 t 69.46 98.62 0.06 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.902 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -84.42 -28.26 27.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.865 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 74.3 mtp 60.81 -170.47 0.15 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 111.668 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -127.96 115.21 18.18 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 61.12 125.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.607 1.163 . . . . 0.0 111.135 -171.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 410' ' ' LEU . 1.9 pt? -117.04 -9.47 11.08 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp 52.7 32.85 12.71 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.476 0.485 . . . . 0.0 112.198 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -75.8 -58.98 2.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.675 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.441 ' HB2' ' OG1' ' A' ' 421' ' ' THR . 9.3 t-20 -142.95 137.91 15.39 Favored Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.016 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.9 -20.4 58.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.931 2.42 . . . . 0.0 113.35 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.49 -57.48 1.98 Allowed 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.018 -0.426 . . . . 0.0 110.707 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 66.27 17.74 10.78 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.408 1.083 . . . . 0.0 112.174 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -105.01 -54.71 2.44 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.944 -1.097 . . . . 0.0 112.901 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -107.11 8.06 29.98 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.617 0.723 . . . . 0.0 109.924 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.71 172.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.72 -179.04 19.19 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 413' ' ' ASN . 61.1 m -126.36 144.34 50.85 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.324 0.583 . . . . 0.0 110.535 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.13 132.87 30.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.9 pt -86.7 -39.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.65 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.51 146.42 22.37 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.86 146.51 27.15 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -173.85 177.15 2.49 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.3 pt? -85.39 148.73 25.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.98 131.1 51.13 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.982 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -15.7 60.96 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.625 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -91.3 -58.53 1.45 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.935 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -95.81 -42.47 8.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.144 0.472 . . . . 0.0 112.056 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 135.35 -135.89 8.16 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.53 116.05 4.38 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.971 1.78 . . . . 0.0 110.708 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.47 142.63 33.9 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 CA-C-O 121.38 0.609 . . . . 0.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -139.94 113.42 8.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.871 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.64 120.82 27.49 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -135.88 173.44 11.71 Favored 'General case' 0 C--N 1.273 -2.743 0 O-C-N 122.188 -0.32 . . . . 0.0 111.756 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -121.39 106.3 11.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.35 121.85 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.634 0.73 . . . . 0.0 112.891 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -125.38 -15.97 6.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.772 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 496' ' ' VAL . . . -73.24 -9.51 58.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.407 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.02 -97.01 0.16 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.887 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.3 m -144.51 139.64 28.36 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.446 ' CD1' HD11 ' A' ' 437' ' ' LEU . 0.6 OUTLIER -111.05 115.52 29.59 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.487 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -131.75 154.22 49.28 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -70.46 146.14 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.778 0.799 . . . . 0.0 112.774 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 502' ' ' LYS . . . 97.23 -10.61 65.49 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.577 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 499' ' ' ASP . 1.1 m-20 -96.56 153.43 38.82 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.04 134.64 6.17 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 C-N-CA 122.401 2.068 . . . . 0.0 112.501 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.2 150.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.28 122.49 67.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.43 108.75 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.91 -90.96 0.22 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.233 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.7 t -118.25 -19.78 8.83 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.887 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 486' ' ' ASP . 29.6 m -105.68 137.92 42.74 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.364 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -114.82 148.5 38.41 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.066 0.46 . . . . 0.0 110.858 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -155.73 -164.93 13.71 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -126.6 143.13 51.32 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 32.6 t -73.21 113.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.492 ' HD3' ' C ' ' A' ' 460' ' ' ARG . 1.2 tmt_? -88.69 -59.28 2.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.98 148.43 50.09 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 470' ' ' VAL . 40.0 tpp -114.74 117.78 31.75 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.97 157.65 22.25 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.421 HD22 ' HB2' ' A' ' 468' ' ' ARG . 44.4 p30 -108.18 -176.68 3.12 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.548 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.1 -25.29 61.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.375 0.607 . . . . 0.0 110.251 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.1 m -81.89 -13.27 57.8 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.36 6.61 50.61 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.421 ' HB2' HD22 ' A' ' 464' ' ' ASN . 10.8 mpt_? -88.97 140.78 29.08 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -101.58 126.58 48.42 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 462' ' ' MET . 31.0 m -131.54 -175.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.63 -23.13 8.87 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -154.17 137.28 15.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.13 147.67 32.76 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.658 0.383 . . . . 0.0 110.694 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -95.3 179.82 36.45 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.44 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.56 160.51 49.03 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.921 2.414 . . . . 0.0 113.463 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 36.8 m 65.4 29.64 11.31 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.236 1.017 . . . . 0.0 110.704 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.2 ttt -131.59 131.01 22.57 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.502 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.03 125.17 7.09 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.653 1.569 . . . . 0.0 111.884 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.4 m -137.66 158.48 34.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.585 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 33.3 tt0 -121.48 114.78 21.73 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.7 pt -97.74 170.78 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.561 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 5.3 p -147.96 160.44 42.82 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.85 7.51 38.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.096 -1.05 . . . . 0.0 114.332 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.47 -30.91 64.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.182 0.491 . . . . 0.0 109.938 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 23.5 t60 64.3 21.45 12.52 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.959 1.304 . . . . 0.0 110.73 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.422 ' CB ' HG22 ' A' ' 455' ' ' THR . 14.8 t70 -147.68 179.6 7.58 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.61 111.15 64.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-O 121.645 0.736 . . . . 0.0 111.251 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.11 161.43 18.0 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.203 1.936 . . . . 0.0 111.193 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -114.93 148.03 39.21 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-O 121.284 0.564 . . . . 0.0 109.487 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.07 128.55 36.32 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.626 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.4 64.05 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.002 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.76 178.63 7.21 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.432 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -122.91 130.52 52.95 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 44.8 p90 -122.99 151.77 41.53 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 121.26 0.552 . . . . 0.0 110.235 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.7 ttm -121.62 116.67 25.02 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 441' ' ' ALA . 92.7 t -88.74 110.56 21.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -115.86 162.6 17.09 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.849 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.561 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 55.4 tt0 68.06 -111.36 0.12 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.501 1.12 . . . . 0.0 111.95 -174.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.561 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 19.6 t70 65.05 -55.23 0.31 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.019 1.327 . . . . 0.0 112.277 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 6.9 pt-20 -57.05 -38.35 73.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.238 1.415 . . . . 0.0 113.03 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 48.3 mmtm -64.12 -49.66 71.31 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.346 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 447' ' ' GLY . 61.9 mttp -68.25 -35.24 77.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.81 -57.07 12.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.784 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -58.69 -40.2 82.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 111.861 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.09 -25.23 65.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.28 . . . . 0.0 111.705 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 502' ' ' LYS . 42.0 mm -78.36 -51.47 17.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 158.42 -12.28 0.23 Allowed Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.654 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 62.66 0.21 0.63 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.564 1.946 . . . . 0.0 113.524 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -99.83 -74.1 0.61 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.494 -0.754 . . . . 0.0 112.551 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 64.08 -68.11 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.491 1.516 . . . . 0.0 112.316 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -171.05 -61.58 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.773 1.229 . . . . 0.0 108.169 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -136.26 110.58 8.44 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.285 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 178.2 153.65 0.33 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.719 1.207 . . . . 0.0 108.009 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 . . . . . 0 C--N 1.282 -2.346 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.311 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 10.8 m -93.87 126.48 39.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -124.12 -73.31 0.64 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 14.0 tpt 162.44 -58.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -110.91 114.86 28.52 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 170.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.59 -33.55 9.97 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 -168.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 35.8 t60 75.24 -49.0 0.64 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.333 1.053 . . . . 0.0 111.01 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 399' ' ' GLU . 7.0 mp -77.82 150.4 34.24 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.5 mp 74.28 -25.92 0.19 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.563 1.145 . . . . 0.0 111.611 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 397' ' ' LEU . 37.5 mt-10 -85.26 127.06 34.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 88.0 mtp 73.27 173.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 403' ' ' LEU . 50.7 mm 64.06 92.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 67.9 mt -76.4 17.81 0.35 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.684 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 401' ' ' ILE . 2.5 mm? -105.69 23.5 13.77 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.422 0.689 . . . . 0.0 109.558 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 98.9 t 77.22 -39.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.073 1.349 . . . . 0.0 113.311 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 19.4 m 79.53 115.46 0.06 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.572 1.549 . . . . 0.0 108.615 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 164.18 18.06 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.974 -175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 56.9 ttp -90.57 84.44 5.93 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.79 117.1 24.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -94.97 154.98 16.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.71 -16.74 5.65 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.006 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -21.45 4.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -116.36 175.46 5.55 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -122.41 109.36 33.02 Favored Pre-proline 0 C--N 1.275 -2.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.14 -4.82 11.19 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.784 2.322 . . . . 0.0 113.809 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 419' ' ' VAL . 66.4 t30 -123.0 30.64 6.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.281 1.039 . . . . 0.0 108.387 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -57.74 20.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 127.888 2.475 . . . . 0.0 115.543 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 415' ' ' ASN . 22.6 ptt180 -129.61 -18.82 3.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.724 -0.61 . . . . 0.0 111.254 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -123.57 2.63 8.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.089 0.471 . . . . 0.0 110.747 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 415' ' ' ASN . 35.4 m -147.87 168.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.03 -178.29 18.27 Favored Glycine 0 C--N 1.289 -2.04 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.9 m -120.69 141.69 50.17 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 117.812 0.806 . . . . 0.0 109.507 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.23 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.8 pt -94.35 -34.7 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.318 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.4 147.85 21.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.48 17.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 178.15 2.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.14 151.97 29.5 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.728 0.775 . . . . 0.0 111.445 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -17.7 59.53 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.27 -36.35 2.71 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.058 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -95.81 -29.01 14.46 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.065 0.459 . . . . 0.0 110.891 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 110.28 -149.33 17.54 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.461 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 13.8 Cg_exo -68.85 115.65 4.06 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.809 1.673 . . . . 0.0 109.217 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.98 137.53 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 122.309 1.052 . . . . 0.0 112.621 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.91 15.23 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.3 m -88.72 123.09 32.82 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -140.36 170.99 14.78 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.474 -173.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 106.42 12.47 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.63 121.95 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.631 . . . . 0.0 112.229 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -120.84 -15.12 8.4 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.689 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.8 -7.54 59.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.659 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.73 -110.79 0.46 Allowed Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.348 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.4 m -139.9 139.78 36.29 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.469 HD21 ' HE2' ' A' ' 462' ' ' MET . 0.5 OUTLIER -112.7 126.41 55.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -174.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 8.2 ttpt -136.83 150.83 48.54 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 110.223 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.46 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.2 m -68.5 146.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.471 0.653 . . . . 0.0 112.193 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.7 -3.44 84.97 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.768 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.46 139.31 19.99 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.39 133.56 19.37 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.449 2.099 . . . . 0.0 113.281 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 14.3 pt -126.25 172.46 13.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.22 122.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 494' ' ' PHE . 44.4 t -122.8 105.29 15.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.61 -118.92 14.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.4 p -102.38 -3.5 26.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 87.1 m -104.07 129.52 51.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -123.53 167.39 13.96 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 122.032 -0.417 . . . . 0.0 109.88 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.26 -164.61 37.07 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -115.07 143.33 45.37 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.36 124.43 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.446 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.1 tmt_? -93.79 -58.89 2.13 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.19 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.89 148.47 50.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.469 ' HE2' HD21 ' A' ' 444' ' ' LEU . 50.4 tpp -119.15 117.25 28.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.82 125.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 468' ' ' ARG . 5.1 p30 -95.1 176.26 6.31 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.325 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.44 -23.17 62.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 113.083 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.4 m -77.83 -16.34 58.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.04 32.37 8.47 Favored Glycine 0 CA--C 1.486 -1.743 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.562 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.4 ' HB2' ' ND2' ' A' ' 464' ' ' ASN . 80.9 mtt180 -116.9 126.65 53.3 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -81.45 123.45 28.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.61 -174.46 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -98.68 -34.06 10.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.892 0.377 . . . . 0.0 109.986 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.67 166.1 31.39 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.941 0.401 . . . . 0.0 111.38 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.69 150.51 34.46 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.745 0.818 . . . . 0.0 109.089 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -96.39 -179.96 35.04 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.166 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.401 ' HA ' HG12 ' A' ' 439' ' ' VAL . 51.4 Cg_endo -67.06 161.9 40.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.814 2.343 . . . . 0.0 112.066 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . 0.258 51.9 p 66.47 6.79 4.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.775 1.63 . . . . 0.0 113.516 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 40.0 ttm -107.98 136.92 19.7 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.232 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.34 126.62 4.9 Favored 'Trans proline' 0 C--O 1.252 1.187 0 C-N-CA 122.46 2.107 . . . . 0.0 110.6 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 473' ' ' ALA . 20.0 m -137.33 155.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.194 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.09 115.74 30.7 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.7 pt -97.93 167.95 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 7.8 p -150.1 166.49 29.63 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.43 -15.68 19.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.877 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.76 -40.32 91.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.998 0.427 . . . . 0.0 110.802 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 72.1 t60 61.83 20.12 11.17 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.578 1.551 . . . . 0.0 110.627 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -142.38 167.21 22.63 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.6 p -110.05 119.76 46.41 Favored Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.882 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.73 176.52 7.69 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.194 2.596 . . . . 0.0 110.604 175.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -102.05 140.15 36.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.36 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -67.18 124.53 23.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.7 -0.36 57.94 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.478 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.39 176.93 8.73 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.45 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 1.4 mpt_? -118.77 124.83 48.22 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.387 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 31.8 p90 -119.96 148.84 43.04 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 53.2 ttp -118.51 127.01 53.23 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.37 107.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.245 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -125.23 122.84 38.15 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 172.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -73.18 131.63 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.035 0.921 . . . . 0.0 111.995 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 502' ' ' LYS . 23.6 t70 -62.9 -41.85 99.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.24 -15.5 61.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.688 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -77.91 -39.06 44.2 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 499' ' ' ASP . 23.1 ttpp -58.42 -47.94 82.29 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.98 88.06 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.804 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -58.82 -43.11 90.55 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.738 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -75.13 -35.36 61.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.89 -30.52 14.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.472 0.653 . . . . 0.0 109.907 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 104.32 32.09 4.4 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.561 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.64 -23.63 15.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -99.0 165.64 11.65 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.916 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.99 95.38 10.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.599 0.714 . . . . 0.0 111.733 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -93.35 -4.47 51.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.729 0.776 . . . . 0.0 109.584 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -139.33 157.11 46.46 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.812 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -85.11 139.03 32.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.95 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 11.1 p -73.9 -26.55 60.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -113.09 81.34 1.48 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.471 ' HA ' ' HE2' ' A' ' 393' ' ' MET . 3.0 mmt 50.97 -102.54 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.93 139.11 54.4 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.608 0.718 . . . . 0.0 112.773 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -140.97 10.91 2.19 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 39.5 m80 63.47 85.63 0.13 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.567 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 44.7 tp -71.52 93.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.752 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.02 122.69 44.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.39 -45.91 16.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.037 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -115.66 107.27 14.89 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 13.5 mt -117.13 27.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 9.3 mp 73.58 174.02 0.28 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.119 1.368 . . . . 0.0 110.742 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.87 89.55 3.07 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.5 m -81.8 -24.74 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.7 m 69.03 -86.18 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.849 -1.978 . . . . 0.0 116.033 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.74 -177.99 6.54 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.464 -167.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 13.1 tpt 72.13 -81.14 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 111.599 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -106.79 133.22 51.78 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.122 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -75.42 149.92 38.45 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 93.0 mt -127.14 75.62 1.59 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.365 0.602 . . . . 0.0 110.746 -174.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -106.64 142.13 36.79 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.543 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.422 ' C ' ' HD2' ' A' ' 414' ' ' PRO . . . 172.14 -167.17 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.703 ' OD1' ' HB1' ' A' ' 441' ' ' ALA 0.254 1.8 m-20 -78.56 -9.91 0.15 Allowed Pre-proline 0 CA--C 1.582 2.186 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 413' ' ' ASN . 28.8 Cg_endo -64.89 29.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.492 2.128 . . . . 0.0 112.946 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 413' ' ' ASN . 25.9 t-20 -96.58 153.09 18.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -83.52 22.63 1.03 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -165.79 -27.87 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.125 0.488 . . . . 0.0 109.784 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.98 31.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.375 0.607 . . . . 0.0 112.236 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 4.8 m -154.17 -178.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.878 0 C-N-CA 128.72 2.808 . . . . 0.0 104.786 175.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -114.89 172.2 14.09 Favored Glycine 1 N--CA 1.385 -4.705 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.2 p -131.18 141.99 50.15 Favored 'General case' 0 C--N 1.245 -3.937 0 O-C-N 124.225 0.603 . . . . 0.0 110.903 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 53.7 t -89.13 130.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 13.9 pt -89.8 -38.82 11.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.698 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -154.74 154.45 32.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -139.99 139.19 35.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.35 177.92 3.94 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.514 0.673 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -88.24 149.45 23.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.875 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.6 129.9 46.56 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 173.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -20.85 64.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -104.66 -40.6 2.15 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.723 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.454 ' HB3' HG21 ' A' ' 482' ' ' THR . 91.8 mtm180 -94.94 -22.76 17.77 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.5 -159.69 21.11 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.64 116.4 3.17 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.28 1.987 . . . . 0.0 111.095 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.428 HG13 ' CG2' ' A' ' 482' ' ' THR . 34.6 m -118.17 154.39 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -136.8 116.34 12.86 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.419 ' HG1' ' HG2' ' A' ' 480' ' ' GLU . 2.2 m -85.3 116.69 23.79 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 0.9 OUTLIER -134.18 170.91 14.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.23 108.03 12.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.56 122.05 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.398 0.618 . . . . 0.0 110.913 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 45.7 mt-30 -120.28 -21.42 6.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.703 ' HB1' ' OD1' ' A' ' 413' ' ' ASN . . . -97.1 -8.9 29.12 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 113.956 -3.098 . . . . 0.0 114.666 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . -164.94 -110.09 0.23 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 118.255 -1.926 . . . . 0.0 113.299 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.1 m -147.94 138.08 22.78 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.448 HD21 ' HE3' ' A' ' 462' ' ' MET . 0.6 OUTLIER -108.23 130.91 55.13 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.0 ttpt -146.02 151.74 38.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.508 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 26.9 m -67.22 146.96 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.91 -17.21 59.12 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.55 -1.204 . . . . 0.0 114.117 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -111.09 152.9 44.02 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.167 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 33.0 Cg_endo -64.15 147.47 91.37 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.342 2.695 . . . . 0.0 113.689 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.55 158.86 16.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 124.969 1.308 . . . . 0.0 108.455 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.51 118.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.66 107.66 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.1 -111.28 3.83 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.063 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.4 p -104.4 -4.14 23.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.148 0.579 . . . . 0.0 111.672 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 486' ' ' ASP . 65.1 m -125.92 141.89 51.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 120.945 0.403 . . . . 0.0 110.943 -175.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -118.05 154.48 31.97 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -160.56 -164.22 15.17 Favored Glycine 0 C--N 1.282 -2.427 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . 0.402 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 35.1 ttm180 -126.71 136.67 52.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 482' ' ' THR . 26.2 t -73.69 111.69 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.532 0.52 . . . . 0.0 110.612 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -83.36 -50.51 8.27 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.855 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.31 144.92 42.86 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.448 ' HE3' HD21 ' A' ' 444' ' ' LEU . 41.5 tpp -115.06 117.2 29.89 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.05 126.73 68.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 6.2 p30 -87.13 177.86 7.07 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.831 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.01 -30.62 36.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.1 m -76.16 -26.17 55.99 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.899 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.12 38.64 3.28 Favored Glycine 0 CA--C 1.475 -2.46 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.628 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 69.7 ttt180 -119.63 127.37 52.86 Favored 'General case' 0 N--CA 1.404 -2.748 0 CA-C-N 112.171 -2.015 . . . . 0.0 105.977 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -81.32 129.83 34.78 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.93 -178.72 2.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -111.45 -28.56 8.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.878 0.371 . . . . 0.0 111.368 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -150.67 168.22 25.0 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -147.45 134.33 20.18 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.57 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.85 176.6 53.34 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.2 156.22 66.55 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.028 1.819 . . . . 0.0 112.754 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.8 t 77.85 -0.34 2.72 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.15 1.38 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 33.6 ttm -98.93 133.66 22.1 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -84.92 126.0 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.374 2.05 . . . . 0.0 112.083 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.74 155.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.419 ' HG2' ' HG1' ' A' ' 436' ' ' THR . 37.4 mt-10 -107.3 118.96 38.09 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 45.4 pt -98.02 170.01 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.083 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 431' ' ' ARG . 3.0 p -146.3 156.57 43.45 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 109.26 22.17 6.95 Favored Glycine 0 N--CA 1.427 -1.964 0 O-C-N 124.081 0.863 . . . . 0.0 113.807 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.95 -38.31 16.77 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 60.09 21.97 11.2 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.279 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.7 t0 -139.33 179.96 6.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 5.9 p -90.19 114.69 61.87 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-O 121.304 0.573 . . . . 0.0 111.487 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.68 168.43 8.33 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -129.48 131.93 46.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.773 0.321 . . . . 0.0 111.36 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.46 134.91 46.92 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.97 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 91.01 -5.0 81.88 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.24 -179.09 7.13 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -109.82 141.35 42.61 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 8.7 p90 -128.84 153.3 47.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.86 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' MET . . . . . 0.648 ' HA ' ' CB ' ' A' ' 413' ' ' ASN . 44.0 ttp -122.5 117.0 24.9 Favored 'General case' 0 C--N 1.248 -3.821 0 C-N-CA 125.399 1.48 . . . . 0.0 110.582 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.65 ' H ' ' CG ' ' A' ' 413' ' ' ASN . 0.5 OUTLIER -86.91 144.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.316 174.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -97.67 167.47 10.94 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.32 0.581 . . . . 0.0 110.83 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 501' ' ' LYS . 33.3 tt0 -74.16 138.85 44.09 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.401 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.51 -45.67 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.203 1.001 . . . . 0.0 111.195 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.37 -5.43 52.24 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.512 ' HE2' ' HB3' ' A' ' 498' ' ' GLU . 7.2 tppt? -57.65 -34.46 69.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.369 0.668 . . . . 0.0 111.135 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.413 ' O ' HG12 ' A' ' 506' ' ' ILE . 13.1 mmmm -60.89 -51.59 68.64 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.683 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.31 99.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.9 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 501' ' ' LYS . 21.9 tpp180 -50.2 -54.22 22.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.456 1.502 . . . . 0.0 109.239 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.62 -39.86 89.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.901 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 502' ' ' LYS . 50.9 mm -75.68 -53.9 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.598 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -152.44 -11.02 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 118.931 -1.604 . . . . 0.0 115.794 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -89.15 14.14 11.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 118.403 1.101 . . . . 0.0 113.441 -173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -107.29 -67.56 0.95 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.907 0.385 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 53.71 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.57 1.548 . . . . 0.0 113.812 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -87.95 -26.05 22.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -96.45 85.73 3.99 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.806 0.336 . . . . 0.0 110.67 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -160.87 40.54 0.16 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.365 0.602 . . . . 0.0 111.11 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.247 0.956 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.141 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.2 p -86.23 103.8 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 121.375 0.607 . . . . 0.0 111.902 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -98.15 -6.79 30.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.868 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 34.4 tpp 71.01 117.34 0.04 OUTLIER 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.032 0.933 . . . . 0.0 111.227 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.542 ' HB2' ' CD2' ' A' ' 396' ' ' HIS . 77.0 mt -81.66 -14.95 56.0 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.103 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.5 t70 60.17 78.05 0.29 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.438 1.095 . . . . 0.0 110.43 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 394' ' ' LEU . 1.6 p80 -160.15 19.82 0.15 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.699 -173.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.27 26.49 2.18 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.3 0.571 . . . . 0.0 111.792 -173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.27 -70.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.202 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 50.7 -87.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.412 1.085 . . . . 0.0 113.705 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 86.2 mtp -73.32 -30.41 63.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 0.0 110.049 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 43.0 pt -102.17 17.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.431 0.634 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.92 -23.14 62.2 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.479 1.133 . . . . 0.0 108.415 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.05 98.52 6.53 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.182 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.84 -28.05 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.838 0.828 . . . . 0.0 109.223 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 51.2 m -114.84 141.38 47.98 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.88 123.96 22.01 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 22.1 ttt -85.56 92.01 8.41 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.749 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.38 145.06 30.79 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -106.28 -177.14 3.28 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.16 -13.58 38.74 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.648 0.737 . . . . 0.0 109.723 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt 72.23 97.82 0.07 Allowed 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.041 1.736 . . . . 0.0 112.907 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 414' ' ' PRO . . . -94.76 -159.7 0.73 Allowed 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -104.61 98.09 13.97 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 412' ' ' ALA . 81.7 Cg_endo -97.05 17.99 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.527 2.818 . . . . 0.0 112.807 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -80.21 105.87 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.417 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 72.11 -35.9 0.34 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 81.93 129.04 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.777 1.631 . . . . 0.0 109.697 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . 69.95 67.39 0.23 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.356 1.063 . . . . 0.0 109.72 -174.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.8 m -142.35 -178.89 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 113.628 -1.624 . . . . 0.0 106.951 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -138.08 176.31 20.8 Favored Glycine 0 C--N 1.293 -1.856 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.722 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 19.2 m -120.82 141.99 50.03 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.6 138.57 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.41 -39.02 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.62 148.86 26.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.79 131.4 12.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.5 178.46 1.96 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.95 149.23 29.46 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.234 0.54 . . . . 0.0 110.151 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -126.7 122.56 35.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.571 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.4 -17.09 52.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -178.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.26 -42.88 1.13 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -84.51 -31.63 24.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.68 -158.08 14.56 Favored Glycine 0 C--N 1.314 -0.639 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.56 116.25 4.14 Favored 'Trans proline' 0 C--O 1.244 0.8 0 CA-C-N 120.047 1.924 . . . . 0.0 108.949 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.44 150.94 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.943 0.878 . . . . 0.0 112.386 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -141.56 111.52 6.71 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.519 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -88.22 122.86 32.25 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.55 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -139.21 173.2 11.8 Favored 'General case' 0 C--N 1.272 -2.77 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.425 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -117.24 106.01 12.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -73.48 119.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 112.143 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 77.6 mt-30 -124.28 -15.03 6.84 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.865 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.24 -15.57 60.0 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.189 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 166.98 -100.93 0.17 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' THR . . . . . 0.405 ' HB ' ' OE1' ' A' ' 498' ' ' GLU . 3.3 m -144.93 144.15 30.92 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.464 ' CD1' HD12 ' A' ' 437' ' ' LEU . 0.5 OUTLIER -108.65 129.75 55.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 448' ' ' ASP . 18.0 ttpt -138.81 148.39 43.71 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.417 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.8 m -70.76 141.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.21 0.529 . . . . 0.0 111.058 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.14 83.8 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.601 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.427 ' HB2' ' HE2' ' A' ' 445' ' ' LYS . 1.2 t70 -94.9 130.71 32.11 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.57 123.22 10.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.284 1.989 . . . . 0.0 109.755 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.45 162.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 122.639 0.376 . . . . 0.0 110.498 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.35 122.56 56.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.25 125.33 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.14 97.29 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.999 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 2.3 m 65.07 9.51 5.56 Favored 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 124.905 1.282 . . . . 0.0 112.758 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 59.7 m -113.23 137.48 51.42 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -111.55 150.87 29.39 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -157.15 -164.11 13.26 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -134.06 129.53 36.18 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 482' ' ' THR . 47.5 t -62.16 114.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.432 0.458 . . . . 0.0 111.58 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -81.3 -55.19 4.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.259 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.51 152.64 51.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.456 ' HE2' HD21 ' A' ' 444' ' ' LEU . 51.1 tpp -115.01 117.57 30.98 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.74 136.52 53.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -99.38 -179.22 4.15 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.463 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.08 -29.57 60.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.8 m -74.86 -25.29 58.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.028 0.442 . . . . 0.0 110.378 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.75 30.02 6.3 Favored Glycine 0 CA--C 1.5 -0.899 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.588 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -115.77 144.45 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -76.58 129.79 36.94 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 124.239 0.962 . . . . 0.0 110.329 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.8 m -135.87 -178.25 2.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -115.72 -23.74 8.55 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.08 143.77 19.48 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -173.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.48 146.82 32.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.78 177.35 40.21 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.678 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.41 ' HA ' HG11 ' A' ' 439' ' ' VAL . 54.7 Cg_endo -65.07 161.26 37.81 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 123.167 2.578 . . . . 0.0 113.666 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 20.4 t 67.74 16.77 9.78 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 125.124 1.37 . . . . 0.0 111.076 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 23.8 ttt -120.16 133.92 24.0 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -72.73 125.88 10.92 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.559 2.172 . . . . 0.0 112.129 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 8.3 m -141.81 159.38 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.64 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -122.35 115.81 22.94 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.8 172.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.655 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.6 p -149.08 167.16 26.61 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.23 33.37 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.779 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.36 -33.37 25.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 70.6 t60 64.93 21.31 12.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.859 1.663 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -145.91 179.6 7.35 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.7 t -121.67 109.65 34.18 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 118.389 0.541 . . . . 0.0 109.544 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.0 175.57 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.894 2.396 . . . . 0.0 110.952 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -118.59 148.32 42.8 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.25 0.547 . . . . 0.0 112.052 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.95 141.93 54.83 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.829 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.38 0.03 89.88 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.091 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -92.56 -179.21 5.12 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.34 145.2 43.39 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.308 0.575 . . . . 0.0 110.653 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -132.14 159.15 39.78 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.6 ttt -132.15 118.03 19.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.235 0.54 . . . . 0.0 109.814 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.06 106.91 21.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -100.03 121.56 41.57 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.548 ' OE1' ' HB2' ' A' ' 501' ' ' LYS . 2.4 tt0 -100.48 148.54 24.64 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.502 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.77 -49.89 3.85 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.238 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.04 -16.11 63.89 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.305 0.574 . . . . 0.0 112.253 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.548 ' HB2' ' OE1' ' A' ' 498' ' ' GLU . 65.0 tttm -62.49 -51.36 67.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.552 ' HZ2' ' HB2' ' A' ' 502' ' ' LYS . 10.3 mtmp? -64.2 -40.74 96.72 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.519 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.21 40.41 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 123.379 0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.01 -39.75 86.89 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.68 -46.74 71.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.786 0.327 . . . . 0.0 111.558 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.85 -32.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.292 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.39 28.62 5.4 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.81 -41.37 16.16 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 61.31 -174.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.839 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -160.2 163.28 33.73 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -89.55 99.09 12.16 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -74.34 145.89 43.5 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.184 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -149.41 7.21 0.67 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.265 1.026 . . . . 0.0 111.222 -175.484 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.615 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.5 p -155.43 164.16 39.08 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 395' ' ' ASP . 27.8 m80 64.12 39.16 7.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 124.076 0.86 . . . . 0.0 110.718 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 25.2 mmt -117.21 -44.33 2.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.017 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.74 31.39 4.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 392' ' ' HIS . 5.5 m-20 -118.68 -156.99 0.67 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.001 -1.908 . . . . 0.0 107.839 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -136.74 146.17 45.49 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.76 115.14 16.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.63 -50.96 2.4 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 69.7 112.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.191 . . . . 0.0 109.451 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 21.0 mmt 65.74 81.72 0.2 Allowed 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.176 0.989 . . . . 0.0 109.958 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 68.1 mt -71.68 128.06 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.403 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.9 137.57 57.84 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.92 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.0 tp 73.89 119.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 O-C-N 125.035 1.46 . . . . 0.0 110.07 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 12.9 p -66.6 -11.4 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.359 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.9 m 72.89 -4.68 2.08 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.413 1.485 . . . . 0.0 112.461 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.62 104.35 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 110.819 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 55.2 ttp -142.97 22.46 1.92 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.001 -167.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -86.07 83.65 7.71 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.926 0.869 . . . . 0.0 110.784 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.0 pp -129.98 17.28 5.65 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.472 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -88.14 89.01 7.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -151.62 27.86 0.64 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -141.04 92.05 8.7 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.484 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -101.12 20.07 0.24 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.372 2.715 . . . . 0.0 111.721 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.37 -66.49 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.536 ' HD2' ' SD ' ' A' ' 495' ' ' MET . 43.2 ttm180 -130.64 -85.13 0.52 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.439 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -173.09 -68.76 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -85.72 85.55 7.4 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 16.4 m -142.21 179.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.49 169.22 25.57 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.3 m -119.06 141.93 48.3 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.59 137.13 22.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.1 pt -89.53 -39.83 12.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.844 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -159.39 148.52 18.23 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.3 144.2 33.15 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -170.07 176.02 4.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.9 pt? -84.46 142.06 30.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.55 120.45 37.53 Favored 'General case' 0 C--N 1.255 -3.51 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.43 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.59 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.35 -17.08 6.74 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.26 -40.85 0.85 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.355 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -88.4 -16.05 33.91 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 90.86 -158.92 26.34 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -59.79 116.45 3.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 121.894 1.729 . . . . 0.0 110.363 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 482' ' ' THR . 33.3 m -122.54 163.86 20.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -147.76 112.2 5.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.323 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.87 117.28 24.63 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.678 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.8 pp -132.92 173.14 11.71 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -173.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -119.48 105.72 11.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.56 121.57 27.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.636 0.731 . . . . 0.0 112.189 -175.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 37.8 mt-30 -124.04 -14.26 7.13 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.401 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.47 61.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.187 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 152.04 -104.71 0.27 Allowed Glycine 0 N--CA 1.411 -2.981 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.823 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 6.8 m -130.82 136.5 48.74 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.489 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -111.39 124.06 51.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.5 ' HB3' ' HZ2' ' A' ' 445' ' ' LYS . 2.4 ttpm? -134.07 157.24 46.64 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.492 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.7 m -67.64 126.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.24 0.543 . . . . 0.0 109.987 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 110.91 -11.1 29.63 Favored Glycine 0 C--N 1.306 -1.137 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 445' ' ' LYS . 1.0 OUTLIER -71.0 131.2 87.45 Favored Pre-proline 0 C--O 1.247 0.938 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -79.44 112.38 2.97 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 122.239 1.959 . . . . 0.0 108.935 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.24 149.28 14.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.216 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 40.5 t -122.85 115.03 44.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.525 HG11 ' CB ' ' A' ' 494' ' ' PHE . 30.0 m -120.31 116.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.11 0.481 . . . . 0.0 109.723 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.94 -96.62 0.16 Allowed Glycine 0 C--N 1.307 -1.068 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.345 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 30.9 p -118.26 -7.21 10.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 122.734 0.413 . . . . 0.0 111.205 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.493 HG22 ' CB ' ' A' ' 486' ' ' ASP . 21.1 m -113.67 145.84 40.71 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.201 -0.312 . . . . 0.0 110.899 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -120.72 156.25 32.19 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.22 -168.51 27.49 Favored Glycine 0 C--N 1.295 -1.733 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.305 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -127.66 132.6 49.68 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 444' ' ' LEU . 51.1 t -65.75 121.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.586 0.554 . . . . 0.0 110.735 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -91.4 -52.26 4.88 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.672 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.15 150.37 50.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.489 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.1 tpp -115.1 117.11 29.64 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 9.4 t -120.35 141.42 40.72 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.63 175.06 5.6 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.193 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.71 -25.86 55.47 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.075 0.95 . . . . 0.0 113.087 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.3 t -78.19 -10.66 59.74 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.222 0.534 . . . . 0.0 110.097 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.99 8.16 61.94 Favored Glycine 0 CA--C 1.491 -1.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.83 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -96.79 129.69 44.17 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.558 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.0 tmm_? -86.65 129.99 34.66 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 19.3 m -135.12 -174.21 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.236 0.614 . . . . 0.0 109.907 -174.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -98.04 -36.12 10.21 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 122.96 0.504 . . . . 0.0 111.404 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -156.0 151.74 27.29 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.535 -172.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -142.91 150.23 39.5 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 123.924 0.765 . . . . 0.0 109.549 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.11 179.53 39.46 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.352 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.83 161.42 46.13 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 123.052 2.501 . . . . 0.0 113.888 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.2 m 68.83 18.63 8.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.834 1.254 . . . . 0.0 111.116 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.4 ttt -122.23 133.98 24.6 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.561 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 46.5 Cg_endo -77.55 125.9 7.9 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 122.293 1.995 . . . . 0.0 112.577 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.11 157.83 22.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.19 117.51 29.77 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -97.68 168.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.859 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 434' ' ' VAL . 6.0 p -146.74 165.66 28.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.574 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.45 20.53 22.24 Favored Glycine 0 C--N 1.296 -1.684 0 O-C-N 123.929 0.768 . . . . 0.0 112.576 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 41.6 tp -85.34 -39.35 17.75 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 64.41 21.44 12.48 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.776 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.493 ' CB ' HG22 ' A' ' 455' ' ' THR . 15.0 t70 -138.92 179.24 6.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 38.0 t -111.47 107.08 57.04 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 118.214 0.461 . . . . 0.0 111.175 -173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -85.84 174.7 6.36 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.556 2.171 . . . . 0.0 111.61 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.71 145.53 50.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.922 0.392 . . . . 0.0 110.701 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -66.69 128.62 36.95 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.571 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.28 60.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.123 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.48 179.18 6.06 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.333 0.587 . . . . 0.0 110.591 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 0.4 OUTLIER -114.73 129.2 56.65 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.678 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 45.8 p90 -131.87 158.95 40.0 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.671 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' MET . . . . . 0.536 ' SD ' ' HD2' ' A' ' 416' ' ' ARG . 27.0 ttt -131.44 134.45 46.22 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.311 174.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 58.1 t -119.26 107.77 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -150.65 122.62 8.19 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -105.91 141.28 37.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 502' ' ' LYS . 17.5 t70 -68.17 -38.84 82.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -68.75 -21.16 64.38 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.284 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.3 -43.66 73.34 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 499' ' ' ASP . 33.8 ttpt -61.22 -46.22 91.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.93 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.8 92.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.727 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -63.74 -34.72 78.51 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.781 0.832 . . . . 0.0 111.24 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.7 -38.77 91.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.75 -42.95 77.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 119.05 9.89 8.54 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.503 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -63.3 -37.76 88.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.72 61.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.056 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -129.64 20.33 5.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.795 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -118.34 -9.58 10.37 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.332 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.04 154.82 29.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -154.71 143.71 20.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.29 -2.004 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 m -79.07 -29.06 43.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 59.26 85.71 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -70.47 113.37 7.53 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 77.26 156.38 0.17 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.895 1.278 . . . . 0.0 110.337 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -47.34 46.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.192 0.52 . . . . 0.0 110.738 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -135.08 144.2 47.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 40.6 tp 63.5 82.23 0.19 Allowed 'General case' 0 C--O 1.246 0.88 0 O-C-N 124.52 1.138 . . . . 0.0 109.027 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.8 pp -84.86 166.56 16.77 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.8 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -84.79 146.56 27.3 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.737 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -81.37 -36.7 29.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 15.5 tt -157.8 147.74 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.932 0.396 . . . . 0.0 110.368 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.0 mp -89.49 155.97 18.95 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.89 168.8 18.77 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.166 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.59 -18.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 49.7 m -83.05 94.62 7.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.53 122.45 16.32 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.265 -175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -95.68 -17.67 21.11 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.37 118.24 33.41 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.901 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.19 144.04 29.66 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 22.5 tp -151.77 7.98 0.49 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.052 0.453 . . . . 0.0 111.115 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -88.0 -39.44 14.68 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.199 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -78.64 -40.63 33.68 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.436 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.407 HD22 HG23 ' A' ' 419' ' ' VAL . 13.6 t-20 -145.9 134.91 11.17 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.28 -4.29 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.0 2.467 . . . . 0.0 114.269 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -121.88 158.98 27.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.53 -16.59 41.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.784 0.326 . . . . 0.0 110.359 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -71.55 166.98 20.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 112.131 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -86.87 94.19 9.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.4 m -146.91 178.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -124.22 169.75 16.33 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.8 m -115.99 139.54 50.16 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.24 133.91 28.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 12.6 pt -91.94 -39.8 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.884 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.87 153.76 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.42 29.95 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -165.63 176.34 8.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.478 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.6 pt? -94.83 148.23 22.51 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.44 121.94 32.16 Favored 'General case' 0 N--CA 1.391 -3.412 0 C-N-CA 116.929 -1.908 . . . . 0.0 109.697 167.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.609 ' HD2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.9 -22.58 62.57 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.026 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.8 -51.99 0.82 Allowed Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.702 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.68 -26.56 57.74 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 122.935 0.494 . . . . 0.0 111.379 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 107.79 -163.74 12.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -69.21 115.56 4.07 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 121.914 1.743 . . . . 0.0 108.215 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.435 ' HB ' ' CG ' ' A' ' 480' ' ' GLU . 28.3 m -124.46 162.79 25.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -154.39 114.82 3.92 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.603 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 119.64 25.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.54 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.0 OUTLIER -136.24 173.48 11.66 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 476' ' ' SER . 1.2 tm? -122.61 107.98 12.59 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 475' ' ' PRO . 6.4 p -73.98 119.85 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 111.751 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 40.5 mt-30 -123.59 -15.81 6.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.794 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.434 ' HB3' HG13 ' A' ' 496' ' ' VAL . . . -92.23 2.17 56.77 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 158.87 -125.67 1.55 Allowed Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.185 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.3 m -129.83 134.19 47.39 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.491 HD22 ' HE2' ' A' ' 462' ' ' MET . 0.6 OUTLIER -104.6 133.2 49.86 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.557 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 2.1 ttpm? -148.29 159.66 43.76 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.557 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -68.06 136.27 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.159 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.59 -2.83 60.8 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.403 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.76 132.77 30.51 Favored Pre-proline 0 C--O 1.25 1.115 0 CA-C-N 117.317 0.559 . . . . 0.0 110.003 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.35 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.08 1.853 . . . . 0.0 111.762 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.92 172.65 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.25 124.29 18.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.178 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.4 111.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.32 11.13 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.1 m -99.15 -4.45 32.15 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.32 0.581 . . . . 0.0 110.3 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 48.9 m -102.86 136.32 42.9 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.602 -0.686 . . . . 0.0 112.053 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.75 161.88 16.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -177.3 -169.33 38.31 Favored Glycine 0 CA--C 1.475 -2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . 0.479 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 55.2 ttp180 -130.6 137.71 49.77 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.99 116.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.04 0.448 . . . . 0.0 111.824 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -79.43 -60.07 2.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -143.49 160.25 40.93 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.491 ' HE2' HD22 ' A' ' 444' ' ' LEU . 35.6 tpp -121.48 134.65 55.07 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 480' ' ' GLU . 6.1 t -117.24 142.09 32.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -103.62 179.73 4.19 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.178 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.42 -29.25 48.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.612 1.165 . . . . 0.0 112.94 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 -6.85 58.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.0 4.13 63.38 Favored Glycine 0 N--CA 1.466 0.654 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.255 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -93.09 156.93 16.56 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.4 ' NH1' HG22 ' A' ' 463' ' ' VAL . 20.2 tpp180 -75.41 132.88 41.17 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.824 0.85 . . . . 0.0 110.97 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.3 175.59 5.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.76 -28.89 3.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.719 0.295 . . . . 0.0 111.673 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.465 ' HG2' ' HG3' ' A' ' 445' ' ' LYS . 30.7 mt-10 -123.6 141.17 52.27 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.44 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . 0.424 ' CB ' HG13 ' A' ' 479' ' ' VAL . . . -139.29 126.01 20.73 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.54 161.36 40.61 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' A' ' 439' ' ' VAL . 19.3 Cg_endo -59.67 150.75 74.72 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.931 2.421 . . . . 0.0 113.031 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 438' ' ' LEU . 22.2 m 75.77 4.45 3.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.351 1.46 . . . . 0.0 112.268 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 47.0 ttp -103.86 136.11 19.25 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 122.275 -0.266 . . . . 0.0 110.953 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.77 126.2 8.67 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.423 2.082 . . . . 0.0 111.326 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 473' ' ' ALA . 12.7 m -142.06 159.02 20.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 463' ' ' VAL . 37.7 tt0 -117.56 124.94 49.91 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.45 172.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.725 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.9 p -151.22 161.99 41.7 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 112.73 8.11 21.13 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.941 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 58.2 mt -89.95 -40.33 12.43 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.478 -0.425 . . . . 0.0 110.166 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 58.17 21.29 7.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 111.07 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 488' ' ' PRO . 5.4 t70 -126.74 -178.89 4.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.27 110.09 46.37 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 4.6 Cg_endo -84.24 156.42 12.84 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.178 1.919 . . . . 0.0 109.988 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -121.29 134.8 55.17 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -69.17 124.5 23.98 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.141 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.04 -0.37 56.19 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.62 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.01 178.51 8.12 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.859 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -110.44 130.07 55.63 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 32.5 p90 -125.86 154.86 42.08 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.123 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 59.6 ttp -119.28 127.13 52.94 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 441' ' ' ALA . 10.6 p -86.76 123.76 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -127.82 122.07 31.74 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -107.43 -161.89 0.81 Allowed 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.412 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 23.7 t70 -125.54 -68.34 0.84 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -52.46 -34.69 50.06 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.4 -44.76 70.78 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.501 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 506' ' ' ILE . 60.4 mttp -79.96 -30.57 39.83 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.141 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.7 88.98 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 508' ' ' GLU . 42.9 ttp180 -59.36 -41.88 90.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.488 0.661 . . . . 0.0 109.983 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -68.8 -29.86 68.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.6 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 502' ' ' LYS . 85.1 mt -83.5 -52.16 13.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.895 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -169.13 -17.44 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 119.411 -1.376 . . . . 0.0 113.552 -173.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 504' ' ' ARG . 7.6 tp10 -81.7 57.04 3.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.655 1.217 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -126.99 118.83 25.27 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.853 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -85.18 92.61 8.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.08 0.943 . . . . 0.0 109.662 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -73.33 95.11 2.12 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.782 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -131.34 86.0 2.32 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -154.13 119.1 5.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.194 -176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 C--N 1.284 -2.263 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 19.2 m -83.67 -17.24 42.12 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -76.67 -34.03 58.26 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.702 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 87.7 mtp 63.87 -179.98 0.16 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.793 1.237 . . . . 0.0 112.774 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.5 pp -118.76 27.2 9.04 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.103 0.954 . . . . 0.0 109.663 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.02 -50.15 67.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.559 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -144.87 112.62 6.28 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 125.102 1.361 . . . . 0.0 107.332 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.43 -58.94 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.7 mp -125.84 -67.81 0.86 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 42.42 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.787 2.035 . . . . 0.0 115.81 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -83.53 26.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.679 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.9 -39.54 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.03 137.47 53.07 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.95 105.49 15.76 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.429 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 78.0 t -70.89 -53.87 20.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 22.6 t 57.7 84.72 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.017 0.927 . . . . 0.0 112.144 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -81.67 -68.9 0.65 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 27.0 ttt 41.1 83.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.693 1.597 . . . . 0.0 112.436 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -130.52 161.32 31.74 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.137 -173.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -70.1 109.41 4.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.21 -20.28 20.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -123.01 -74.11 0.63 Allowed 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.62 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 179.06 133.19 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 125.171 1.388 . . . . 0.0 107.977 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 493' ' ' ARG . 51.7 m-80 85.32 125.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 125.797 1.639 . . . . 0.0 110.333 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -69.67 -44.15 2.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.598 1.532 . . . . 0.0 110.674 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -121.26 95.02 4.52 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.084 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -76.63 92.42 3.5 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.535 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -125.88 -86.77 0.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -116.62 75.98 1.0 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.85 166.17 3.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -140.16 -175.16 14.23 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.055 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.7 p -125.57 145.13 50.26 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 124.156 0.983 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 37.7 t -87.73 134.01 28.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.76 -39.69 12.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.506 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 490' ' ' ALA . 8.5 pt-20 -158.31 149.43 20.84 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.35 149.13 34.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.491 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -172.65 177.1 3.02 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -95.26 146.72 24.15 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -123.38 120.57 33.41 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.551 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -55.84 -18.77 9.5 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -107.62 -42.57 1.44 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.403 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -81.2 -34.25 32.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.728 0.299 . . . . 0.0 111.489 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.09 -145.85 17.98 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.32 115.99 4.24 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 121.86 1.706 . . . . 0.0 108.648 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.491 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 18.1 m -116.09 153.53 17.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.259 0.552 . . . . 0.0 111.134 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -144.91 112.74 6.32 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.482 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.62 114.91 22.98 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.9 pp -132.95 173.27 11.58 Favored 'General case' 0 C--N 1.266 -3.022 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.007 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.92 106.78 14.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -65.94 114.85 3.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.421 1.105 . . . . 0.0 111.943 -176.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.63 -14.33 7.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.08 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -85.24 0.29 52.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.829 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 140.85 -115.27 1.02 Allowed Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 144.53 49.35 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.498 ' CD1' HD12 ' A' ' 437' ' ' LEU . 0.9 OUTLIER -125.82 120.23 29.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.563 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.2 ttpm? -138.38 161.71 36.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.563 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.6 m -66.09 130.67 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.557 0.694 . . . . 0.0 111.443 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.12 50.98 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.851 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 67.5 m-20 -88.32 147.17 39.5 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.959 0.379 . . . . 0.0 110.788 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -81.74 131.86 7.38 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.391 2.061 . . . . 0.0 110.731 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.79 140.46 48.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.478 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.84 111.62 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.41 138.22 26.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.74 26.09 74.73 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.33 -0.938 . . . . 0.0 110.875 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 65.0 p 63.68 7.05 2.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.166 1.786 . . . . 0.0 113.036 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.433 HG22 ' CB ' ' A' ' 486' ' ' ASP . 88.2 m -107.34 146.36 31.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -122.68 151.86 41.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.633 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -154.09 -164.3 12.66 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . 0.524 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 47.7 ttp180 -131.49 137.15 48.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.153 0.477 . . . . 0.0 110.005 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 482' ' ' THR . 28.3 t -67.9 123.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 122.688 0.395 . . . . 0.0 111.314 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . 0.404 ' HD3' ' C ' ' A' ' 460' ' ' ARG . 1.2 tmt_? -98.81 -51.04 4.01 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.767 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.81 153.86 51.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.444 ' HE3' HD22 ' A' ' 444' ' ' LEU . 42.1 tpp -122.5 121.47 36.64 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.85 148.6 32.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 468' ' ' ARG . 5.9 p30 -109.27 179.46 4.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.736 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -58.97 -32.19 69.42 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.7 t -78.61 -9.12 59.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.311 0.577 . . . . 0.0 110.401 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.41 63.04 Favored Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.787 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.433 ' HB2' HD22 ' A' ' 464' ' ' ASN . 11.2 mpt_? -73.38 116.86 14.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 4.0 tmm_? -81.09 133.48 35.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.0 m -136.11 -173.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 123.844 0.858 . . . . 0.0 108.791 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -117.39 -20.46 9.1 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.147 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.37 147.35 33.3 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.68 139.14 26.34 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.208 0.603 . . . . 0.0 110.169 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -97.92 167.1 22.75 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.463 ' HA ' HG11 ' A' ' 439' ' ' VAL . 18.9 Cg_endo -58.63 150.66 68.26 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.09 2.527 . . . . 0.0 112.878 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 32.6 m 75.32 17.83 2.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.431 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.5 ttt -117.16 136.36 23.36 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.12 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 3.6 Cg_exo -80.55 126.77 6.17 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.201 1.934 . . . . 0.0 110.933 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.36 149.87 19.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.005 0.431 . . . . 0.0 110.865 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.4 tt0 -108.67 112.56 24.95 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 434' ' ' VAL . 48.6 pt -99.84 172.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.576 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 5.5 p -145.33 157.55 44.02 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 113.23 4.44 23.83 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.16 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 51.2 tp -73.3 -37.58 66.16 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.483 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 64.62 24.14 12.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.278 1.431 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' A' ' 455' ' ' THR . 37.5 t70 -144.93 171.62 14.19 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.85 109.23 47.64 Favored Pre-proline 0 C--N 1.291 -1.956 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.44 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.02 174.52 4.56 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.595 2.197 . . . . 0.0 111.783 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -129.94 150.78 51.08 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.116 0.484 . . . . 0.0 111.327 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 424' ' ' GLU . . . -63.74 130.03 42.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.346 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.28 58.83 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.749 -1.215 . . . . 0.0 111.588 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 493' ' ' ARG . 7.3 t70 -86.29 -166.63 1.6 Allowed 'General case' 0 C--O 1.248 0.974 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.465 ' H ' ' CG ' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -131.24 136.89 48.61 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.295 -169.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 38.4 p90 -136.74 158.53 44.23 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.824 0.821 . . . . 0.0 111.758 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.2 ttp -134.05 119.53 19.08 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.862 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 83.1 t -108.64 136.77 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.74 122.7 30.19 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.629 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -70.0 -48.57 57.61 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.676 -174.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.629 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 27.4 t70 60.53 -58.0 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.844 1.658 . . . . 0.0 115.166 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -13.25 62.27 Favored 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -70.19 -47.0 63.45 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -61.33 -37.71 84.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.207 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.58 64.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.901 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -55.44 -40.29 71.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 123.891 0.876 . . . . 0.0 112.274 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.01 -31.8 69.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.967 0.792 . . . . 0.0 111.147 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.63 -9.0 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.451 0.7 . . . . 0.0 110.219 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 108.48 37.93 2.01 Favored Glycine 0 C--N 1.32 -0.342 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 54.87 35.51 24.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.782 1.633 . . . . 0.0 113.221 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -79.44 105.11 10.51 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.884 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -108.1 140.13 41.74 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.433 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -68.46 -77.86 0.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.428 0.455 . . . . 0.0 111.947 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -150.75 93.78 2.0 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.356 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 178.28 107.88 0.03 OUTLIER 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.481 1.112 . . . . 0.0 110.465 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 . . . . . 0 C--N 1.296 -1.754 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.97 179.832 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.396 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 32.4 t -63.87 106.98 1.11 Allowed 'General case' 0 C--O 1.253 1.237 0 C-N-CA 123.388 0.675 . . . . 0.0 110.711 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 55.32 -108.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.409 1.084 . . . . 0.0 110.015 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 72.6 mtm -142.55 13.98 1.96 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 pp -108.1 2.99 23.41 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.02 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 123.16 17.94 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.639 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -124.1 24.14 8.26 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 121.363 0.601 . . . . 0.0 109.723 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.3 mp -89.62 73.35 7.72 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.861 0.839 . . . . 0.0 109.896 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 47.2 tp -94.65 90.82 6.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.94 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.0 -44.2 55.4 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.233 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -138.1 138.76 39.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.93 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 6.9 tp -120.3 125.7 74.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 31.1 tp 68.87 12.46 8.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.583 1.153 . . . . 0.0 110.458 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.0 tp -93.86 -50.07 5.52 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.0 t 57.48 24.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 122.185 0.993 . . . . 0.0 111.232 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 16.8 m -80.57 67.6 6.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.907 0.86 . . . . 0.0 110.508 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.53 16.46 0.9 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.357 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 42.8 ttm -99.88 -65.49 0.96 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.156 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.93 140.04 48.07 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -101.37 122.82 44.43 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.195 0.521 . . . . 0.0 110.946 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.51 -32.87 71.99 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.557 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 88.7 tttt 60.34 83.01 0.15 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.568 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -83.65 -34.92 24.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -139.03 142.23 32.63 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.209 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.37 -22.59 24.94 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.443 2.096 . . . . 0.0 110.137 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -81.61 146.19 30.22 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.917 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -114.81 -126.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 69.78 -74.82 0.08 Allowed 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.905 0.882 . . . . 0.0 109.599 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 495' ' ' MET . . . 177.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.984 1.314 . . . . 0.0 108.291 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 9.7 m -146.39 169.61 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 122.679 0.392 . . . . 0.0 110.551 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -151.43 -174.68 22.48 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 18.8 m -127.89 143.87 51.1 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 117.049 0.424 . . . . 0.0 110.558 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.64 136.38 22.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.0 pt -89.77 -43.21 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.687 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.01 155.75 37.51 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.093 0.473 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -134.2 129.83 36.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.497 ' HG2' ' N ' ' A' ' 427' ' ' LEU . 0.3 OUTLIER -134.8 159.53 41.06 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -170.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.497 ' N ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -94.68 139.64 30.95 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.472 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 9.9 t70 -127.66 117.62 22.31 Favored 'General case' 0 C--N 1.261 -3.25 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.465 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.69 -26.15 65.34 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.24 -37.95 1.73 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.9 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.472 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.1 mtp180 -86.51 -24.37 25.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.14 -166.91 19.09 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -58.11 116.11 3.01 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.529 2.153 . . . . 0.0 111.049 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 20.1 m -114.94 136.62 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.341 0.591 . . . . 0.0 110.508 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -126.75 124.66 40.24 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.381 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 479' ' ' VAL . 2.0 m -98.7 118.78 36.2 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 170.14 15.31 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.44 105.29 11.53 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 475' ' ' PRO . 3.3 p -71.14 118.6 16.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.708 0.766 . . . . 0.0 112.197 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 47.0 mt-30 -123.3 -16.22 6.96 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.468 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.4 31.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.957 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 145.81 -89.89 0.16 Allowed Glycine 0 C--O 1.212 -1.244 0 C-N-CA 119.019 -1.562 . . . . 0.0 113.219 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 56.3 m -146.64 146.89 30.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.451 HD22 ' HE1' ' A' ' 462' ' ' MET . 2.2 tt -128.23 115.58 18.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 0.0 OUTLIER -135.81 158.9 43.26 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 120.708 0.29 . . . . 0.0 110.847 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.435 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.7 m -61.81 133.71 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.89 0.376 . . . . 0.0 110.119 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.82 4.04 56.95 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.259 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.36 127.91 59.29 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.997 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 5.5 Cg_exo -77.18 106.65 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.814 1.676 . . . . 0.0 108.073 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -104.9 140.84 21.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.035 -172.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.34 119.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 494' ' ' PHE . 8.5 m -125.27 133.94 68.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . 0.438 ' HA2' ' NH1' ' A' ' 493' ' ' ARG . . . 57.97 -100.17 0.14 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.515 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 7.0 p -131.54 10.86 4.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.639 0.776 . . . . 0.0 110.895 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.504 HG22 ' CB ' ' A' ' 486' ' ' ASP . 89.3 m -119.7 144.8 47.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.777 0.322 . . . . 0.0 110.282 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -120.5 150.85 40.18 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -150.36 -170.68 17.86 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -134.82 127.89 31.68 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.73 118.23 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.15 -52.82 3.87 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.1 35.86 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.451 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -133.18 117.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.78 131.43 72.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.88 177.74 5.8 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.369 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.73 -30.55 33.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.37 1.068 . . . . 0.0 113.148 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.2 t -76.95 -16.14 59.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.078 0.466 . . . . 0.0 110.483 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.64 15.09 47.8 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.23 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -99.87 133.82 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.541 -0.33 . . . . 0.0 110.184 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.4 tpt85 -73.16 126.06 29.16 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.181 0.926 . . . . 0.0 108.981 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 462' ' ' MET . 30.6 m -135.66 -177.2 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 471' ' ' LYS . 0.0 OUTLIER -120.9 -12.71 8.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.947 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.68 152.18 33.58 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.04 145.96 31.68 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 123.719 0.637 . . . . 0.0 109.866 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -94.84 173.91 32.48 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.426 ' HA ' HG13 ' A' ' 439' ' ' VAL . 58.5 Cg_endo -69.57 156.66 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.637 2.224 . . . . 0.0 113.378 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.1 t 72.08 16.51 5.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.022 1.329 . . . . 0.0 110.892 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 34.8 ttp -119.76 129.53 25.31 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.638 -0.664 . . . . 0.0 112.069 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.77 125.93 12.71 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.777 2.318 . . . . 0.0 112.345 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 436' ' ' THR . 6.0 m -140.41 151.74 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.163 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 40.8 tt0 -112.42 112.78 24.58 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . 0.416 ' C ' ' HG1' ' A' ' 482' ' ' THR . 48.3 pt -98.23 170.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.699 -177.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.416 ' HG1' ' C ' ' A' ' 481' ' ' ILE . 0.2 OUTLIER -150.72 150.1 30.63 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 109.72 31.94 3.04 Favored Glycine 0 C--N 1.304 -1.25 0 O-C-N 123.742 0.651 . . . . 0.0 113.295 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 54.9 tp -82.94 -35.84 25.68 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.0 t60 65.4 27.72 11.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.185 1.394 . . . . 0.0 109.404 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.504 ' CB ' HG22 ' A' ' 455' ' ' THR . 8.3 t0 -148.01 -179.95 7.29 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.91 108.97 44.06 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.77 158.1 56.59 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.902 1.735 . . . . 0.0 110.733 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -126.48 131.35 51.66 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.391 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -72.48 135.66 45.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.295 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.44 89.35 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.664 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.45 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 1.6 t70 -84.7 -172.69 4.31 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.45 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -129.16 150.92 50.34 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.742 -173.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.458 ' CB ' HG11 ' A' ' 452' ' ' VAL . 40.7 p90 -140.28 168.68 19.25 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 418' ' ' ALA . 52.3 ttp -134.02 115.98 14.97 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 494' ' ' PHE . 61.7 t -121.72 106.06 17.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -131.63 122.95 26.85 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 501' ' ' LYS . 10.1 tp10 -78.23 142.91 37.55 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 122.338 1.065 . . . . 0.0 111.284 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -102.43 -40.28 6.78 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.833 -175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.46 -25.0 59.13 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.841 -0.537 . . . . 0.0 112.444 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.524 ' H ' ' HG3' ' A' ' 498' ' ' GLU . 48.3 mtpt -72.48 -38.97 68.06 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.486 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -70.88 -26.64 63.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.855 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.67 50.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.39 -45.76 55.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.579 1.552 . . . . 0.0 110.32 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.62 -36.21 75.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.2 -10.96 11.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.432 0.634 . . . . 0.0 109.838 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 101.45 28.26 6.82 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.893 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 62.7 31.31 16.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.831 1.3 . . . . 0.0 109.932 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.85 -8.63 57.01 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.878 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -96.73 104.39 16.38 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.47 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -98.75 -17.31 18.58 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -114.03 135.11 54.37 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.333 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -77.74 -43.13 31.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--N 1.319 -0.754 0 C-N-CA 123.439 0.695 . . . . 0.0 109.986 -178.5 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.858 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 36.4 m 64.96 114.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.574 1.149 . . . . 0.0 111.228 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -78.01 70.87 4.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.424 1.107 . . . . 0.0 112.616 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 26.0 ptm -153.12 9.89 0.44 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.205 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.66 101.62 14.31 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.967 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.78 115.28 15.3 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -65.39 123.39 19.49 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.616 0.722 . . . . 0.0 112.544 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.1 mp -75.23 165.1 25.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.274 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.48 88.19 6.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.574 0.702 . . . . 0.0 110.14 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -86.14 176.29 8.06 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.614 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 23.1 ptp -78.38 153.74 31.34 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 34.8 pt -73.89 127.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.88 131.59 35.26 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.482 -173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.1 -23.7 23.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 58.0 t 63.74 89.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.71 1.204 . . . . 0.0 110.036 -177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 20.3 m -144.56 150.2 37.11 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.215 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 142.14 31.49 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.014 0.435 . . . . 0.0 111.924 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 27.1 ttt -101.91 13.37 34.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.593 1.187 . . . . 0.0 108.031 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.47 156.61 19.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.217 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.98 -73.59 0.28 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 411' ' ' LYS . 3.5 pp -179.99 -30.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.796 0.838 . . . . 0.0 110.994 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.439 ' N ' HD13 ' A' ' 410' ' ' LEU . 0.9 OUTLIER -86.59 -76.08 0.36 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 179.43 130.71 0.08 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 71.02 104.89 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 125.103 1.361 . . . . 0.0 111.333 171.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.47 -27.51 23.01 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.491 2.128 . . . . 0.0 113.501 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.47 HD22 ' HB3' ' A' ' 418' ' ' ALA . 30.3 t-20 -86.35 -58.61 2.56 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 65.48 9.8 6.09 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.455 1.502 . . . . 0.0 114.061 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 441' ' ' ALA . 55.5 ttt180 -131.18 -54.61 1.04 Allowed 'General case' 0 C--O 1.204 -1.324 0 O-C-N 121.391 -0.818 . . . . 0.0 111.027 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 415' ' ' ASN . . . -82.59 5.46 20.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.924 0.392 . . . . 0.0 111.69 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.35 155.34 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -117.74 178.59 17.01 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.6 m -122.02 139.09 54.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 52.1 t -82.51 135.07 25.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 11.3 pt -93.73 -37.05 7.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.905 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 490' ' ' ALA . 12.6 pt-20 -156.7 148.14 22.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.46 136.76 17.6 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 176.43 8.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.44 145.92 24.23 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.69 122.81 33.91 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.542 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.13 -13.4 58.01 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -109.67 -46.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.401 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.49 -40.59 42.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 109.605 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 121.7 -176.45 16.38 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.45 116.13 3.07 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.141 1.894 . . . . 0.0 109.445 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.406 HG11 ' CG2' ' A' ' 482' ' ' THR . 29.1 m -121.94 146.56 26.88 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.391 0.615 . . . . 0.0 112.229 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -137.53 119.14 14.95 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.3 m -88.22 125.06 34.44 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.91 168.05 20.67 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.399 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.83 105.9 12.43 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 475' ' ' PRO . 4.3 p -70.84 121.21 20.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.836 0.827 . . . . 0.0 111.529 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -121.84 -20.5 6.38 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 417' ' ' ARG . . . -81.63 -11.41 59.12 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -170.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 165.13 -111.38 0.46 Allowed Glycine 0 N--CA 1.416 -2.663 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.86 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 24.7 m -137.16 133.75 35.59 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.449 HD21 ' HE1' ' A' ' 462' ' ' MET . 0.7 OUTLIER -101.28 115.79 31.32 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.0 OUTLIER -129.04 150.99 50.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.446 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.4 m -71.0 141.32 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.257 0.551 . . . . 0.0 111.297 177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.38 8.6 70.91 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.792 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -101.07 128.17 30.15 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 6.8 Cg_exo -72.38 120.81 6.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 18.9 pt -114.36 160.63 13.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.404 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.44 127.25 59.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.466 HG11 ' CB ' ' A' ' 494' ' ' PHE . 3.0 m -127.22 128.19 70.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 55.47 -97.09 0.04 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 121.597 -0.335 . . . . 0.0 113.595 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 8.9 t -127.84 11.33 6.63 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.072 0.463 . . . . 0.0 110.623 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.464 HG22 ' CB ' ' A' ' 486' ' ' ASP . 91.2 m -124.21 150.12 45.61 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -127.92 162.1 27.53 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -173.91 -165.09 30.06 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -135.61 134.77 39.66 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 482' ' ' THR . 31.0 t -70.2 122.58 22.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 123.369 0.418 . . . . 0.0 110.352 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -93.09 -56.74 2.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.651 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.45 146.62 50.02 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.449 ' HE1' HD21 ' A' ' 444' ' ' LEU . 42.5 tpp -121.8 117.47 26.62 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.17 136.74 49.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.87 174.18 5.99 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.046 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.53 -29.82 38.55 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.602 1.161 . . . . 0.0 113.491 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 68.7 m -77.17 -11.81 59.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.821 -0.55 . . . . 0.0 111.33 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.77 -11.56 59.25 Favored Glycine 0 CA--C 1.494 -1.273 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.785 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -77.7 137.09 38.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.006 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.16 127.48 34.29 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.39 174.52 10.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.558 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -102.74 -35.24 8.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 151.25 37.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.483 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -139.17 145.22 39.09 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.43 174.14 37.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.994 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 439' ' ' VAL . 36.2 Cg_endo -64.51 158.6 48.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 38.6 m 68.67 17.0 8.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.521 0.728 . . . . 0.0 112.39 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.5 ttp -122.6 127.14 25.91 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.156 -0.34 . . . . 0.0 110.927 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.79 126.38 13.88 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 121.99 1.793 . . . . 0.0 111.72 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 473' ' ' ALA . 17.6 m -139.12 167.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.514 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 34.4 tt0 -125.33 118.3 25.64 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -98.52 173.02 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.472 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.1 p -152.77 155.04 36.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.399 1.08 . . . . 0.0 108.352 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.18 8.15 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 172.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.21 -31.14 38.69 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 63.51 21.36 12.71 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.823 1.249 . . . . 0.0 109.263 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.464 ' CB ' HG22 ' A' ' 455' ' ' THR . 5.4 t70 -140.79 -179.77 6.24 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.67 107.63 58.7 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-O 121.538 0.685 . . . . 0.0 111.779 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.45 167.92 14.98 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.019 1.812 . . . . 0.0 110.059 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 492' ' ' ASP . 21.9 mt-30 -134.8 154.2 51.71 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.109 -0.369 . . . . 0.0 110.356 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 424' ' ' GLU . . . -70.97 133.42 46.36 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.2 -11.39 63.73 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.116 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 489' ' ' GLN . 4.3 m-20 -79.5 164.61 23.78 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.779 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 493' ' ' ARG . 5.9 mpt_? -113.11 128.75 56.58 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.466 ' CB ' HG11 ' A' ' 452' ' ' VAL . 53.9 p90 -118.94 155.73 30.81 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.3 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 51.6 ttm -121.03 116.29 24.77 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.172 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.65 105.05 15.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -114.53 151.31 33.55 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 499' ' ' ASP . 3.2 pt-20 54.36 -160.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.901 1.68 . . . . 0.0 110.118 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.522 ' N ' ' HG3' ' A' ' 498' ' ' GLU . 18.6 t70 178.47 -49.79 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 125.279 1.432 . . . . 0.0 108.214 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -77.76 -28.77 50.7 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-N 114.149 -1.387 . . . . 0.0 114.348 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 0.1 OUTLIER -63.86 -54.11 40.07 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.633 0.652 . . . . 0.0 110.899 -174.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.485 ' O ' HG12 ' A' ' 506' ' ' ILE . 10.8 ptpp? -65.28 -35.35 80.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.074 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.55 77.64 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.848 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -55.61 -50.17 70.85 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.127 1.371 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 12.0 mm100 -70.08 -26.31 63.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.926 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 502' ' ' LYS . 44.6 mm -74.06 -41.65 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 167.92 -14.95 0.07 OUTLIER Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.827 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.99 43.79 0.96 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 122.683 1.23 . . . . 0.0 110.321 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -91.77 10.53 28.08 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.392 1.092 . . . . 0.0 108.592 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -90.09 96.62 10.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.411 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.12 34.2 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -85.11 91.39 8.1 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.89 24.98 2.36 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 N--CA 1.416 -2.133 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.002 -178.084 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.851 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 39.4 m -91.58 102.81 15.46 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 117.016 0.408 . . . . 0.0 110.312 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 72.98 128.71 0.04 OUTLIER 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.333 1.453 . . . . 0.0 112.498 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 398' ' ' LEU . 50.7 ttm -75.34 81.29 2.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.044 0.926 . . . . 0.0 109.606 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 90.9 mt -108.27 -83.73 0.54 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -108.34 8.61 27.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -115.45 105.24 12.59 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.299 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 89.4 mt 62.02 -169.54 0.18 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 124.853 1.346 . . . . 0.0 112.209 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.476 ' HA ' ' SD ' ' A' ' 393' ' ' MET . 19.7 tp -163.76 -173.18 3.14 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 102.303 -3.221 . . . . 0.0 102.303 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.458 ' H ' ' HG ' ' A' ' 398' ' ' LEU . 43.9 tt0 -66.98 99.79 0.68 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 119.537 1.062 . . . . 0.0 111.261 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 13.0 tpt 72.72 -55.23 0.68 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.782 1.633 . . . . 0.0 112.737 177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 24.9 pt -139.61 174.75 8.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 123.778 0.831 . . . . 0.0 108.805 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.97 172.13 8.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 67.9 mt -84.96 -178.43 6.83 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 27.9 m -78.63 37.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.595 0.758 . . . . 0.0 112.123 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 49.4 m 63.18 82.02 0.19 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.732 1.213 . . . . 0.0 111.499 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -98.85 132.85 43.88 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.71 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 24.9 ptp -74.04 113.32 11.08 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.533 0.682 . . . . 0.0 110.737 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.58 135.86 46.21 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 411' ' ' LYS . 0.7 OUTLIER -133.86 144.32 48.84 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 76.1 mt -128.72 4.65 5.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.411 ' H ' ' CD ' ' A' ' 409' ' ' GLU . 99.0 mttt -111.76 31.82 5.9 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.991 0.424 . . . . 0.0 111.781 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 73.78 -6.19 1.85 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 176.92 126.98 0.18 Allowed Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.96 -19.12 66.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.108 2.539 . . . . 0.0 113.117 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -95.56 169.2 10.2 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -78.38 178.21 7.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.22 57.71 1.49 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.014 0.911 . . . . 0.0 110.22 173.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -125.77 2.81 7.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.54 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 17.5 m -147.45 161.66 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.35 176.48 17.88 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.0 m -127.2 139.6 52.83 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 42.7 t -83.58 137.29 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -97.54 -37.55 6.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.232 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.35 166.07 33.0 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.39 128.59 17.72 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.485 ' HB3' ' HZ2' ' A' ' 426' ' ' LYS . 0.0 OUTLIER -146.54 146.85 30.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.67 144.71 26.51 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.299 0.571 . . . . 0.0 109.885 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.24 129.48 50.86 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.51 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -64.0 -19.98 65.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -111.61 -48.42 0.69 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.878 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -74.68 -26.94 60.18 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 123.594 0.758 . . . . 0.0 110.59 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 98.98 -158.91 20.14 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.25 116.46 3.51 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.567 2.178 . . . . 0.0 111.084 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 482' ' ' THR . 15.1 m -121.33 157.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -148.26 120.37 8.29 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 480' ' ' GLU . 3.4 m -82.74 123.67 29.53 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 478' ' ' PRO . 1.3 pp -133.03 173.3 11.57 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -119.44 110.99 17.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -75.5 122.58 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.763 0.792 . . . . 0.0 111.24 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 18.8 mt-30 -123.83 -14.45 7.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.095 -174.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -96.36 8.42 44.02 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.049 0.452 . . . . 0.0 110.133 -173.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.62 -126.55 2.92 Favored Glycine 0 N--CA 1.403 -3.513 0 C-N-CA 120.033 -1.08 . . . . 0.0 111.347 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.3 m -115.62 142.7 46.38 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.457 HD21 ' HE3' ' A' ' 462' ' ' MET . 0.4 OUTLIER -111.45 117.69 33.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.535 ' HB3' ' OD2' ' A' ' 448' ' ' ASP . 12.3 ttpt -122.86 148.36 45.51 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.02 123.88 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.413 0.625 . . . . 0.0 109.768 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 109.5 -8.51 32.52 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.125 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.535 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 42.7 m-20 -90.32 146.02 33.82 Favored Pre-proline 0 C--O 1.25 1.081 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.448 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.03 145.37 24.71 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.536 2.157 . . . . 0.0 111.391 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 13.8 pt -136.44 156.88 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.345 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.74 115.34 44.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.0 115.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.38 -102.56 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 12.6 t -127.9 8.23 6.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.476 HG23 ' CB ' ' A' ' 486' ' ' ASP . 26.6 m -115.76 145.02 43.16 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.618 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -127.95 158.77 36.93 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -173.05 -164.3 28.2 Favored Glycine 0 C--N 1.29 -2.015 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -125.48 134.68 51.97 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.444 HG23 ' CD2' ' A' ' 444' ' ' LEU . 41.6 t -72.15 123.47 26.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -95.79 -50.38 4.93 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.693 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.05 159.66 32.19 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.457 ' HE3' HD21 ' A' ' 444' ' ' LEU . 39.9 tpp -130.8 117.33 19.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.79 128.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' A' ' 468' ' ' ARG . 8.8 p30 -92.9 -175.71 3.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.227 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.94 -20.26 66.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 112.402 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 31.5 t -84.21 -20.31 32.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.71 40.62 5.26 Favored Glycine 0 CA--C 1.488 -1.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.706 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 464' ' ' ASN . 85.2 mtt180 -118.34 129.88 55.69 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 2.3 tmm_? -80.17 129.51 34.55 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.4 m -130.55 -179.23 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 120.583 0.23 . . . . 0.0 110.385 -176.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -98.97 -35.98 9.89 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.231 0.612 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -157.74 147.59 20.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.017 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -134.7 142.99 46.95 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.059 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.04 173.85 45.18 Favored Glycine 0 N--CA 1.442 -0.928 0 O-C-N 123.717 0.636 . . . . 0.0 112.304 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.423 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.9 Cg_endo -64.98 156.52 62.07 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.551 2.168 . . . . 0.0 113.23 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 28.3 m 72.54 10.85 5.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.439 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' MET . . . . . 0.452 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.1 ttt -111.08 138.26 21.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 4.5 Cg_exo -83.91 126.34 3.88 Favored 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.925 2.416 . . . . 0.0 112.001 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.7 151.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.171 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.7 mt-10 -96.82 129.19 44.29 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -100.87 170.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.467 ' CG2' HG11 ' A' ' 434' ' ' VAL . 1.7 p -151.07 158.86 44.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 124.237 1.015 . . . . 0.0 108.503 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.12 8.15 Favored Glycine 0 N--CA 1.422 -2.277 0 O-C-N 124.059 0.849 . . . . 0.0 114.428 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.57 -36.39 13.72 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.1 t60 64.62 20.95 12.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.357 1.463 . . . . 0.0 108.423 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.476 ' CB ' HG23 ' A' ' 455' ' ' THR . 30.9 t70 -135.9 173.52 11.62 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.12 103.6 36.06 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 118.094 0.406 . . . . 0.0 110.008 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.61 174.97 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.814 2.343 . . . . 0.0 111.124 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -111.17 145.56 38.43 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.308 0.575 . . . . 0.0 111.365 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -64.02 127.62 32.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.185 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.67 -3.48 56.15 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.609 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.18 178.11 8.44 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.751 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.61 140.73 48.91 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 124.105 0.962 . . . . 0.0 108.779 -175.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.05 155.18 49.68 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.998 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 49.7 ttp -122.02 120.34 34.09 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' A' ' 441' ' ' ALA . 7.0 p -95.47 143.07 12.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -101.74 120.54 40.52 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.493 ' OE2' ' HG2' ' A' ' 501' ' ' LYS . 37.4 tt0 -81.02 137.54 36.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 123.548 0.53 . . . . 0.0 110.888 -174.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.97 -58.2 8.57 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 124.719 1.207 . . . . 0.0 111.778 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.2 -20.91 62.22 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.139 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.493 ' HG2' ' OE2' ' A' ' 498' ' ' GLU . 41.9 mmtm -68.88 -49.24 59.93 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -69.2 -40.6 77.92 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.572 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.92 88.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -73.71 -16.1 61.2 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.878 0.471 . . . . 0.0 111.033 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.6 -28.65 61.0 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 2.4 mp -86.93 -34.96 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 129.44 20.22 1.42 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.466 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 54.56 21.17 3.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.398 1.479 . . . . 0.0 112.932 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -152.09 171.48 17.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.55 179.75 4.15 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -69.65 -41.39 75.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 62.95 84.69 0.14 Allowed 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.521 1.138 . . . . 0.0 108.937 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -72.91 114.07 10.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.626 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.127 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 39.2 m -75.52 -30.4 59.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.955 0.378 . . . . 0.0 111.66 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 63.86 17.38 10.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.829 0.852 . . . . 0.0 111.91 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 28.1 ttt -98.1 86.67 3.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.23 117.28 27.02 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.79 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.22 137.04 32.67 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -90.48 92.68 8.98 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.721 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.05 132.0 20.24 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 398' ' ' LEU . 2.8 pp -168.22 125.37 1.09 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.795 0.685 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -78.66 111.01 14.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 73.1 mtm -78.37 93.0 4.63 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 58.4 mt -76.7 -46.87 30.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 60.3 tp -101.64 139.3 37.48 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.592 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.71 168.06 11.47 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.71 70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.64 1.21 . . . . 0.0 108.05 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 17.1 m -143.38 99.18 3.39 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -91.72 116.16 28.65 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -133.27 124.55 27.54 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 411' ' ' LYS . 1.9 mp0 -91.3 147.62 22.92 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.716 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -48.32 7.77 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 59.6 tp -116.7 -12.62 10.85 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 408' ' ' GLU . 58.2 tttp 75.88 -38.6 0.35 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.417 1.887 . . . . 0.0 112.84 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -87.28 83.71 7.33 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.343 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 58.62 103.46 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 0.0 114.118 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -86.09 -17.61 3.78 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.055 1.837 . . . . 0.0 113.076 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -96.78 -35.51 10.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.235 0.541 . . . . 0.0 111.064 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . 0.273 14.4 mmt180 69.85 -44.73 0.56 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 174.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -107.75 -6.64 16.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 118.49 0.587 . . . . 0.0 112.272 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -92.9 -25.33 18.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.262 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' A' ' 441' ' ' ALA . 15.9 m -144.86 162.03 13.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.52 166.11 12.82 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.12 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.6 m -114.2 143.01 45.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.11 131.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.1 pt -88.75 -36.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.747 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -160.11 153.36 21.99 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.38 143.33 23.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -163.49 175.73 10.44 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.2 pt? -85.07 143.38 28.91 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -126.41 129.77 49.41 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.04 -24.68 67.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.743 -178.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -97.32 -47.63 2.16 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.723 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -91.4 -33.43 15.25 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.24 -134.56 12.23 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.83 115.96 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.679 1.74 . . . . 0.0 110.782 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.445 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 25.3 m -118.2 148.26 21.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -143.54 114.24 7.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.2 m -85.58 116.91 24.15 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.4 pp -132.89 171.54 13.79 Favored 'General case' 0 C--N 1.279 -2.476 0 O-C-N 122.205 -0.309 . . . . 0.0 111.795 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.51 106.37 11.73 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.83 123.89 36.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.241 0.544 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -124.72 -15.88 6.38 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 419' ' ' VAL . . . -77.84 -15.29 59.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.03 -0.987 . . . . 0.0 113.34 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 169.97 -102.26 0.18 Allowed Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.051 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 32.5 m -148.04 131.94 17.11 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.48 HD22 ' HE1' ' A' ' 462' ' ' MET . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.608 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.1 ttpt -148.3 153.23 38.39 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.608 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 28.2 m -71.24 134.7 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.25 0.547 . . . . 0.0 110.746 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.05 8.44 72.24 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.79 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.8 132.86 20.51 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 123.92 11.77 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.779 2.32 . . . . 0.0 111.495 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.73 151.7 26.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.452 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.95 123.12 70.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.424 HG11 ' CB ' ' A' ' 494' ' ' PHE . 4.1 m -128.0 135.13 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 54.89 -100.44 0.08 OUTLIER Glycine 0 CA--C 1.533 1.164 0 N-CA-C 114.221 0.448 . . . . 0.0 114.221 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 42.2 p -121.94 4.54 9.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 122.652 0.381 . . . . 0.0 111.239 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.521 HG22 ' CB ' ' A' ' 486' ' ' ASP . 44.3 m -125.36 145.62 49.96 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.835 0.35 . . . . 0.0 111.419 -173.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.0 144.38 48.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -149.74 -175.54 22.07 Favored Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -124.77 126.9 46.38 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 482' ' ' THR . 48.3 t -63.62 132.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.938 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -97.62 -59.42 1.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -122.6 167.79 12.97 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.48 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.8 tpp -143.23 117.14 9.36 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.74 132.03 72.03 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -98.71 -179.77 4.41 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.006 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.38 -30.15 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.065 0.946 . . . . 0.0 112.539 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 28.3 m -80.7 -13.18 59.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.188 -0.32 . . . . 0.0 111.445 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 95.95 7.96 58.31 Favored Glycine 0 CA--C 1.501 -0.795 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.206 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -91.72 138.94 31.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.567 -0.317 . . . . 0.0 110.336 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 462' ' ' MET . 9.2 tpt180 -74.22 131.33 41.12 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.39 174.49 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.9 -36.16 8.74 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.086 0.469 . . . . 0.0 110.02 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.83 151.98 49.75 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.851 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -137.81 137.48 38.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.022 0.529 . . . . 0.0 109.597 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 169.17 30.19 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.89 151.93 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 31.1 t 75.44 15.71 2.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.139 1.376 . . . . 0.0 110.637 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 44.1 ttm -113.71 135.11 21.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.062 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.7 Cg_exo -79.53 126.23 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.394 2.063 . . . . 0.0 110.427 173.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 10.2 m -141.71 146.67 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 123.068 0.547 . . . . 0.0 110.07 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.9 tt0 -105.67 118.63 37.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.8 172.0 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.82 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.1 p -148.49 166.07 29.31 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 87.51 22.81 42.16 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.158 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 50.3 tp -72.98 -28.64 62.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.139 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 64.23 20.01 12.01 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.279 1.031 . . . . 0.0 110.213 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.521 ' CB ' HG22 ' A' ' 455' ' ' THR . 33.2 t70 -149.03 179.39 7.91 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.47 114.9 65.8 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 118.415 0.552 . . . . 0.0 110.395 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.21 157.63 23.08 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.05 1.833 . . . . 0.0 111.091 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -124.6 137.91 54.35 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-O 121.529 0.681 . . . . 0.0 110.59 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.32 139.83 50.05 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.944 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.81 89.46 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . 0.463 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 2.5 t70 -85.13 -170.87 3.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.463 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.3 OUTLIER -137.75 148.87 45.97 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.09 0.471 . . . . 0.0 109.903 -174.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.606 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.7 p90 -139.4 162.7 34.39 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.356 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.09 116.06 16.56 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.115 0.483 . . . . 0.0 109.87 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 62.2 t -115.73 103.71 15.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -152.14 130.89 12.38 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 501' ' ' LYS . 11.2 tp10 -176.11 137.31 0.31 Allowed 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.142 166.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 502' ' ' LYS . 34.0 t70 -87.71 -50.05 6.74 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.45 -18.28 61.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.689 0.757 . . . . 0.0 110.531 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 498' ' ' GLU . 17.4 tptp -63.1 -41.21 99.32 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.649 1.18 . . . . 0.0 109.553 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 499' ' ' ASP . 22.0 pttm -75.45 -19.8 59.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.655 0.741 . . . . 0.0 110.496 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.54 -44.07 21.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 108.877 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -70.56 -19.74 62.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.538 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . 0.46 ' OE1' ' HD3' ' A' ' 445' ' ' LYS . 45.0 tp60 -64.17 -40.67 96.62 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.613 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 40.0 mm -76.23 -35.27 27.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 129.18 20.75 1.4 Allowed Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.078 -0.964 . . . . 0.0 113.325 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 60.22 27.55 17.07 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.484 1.114 . . . . 0.0 111.024 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 178.84 166.7 0.9 Allowed 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -71.28 139.44 49.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -71.11 93.6 1.06 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -114.83 170.0 8.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -86.28 -43.29 13.04 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 . . . . . 0 N--CA 1.427 -1.575 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.411 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.24 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.2 m -94.14 169.74 10.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -68.5 -40.46 80.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 57.6 mtt -97.36 120.66 38.13 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.56 133.06 37.26 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.101 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.82 103.44 15.33 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -105.15 9.44 34.18 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.712 0.768 . . . . 0.0 111.195 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 52.1 mt -148.6 104.66 3.51 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 114.189 -1.368 . . . . 0.0 107.4 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.77 134.54 37.01 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -82.32 -0.6 46.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.419 0.628 . . . . 0.0 111.307 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -139.66 95.03 2.85 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 8.9 tp -153.2 -33.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.5 -169.04 2.11 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 7.1 mp 69.04 169.78 0.29 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.683 0.754 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.01 -31.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.796 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 18.1 m -68.04 101.28 1.1 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.245 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -74.06 78.67 1.72 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 122.488 1.137 . . . . 0.0 111.626 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 63.1 mtm -88.83 -16.8 31.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.281 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.17 151.69 38.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.43 123.47 25.36 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 123.469 0.481 . . . . 0.0 110.265 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.73 6.94 4.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -102.4 7.89 40.3 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.414 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -85.0 100.57 11.75 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 74.87 150.76 0.13 Allowed Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.733 1.213 . . . . 0.0 113.695 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -69.81 -38.32 7.83 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.379 2.053 . . . . 0.0 112.16 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.438 ' HB2' HG21 ' A' ' 419' ' ' VAL . 13.3 m120 -84.12 -37.32 22.13 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 75.32 -43.99 0.52 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 114.111 174.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -104.7 -40.08 6.12 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.407 0.549 . . . . 0.0 112.333 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -77.05 4.77 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 415' ' ' ASN . 18.7 m -146.08 156.37 12.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.2 162.75 12.31 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.24 140.22 41.8 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.13 139.61 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.26 -39.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.27 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.22 158.45 44.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.62 135.32 14.45 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 177.52 8.36 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 123.582 0.551 . . . . 0.0 109.84 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.8 149.0 22.16 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.094 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.04 127.95 45.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -32.97 74.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.21 -39.27 2.3 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.641 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -87.85 -20.2 26.37 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.697 0.284 . . . . 0.0 111.717 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.24 -166.48 23.22 Favored Glycine 0 C--O 1.222 -0.633 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.84 117.01 3.66 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.589 2.193 . . . . 0.0 111.063 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.57 153.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.467 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -147.88 123.95 10.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.926 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 5.9 m -96.32 126.39 41.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.408 HD23 ' CD1' ' A' ' 444' ' ' LEU . 0.0 OUTLIER -134.97 173.43 11.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 121.04 0.448 . . . . 0.0 111.208 -177.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.7 tm? -116.52 107.58 14.93 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -74.69 119.58 22.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.274 0.559 . . . . 0.0 112.063 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -124.39 -16.65 6.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 419' ' ' VAL . . . -69.21 -28.0 65.98 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.673 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . 0.479 ' HA3' ' OE2' ' A' ' 498' ' ' GLU . . . 175.01 -96.07 0.1 Allowed Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.103 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 40.2 m -149.2 143.92 26.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.46 ' CD2' HG21 ' A' ' 459' ' ' VAL . 0.5 OUTLIER -109.79 136.24 49.43 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.631 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 25.7 ttpt -147.23 150.57 35.13 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.631 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 34.1 m -69.69 131.04 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.167 0.508 . . . . 0.0 110.042 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.48 -10.46 61.18 Favored Glycine 0 N--CA 1.417 -2.586 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.415 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.517 ' OD2' ' HE2' ' A' ' 445' ' ' LYS . 17.2 m-20 -89.19 146.2 35.77 Favored Pre-proline 0 C--O 1.252 1.191 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.085 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.36 148.27 33.72 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.33 2.02 . . . . 0.0 111.702 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.27 153.45 37.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.682 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.07 107.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.88 162.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . -39.85 108.7 0.1 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.263 0.483 . . . . 0.0 113.191 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.3 m 70.78 -25.34 0.16 Allowed 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 126.523 1.929 . . . . 0.0 115.198 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.403 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.1 m -119.6 132.82 55.8 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 120.955 -1.091 . . . . 0.0 112.295 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -111.46 165.44 11.98 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -169.8 -164.04 24.85 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -137.89 135.84 36.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 444' ' ' LEU . 38.6 t -69.99 118.48 14.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 120.905 0.383 . . . . 0.0 111.548 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -88.29 -54.86 3.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.149 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -133.19 146.37 51.45 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.444 ' HE3' HD21 ' A' ' 444' ' ' LEU . 49.6 tpp -115.54 116.69 28.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.24 132.13 60.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -103.7 178.22 4.62 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.945 -174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.27 -29.83 25.01 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.323 1.449 . . . . 0.0 112.985 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 47.6 t -78.52 -17.2 56.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.034 0.445 . . . . 0.0 110.494 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.74 56.69 Favored Glycine 0 CA--C 1.501 -0.814 0 O-C-N 122.013 -0.43 . . . . 0.0 112.157 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -92.08 149.19 21.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 120.722 0.296 . . . . 0.0 111.607 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -75.33 129.78 37.95 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.763 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.33 -176.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -111.54 -24.68 9.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.129 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -149.02 157.57 43.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . 0.442 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.84 136.01 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 122.979 0.512 . . . . 0.0 110.189 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.0 167.86 38.48 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 439' ' ' VAL . 38.6 Cg_endo -63.04 153.02 76.41 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.02 2.48 . . . . 0.0 112.925 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.416 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.1 m 71.61 21.63 4.33 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.649 1.18 . . . . 0.0 111.714 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.9 ttt -121.0 137.07 26.13 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.84 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.61 126.84 7.66 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.84 2.36 . . . . 0.0 111.64 176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 473' ' ' ALA . 13.4 m -143.78 155.93 16.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 122.516 0.326 . . . . 0.0 110.536 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.3 tt0 -116.11 115.43 26.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.32 177.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.035 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.0 p -152.44 166.68 31.2 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.91 20.35 24.1 Favored Glycine 0 C--N 1.294 -1.797 0 O-C-N 123.823 0.702 . . . . 0.0 114.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 43.3 tp -85.18 -33.37 22.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 7.6 t60 60.82 23.59 13.57 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.346 1.459 . . . . 0.0 110.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.403 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.2 t70 -144.82 -179.91 6.9 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.18 112.49 56.48 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -78.19 166.2 24.88 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.961 1.774 . . . . 0.0 110.41 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -120.09 132.81 55.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.785 0.802 . . . . 0.0 110.587 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.53 121.46 18.74 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.032 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.45 -0.25 59.76 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -80.28 -167.43 1.32 Allowed 'General case' 0 C--O 1.247 0.93 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -137.76 129.71 28.76 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.385 0.612 . . . . 0.0 110.422 -172.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.33 158.95 29.9 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.715 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.8 ttt -118.4 123.23 44.75 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 2.5 p -87.21 143.99 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -108.23 122.06 46.16 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.818 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -150.79 -162.86 1.64 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.571 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 16.8 t70 -160.72 -63.61 0.06 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -61.81 -36.91 82.51 Favored 'General case' 0 C--O 1.188 -2.156 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.819 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -62.97 -45.32 93.0 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.297 0.57 . . . . 0.0 112.174 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -74.82 -27.51 60.32 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.75 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.13 31.75 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 500' ' ' GLU . 3.9 ptp180 -64.66 -23.22 67.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.87 -32.79 72.22 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.208 1.004 . . . . 0.0 109.028 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 60.6 mt -87.31 -44.89 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.564 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 509' ' ' ALA . . . 162.87 -6.93 0.08 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.151 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 75.16 -28.77 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.457 2.303 . . . . 0.0 111.779 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 507' ' ' GLY . . . -76.04 -28.03 57.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.361 1.077 . . . . 0.0 108.712 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -102.28 146.04 28.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . 68.19 27.64 6.7 Favored 'General case' 0 C--O 1.253 1.257 0 O-C-N 124.397 1.061 . . . . 0.0 110.156 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -81.89 161.42 23.14 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.878 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.88 163.37 13.73 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--N 1.261 -3.242 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.125 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.538 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 12.5 p -151.35 32.92 0.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -93.53 -82.21 0.35 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.996 -0.44 . . . . 0.0 111.567 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -65.69 0.88 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.102 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 50.7 tp -97.82 72.34 2.25 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.21 1.005 . . . . 0.0 108.994 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -126.94 9.15 6.85 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.963 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -85.21 103.86 14.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.494 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 399' ' ' GLU . 84.5 mt -79.7 -35.97 38.22 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.869 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 86.4 mt 72.43 -35.85 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.09 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 397' ' ' LEU . 38.4 tt0 -66.19 111.32 3.37 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 170.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 24.4 mmt -96.8 145.65 25.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.67 -22.01 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 98.8 mt -74.97 137.02 41.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.24 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 67.7 mt 70.69 -143.58 0.07 Allowed 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.642 1.214 . . . . 0.0 109.464 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 40.6 t 70.6 18.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 123.592 1.663 . . . . 0.0 108.142 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 34.4 t -176.52 169.13 2.65 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 77.33 6.87 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.764 1.269 . . . . 0.0 109.403 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 26.5 ttt -92.03 98.94 11.87 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.411 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -106.93 118.71 37.42 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.425 -174.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 410' ' ' LEU . 1.3 pt-20 -94.38 -88.21 0.25 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.494 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.442 ' H ' ' HG3' ' A' ' 409' ' ' GLU . 49.1 tp -131.91 79.95 1.89 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.04 112.53 15.99 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.08 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.67 -29.42 8.72 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -125.67 139.54 34.34 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.95 -29.07 49.67 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.02 102.67 13.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -53.88 109.7 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.346 1.058 . . . . 0.0 112.098 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 63.3 8.83 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.794 1.237 . . . . 0.0 113.19 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -98.24 -5.06 33.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.095 0.474 . . . . 0.0 111.436 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -151.25 167.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -125.72 170.86 17.58 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.8 m -114.65 139.74 49.4 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.37 127.91 38.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.07 -37.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.83 154.96 26.97 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.58 139.13 25.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.415 ' CD ' HG22 ' A' ' 434' ' ' VAL . 0.0 OUTLIER -156.99 176.85 12.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.41 150.09 22.98 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.88 119.48 32.76 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.555 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -50.85 -25.46 4.54 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.24 -36.28 1.23 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.119 -1.038 . . . . 0.0 113.646 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -90.08 -15.09 32.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 122.398 -0.472 . . . . 0.0 111.333 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 91.68 -144.93 17.45 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.02 116.42 4.14 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.388 2.059 . . . . 0.0 111.879 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.415 HG22 ' CD ' ' A' ' 426' ' ' LYS . 2.9 m -121.14 123.92 71.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 124.532 1.133 . . . . 0.0 108.943 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -130.18 125.22 34.45 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.175 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.11 122.2 40.96 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.5 pp -132.3 173.18 11.54 Favored 'General case' 0 C--N 1.257 -3.417 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 476' ' ' SER . 4.5 tt -124.17 110.63 14.92 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -69.12 121.63 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.806 0.812 . . . . 0.0 111.761 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -122.2 -16.03 7.55 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.655 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.0 -3.83 55.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.61 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 149.84 -103.56 0.25 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 119.943 -1.123 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.8 m -142.51 130.44 21.77 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.466 ' CD1' HD12 ' A' ' 437' ' ' LEU . 2.9 tt -107.26 138.47 43.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -145.94 151.94 38.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.866 0.757 . . . . 0.0 110.946 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.536 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.9 m -62.77 128.29 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.331 0.586 . . . . 0.0 111.123 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.59 54.0 Favored Glycine 0 N--CA 1.428 -1.865 0 C-N-CA 119.845 -1.169 . . . . 0.0 114.219 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 445' ' ' LYS 0.254 2.2 p30 -101.17 149.58 36.4 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 118.904 1.352 . . . . 0.0 112.55 177.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.37 124.83 6.67 Favored 'Trans proline' 0 C--N 1.364 1.393 0 C-N-CA 122.881 2.387 . . . . 0.0 113.04 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.39 151.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.364 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.03 120.61 65.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.24 111.36 26.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.68 -113.83 6.23 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.235 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 17.5 p -104.06 2.92 32.68 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.889 0.376 . . . . 0.0 111.53 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.441 HG22 ' CB ' ' A' ' 486' ' ' ASP . 25.3 m -124.78 151.33 45.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.685 0.278 . . . . 0.0 110.692 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -127.56 144.34 51.08 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -147.26 -164.36 11.12 Favored Glycine 0 C--N 1.287 -2.149 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -135.39 134.67 39.95 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.67 121.58 16.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -86.88 -61.24 1.77 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.005 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.13 155.25 51.03 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 123.892 0.877 . . . . 0.0 109.091 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.438 ' HE3' HD21 ' A' ' 444' ' ' LEU . 36.4 tpp -123.68 117.83 25.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.27 132.01 70.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -96.65 175.03 6.53 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.617 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.16 -27.35 61.83 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.53 0.732 . . . . 0.0 112.884 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.8 t -79.42 -11.03 59.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 96.55 6.0 58.69 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.134 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -87.75 130.79 34.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.625 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.39 127.27 32.59 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.46 178.57 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -103.34 -35.4 8.42 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.647 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.65 162.16 33.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.905 0.383 . . . . 0.0 111.434 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -129.65 129.49 44.36 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.213 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.25 163.99 34.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 439' ' ' VAL . 36.4 Cg_endo -65.26 152.37 82.36 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.402 2.068 . . . . 0.0 112.409 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.463 ' HA ' HD23 ' A' ' 438' ' ' LEU . 23.0 t 74.43 15.34 3.47 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.415 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.1 ttm -113.14 134.81 21.77 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.21 126.09 5.45 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.675 2.25 . . . . 0.0 110.882 173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.86 142.49 35.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.216 0.532 . . . . 0.0 112.221 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -91.25 112.2 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.47 167.37 2.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.17 0.51 . . . . 0.0 109.652 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.3 29.37 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.27 12.87 55.67 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.512 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.05 -31.85 61.39 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t60 61.73 20.52 11.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 111.499 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ASP . . . . . 0.441 ' CB ' HG22 ' A' ' 455' ' ' THR . 4.1 t70 -149.26 -179.54 7.13 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 11.8 p -90.15 120.4 69.2 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-O 121.003 0.43 . . . . 0.0 110.369 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.01 172.05 5.49 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.064 1.843 . . . . 0.0 111.425 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -128.53 131.07 48.25 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.71 33.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.85 -0.4 59.21 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.383 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -89.36 -178.35 5.59 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 152.55 24.17 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' PHE . . . . . 0.635 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.6 p90 -141.59 154.54 45.49 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.0 ttp -126.26 121.41 32.6 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.49 114.58 47.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.409 ' HD1' ' N ' ' A' ' 498' ' ' GLU . 0.3 OUTLIER -139.69 132.02 28.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' GLU . . . . . 0.409 ' N ' ' HD1' ' A' ' 497' ' ' PHE . 9.6 tp10 -67.0 141.37 57.6 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 123.724 0.64 . . . . 0.0 110.043 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -62.68 -61.21 2.58 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 125.242 1.417 . . . . 0.0 110.478 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.2 -28.72 70.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.376 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -68.77 -39.59 80.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.106 0.479 . . . . 0.0 111.374 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -80.24 -39.57 28.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.57 -52.44 61.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 508' ' ' GLU . 37.6 ttp180 -67.84 -15.79 63.79 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.389 0.676 . . . . 0.0 111.591 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -80.95 -33.87 33.62 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.411 0.624 . . . . 0.0 109.375 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.83 -54.73 7.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.351 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 509' ' ' ALA . . . -164.64 3.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.447 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 35.7 tt0 75.58 -39.99 0.4 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.869 2.068 . . . . 0.0 111.347 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 507' ' ' GLY . . . -91.39 -32.03 15.81 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.615 177.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -99.02 132.68 44.15 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.128 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -106.8 -179.09 3.84 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -164.45 107.05 0.89 Allowed 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -90.41 -37.31 14.05 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 128.593 2.757 . . . . 0.0 105.374 178.904 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -149.26 -179.35 25.06 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 p -117.38 143.12 46.31 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.313 0.578 . . . . 0.0 112.187 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.9 137.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.4 pt -93.18 -38.46 9.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -154.33 147.34 24.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.63 134.36 13.74 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -159.15 175.75 13.08 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -97.24 146.56 24.98 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -120.24 123.32 42.94 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.543 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.79 -10.03 3.44 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.08 -44.62 0.56 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.023 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -82.81 -25.39 32.74 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 122.859 0.464 . . . . 0.0 110.847 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.15 -166.58 15.48 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.75 116.41 4.09 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 121.84 1.693 . . . . 0.0 110.307 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 482' ' ' THR . 22.5 m -113.05 144.65 20.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-O 121.204 0.526 . . . . 0.0 109.939 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.71 111.98 9.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -85.04 120.9 27.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.0 pp -140.15 173.11 11.84 Favored 'General case' 0 C--N 1.278 -2.516 0 O-C-N 122.281 -0.262 . . . . 0.0 111.521 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.42 107.81 16.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.3 p -67.16 116.69 6.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.49 -15.64 6.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.509 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.31 -17.28 56.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.066 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.6 -107.83 0.33 Allowed Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 96.6 m -131.92 137.48 48.0 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.476 ' HG ' HG11 ' A' ' 496' ' ' VAL . 0.5 OUTLIER -109.84 127.18 54.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.602 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.7 ttpm? -131.71 158.28 41.55 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.431 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.8 m -71.19 137.13 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 O-C-N 121.777 -0.577 . . . . 0.0 110.384 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.17 -8.05 60.61 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.604 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 5.8 m-20 -68.5 136.86 90.78 Favored Pre-proline 0 CA--C 1.494 -1.202 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 55.1 Cg_endo -81.4 106.43 1.71 Allowed 'Trans proline' 0 N--CA 1.429 -2.29 0 C-N-CA 122.117 1.878 . . . . 0.0 107.544 171.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.618 HG22 HG22 ' A' ' 496' ' ' VAL . 2.8 pp -108.23 139.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.175 -170.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 58.5 t -110.39 113.99 45.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.24 112.0 38.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.08 -97.36 0.65 Allowed Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.85 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.0 t -131.74 3.95 4.18 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 120.963 0.411 . . . . 0.0 110.233 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.454 HG21 ' CB ' ' A' ' 486' ' ' ASP . 96.2 m -116.46 141.64 47.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 44.5 p90 -114.97 151.03 34.84 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -153.81 -164.3 12.59 Favored Glycine 0 C--N 1.296 -1.664 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 448' ' ' ASP . 19.9 ttm180 -134.58 127.43 31.23 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 482' ' ' THR . 60.9 t -58.88 115.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.72 0.638 . . . . 0.0 111.536 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -84.33 -59.27 2.44 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.0 151.22 48.87 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.549 0.739 . . . . 0.0 109.451 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 469' ' ' ARG . 54.7 tpp -122.49 117.33 25.69 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.3 127.91 75.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -96.45 -176.76 3.73 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.16 -173.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -48.54 -37.06 16.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 126.825 2.05 . . . . 0.0 113.114 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.0 m -88.71 -6.73 57.25 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.33 15.18 48.55 Favored Glycine 0 CA--C 1.496 -1.11 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.13 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.47 ' HB2' HD21 ' A' ' 464' ' ' ASN . 0.1 OUTLIER -100.4 135.17 42.26 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.086 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 462' ' ' MET . 6.6 tpt180 -68.89 130.99 44.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 462' ' ' MET . 14.0 m -139.71 -177.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.172 0.295 . . . . 0.0 110.681 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 472' ' ' GLU . 0.8 OUTLIER -106.32 -34.34 7.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 471' ' ' LYS . 32.8 tt0 -148.13 135.27 20.32 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.641 -172.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -128.84 144.74 51.25 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 171.11 31.96 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.233 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.506 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.5 Cg_endo -63.44 156.67 55.02 Favored 'Trans proline' 0 C--O 1.247 0.931 0 C-N-CA 122.969 2.446 . . . . 0.0 112.598 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 44.3 m 71.98 12.32 6.07 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.218 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.0 ttp -118.88 129.73 25.23 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.2 Cg_exo -67.48 127.22 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.694 2.263 . . . . 0.0 111.108 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 473' ' ' ALA . 24.5 m -139.85 154.96 24.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 39.4 tt0 -115.7 119.21 35.33 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -98.19 173.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.969 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.465 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.2 p -149.38 167.63 25.63 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.62 31.42 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.452 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 53.9 tp -81.22 -30.89 34.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.648 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 61.46 20.58 11.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.351 1.46 . . . . 0.0 111.345 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.454 ' CB ' HG21 ' A' ' 455' ' ' THR . 34.5 t70 -147.81 175.09 11.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.42 114.76 53.83 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 118.983 0.811 . . . . 0.0 112.318 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.75 146.61 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.686 1.59 . . . . 0.0 110.25 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.37 139.58 50.68 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.08 131.6 43.86 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.091 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.38 -0.12 68.05 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.091 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.56 ' OD1' ' HD2' ' A' ' 493' ' ' ARG . 1.6 t0 -85.02 -173.63 4.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.6 ' H ' ' HD2' ' A' ' 493' ' ' ARG . 0.9 OUTLIER -130.0 133.85 47.04 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.485 -175.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 40.5 p90 -127.15 150.23 49.59 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 54.2 ttp -119.98 115.81 24.5 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.822 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 450' ' ' ILE . 26.3 t . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.214 -0.768 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -47.37 -54.15 11.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 112.144 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.47 -34.92 41.05 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.241 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.57 73.04 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 122.006 0.908 . . . . 0.0 108.885 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -61.03 -37.62 83.22 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 125.675 1.59 . . . . 0.0 110.289 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -63.62 -45.32 90.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.798 0.332 . . . . 0.0 110.251 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 80.1 mt -67.67 -34.21 66.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.152 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -177.559 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 495' ' ' MET . 10.9 m . . . . . 0 CA--C 1.51 -0.576 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -139.63 -178.13 16.36 Favored Glycine 0 C--N 1.295 -1.697 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 26.7 m -124.22 143.8 50.32 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.4 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.045 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.7 pt -91.7 -35.19 6.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.423 ' HG3' ' OG1' ' A' ' 436' ' ' THR . 9.8 pt-20 -159.21 148.66 18.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.22 130.54 12.06 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 177.46 10.71 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -174.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 427' ' ' LEU . 2.0 pt? -94.72 150.12 20.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.84 135.09 50.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.29 -18.2 59.08 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.834 -174.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -114.82 -36.31 1.28 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.549 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.52 -30.48 19.3 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.418 -0.46 . . . . 0.0 111.796 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.67 -152.28 17.7 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 482' ' ' THR . 14.4 Cg_exo -71.67 116.33 4.66 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.725 1.617 . . . . 0.0 110.017 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.93 124.06 68.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.63 0.729 . . . . 0.0 111.537 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -123.08 112.18 17.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.889 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 424' ' ' GLU . 1.2 m -83.59 115.45 22.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.2 pp -132.21 170.85 14.44 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.898 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.467 ' O ' ' HG3' ' A' ' 440' ' ' GLN . 2.1 tm? -117.03 106.13 13.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -64.64 117.7 5.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-O 121.827 0.823 . . . . 0.0 112.346 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 438' ' ' LEU . 72.1 mt-30 -123.66 -15.46 7.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.698 -175.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.579 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -78.28 -14.99 59.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.831 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 153.97 -108.05 0.35 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 27.2 m -128.8 142.5 50.96 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.554 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.13 135.98 53.22 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.3 ttpt -146.0 150.83 36.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 33.5 m -70.74 134.23 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.235 0.541 . . . . 0.0 110.707 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 105.2 -21.19 36.11 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.488 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 43.8 m-20 -79.47 146.44 65.85 Favored Pre-proline 0 C--O 1.251 1.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 458' ' ' ARG . 10.7 Cg_endo -77.8 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.114 1.876 . . . . 0.0 111.179 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.58 152.03 30.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.67 121.9 48.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-O 121.195 0.521 . . . . 0.0 109.64 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.462 ' HB ' ' CB ' ' A' ' 494' ' ' PHE . 2.5 p -143.78 133.45 20.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.644 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.75 33.82 88.26 Favored Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.261 26.7 p 62.05 1.76 0.71 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.928 1.691 . . . . 0.0 114.306 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 39.0 m -98.38 141.15 31.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -120.18 151.37 39.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.171 -1.011 . . . . 0.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.25 14.04 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 449' ' ' PRO . 32.7 ttp180 -127.76 146.65 50.52 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.521 HG11 ' HE2' ' A' ' 462' ' ' MET . 45.9 t -74.08 120.17 22.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -92.63 -45.16 8.21 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.782 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -144.04 152.56 41.17 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.554 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -122.47 117.59 26.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.94 133.81 65.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.542 HD21 ' HB2' ' A' ' 468' ' ' ARG . 4.7 p30 -101.63 172.77 6.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.816 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.67 -26.1 61.2 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.335 1.054 . . . . 0.0 113.061 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.7 m -86.02 -2.22 58.1 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 122.099 -0.375 . . . . 0.0 111.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 93.92 1.98 64.98 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.413 170.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.8 mpt_? -86.35 131.83 34.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.597 -0.301 . . . . 0.0 110.439 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -77.85 129.63 35.64 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.08 176.04 9.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 -8.35 10.38 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.736 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -151.65 139.4 19.81 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.55 131.55 29.73 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.74 166.9 31.73 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.439 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 439' ' ' VAL . 17.7 Cg_endo -58.05 149.81 68.86 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 123.252 2.635 . . . . 0.0 112.175 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 43.4 t 77.55 6.44 2.92 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.917 0.887 . . . . 0.0 112.133 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 39.5 ttp -110.26 127.09 27.62 Favored Pre-proline 0 N--CA 1.439 -0.993 0 O-C-N 121.403 -0.811 . . . . 0.0 111.417 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.8 Cg_endo -74.15 126.59 10.62 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.627 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 17.4 m -141.17 152.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.327 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 35.4 mt-10 -99.62 123.1 43.57 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.5 pt -97.58 164.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 4.1 p -145.77 158.38 43.86 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 100.9 12.48 36.96 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.919 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.31 -36.58 71.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 67.33 21.43 9.81 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.731 1.612 . . . . 0.0 109.873 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.451 ' CB ' HG21 ' A' ' 455' ' ' THR . 6.7 t70 -145.63 -179.05 6.42 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.29 110.05 48.36 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 123.405 0.441 . . . . 0.0 110.982 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 36.2 Cg_endo -82.73 148.49 13.98 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.931 1.754 . . . . 0.0 110.561 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -111.29 135.98 51.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.024 0.44 . . . . 0.0 111.958 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.87 127.26 32.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.99 -0.24 66.69 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.866 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.2 t70 -88.41 -172.13 3.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.0 OUTLIER -128.31 139.0 52.65 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -171.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 46.7 p90 -127.63 159.69 33.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.01 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' MET . . . . . 0.414 ' HB2' HG12 ' A' ' 419' ' ' VAL . 28.1 ttt -132.44 130.68 40.88 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.579 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.0 p . . . . . 0 N--CA 1.426 -1.657 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 . . . . . 0 C--O 1.199 -1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -62.27 -52.97 61.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.903 -170.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.22 -40.72 95.05 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.282 0.363 . . . . 0.0 110.257 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.05 60.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.104 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -60.29 -38.11 82.61 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.961 0.904 . . . . 0.0 110.928 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -69.84 -34.62 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.645 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.65 -23.21 14.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.655 0.741 . . . . 0.0 110.116 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.086 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -177.573 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.591 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 30.4 m . . . . . 0 CA--C 1.498 -1.041 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.99 162.02 13.29 Favored Glycine 0 C--N 1.279 -2.62 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 m -117.01 138.76 51.36 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.88 139.45 17.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 18.2 pt -99.3 -39.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 490' ' ' ALA . 8.5 pt-20 -153.39 152.29 30.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.22 134.34 29.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.69 177.39 10.91 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.311 0.577 . . . . 0.0 111.185 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.97 145.08 26.19 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.771 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 10.4 t70 -128.02 129.16 46.25 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -75.55 -11.23 59.98 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -175.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -119.34 -35.64 0.92 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.478 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.0 mtp180 -94.08 -15.22 24.94 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.844 0.458 . . . . 0.0 111.028 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 88.15 -154.1 25.08 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -60.27 116.16 3.13 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.108 1.872 . . . . 0.0 111.173 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.8 137.18 53.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.434 0.635 . . . . 0.0 110.377 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -131.4 114.62 15.19 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.104 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -83.39 119.44 24.64 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.482 HD22 ' CE1' ' A' ' 494' ' ' PHE . 1.6 pp -135.73 173.07 12.12 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -120.01 112.41 19.12 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -75.77 125.2 35.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.526 0.679 . . . . 0.0 111.799 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 26.1 mt-30 -124.03 -15.11 6.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.937 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -97.3 6.31 48.55 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 147.62 -125.77 2.22 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.15 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.7 m -116.39 141.63 47.92 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.73 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.77 119.25 36.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.4 ttpm? -130.02 155.14 46.61 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.494 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.0 m -67.06 132.16 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.84 -7.09 48.76 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.916 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 445' ' ' LYS . 13.7 m-20 -73.88 135.02 77.68 Favored Pre-proline 0 C--O 1.25 1.089 0 CA-C-N 117.555 0.678 . . . . 0.0 111.932 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.32 119.15 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.629 2.219 . . . . 0.0 109.306 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.07 159.81 29.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.73 115.59 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 494' ' ' PHE . 16.6 t -128.38 124.17 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 56.98 42.35 92.78 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.264 6.6 t 60.39 4.09 0.65 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.549 2.34 . . . . 0.0 113.436 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.462 HG21 ' CB ' ' A' ' 486' ' ' ASP . 22.4 m -96.53 135.62 38.18 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -111.5 151.65 28.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.604 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.95 -163.97 19.29 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -134.62 137.21 43.48 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 444' ' ' LEU . 48.7 t -66.69 119.36 11.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.184 0.516 . . . . 0.0 112.097 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -81.54 -60.59 2.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.92 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -136.2 152.05 50.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.73 ' HE1' HD22 ' A' ' 444' ' ' LEU . 41.2 tpp -115.23 117.07 29.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 469' ' ' ARG . 11.9 t -122.88 126.49 73.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.444 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -92.81 174.77 7.08 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.625 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.21 -27.82 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.949 0.9 . . . . 0.0 113.144 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.5 m -78.81 -12.1 60.01 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.756 0.312 . . . . 0.0 111.0 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 98.41 8.32 54.95 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.93 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -97.0 128.81 44.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 463' ' ' VAL . 3.8 tmm_? -84.77 124.33 31.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.43 -174.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -99.31 -31.85 11.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.11 156.67 40.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.304 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.53 42.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -100.58 177.04 28.0 Favored Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.44 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.7 Cg_endo -59.76 155.37 43.6 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.971 2.447 . . . . 0.0 112.641 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 47.6 m 70.81 16.94 6.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.955 0.902 . . . . 0.0 112.144 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 45.5 ttm -117.81 136.68 23.8 Favored Pre-proline 0 C--N 1.316 -0.861 0 O-C-N 122.007 -0.433 . . . . 0.0 111.185 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.1 Cg_endo -82.57 125.85 4.5 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.234 1.956 . . . . 0.0 110.884 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 464' ' ' ASN . 16.9 m -143.22 156.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.0 mt-10 -105.0 126.55 52.18 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 50.0 pt -97.95 170.4 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 1.2 p -150.42 167.46 27.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.75 13.89 62.05 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.914 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.63 -32.54 64.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.9 t60 67.45 19.85 9.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.076 1.75 . . . . 0.0 109.788 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.462 ' CB ' HG21 ' A' ' 455' ' ' THR . 7.3 t70 -148.39 -179.98 7.36 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.9 t -120.42 113.41 33.68 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.46 175.38 10.24 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.773 2.315 . . . . 0.0 111.509 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -111.03 148.0 33.54 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 424' ' ' GLU . . . -70.22 138.84 52.05 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.255 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.85 -0.23 86.26 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.18 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.613 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 4.5 t70 -83.96 -165.34 1.11 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.613 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -138.59 148.98 44.78 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.688 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.482 ' CE1' HD22 ' A' ' 437' ' ' LEU . 15.0 p90 -139.56 156.19 47.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.833 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.1 ttt -118.86 127.39 53.46 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.8 p . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.096 0.474 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -72.53 -38.63 67.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.607 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.49 -46.78 88.84 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.611 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.94 -45.03 94.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -58.94 -36.03 74.1 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 125.374 1.469 . . . . 0.0 111.757 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -34.14 59.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.9 mm -80.18 -54.06 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.316 0 C-N-CA 118.695 -1.717 . . . . 0.0 115.052 -178.378 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.503 -0.85 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -129.47 178.37 17.43 Favored Glycine 0 C--N 1.298 -1.554 0 C-N-CA 119.233 -1.46 . . . . 0.0 112.542 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.84 145.16 45.89 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 123.335 0.654 . . . . 0.0 111.107 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 30.0 t -86.55 134.06 28.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 436' ' ' THR . 17.2 pt -94.26 -33.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.31 149.13 20.56 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.58 131.27 18.93 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.78 177.98 4.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.89 152.85 21.77 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -126.62 119.32 26.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -58.11 -19.55 33.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -112.53 -38.78 1.28 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.784 -1.198 . . . . 0.0 112.839 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.57 -32.59 19.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.37 -155.53 16.17 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.56 116.38 4.38 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.075 1.85 . . . . 0.0 110.068 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 32.4 m -116.3 143.94 25.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.793 0.806 . . . . 0.0 111.684 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -133.17 112.03 11.4 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.488 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 423' ' ' ILE . 2.7 m -87.55 115.36 24.92 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.646 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.4 pp -132.86 171.37 14.0 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 476' ' ' SER . 2.4 tm? -113.33 106.38 14.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -70.3 108.84 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.352 1.072 . . . . 0.0 111.928 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -115.0 -15.94 11.71 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.18 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -77.64 -4.12 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.906 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.31 -95.67 0.19 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.218 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.9 m -142.05 139.61 32.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -114.47 135.57 53.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -147.75 164.3 34.01 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 28.6 m -70.62 138.12 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 121.734 0.778 . . . . 0.0 112.134 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.28 -10.62 65.4 Favored Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.207 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 51.1 m-20 -76.66 131.76 73.37 Favored Pre-proline 0 C--O 1.245 0.848 0 CA-C-N 117.651 0.725 . . . . 0.0 111.536 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 4.9 Cg_exo -77.42 107.68 2.44 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.681 2.254 . . . . 0.0 109.26 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -112.48 161.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.898 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.56 114.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.444 HG23 HD13 ' A' ' 450' ' ' ILE . 61.7 t -120.34 112.42 36.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.55 -115.61 7.52 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.8 p -107.34 7.02 28.94 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.997 0.427 . . . . 0.0 111.259 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 486' ' ' ASP . 90.0 m -121.59 129.53 52.9 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.781 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -111.31 151.99 27.74 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -165.66 -164.27 20.77 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.593 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 56.7 ttp180 -131.91 128.72 39.15 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 482' ' ' THR . 40.1 t -61.28 122.86 12.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 123.859 0.724 . . . . 0.0 111.767 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -95.71 -56.93 2.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.31 52.28 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.6 tpp -115.37 117.68 31.09 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 16.8 t -116.36 139.6 42.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -105.43 171.97 7.04 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.095 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.6 -25.89 54.02 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 41.2 m -77.09 -11.71 59.85 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.011 -0.43 . . . . 0.0 110.954 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.74 -4.64 56.41 Favored Glycine 0 CA--C 1.496 -1.12 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.484 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -91.89 140.26 29.85 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.4 tmm_? -86.44 138.01 32.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 16.7 m -136.17 -173.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 124.41 1.084 . . . . 0.0 108.493 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -119.34 -17.07 8.91 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.113 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 445' ' ' LYS . 34.0 tt0 -149.19 152.25 35.72 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.44 135.36 30.25 Favored 'General case' 0 C--O 1.25 1.11 0 O-C-N 123.536 0.522 . . . . 0.0 110.876 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -86.45 168.43 40.19 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.641 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 439' ' ' VAL . 37.0 Cg_endo -64.26 154.99 68.0 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 122.941 2.427 . . . . 0.0 113.729 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 438' ' ' LEU . 34.1 m 70.17 16.55 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.016 1.326 . . . . 0.0 112.19 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.6 ttp -117.0 130.07 24.87 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.475 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 11.2 Cg_endo -72.68 126.12 11.16 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.27 1.98 . . . . 0.0 111.788 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.72 155.05 22.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.672 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 463' ' ' VAL . 43.5 mt-10 -108.64 113.63 26.78 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 124.516 1.127 . . . . 0.0 108.575 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.8 pt -98.13 172.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.805 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.6 p -146.45 163.03 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 107.29 11.56 25.34 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.972 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.4 mt -83.71 -27.29 29.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.706 0.289 . . . . 0.0 111.749 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 60.27 19.26 8.73 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.61 1.164 . . . . 0.0 110.518 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 455' ' ' THR . 34.4 t70 -149.26 174.39 12.44 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.22 112.26 52.37 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.92 2.413 . . . . 0.0 111.37 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -105.31 132.43 51.51 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.484 0.659 . . . . 0.0 111.656 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.03 28.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 101.63 -5.11 54.16 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.24 -177.48 6.25 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.09 143.66 44.41 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.656 0.782 . . . . 0.0 110.758 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.646 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 50.1 p90 -136.83 163.16 31.3 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.5 ttm -130.17 115.88 17.65 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.851 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' A' ' 444' ' ' LEU . 74.6 t . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 49.3 mt-10 . . . . . 0 C--O 1.182 -2.458 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -62.42 -39.12 92.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.74 0.781 . . . . 0.0 111.141 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.12 -41.2 86.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.914 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.65 -25.92 41.22 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.159 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 28.7 ttt180 -70.76 -29.06 65.17 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.74 1.216 . . . . 0.0 110.014 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -65.2 -34.52 78.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.033 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 70.9 mt -79.08 -35.02 17.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.437 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.272 177.256 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -147.8 -175.35 20.46 Favored Glycine 0 C--N 1.299 -1.508 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 6.6 m -123.76 141.96 51.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.098 0.449 . . . . 0.0 109.891 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.87 138.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.4 pt -94.19 -42.22 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.779 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.77 146.72 27.34 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.71 19.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 177.44 4.34 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.98 150.78 20.05 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.043 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -127.46 129.84 48.18 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -67.21 -16.87 64.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.7 -53.78 0.55 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.93 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.72 -29.25 64.33 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.49 0.662 . . . . 0.0 110.15 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 434' ' ' VAL . . . 104.16 -179.42 24.89 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 486' ' ' ASP . 35.6 Cg_exo -49.73 119.55 4.87 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.341 2.027 . . . . 0.0 111.179 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 432' ' ' GLY . 21.0 m -117.98 158.81 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.444 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -150.76 113.38 4.69 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.095 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 m -90.47 119.84 31.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -134.63 173.3 11.82 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.54 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.6 tm? -117.07 106.16 13.06 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.8 p -78.71 123.41 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.415 0.626 . . . . 0.0 112.506 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -124.09 -16.31 6.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.403 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -63.82 -16.99 62.64 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.541 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.89 -92.79 0.11 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.433 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.3 m -148.1 141.86 25.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.729 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.22 117.76 34.94 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.8 ttpm? -125.62 153.46 43.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.2 m -71.02 139.02 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.775 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 101.75 -10.23 57.3 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.405 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 66.1 m-20 -82.08 138.19 46.01 Favored Pre-proline 0 C--O 1.244 0.789 0 CA-C-N 117.271 0.535 . . . . 0.0 111.846 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 18.5 Cg_endo -83.68 106.87 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.542 2.161 . . . . 0.0 110.161 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -108.4 162.98 6.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.034 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 6.9 p -133.18 125.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.67 125.5 70.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.64 -103.12 1.13 Allowed Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 19.6 m -126.33 0.24 7.02 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.739 0.78 . . . . 0.0 109.662 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 74.7 m -116.23 146.01 42.68 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.491 -0.755 . . . . 0.0 111.158 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 54.7 p90 -119.24 159.89 23.23 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -164.81 -164.44 20.14 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 35.3 ttm-85 -135.43 130.03 34.16 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 482' ' ' THR . 38.2 t -64.46 120.78 12.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.69 0.757 . . . . 0.0 112.858 -172.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -85.33 -60.28 2.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.812 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.8 160.75 37.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.921 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.729 ' HE1' HD22 ' A' ' 444' ' ' LEU . 36.7 tpp -130.69 117.51 19.56 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.16 138.78 53.72 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.0 p30 -103.62 176.48 5.14 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.932 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -51.33 -38.39 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.517 1.136 . . . . 0.0 111.783 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.0 m -76.74 -5.9 49.98 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.01 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.44 2.64 63.5 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.38 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.477 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.9 mpt_? -88.67 128.63 35.6 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.755 0.312 . . . . 0.0 110.365 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -84.31 134.15 34.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.1 176.15 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -96.52 -35.51 11.09 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.962 0.411 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.75 151.43 28.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.304 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.91 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.135 0.574 . . . . 0.0 109.755 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.77 179.29 42.87 Favored Glycine 0 N--CA 1.439 -1.148 0 O-C-N 123.534 0.521 . . . . 0.0 112.327 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.411 ' HA ' HG13 ' A' ' 439' ' ' VAL . 65.1 Cg_endo -71.72 161.01 46.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.696 2.264 . . . . 0.0 112.689 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 438' ' ' LEU . 18.7 m 67.25 23.14 9.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.406 1.082 . . . . 0.0 110.591 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.0 ttt -125.86 137.62 30.43 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.884 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 5.7 Cg_exo -83.21 125.75 4.1 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.0 m -142.69 151.66 17.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.248 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.7 tt0 -108.63 119.05 38.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.5 pt -98.15 172.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.262 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.6 p -148.9 157.24 43.28 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.823 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.49 4.96 Favored Glycine 0 C--N 1.308 -0.988 0 O-C-N 123.566 0.541 . . . . 0.0 112.379 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.27 -31.65 11.95 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.76 21.16 11.22 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.992 1.317 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 433' ' ' PRO . 38.1 t70 -147.78 167.43 24.72 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 4.8 p -94.75 115.93 65.85 Favored Pre-proline 0 C--N 1.287 -2.117 0 CA-C-O 121.035 0.445 . . . . 0.0 110.762 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 488' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.9 Cg_endo -84.97 173.7 7.88 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.617 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -122.47 136.63 54.93 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.962 0.411 . . . . 0.0 111.383 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.85 140.6 51.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.922 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.51 89.38 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.585 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.84 -176.4 4.43 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 6.3 mpt_? -113.14 150.4 32.26 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.241 0.543 . . . . 0.0 110.196 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.2 p90 -139.54 165.13 28.07 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.14 131.99 45.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 444' ' ' LEU . 84.5 t . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 503' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.968 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 505' ' ' GLN . 6.7 mmmm -56.36 -42.48 77.87 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.277 0.361 . . . . 0.0 110.363 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -80.82 -37.38 30.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 500' ' ' GLU . . . -54.64 -56.6 17.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.23 0.612 . . . . 0.0 111.425 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -72.73 -19.49 61.37 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.394 0.616 . . . . 0.0 111.296 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 501' ' ' LYS . 47.6 tt0 -81.21 -31.05 34.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.01 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 83.3 mt -87.29 -53.89 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.607 0 C-N-CA 119.237 -1.459 . . . . 0.0 114.173 179.278 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.504 -0.791 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -141.84 -178.35 17.87 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.3 m -124.21 138.97 54.34 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.64 138.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 436' ' ' THR . 24.7 pt -89.13 -44.3 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.045 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 7.4 pt-20 -155.45 157.42 36.95 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.05 136.98 32.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 177.74 5.54 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.18 152.48 21.08 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.344 0.593 . . . . 0.0 110.047 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -122.76 118.28 27.68 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.466 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.2 -19.37 13.44 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.31 -41.32 1.79 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.642 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.55 -37.25 19.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 110.817 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.63 -146.42 18.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.53 116.51 4.27 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.507 2.138 . . . . 0.0 111.331 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 482' ' ' THR . 27.4 m -119.81 158.6 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.2 121.77 13.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 480' ' ' GLU . 1.6 m -92.55 117.65 30.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.613 HD23 ' CZ ' ' A' ' 494' ' ' PHE . 0.0 OUTLIER -133.75 168.87 17.92 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.506 -177.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -114.86 106.35 14.07 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -72.72 117.08 15.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.779 0.799 . . . . 0.0 112.494 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.41 -15.96 9.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.123 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.68 60.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.802 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 155.63 -106.92 0.3 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 90.1 m -134.74 133.69 40.2 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.559 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -101.9 126.02 48.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.1 ttpt -140.09 145.71 37.98 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -64.93 145.58 13.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.368 0.604 . . . . 0.0 112.449 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 -21.87 42.52 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.419 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 0.3 OUTLIER -94.7 144.03 27.21 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 26.1 Cg_exo -66.55 136.69 43.7 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.914 2.409 . . . . 0.0 111.346 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 452' ' ' VAL . 2.7 pp -131.5 161.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.262 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.22 116.19 47.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.48 HG23 HD13 ' A' ' 450' ' ' ILE . 85.0 t -128.58 122.62 57.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' GLY . . . . . 0.513 ' HA2' ' OD1' ' A' ' 492' ' ' ASP . . . 60.89 36.63 92.39 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 121.18 -0.534 . . . . 0.0 111.966 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.295 8.3 p 60.97 8.93 2.08 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.498 HG21 ' CB ' ' A' ' 486' ' ' ASP . 87.0 m -102.81 139.41 38.42 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -111.65 146.77 36.87 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.493 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -152.6 -167.86 15.94 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.67 135.92 47.27 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.561 HG11 ' HE2' ' A' ' 462' ' ' MET . 46.2 t -73.73 117.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 123.404 0.44 . . . . 0.0 110.292 -176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.97 -56.22 3.42 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -130.63 153.76 48.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.561 ' HE2' HG11 ' A' ' 459' ' ' VAL . 39.5 tpp -121.09 120.02 34.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.87 139.13 51.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 5.5 p30 -97.02 174.53 6.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.12 -25.88 67.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 44.0 m -78.83 -19.8 51.21 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.189 0.519 . . . . 0.0 111.102 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.88 2.21 Favored Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.191 165.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.468 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 25.8 ttm180 -120.27 136.5 54.65 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.021 -1.59 . . . . 0.0 109.941 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -79.77 132.05 36.06 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.16 0.913 . . . . 0.0 110.728 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.29 -32.0 8.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.138 0.494 . . . . 0.0 110.284 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.04 163.95 37.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.388 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.64 38.45 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.09 172.31 38.19 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.555 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.498 ' HA ' HG13 ' A' ' 439' ' ' VAL . 35.6 Cg_endo -65.79 158.55 53.11 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.9 m 70.54 16.83 6.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.598 1.159 . . . . 0.0 111.362 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 25.1 ttt -117.04 137.53 23.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.677 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 1.9 Cg_endo -82.06 126.15 4.93 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.417 2.078 . . . . 0.0 111.298 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.57 158.0 16.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.334 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 37.8 mt-10 -111.62 121.24 44.61 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.7 pt -98.44 172.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.773 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.447 ' CG2' HG12 ' A' ' 434' ' ' VAL . 3.1 p -147.43 163.19 37.29 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.65 7.73 58.79 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.159 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.89 -39.05 64.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.22 30.41 19.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.003 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 455' ' ' THR . 35.2 t70 -140.77 179.67 6.57 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.58 109.73 47.27 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 118.317 0.508 . . . . 0.0 109.939 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 1.2 Cg_endo -80.58 164.19 21.15 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 121.602 1.535 . . . . 0.0 109.73 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -131.4 140.06 49.57 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-O 121.318 0.58 . . . . 0.0 110.458 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -71.11 132.08 44.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.285 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 88.24 0.61 82.57 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.968 -1.111 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.595 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.6 t70 -88.41 -173.26 4.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.595 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -128.4 153.54 46.96 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.156 0.503 . . . . 0.0 111.0 -171.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.613 ' CZ ' HD23 ' A' ' 437' ' ' LEU . 44.2 p90 -145.65 165.7 27.96 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.105 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.3 ttt -133.15 123.44 25.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' CD1' ' A' ' 494' ' ' PHE . 84.0 t . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 7.1 pt-20 . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.491 0.662 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 61.6 mtpt -66.49 -37.7 85.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.562 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 506' ' ' ILE . 87.8 tttt -77.79 -40.0 42.09 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.035 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.22 86.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.481 0.657 . . . . 0.0 110.924 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -58.5 -38.83 78.47 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.835 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -74.32 -35.43 63.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.534 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 502' ' ' LYS . 75.7 mt -64.68 -38.42 82.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.724 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.31 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.117 -179.423 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -126.41 171.07 18.17 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.1 m -121.86 139.94 53.01 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 34.1 t -84.61 134.78 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.93 -38.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.196 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.33 132.05 12.32 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -166.33 175.48 8.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -82.62 142.75 31.5 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.992 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.46 122.56 48.05 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.515 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.21 -16.33 43.88 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.09 -36.15 1.05 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.508 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -93.76 -15.25 25.37 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 94.13 -167.56 27.91 Favored Glycine 0 C--O 1.206 -1.597 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.32 116.46 3.2 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.207 1.938 . . . . 0.0 111.06 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.75 145.36 21.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-O 121.292 0.568 . . . . 0.0 111.043 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.79 114.92 8.32 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.36 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 480' ' ' GLU . 6.7 m -87.04 127.56 35.1 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -141.6 169.87 16.79 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.543 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -118.44 109.48 16.29 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -78.06 122.51 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.572 0.701 . . . . 0.0 112.293 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -123.92 -13.4 7.37 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.38 -19.82 41.84 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.03 -171.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 167.53 -118.32 0.78 Allowed Glycine 0 N--CA 1.414 -2.77 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.024 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.3 m -130.85 120.82 24.23 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.654 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -98.18 123.19 42.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 24.6 ttpt -137.87 153.12 49.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -70.78 141.25 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.372 0.606 . . . . 0.0 112.554 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.39 87.14 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.403 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.32 139.63 21.66 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.16 134.7 47.0 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.085 2.523 . . . . 0.0 113.192 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -134.22 162.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.651 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 121.42 49.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 450' ' ' ILE . 59.9 t -128.45 119.25 49.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.99 96.9 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 123.474 0.484 . . . . 0.0 112.069 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.304 35.0 p 66.82 -6.34 0.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.83 1.652 . . . . 0.0 115.027 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.0 m -90.94 140.92 29.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -110.78 155.48 22.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.688 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -161.47 -164.33 16.15 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 40.9 ttm180 -135.7 131.66 35.94 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 446' ' ' VAL . 35.2 t -67.96 114.06 4.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -79.22 -56.55 4.27 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.732 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.65 148.93 46.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.654 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.9 tpp -114.69 116.97 29.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.4 136.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.43 178.01 5.01 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.792 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.14 -34.76 58.18 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.157 0.983 . . . . 0.0 112.375 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.6 m -83.88 -4.03 58.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.53 62.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.97 171.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.46 136.9 37.72 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -90.07 128.65 36.35 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.46 -175.37 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.428 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.53 -36.26 6.25 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.79 148.3 35.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.631 -174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.39 142.15 39.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.51 176.26 36.62 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.447 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.5 Cg_endo -64.28 155.44 65.47 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 438' ' ' LEU . 70.8 m 70.23 22.04 5.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.383 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.8 ttt -120.52 133.74 24.08 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.244 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 4.9 Cg_exo -79.2 126.5 7.01 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.866 2.377 . . . . 0.0 110.718 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.48 155.01 14.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.49 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 436' ' ' THR . 33.4 mt-10 -106.72 116.63 32.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -98.19 168.25 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.2 p -147.77 165.81 29.42 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 98.93 13.49 39.77 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.597 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.56 -28.3 33.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 58.11 25.48 12.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.141 1.376 . . . . 0.0 110.944 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 455' ' ' THR . 11.2 t70 -147.53 -179.61 6.99 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.21 105.1 51.32 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.69 170.88 19.29 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.939 1.759 . . . . 0.0 111.144 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -111.92 141.01 46.1 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.76 21.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.03 59.25 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.905 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.44 174.62 10.48 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 141.93 43.31 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.394 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -133.77 158.33 43.61 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.9 ttt -132.37 131.27 41.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.159 0.504 . . . . 0.0 109.801 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.8 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 86.7 mttt -62.84 -47.04 85.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.815 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -79.97 -29.01 39.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.036 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.1 -47.03 86.45 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -57.22 -39.55 75.69 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.957 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 81.5 mm-40 -64.32 -44.82 90.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.239 0.337 . . . . 0.0 110.633 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.96 -38.84 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.612 0.72 . . . . 0.0 110.345 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.334 -177.581 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.508 -0.665 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.72 -179.04 19.19 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 61.1 m -126.36 144.34 50.85 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.324 0.583 . . . . 0.0 110.535 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 425' ' ' ALA . 43.1 t -80.13 132.87 30.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.9 pt -86.7 -39.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.65 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.51 146.42 22.37 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . 0.489 ' HB2' HG11 ' A' ' 422' ' ' VAL . . . -149.86 146.51 27.15 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -173.85 177.15 2.49 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.3 pt? -85.39 148.73 25.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.98 131.1 51.13 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.982 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -74.28 -15.7 60.96 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.625 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -91.3 -58.53 1.45 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.935 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -95.81 -42.47 8.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.144 0.472 . . . . 0.0 112.056 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 135.35 -135.89 8.16 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.53 116.05 4.38 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.971 1.78 . . . . 0.0 110.708 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.47 142.63 33.9 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 CA-C-O 121.38 0.609 . . . . 0.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -139.94 113.42 8.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.871 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.64 120.82 27.49 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -135.88 173.44 11.71 Favored 'General case' 0 C--N 1.273 -2.743 0 O-C-N 122.188 -0.32 . . . . 0.0 111.756 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -121.39 106.3 11.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.8 p -74.35 121.85 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.634 0.73 . . . . 0.0 112.891 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -125.38 -15.97 6.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.772 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 496' ' ' VAL . . . -73.24 -9.51 58.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.407 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.02 -97.01 0.16 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.887 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.3 m -144.51 139.64 28.36 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -111.05 115.52 29.59 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -131.75 154.22 49.28 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.486 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -70.46 146.14 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.778 0.799 . . . . 0.0 112.774 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 502' ' ' LYS . . . 97.23 -10.61 65.49 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.577 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.56 153.43 38.82 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.04 134.64 6.17 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 C-N-CA 122.401 2.068 . . . . 0.0 112.501 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.2 150.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.9 p -121.28 122.49 67.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.43 108.75 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.91 -90.96 0.22 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.233 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.7 t -118.25 -19.78 8.83 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.887 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 486' ' ' ASP . 29.6 m -105.68 137.92 42.74 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.364 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 51.1 p90 -114.82 148.5 38.41 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.066 0.46 . . . . 0.0 110.858 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -155.73 -164.93 13.71 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -126.6 143.13 51.32 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.445 HG11 ' HE2' ' A' ' 462' ' ' MET . 32.6 t -73.21 113.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.487 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -88.69 -59.28 2.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.98 148.43 50.09 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 40.0 tpp -114.74 117.78 31.75 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.97 157.65 22.25 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 44.4 p30 -108.18 -176.68 3.12 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.548 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.1 -25.29 61.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.375 0.607 . . . . 0.0 110.251 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.1 m -81.89 -13.27 57.8 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.36 6.61 50.61 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.435 ' HB2' HD21 ' A' ' 464' ' ' ASN . 10.8 mpt_? -88.97 140.78 29.08 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -101.58 126.58 48.42 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 462' ' ' MET . 31.0 m -131.54 -175.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.63 -23.13 8.87 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -154.17 137.28 15.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.13 147.67 32.76 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.658 0.383 . . . . 0.0 110.694 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -95.3 179.82 36.45 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.44 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.415 ' HA ' HG13 ' A' ' 439' ' ' VAL . 55.5 Cg_endo -68.56 160.51 49.03 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.921 2.414 . . . . 0.0 113.463 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.423 ' HA ' HD11 ' A' ' 438' ' ' LEU . 36.8 m 65.4 29.64 11.31 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.236 1.017 . . . . 0.0 110.704 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.2 ttt -131.59 131.01 22.57 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.502 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.3 Cg_endo -78.03 125.17 7.09 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.653 1.569 . . . . 0.0 111.884 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.4 m -137.66 158.48 34.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.585 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 33.3 tt0 -121.48 114.78 21.73 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.7 pt -97.74 170.78 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.561 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 5.3 p -147.96 160.44 42.82 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.85 7.51 38.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.096 -1.05 . . . . 0.0 114.332 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.47 -30.91 64.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.182 0.491 . . . . 0.0 109.938 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 23.5 t60 64.3 21.45 12.52 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.959 1.304 . . . . 0.0 110.73 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.433 ' CB ' HG21 ' A' ' 455' ' ' THR . 14.8 t70 -147.68 179.6 7.58 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.61 111.15 64.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-O 121.645 0.736 . . . . 0.0 111.251 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.11 161.43 18.0 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.203 1.936 . . . . 0.0 111.193 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -114.93 148.03 39.21 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-O 121.284 0.564 . . . . 0.0 109.487 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.07 128.55 36.32 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.626 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.4 64.05 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.002 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.76 178.63 7.21 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.527 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -122.91 130.52 52.95 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 44.8 p90 -122.99 151.77 41.53 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 121.26 0.552 . . . . 0.0 110.235 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.7 ttm -121.62 116.67 25.02 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 441' ' ' ALA . 92.7 t . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 6.9 pt-20 . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 48.3 mmtm -64.12 -49.66 71.31 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.346 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 447' ' ' GLY . 61.9 mttp -68.25 -35.24 77.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.81 -57.07 12.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.784 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -58.69 -40.2 82.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 111.861 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.09 -25.23 65.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.28 . . . . 0.0 111.705 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 502' ' ' LYS . 42.0 mm -78.36 -51.47 17.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.202 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.654 -179.31 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 494' ' ' PHE . 35.4 m . . . . . 0 N--CA 1.434 -1.225 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.03 -178.29 18.27 Favored Glycine 0 C--N 1.289 -2.04 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.9 m -120.69 141.69 50.17 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 117.812 0.806 . . . . 0.0 109.507 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.23 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 436' ' ' THR . 14.8 pt -94.35 -34.7 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.318 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.402 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 11.8 pt-20 -157.4 147.85 21.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.48 17.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 178.15 2.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.14 151.97 29.5 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.728 0.775 . . . . 0.0 111.445 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.07 -17.7 59.53 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.27 -36.35 2.71 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.058 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -95.81 -29.01 14.46 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.065 0.459 . . . . 0.0 110.891 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 110.28 -149.33 17.54 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.516 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 13.8 Cg_exo -68.85 115.65 4.06 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.809 1.673 . . . . 0.0 109.217 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.98 137.53 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 122.309 1.052 . . . . 0.0 112.621 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.91 15.23 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.485 HG22 HD11 ' A' ' 423' ' ' ILE . 3.3 m -88.72 123.09 32.82 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -140.36 170.99 14.78 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.474 -173.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 476' ' ' SER . 0.8 OUTLIER -118.91 106.42 12.47 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.63 121.95 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.631 . . . . 0.0 112.229 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -120.84 -15.12 8.4 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.689 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.8 -7.54 59.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.659 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.73 -110.79 0.46 Allowed Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.348 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.4 m -139.9 139.78 36.29 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -112.7 126.41 55.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -174.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 8.2 ttpt -136.83 150.83 48.54 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 110.223 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.2 m -68.5 146.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.471 0.653 . . . . 0.0 112.193 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.7 -3.44 84.97 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.768 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.46 139.31 19.99 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.39 133.56 19.37 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.449 2.099 . . . . 0.0 113.281 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 14.3 pt -126.25 172.46 13.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.22 122.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 494' ' ' PHE . 44.4 t -122.8 105.29 15.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.61 -118.92 14.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.4 p -102.38 -3.5 26.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 486' ' ' ASP . 87.1 m -104.07 129.52 51.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -123.53 167.39 13.96 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 122.032 -0.417 . . . . 0.0 109.88 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.26 -164.61 37.07 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -115.07 143.33 45.37 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.36 124.43 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.448 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.1 tmt_? -93.79 -58.89 2.13 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.19 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.89 148.47 50.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 444' ' ' LEU . 50.4 tpp -119.15 117.25 28.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.82 125.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.45 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.1 p30 -95.1 176.26 6.31 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.325 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.44 -23.17 62.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 113.083 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.4 m -77.83 -16.34 58.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.04 32.37 8.47 Favored Glycine 0 CA--C 1.486 -1.743 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.562 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.45 ' HB2' HD21 ' A' ' 464' ' ' ASN . 80.9 mtt180 -116.9 126.65 53.3 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -81.45 123.45 28.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.61 -174.46 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -98.68 -34.06 10.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.892 0.377 . . . . 0.0 109.986 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.67 166.1 31.39 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.941 0.401 . . . . 0.0 111.38 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.69 150.51 34.46 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.745 0.818 . . . . 0.0 109.089 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -96.39 -179.96 35.04 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.166 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HA ' HG13 ' A' ' 439' ' ' VAL . 51.4 Cg_endo -67.06 161.9 40.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.814 2.343 . . . . 0.0 112.066 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.422 ' HA ' HD11 ' A' ' 438' ' ' LEU 0.258 51.9 p 66.47 6.79 4.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.775 1.63 . . . . 0.0 113.516 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 40.0 ttm -107.98 136.92 19.7 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.232 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.4 Cg_endo -82.34 126.62 4.9 Favored 'Trans proline' 0 C--O 1.252 1.187 0 C-N-CA 122.46 2.107 . . . . 0.0 110.6 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 473' ' ' ALA . 20.0 m -137.33 155.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.194 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.09 115.74 30.7 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.7 pt -97.93 167.95 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 7.8 p -150.1 166.49 29.63 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.43 -15.68 19.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.877 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.76 -40.32 91.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.998 0.427 . . . . 0.0 110.802 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' HIS . . . . . 0.516 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 72.1 t60 61.83 20.12 11.17 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.578 1.551 . . . . 0.0 110.627 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.425 ' HB2' HG21 ' A' ' 455' ' ' THR . 10.5 m-20 -142.38 167.21 22.63 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.6 p -110.05 119.76 46.41 Favored Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.882 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.73 176.52 7.69 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.194 2.596 . . . . 0.0 110.604 175.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -102.05 140.15 36.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.36 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -67.18 124.53 23.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.7 -0.36 57.94 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.478 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.39 176.93 8.73 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.45 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 1.4 mpt_? -118.77 124.83 48.22 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.387 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 31.8 p90 -119.96 148.84 43.04 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 53.2 ttp -118.51 127.01 53.23 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 494' ' ' PHE . 59.0 t . . . . . 0 N--CA 1.433 -1.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.245 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 42.0 mt-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -77.91 -39.06 44.2 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.42 -47.94 82.29 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.98 88.06 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.804 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 3.4 tmt_? -58.82 -43.11 90.55 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.738 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -75.13 -35.36 61.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.89 -30.52 14.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.472 0.653 . . . . 0.0 109.907 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.561 -179.565 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 4.8 m . . . . . 0 CA--C 1.476 -1.878 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -114.89 172.2 14.09 Favored Glycine 1 N--CA 1.385 -4.705 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.2 p -131.18 141.99 50.15 Favored 'General case' 0 C--N 1.245 -3.937 0 O-C-N 124.225 0.603 . . . . 0.0 110.903 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 53.7 t -89.13 130.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 436' ' ' THR . 13.9 pt -89.8 -38.82 11.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.698 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -154.74 154.45 32.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -139.99 139.19 35.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.35 177.92 3.94 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.514 0.673 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -88.24 149.45 23.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.875 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.6 129.9 46.56 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 173.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.412 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -68.86 -20.85 64.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -104.66 -40.6 2.15 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.723 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.497 ' HB3' HG21 ' A' ' 482' ' ' THR . 91.8 mtm180 -94.94 -22.76 17.77 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.5 -159.69 21.11 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.64 116.4 3.17 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.28 1.987 . . . . 0.0 111.095 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 482' ' ' THR . 34.6 m -118.17 154.39 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.8 116.34 12.86 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 480' ' ' GLU . 2.2 m -85.3 116.69 23.79 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 0.9 OUTLIER -134.18 170.91 14.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.23 108.03 12.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.56 122.05 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.398 0.618 . . . . 0.0 110.913 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 45.7 mt-30 -120.28 -21.42 6.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -97.1 -8.9 29.12 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 113.956 -3.098 . . . . 0.0 114.666 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . -164.94 -110.09 0.23 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 118.255 -1.926 . . . . 0.0 113.299 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.1 m -147.94 138.08 22.78 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.474 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -108.23 130.91 55.13 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.0 ttpt -146.02 151.74 38.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.512 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 26.9 m -67.22 146.96 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.91 -17.21 59.12 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.55 -1.204 . . . . 0.0 114.117 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -111.09 152.9 44.02 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.167 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 33.0 Cg_endo -64.15 147.47 91.37 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.342 2.695 . . . . 0.0 113.689 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.55 158.86 16.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 124.969 1.308 . . . . 0.0 108.455 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.51 118.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.66 107.66 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.1 -111.28 3.83 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.063 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.4 p -104.4 -4.14 23.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.148 0.579 . . . . 0.0 111.672 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.432 HG21 ' CB ' ' A' ' 486' ' ' ASP . 65.1 m -125.92 141.89 51.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 120.945 0.403 . . . . 0.0 110.943 -175.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -118.05 154.48 31.97 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -160.56 -164.22 15.17 Favored Glycine 0 C--N 1.282 -2.427 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 35.1 ttm180 -126.71 136.67 52.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.63 HG11 ' HE2' ' A' ' 462' ' ' MET . 26.2 t -73.69 111.69 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.532 0.52 . . . . 0.0 110.612 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -83.36 -50.51 8.27 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.855 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.31 144.92 42.86 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.63 ' HE2' HG11 ' A' ' 459' ' ' VAL . 41.5 tpp -115.06 117.2 29.89 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.05 126.73 68.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 6.2 p30 -87.13 177.86 7.07 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.831 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.01 -30.62 36.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.1 m -76.16 -26.17 55.99 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.899 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.12 38.64 3.28 Favored Glycine 0 CA--C 1.475 -2.46 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.649 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 69.7 ttt180 -119.63 127.37 52.86 Favored 'General case' 0 N--CA 1.404 -2.748 0 CA-C-N 112.171 -2.015 . . . . 0.0 105.977 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -81.32 129.83 34.78 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.93 -178.72 2.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -111.45 -28.56 8.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.878 0.371 . . . . 0.0 111.368 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 445' ' ' LYS . 12.1 pt-20 -150.67 168.22 25.0 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -147.45 134.33 20.18 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.57 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.85 176.6 53.34 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 439' ' ' VAL . 56.1 Cg_endo -68.2 156.22 66.55 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.028 1.819 . . . . 0.0 112.754 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.8 t 77.85 -0.34 2.72 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.15 1.38 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.428 ' HG2' HG13 ' A' ' 479' ' ' VAL . 33.6 ttm -98.93 133.66 22.1 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -84.92 126.0 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.374 2.05 . . . . 0.0 112.083 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 477' ' ' MET . 16.5 m -140.74 155.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' A' ' 436' ' ' THR . 37.4 mt-10 -107.3 118.96 38.09 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 45.4 pt -98.02 170.01 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.083 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 431' ' ' ARG . 3.0 p -146.3 156.57 43.45 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 109.26 22.17 6.95 Favored Glycine 0 N--CA 1.427 -1.964 0 O-C-N 124.081 0.863 . . . . 0.0 113.807 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.95 -38.31 16.77 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 60.09 21.97 11.2 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.279 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.432 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.7 t0 -139.33 179.96 6.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 5.9 p -90.19 114.69 61.87 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-O 121.304 0.573 . . . . 0.0 111.487 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.68 168.43 8.33 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -129.48 131.93 46.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.773 0.321 . . . . 0.0 111.36 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.46 134.91 46.92 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.97 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 91.01 -5.0 81.88 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.24 -179.09 7.13 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -109.82 141.35 42.61 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 8.7 p90 -128.84 153.3 47.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.86 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 44.0 ttp -122.5 117.0 24.9 Favored 'General case' 0 C--N 1.248 -3.821 0 C-N-CA 125.399 1.48 . . . . 0.0 110.582 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.404 ' CG2' ' HG ' ' A' ' 444' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.43 -1.459 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.316 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.202 -1.398 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 504' ' ' ARG . 7.2 tppt? -57.65 -34.46 69.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.369 0.668 . . . . 0.0 111.135 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 506' ' ' ILE . 13.1 mmmm -60.89 -51.59 68.64 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.683 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.31 99.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.9 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 501' ' ' LYS . 21.9 tpp180 -50.2 -54.22 22.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.456 1.502 . . . . 0.0 109.239 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.62 -39.86 89.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.901 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 502' ' ' LYS . 50.9 mm -75.68 -53.9 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.598 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.013 0 C-N-CA 118.931 -1.604 . . . . 0.0 115.794 -176.605 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.8 m . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -138.08 176.31 20.8 Favored Glycine 0 C--N 1.293 -1.856 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.722 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 19.2 m -120.82 141.99 50.03 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.6 138.57 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.41 -39.02 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 10.9 pt-20 -153.62 148.86 26.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.79 131.4 12.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.5 178.46 1.96 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.95 149.23 29.46 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.234 0.54 . . . . 0.0 110.151 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -126.7 122.56 35.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.565 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.4 -17.09 52.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -178.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.26 -42.88 1.13 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -84.51 -31.63 24.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.68 -158.08 14.56 Favored Glycine 0 C--N 1.314 -0.639 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.56 116.25 4.14 Favored 'Trans proline' 0 C--O 1.244 0.8 0 CA-C-N 120.047 1.924 . . . . 0.0 108.949 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.44 150.94 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.943 0.878 . . . . 0.0 112.386 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -141.56 111.52 6.71 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.519 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -88.22 122.86 32.25 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -139.21 173.2 11.8 Favored 'General case' 0 C--N 1.272 -2.77 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.425 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -117.24 106.01 12.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -73.48 119.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 112.143 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 77.6 mt-30 -124.28 -15.03 6.84 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.865 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -76.24 -15.57 60.0 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.189 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 166.98 -100.93 0.17 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.3 m -144.93 144.15 30.92 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.642 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -108.65 129.75 55.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 448' ' ' ASP . 18.0 ttpt -138.81 148.39 43.71 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.8 m -70.76 141.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.21 0.529 . . . . 0.0 111.058 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.14 83.8 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.601 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 445' ' ' LYS . 1.2 t70 -94.9 130.71 32.11 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.57 123.22 10.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.284 1.989 . . . . 0.0 109.755 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -127.45 162.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 122.639 0.376 . . . . 0.0 110.498 -175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.4 p -129.35 122.56 56.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 450' ' ' ILE . 46.2 t -134.25 125.33 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.14 97.29 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.999 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 2.3 m 65.07 9.51 5.56 Favored 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 124.905 1.282 . . . . 0.0 112.758 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 59.7 m -113.23 137.48 51.42 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 17.3 p90 -111.55 150.87 29.39 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.097 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -157.15 -164.11 13.26 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -134.06 129.53 36.18 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 462' ' ' MET . 47.5 t -62.16 114.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.432 0.458 . . . . 0.0 111.58 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -81.3 -55.19 4.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.259 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.51 152.64 51.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.642 ' HE1' HD22 ' A' ' 444' ' ' LEU . 51.1 tpp -115.01 117.57 30.98 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.74 136.52 53.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -99.38 -179.22 4.15 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.463 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.08 -29.57 60.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.8 m -74.86 -25.29 58.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.028 0.442 . . . . 0.0 110.378 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.75 30.02 6.3 Favored Glycine 0 CA--C 1.5 -0.899 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.588 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 464' ' ' ASN . 79.8 mtt180 -115.77 144.45 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -76.58 129.79 36.94 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 124.239 0.962 . . . . 0.0 110.329 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.8 m -135.87 -178.25 2.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -115.72 -23.74 8.55 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.08 143.77 19.48 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -173.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.48 146.82 32.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.78 177.35 40.21 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.678 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HA ' HG13 ' A' ' 439' ' ' VAL . 54.7 Cg_endo -65.07 161.26 37.81 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 123.167 2.578 . . . . 0.0 113.666 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.449 ' HA ' HD11 ' A' ' 438' ' ' LEU . 20.4 t 67.74 16.77 9.78 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 125.124 1.37 . . . . 0.0 111.076 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 23.8 ttt -120.16 133.92 24.0 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -72.73 125.88 10.92 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.559 2.172 . . . . 0.0 112.129 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 8.3 m -141.81 159.38 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.64 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 30.1 tt0 -122.35 115.81 22.94 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.8 172.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.655 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.6 p -149.08 167.16 26.61 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.23 33.37 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.779 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.36 -33.37 25.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 70.6 t60 64.93 21.31 12.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.859 1.663 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -145.91 179.6 7.35 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.7 t -121.67 109.65 34.18 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 118.389 0.541 . . . . 0.0 109.544 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.0 175.57 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.894 2.396 . . . . 0.0 110.952 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -118.59 148.32 42.8 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.25 0.547 . . . . 0.0 112.052 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -68.95 141.93 54.83 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.829 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.38 0.03 89.88 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.091 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -92.56 -179.21 5.12 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.34 145.2 43.39 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.308 0.575 . . . . 0.0 110.653 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -132.14 159.15 39.78 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.6 ttt -132.15 118.03 19.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.235 0.54 . . . . 0.0 109.814 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 C--N 1.3 -1.557 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.118 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.305 0.574 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -62.49 -51.36 67.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -64.2 -40.74 96.72 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.519 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.21 40.41 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 123.379 0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.01 -39.75 86.89 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.68 -46.74 71.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.786 0.327 . . . . 0.0 111.558 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.85 -32.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.292 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.35 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -177.847 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 16.4 m . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.49 169.22 25.57 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.3 m -119.06 141.93 48.3 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.59 137.13 22.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.1 pt -89.53 -39.83 12.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.844 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.442 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 9.6 pt-20 -159.39 148.52 18.23 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.3 144.2 33.15 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -170.07 176.02 4.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.9 pt? -84.46 142.06 30.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.55 120.45 37.53 Favored 'General case' 0 C--N 1.255 -3.51 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.43 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.58 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.35 -17.08 6.74 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.26 -40.85 0.85 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.355 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -88.4 -16.05 33.91 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 90.86 -158.92 26.34 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -59.79 116.45 3.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 121.894 1.729 . . . . 0.0 110.363 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.436 HG12 ' CG2' ' A' ' 482' ' ' THR . 33.3 m -122.54 163.86 20.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -147.76 112.2 5.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.323 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.87 117.28 24.63 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.694 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.8 pp -132.92 173.14 11.71 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -173.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -119.48 105.72 11.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -75.56 121.57 27.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.636 0.731 . . . . 0.0 112.189 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 37.8 mt-30 -124.04 -14.26 7.13 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.401 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.47 61.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.187 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 152.04 -104.71 0.27 Allowed Glycine 0 N--CA 1.411 -2.981 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.823 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 6.8 m -130.82 136.5 48.74 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -111.39 124.06 51.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.522 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 2.4 ttpm? -134.07 157.24 46.64 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.522 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 27.7 m -67.64 126.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.24 0.543 . . . . 0.0 109.987 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 110.91 -11.1 29.63 Favored Glycine 0 C--N 1.306 -1.137 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 445' ' ' LYS . 1.0 OUTLIER -71.0 131.2 87.45 Favored Pre-proline 0 C--O 1.247 0.938 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -79.44 112.38 2.97 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 122.239 1.959 . . . . 0.0 108.935 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.24 149.28 14.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.216 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 40.5 t -122.85 115.03 44.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.562 HG12 ' CB ' ' A' ' 494' ' ' PHE . 30.0 m -120.31 116.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.11 0.481 . . . . 0.0 109.723 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.94 -96.62 0.16 Allowed Glycine 0 C--N 1.307 -1.068 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.345 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 30.9 p -118.26 -7.21 10.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 122.734 0.413 . . . . 0.0 111.205 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.505 HG21 ' CB ' ' A' ' 486' ' ' ASP . 21.1 m -113.67 145.84 40.71 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.201 -0.312 . . . . 0.0 110.899 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -120.72 156.25 32.19 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.22 -168.51 27.49 Favored Glycine 0 C--N 1.295 -1.733 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.305 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -127.66 132.6 49.68 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 444' ' ' LEU . 51.1 t -65.75 121.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.586 0.554 . . . . 0.0 110.735 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -91.4 -52.26 4.88 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.672 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.15 150.37 50.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.552 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.1 tpp -115.1 117.11 29.64 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 9.4 t -120.35 141.42 40.72 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 3.4 p30 -108.63 175.06 5.6 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.193 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.71 -25.86 55.47 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.075 0.95 . . . . 0.0 113.087 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.3 t -78.19 -10.66 59.74 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.222 0.534 . . . . 0.0 110.097 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.99 8.16 61.94 Favored Glycine 0 CA--C 1.491 -1.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.83 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -96.79 129.69 44.17 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.558 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.0 tmm_? -86.65 129.99 34.66 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.12 -174.21 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.236 0.614 . . . . 0.0 109.907 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -98.04 -36.12 10.21 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 122.96 0.504 . . . . 0.0 111.404 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -156.0 151.74 27.29 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.535 -172.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -142.91 150.23 39.5 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 123.924 0.765 . . . . 0.0 109.549 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.11 179.53 39.46 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.352 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 439' ' ' VAL . 59.9 Cg_endo -70.83 161.42 46.13 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 123.052 2.501 . . . . 0.0 113.888 -175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 438' ' ' LEU . 50.2 m 68.83 18.63 8.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.834 1.254 . . . . 0.0 111.116 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.4 ttt -122.23 133.98 24.6 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.561 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 46.5 Cg_endo -77.55 125.9 7.9 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 122.293 1.995 . . . . 0.0 112.577 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 16.1 m -141.11 157.83 22.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.19 117.51 29.77 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -97.68 168.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.859 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.436 ' CG2' HG12 ' A' ' 434' ' ' VAL . 6.0 p -146.74 165.66 28.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.574 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.45 20.53 22.24 Favored Glycine 0 C--N 1.296 -1.684 0 O-C-N 123.929 0.768 . . . . 0.0 112.576 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 41.6 tp -85.34 -39.35 17.75 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 64.41 21.44 12.48 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.776 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.505 ' CB ' HG21 ' A' ' 455' ' ' THR . 15.0 t70 -138.92 179.24 6.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 38.0 t -111.47 107.08 57.04 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 118.214 0.461 . . . . 0.0 111.175 -173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -85.84 174.7 6.36 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.556 2.171 . . . . 0.0 111.61 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.71 145.53 50.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.922 0.392 . . . . 0.0 110.701 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -66.69 128.62 36.95 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.571 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.28 60.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.123 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.48 179.18 6.06 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.333 0.587 . . . . 0.0 110.591 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 0.4 OUTLIER -114.73 129.2 56.65 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.179 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 45.8 p90 -131.87 158.95 40.0 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.671 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.0 ttt -131.44 134.45 46.22 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.311 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.496 HG11 ' HG ' ' A' ' 444' ' ' LEU . 58.1 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--O 1.218 -0.589 0 CA-C-O 120.573 0.225 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.3 -43.66 73.34 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 502' ' ' LYS . 33.8 ttpt -61.22 -46.22 91.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.93 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.8 92.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.727 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -63.74 -34.72 78.51 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.781 0.832 . . . . 0.0 111.24 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.7 -38.77 91.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.75 -42.95 77.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.503 179.329 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.4 m . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -124.22 169.75 16.33 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.8 m -115.99 139.54 50.16 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.24 133.91 28.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 12.6 pt -91.94 -39.8 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.884 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.87 153.76 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.42 29.95 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -165.63 176.34 8.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.6 pt? -94.83 148.23 22.51 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.44 121.94 32.16 Favored 'General case' 0 N--CA 1.391 -3.412 0 C-N-CA 116.929 -1.908 . . . . 0.0 109.697 167.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.9 -22.58 62.57 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.026 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.8 -51.99 0.82 Allowed Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.702 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.68 -26.56 57.74 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 122.935 0.494 . . . . 0.0 111.379 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 107.79 -163.74 12.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 25.2 Cg_exo -69.21 115.56 4.07 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 121.914 1.743 . . . . 0.0 108.215 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.448 ' HB ' ' CG ' ' A' ' 480' ' ' GLU . 28.3 m -124.46 162.79 25.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -154.39 114.82 3.92 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.603 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 119.64 25.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.0 OUTLIER -136.24 173.48 11.66 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.2 tm? -122.61 107.98 12.59 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.4 p -73.98 119.85 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 111.751 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 40.5 mt-30 -123.59 -15.81 6.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.794 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.565 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -92.23 2.17 56.77 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 158.87 -125.67 1.55 Allowed Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.185 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.3 m -129.83 134.19 47.39 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.641 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -104.6 133.2 49.86 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.629 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 2.1 ttpm? -148.29 159.66 43.76 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -68.06 136.27 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.159 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.59 -2.83 60.8 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.403 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 67.8 m-20 -92.76 132.77 30.51 Favored Pre-proline 0 C--O 1.25 1.115 0 CA-C-N 117.317 0.559 . . . . 0.0 110.003 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 2.5 Cg_endo -80.35 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.08 1.853 . . . . 0.0 111.762 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.92 172.65 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.25 124.29 18.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.178 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.4 111.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.32 11.13 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.1 m -99.15 -4.45 32.15 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.32 0.581 . . . . 0.0 110.3 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 486' ' ' ASP . 48.9 m -102.86 136.32 42.9 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.602 -0.686 . . . . 0.0 112.053 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.75 161.88 16.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -177.3 -169.33 38.31 Favored Glycine 0 CA--C 1.475 -2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.488 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 55.2 ttp180 -130.6 137.71 49.77 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.431 HG11 ' HE2' ' A' ' 462' ' ' MET . 49.0 t -65.99 116.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.04 0.448 . . . . 0.0 111.824 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -79.43 -60.07 2.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -143.49 160.25 40.93 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.641 ' HE1' HD22 ' A' ' 444' ' ' LEU . 35.6 tpp -121.48 134.65 55.07 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 480' ' ' GLU . 6.1 t -117.24 142.09 32.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.478 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.0 p30 -103.62 179.73 4.19 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.178 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.42 -29.25 48.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.612 1.165 . . . . 0.0 112.94 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 -6.85 58.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.0 4.13 63.38 Favored Glycine 0 N--CA 1.466 0.654 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.255 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.478 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.0 mpt_? -93.09 156.93 16.56 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.407 ' NH1' HG22 ' A' ' 463' ' ' VAL . 20.2 tpp180 -75.41 132.88 41.17 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.824 0.85 . . . . 0.0 110.97 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.3 175.59 5.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.76 -28.89 3.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.719 0.295 . . . . 0.0 111.673 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 445' ' ' LYS . 30.7 mt-10 -123.6 141.17 52.27 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.44 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -139.29 126.01 20.73 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.54 161.36 40.61 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.488 ' HA ' HG13 ' A' ' 439' ' ' VAL . 19.3 Cg_endo -59.67 150.75 74.72 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.931 2.421 . . . . 0.0 113.031 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 438' ' ' LEU . 22.2 m 75.77 4.45 3.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.351 1.46 . . . . 0.0 112.268 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 47.0 ttp -103.86 136.11 19.25 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 122.275 -0.266 . . . . 0.0 110.953 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.6 Cg_exo -76.77 126.2 8.67 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.423 2.082 . . . . 0.0 111.326 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 473' ' ' ALA . 12.7 m -142.06 159.02 20.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 463' ' ' VAL . 37.7 tt0 -117.56 124.94 49.91 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.45 172.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.725 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.9 p -151.22 161.99 41.7 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 112.73 8.11 21.13 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.941 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 58.2 mt -89.95 -40.33 12.43 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.478 -0.425 . . . . 0.0 110.166 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' HIS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 16.4 t-80 58.17 21.29 7.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 111.07 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.495 ' HB3' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -126.74 -178.89 4.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.27 110.09 46.37 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 4.6 Cg_endo -84.24 156.42 12.84 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.178 1.919 . . . . 0.0 109.988 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -121.29 134.8 55.17 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -69.17 124.5 23.98 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.141 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.04 -0.37 56.19 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.62 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.01 178.51 8.12 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.859 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -110.44 130.07 55.63 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 32.5 p90 -125.86 154.86 42.08 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.123 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 59.6 ttp -119.28 127.13 52.94 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 441' ' ' ALA . 10.6 p . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.4 -44.76 70.78 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.501 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 506' ' ' ILE . 60.4 mttp -79.96 -30.57 39.83 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.141 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.7 88.98 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -59.36 -41.88 90.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.488 0.661 . . . . 0.0 109.983 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -68.8 -29.86 68.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.6 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 502' ' ' LYS . 85.1 mt -83.5 -52.16 13.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.895 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 C-N-CA 119.411 -1.376 . . . . 0.0 113.552 -173.566 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.497 -1.096 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -140.16 -175.16 14.23 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.055 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.7 p -125.57 145.13 50.26 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 124.156 0.983 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 37.7 t -87.73 134.01 28.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.76 -39.69 12.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.506 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 8.5 pt-20 -158.31 149.43 20.84 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.35 149.13 34.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.519 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -172.65 177.1 3.02 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -95.26 146.72 24.15 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -123.38 120.57 33.41 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -55.84 -18.77 9.5 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -107.62 -42.57 1.44 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.403 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -81.2 -34.25 32.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.728 0.299 . . . . 0.0 111.489 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.09 -145.85 17.98 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.32 115.99 4.24 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 121.86 1.706 . . . . 0.0 108.648 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 18.1 m -116.09 153.53 17.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.259 0.552 . . . . 0.0 111.134 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -144.91 112.74 6.32 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.482 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.62 114.91 22.98 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.9 pp -132.95 173.27 11.58 Favored 'General case' 0 C--N 1.266 -3.022 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.007 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.92 106.78 14.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -65.94 114.85 3.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.421 1.105 . . . . 0.0 111.943 -176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.63 -14.33 7.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.08 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.431 ' CB ' ' H ' ' A' ' 496' ' ' VAL . . . -85.24 0.29 52.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.829 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 140.85 -115.27 1.02 Allowed Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 144.53 49.35 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.512 ' CD1' HD11 ' A' ' 437' ' ' LEU . 0.9 OUTLIER -125.82 120.23 29.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.2 ttpm? -138.38 161.71 36.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.566 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.6 m -66.09 130.67 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.557 0.694 . . . . 0.0 111.443 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.12 50.98 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.851 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 67.5 m-20 -88.32 147.17 39.5 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.959 0.379 . . . . 0.0 110.788 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -81.74 131.86 7.38 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.391 2.061 . . . . 0.0 110.731 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 496' ' ' VAL . 2.9 pp -125.79 140.46 48.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.478 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.84 111.62 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.41 138.22 26.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.74 26.09 74.73 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.33 -0.938 . . . . 0.0 110.875 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 65.0 p 63.68 7.05 2.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.166 1.786 . . . . 0.0 113.036 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.441 HG21 ' CB ' ' A' ' 486' ' ' ASP . 88.2 m -107.34 146.36 31.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -122.68 151.86 41.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.633 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -154.09 -164.3 12.66 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.534 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 47.7 ttp180 -131.49 137.15 48.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.153 0.477 . . . . 0.0 110.005 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 482' ' ' THR . 28.3 t -67.9 123.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 122.688 0.395 . . . . 0.0 111.314 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -98.81 -51.04 4.01 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.767 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.81 153.86 51.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.468 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.1 tpp -122.5 121.47 36.64 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 469' ' ' ARG . 13.4 t -127.85 148.6 32.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.538 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.9 p30 -109.27 179.46 4.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.736 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -58.97 -32.19 69.42 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.7 t -78.61 -9.12 59.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.311 0.577 . . . . 0.0 110.401 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.41 63.04 Favored Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.787 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.538 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.2 mpt_? -73.38 116.86 14.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.406 ' HG2' HG22 ' A' ' 463' ' ' VAL . 4.0 tmm_? -81.09 133.48 35.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.11 -173.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 123.844 0.858 . . . . 0.0 108.791 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -117.39 -20.46 9.1 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.147 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.37 147.35 33.3 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.421 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -145.68 139.14 26.34 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.208 0.603 . . . . 0.0 110.169 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -97.92 167.1 22.75 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.9 Cg_endo -58.63 150.66 68.26 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.09 2.527 . . . . 0.0 112.878 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 32.6 m 75.32 17.83 2.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.431 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.5 ttt -117.16 136.36 23.36 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.12 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 3.6 Cg_exo -80.55 126.77 6.17 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.201 1.934 . . . . 0.0 110.933 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.3 m -142.36 149.87 19.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.005 0.431 . . . . 0.0 110.865 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.4 tt0 -108.67 112.56 24.95 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.6 pt -99.84 172.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.576 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.453 ' CG2' HG12 ' A' ' 434' ' ' VAL . 5.5 p -145.33 157.55 44.02 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 483' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 113.23 4.44 23.83 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.16 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 51.2 tp -73.3 -37.58 66.16 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.483 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 64.62 24.14 12.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.278 1.431 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.441 ' CB ' HG21 ' A' ' 455' ' ' THR . 37.5 t70 -144.93 171.62 14.19 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.85 109.23 47.64 Favored Pre-proline 0 C--N 1.291 -1.956 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.44 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.02 174.52 4.56 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.595 2.197 . . . . 0.0 111.783 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -129.94 150.78 51.08 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.116 0.484 . . . . 0.0 111.327 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -63.74 130.03 42.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.346 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.28 58.83 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.749 -1.215 . . . . 0.0 111.588 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 493' ' ' ARG . 7.3 t70 -86.29 -166.63 1.6 Allowed 'General case' 0 C--O 1.248 0.974 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.443 ' H ' ' CG ' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -131.24 136.89 48.61 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.295 -169.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 38.4 p90 -136.74 158.53 44.23 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.824 0.821 . . . . 0.0 111.758 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.2 ttp -134.05 119.53 19.08 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.862 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 450' ' ' ILE . 83.1 t . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.21 -1.008 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -70.19 -47.0 63.45 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -61.33 -37.71 84.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.207 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.58 64.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.901 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -55.44 -40.29 71.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 123.891 0.876 . . . . 0.0 112.274 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -59.01 -31.8 69.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.967 0.792 . . . . 0.0 111.147 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.63 -9.0 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.451 0.7 . . . . 0.0 110.219 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.342 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.315 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 9.7 m . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 120.511 0.196 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -151.43 -174.68 22.48 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 18.8 m -127.89 143.87 51.1 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 117.049 0.424 . . . . 0.0 110.558 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.64 136.38 22.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.0 pt -89.77 -43.21 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.687 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.01 155.75 37.51 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.093 0.473 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -134.2 129.83 36.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 427' ' ' LEU . 0.3 OUTLIER -134.8 159.53 41.06 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -170.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.49 ' N ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -94.68 139.64 30.95 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 9.9 t70 -127.66 117.62 22.31 Favored 'General case' 0 C--N 1.261 -3.25 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.69 -26.15 65.34 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.24 -37.95 1.73 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.9 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.48 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.1 mtp180 -86.51 -24.37 25.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.14 -166.91 19.09 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -58.11 116.11 3.01 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.529 2.153 . . . . 0.0 111.049 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 482' ' ' THR . 20.1 m -114.94 136.62 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.341 0.591 . . . . 0.0 110.508 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -126.75 124.66 40.24 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.381 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 2.0 m -98.7 118.78 36.2 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 170.14 15.31 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -118.44 105.29 11.53 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 475' ' ' PRO . 3.3 p -71.14 118.6 16.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.708 0.766 . . . . 0.0 112.197 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 47.0 mt-30 -123.3 -16.22 6.96 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.468 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.4 31.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.957 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 145.81 -89.89 0.16 Allowed Glycine 0 C--O 1.212 -1.244 0 C-N-CA 119.019 -1.562 . . . . 0.0 113.219 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 56.3 m -146.64 146.89 30.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.537 HD22 ' HE1' ' A' ' 462' ' ' MET . 2.2 tt -128.23 115.58 18.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 0.0 OUTLIER -135.81 158.9 43.26 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 120.708 0.29 . . . . 0.0 110.847 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.7 m -61.81 133.71 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.89 0.376 . . . . 0.0 110.119 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.82 4.04 56.95 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.259 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 33.7 m-20 -86.36 127.91 59.29 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.997 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 5.5 Cg_exo -77.18 106.65 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.814 1.676 . . . . 0.0 108.073 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 456' ' ' TYR . 2.9 pp -104.9 140.84 21.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.035 -172.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.34 119.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.472 HG12 ' CB ' ' A' ' 494' ' ' PHE . 8.5 m -125.27 133.94 68.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' GLY . . . . . 0.451 ' HA2' ' NH1' ' A' ' 493' ' ' ARG . . . 57.97 -100.17 0.14 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.515 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 7.0 p -131.54 10.86 4.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.639 0.776 . . . . 0.0 110.895 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.514 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.3 m -119.7 144.8 47.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.777 0.322 . . . . 0.0 110.282 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 52.8 p90 -120.5 150.85 40.18 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -150.36 -170.68 17.86 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -134.82 127.89 31.68 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.73 118.23 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.15 -52.82 3.87 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.1 35.86 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.537 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -133.18 117.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.78 131.43 72.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.88 177.74 5.8 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.369 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.73 -30.55 33.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.37 1.068 . . . . 0.0 113.148 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.2 t -76.95 -16.14 59.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.078 0.466 . . . . 0.0 110.483 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.64 15.09 47.8 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.23 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -99.87 133.82 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.541 -0.33 . . . . 0.0 110.184 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.4 tpt85 -73.16 126.06 29.16 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.181 0.926 . . . . 0.0 108.981 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 462' ' ' MET . 30.6 m -135.66 -177.2 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 471' ' ' LYS . 0.0 OUTLIER -120.9 -12.71 8.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.947 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.68 152.18 33.58 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.04 145.96 31.68 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 123.719 0.637 . . . . 0.0 109.866 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -94.84 173.91 32.48 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.477 ' HA ' HG13 ' A' ' 439' ' ' VAL . 58.5 Cg_endo -69.57 156.66 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.637 2.224 . . . . 0.0 113.378 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 438' ' ' LEU . 12.1 t 72.08 16.51 5.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.022 1.329 . . . . 0.0 110.892 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 34.8 ttp -119.76 129.53 25.31 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.638 -0.664 . . . . 0.0 112.069 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.77 125.93 12.71 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.777 2.318 . . . . 0.0 112.345 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 436' ' ' THR . 6.0 m -140.41 151.74 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.163 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 40.8 tt0 -112.42 112.78 24.58 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.3 pt -98.23 170.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.699 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.482 HG23 HG12 ' A' ' 434' ' ' VAL . 0.2 OUTLIER -150.72 150.1 30.63 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 109.72 31.94 3.04 Favored Glycine 0 C--N 1.304 -1.25 0 O-C-N 123.742 0.651 . . . . 0.0 113.295 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 457' ' ' GLY . 54.9 tp -82.94 -35.84 25.68 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.0 t60 65.4 27.72 11.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.185 1.394 . . . . 0.0 109.404 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.514 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.3 t0 -148.01 -179.95 7.29 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.91 108.97 44.06 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.77 158.1 56.59 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.902 1.735 . . . . 0.0 110.733 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -126.48 131.35 51.66 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.391 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -72.48 135.66 45.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.295 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.44 89.35 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.664 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 1.6 t70 -84.7 -172.69 4.31 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.496 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.1 OUTLIER -129.16 150.92 50.34 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.742 -173.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 452' ' ' VAL . 40.7 p90 -140.28 168.68 19.25 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 52.3 ttp -134.02 115.98 14.97 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 444' ' ' LEU . 61.7 t . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.48 -38.97 68.06 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.486 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -70.88 -26.64 63.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.855 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.67 50.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.39 -45.76 55.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.579 1.552 . . . . 0.0 110.32 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.62 -36.21 75.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.2 -10.96 11.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.432 0.634 . . . . 0.0 109.838 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.417 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.893 -178.643 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -117.74 178.59 17.01 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.6 m -122.02 139.09 54.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 52.1 t -82.51 135.07 25.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 11.3 pt -93.73 -37.05 7.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.905 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 12.6 pt-20 -156.7 148.14 22.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.46 136.76 17.6 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 176.43 8.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.44 145.92 24.23 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.69 122.81 33.91 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.527 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.13 -13.4 58.01 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -109.67 -46.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.401 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.49 -40.59 42.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 109.605 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 121.7 -176.45 16.38 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.45 116.13 3.07 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.141 1.894 . . . . 0.0 109.445 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 482' ' ' THR . 29.1 m -121.94 146.56 26.88 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.391 0.615 . . . . 0.0 112.229 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -137.53 119.14 14.95 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.3 m -88.22 125.06 34.44 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.91 168.05 20.67 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.399 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.83 105.9 12.43 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 475' ' ' PRO . 4.3 p -70.84 121.21 20.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.836 0.827 . . . . 0.0 111.529 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -121.84 -20.5 6.38 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.63 -11.41 59.12 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 165.13 -111.38 0.46 Allowed Glycine 0 N--CA 1.416 -2.663 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.86 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 24.7 m -137.16 133.75 35.59 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.7 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.7 OUTLIER -101.28 115.79 31.32 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.0 OUTLIER -129.04 150.99 50.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.4 m -71.0 141.32 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.257 0.551 . . . . 0.0 111.297 177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.38 8.6 70.91 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.792 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -101.07 128.17 30.15 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 6.8 Cg_exo -72.38 120.81 6.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.46 HG22 HG22 ' A' ' 496' ' ' VAL . 18.9 pt -114.36 160.63 13.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.404 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.44 127.25 59.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 494' ' ' PHE . 3.0 m -127.22 128.19 70.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 55.47 -97.09 0.04 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 121.597 -0.335 . . . . 0.0 113.595 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 8.9 t -127.84 11.33 6.63 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.072 0.463 . . . . 0.0 110.623 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.477 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.2 m -124.21 150.12 45.61 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -127.92 162.1 27.53 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -173.91 -165.09 30.06 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -135.61 134.77 39.66 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 482' ' ' THR . 31.0 t -70.2 122.58 22.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 123.369 0.418 . . . . 0.0 110.352 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -93.09 -56.74 2.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.651 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.45 146.62 50.02 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.7 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.5 tpp -121.8 117.47 26.62 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.17 136.74 49.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.87 174.18 5.99 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.046 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.53 -29.82 38.55 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.602 1.161 . . . . 0.0 113.491 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 68.7 m -77.17 -11.81 59.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.821 -0.55 . . . . 0.0 111.33 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.77 -11.56 59.25 Favored Glycine 0 CA--C 1.494 -1.273 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.785 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -77.7 137.09 38.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.006 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.16 127.48 34.29 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.2 m -126.39 174.52 10.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.558 -172.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -102.74 -35.24 8.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 151.25 37.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.483 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.408 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -139.17 145.22 39.09 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.43 174.14 37.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.994 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.2 Cg_endo -64.51 158.6 48.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 38.6 m 68.67 17.0 8.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.521 0.728 . . . . 0.0 112.39 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.5 ttp -122.6 127.14 25.91 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.156 -0.34 . . . . 0.0 110.927 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.79 126.38 13.88 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 121.99 1.793 . . . . 0.0 111.72 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.408 HG11 ' CB ' ' A' ' 473' ' ' ALA . 17.6 m -139.12 167.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.514 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 34.4 tt0 -125.33 118.3 25.64 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -98.52 173.02 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.472 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.1 p -152.77 155.04 36.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.399 1.08 . . . . 0.0 108.352 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.18 8.15 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 172.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.21 -31.14 38.69 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 63.51 21.36 12.71 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.823 1.249 . . . . 0.0 109.263 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.477 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -140.79 -179.77 6.24 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.67 107.63 58.7 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-O 121.538 0.685 . . . . 0.0 111.779 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.45 167.92 14.98 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.019 1.812 . . . . 0.0 110.059 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' GLN . . . . . 0.606 ' HB2' ' OD2' ' A' ' 492' ' ' ASP . 21.9 mt-30 -134.8 154.2 51.71 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.109 -0.369 . . . . 0.0 110.356 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -70.97 133.42 46.36 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.2 -11.39 63.73 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.116 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 489' ' ' GLN . 4.3 m-20 -79.5 164.61 23.78 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.779 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 5.9 mpt_? -113.11 128.75 56.58 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.488 ' CB ' HG12 ' A' ' 452' ' ' VAL . 53.9 p90 -118.94 155.73 30.81 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.3 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 51.6 ttm -121.03 116.29 24.77 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.172 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 450' ' ' ILE . 46.7 t . . . . . 0 C--N 1.313 -0.995 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.197 -1.682 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 0.1 OUTLIER -63.86 -54.11 40.07 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.633 0.652 . . . . 0.0 110.899 -174.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 502' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 506' ' ' ILE . 10.8 ptpp? -65.28 -35.35 80.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.074 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.55 77.64 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.848 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -55.61 -50.17 70.85 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.127 1.371 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 12.0 mm100 -70.08 -26.31 63.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.926 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 502' ' ' LYS . 44.6 mm -74.06 -41.65 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.558 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.827 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 17.5 m . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.35 176.48 17.88 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.0 m -127.2 139.6 52.83 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 42.7 t -83.58 137.29 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -97.54 -37.55 6.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.232 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 436' ' ' THR . 0.2 OUTLIER -152.35 166.07 33.0 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.39 128.59 17.72 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.54 146.85 30.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.67 144.71 26.51 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.299 0.571 . . . . 0.0 109.885 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.24 129.48 50.86 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.545 ' H ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -64.0 -19.98 65.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.466 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -111.61 -48.42 0.69 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.878 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -74.68 -26.94 60.18 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 123.594 0.758 . . . . 0.0 110.59 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 98.98 -158.91 20.14 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.25 116.46 3.51 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.567 2.178 . . . . 0.0 111.084 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 482' ' ' THR . 15.1 m -121.33 157.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -148.26 120.37 8.29 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.54 ' HB ' ' HG3' ' A' ' 424' ' ' GLU . 3.4 m -82.74 123.67 29.53 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 478' ' ' PRO . 1.3 pp -133.03 173.3 11.57 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -119.44 110.99 17.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -75.5 122.58 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.763 0.792 . . . . 0.0 111.24 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 18.8 mt-30 -123.83 -14.45 7.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.095 -174.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.671 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -96.36 8.42 44.02 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.049 0.452 . . . . 0.0 110.133 -173.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.62 -126.55 2.92 Favored Glycine 0 N--CA 1.403 -3.513 0 C-N-CA 120.033 -1.08 . . . . 0.0 111.347 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.3 m -115.62 142.7 46.38 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.646 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.4 OUTLIER -111.45 117.69 33.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.541 ' HB3' ' OD2' ' A' ' 448' ' ' ASP . 12.3 ttpt -122.86 148.36 45.51 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.02 123.88 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.413 0.625 . . . . 0.0 109.768 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 109.5 -8.51 32.52 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.125 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.541 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 42.7 m-20 -90.32 146.02 33.82 Favored Pre-proline 0 C--O 1.25 1.081 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.448 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 4.0 Cg_exo -77.03 145.37 24.71 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.536 2.157 . . . . 0.0 111.391 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 13.8 pt -136.44 156.88 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.345 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.74 115.34 44.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.0 115.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.38 -102.56 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 12.6 t -127.9 8.23 6.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 486' ' ' ASP . 26.6 m -115.76 145.02 43.16 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.618 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -127.95 158.77 36.93 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -173.05 -164.3 28.2 Favored Glycine 0 C--N 1.29 -2.015 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -125.48 134.68 51.97 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.467 HG21 ' CD2' ' A' ' 444' ' ' LEU . 41.6 t -72.15 123.47 26.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -95.79 -50.38 4.93 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.693 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.05 159.66 32.19 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.646 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.9 tpp -130.8 117.33 19.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.79 128.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.634 HD21 ' HB2' ' A' ' 468' ' ' ARG . 8.8 p30 -92.9 -175.71 3.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.227 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.94 -20.26 66.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 112.402 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 31.5 t -84.21 -20.31 32.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.71 40.62 5.26 Favored Glycine 0 CA--C 1.488 -1.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.706 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.634 ' HB2' HD21 ' A' ' 464' ' ' ASN . 85.2 mtt180 -118.34 129.88 55.69 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 2.3 tmm_? -80.17 129.51 34.55 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.4 m -130.55 -179.23 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 120.583 0.23 . . . . 0.0 110.385 -176.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -98.97 -35.98 9.89 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.231 0.612 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -157.74 147.59 20.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.017 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -134.7 142.99 46.95 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.059 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.04 173.85 45.18 Favored Glycine 0 N--CA 1.442 -0.928 0 O-C-N 123.717 0.636 . . . . 0.0 112.304 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.9 Cg_endo -64.98 156.52 62.07 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.551 2.168 . . . . 0.0 113.23 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.462 ' HA ' HD11 ' A' ' 438' ' ' LEU . 28.3 m 72.54 10.85 5.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.439 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.1 ttt -111.08 138.26 21.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.5 Cg_exo -83.91 126.34 3.88 Favored 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.925 2.416 . . . . 0.0 112.001 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.7 151.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.171 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.7 mt-10 -96.82 129.19 44.29 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -100.87 170.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.479 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.7 p -151.07 158.86 44.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 124.237 1.015 . . . . 0.0 108.503 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.12 8.15 Favored Glycine 0 N--CA 1.422 -2.277 0 O-C-N 124.059 0.849 . . . . 0.0 114.428 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.57 -36.39 13.72 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.1 t60 64.62 20.95 12.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.357 1.463 . . . . 0.0 108.423 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.487 ' CB ' HG21 ' A' ' 455' ' ' THR . 30.9 t70 -135.9 173.52 11.62 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.12 103.6 36.06 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 118.094 0.406 . . . . 0.0 110.008 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.61 174.97 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.814 2.343 . . . . 0.0 111.124 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -111.17 145.56 38.43 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.308 0.575 . . . . 0.0 111.365 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -64.02 127.62 32.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.185 173.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.67 -3.48 56.15 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.609 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.18 178.11 8.44 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.751 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.61 140.73 48.91 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 124.105 0.962 . . . . 0.0 108.779 -175.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.05 155.18 49.68 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.998 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 49.7 ttp -122.02 120.34 34.09 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.671 HG12 ' HB3' ' A' ' 441' ' ' ALA . 7.0 p . . . . . 0 C--N 1.307 -1.26 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -68.88 -49.24 59.93 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -69.2 -40.6 77.92 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.572 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.92 88.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -73.71 -16.1 61.2 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.878 0.471 . . . . 0.0 111.033 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.6 -28.65 61.0 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 2.4 mp -86.93 -34.96 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.466 176.366 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 441' ' ' ALA . 15.9 m . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.52 166.11 12.82 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.12 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.6 m -114.2 143.01 45.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.11 131.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.1 pt -88.75 -36.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.747 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -160.11 153.36 21.99 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.38 143.33 23.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.478 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -163.49 175.73 10.44 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.2 pt? -85.07 143.38 28.91 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -126.41 129.77 49.41 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.04 -24.68 67.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.743 -178.2 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -97.32 -47.63 2.16 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.723 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HB3' HG21 ' A' ' 482' ' ' THR . 25.3 mmt180 -91.4 -33.43 15.25 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.24 -134.56 12.23 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.83 115.96 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.679 1.74 . . . . 0.0 110.782 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.478 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 25.3 m -118.2 148.26 21.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -143.54 114.24 7.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.2 m -85.58 116.91 24.15 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.4 pp -132.89 171.54 13.79 Favored 'General case' 0 C--N 1.279 -2.476 0 O-C-N 122.205 -0.309 . . . . 0.0 111.795 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.51 106.37 11.73 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.4 ' HB ' HD12 ' A' ' 444' ' ' LEU . 7.2 p -78.83 123.89 36.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.241 0.544 . . . . 0.0 112.009 -177.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -124.72 -15.88 6.38 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -77.84 -15.29 59.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.03 -0.987 . . . . 0.0 113.34 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 169.97 -102.26 0.18 Allowed Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.051 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 32.5 m -148.04 131.94 17.11 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 462' ' ' MET . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.013 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.616 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.1 ttpt -148.3 153.23 38.39 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.616 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 28.2 m -71.24 134.7 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.25 0.547 . . . . 0.0 110.746 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.05 8.44 72.24 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.79 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.8 132.86 20.51 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 123.92 11.77 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.779 2.32 . . . . 0.0 111.495 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.73 151.7 26.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.452 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.95 123.12 70.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 494' ' ' PHE . 4.1 m -128.0 135.13 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 54.89 -100.44 0.08 OUTLIER Glycine 0 CA--C 1.533 1.164 0 N-CA-C 114.221 0.448 . . . . 0.0 114.221 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 42.2 p -121.94 4.54 9.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 122.652 0.381 . . . . 0.0 111.239 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 486' ' ' ASP . 44.3 m -125.36 145.62 49.96 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.835 0.35 . . . . 0.0 111.419 -173.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.0 144.38 48.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -149.74 -175.54 22.07 Favored Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -124.77 126.9 46.38 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 482' ' ' THR . 48.3 t -63.62 132.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.938 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -97.62 -59.42 1.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -122.6 167.79 12.97 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.72 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.8 tpp -143.23 117.14 9.36 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.74 132.03 72.03 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -98.71 -179.77 4.41 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.006 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.38 -30.15 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.065 0.946 . . . . 0.0 112.539 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 28.3 m -80.7 -13.18 59.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.188 -0.32 . . . . 0.0 111.445 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 95.95 7.96 58.31 Favored Glycine 0 CA--C 1.501 -0.795 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.206 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -91.72 138.94 31.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.567 -0.317 . . . . 0.0 110.336 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 462' ' ' MET . 9.2 tpt180 -74.22 131.33 41.12 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.39 174.49 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.9 -36.16 8.74 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.086 0.469 . . . . 0.0 110.02 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.83 151.98 49.75 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.851 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -137.81 137.48 38.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.022 0.529 . . . . 0.0 109.597 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 169.17 30.19 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.89 151.93 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 31.1 t 75.44 15.71 2.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.139 1.376 . . . . 0.0 110.637 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 44.1 ttm -113.71 135.11 21.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.062 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.7 Cg_exo -79.53 126.23 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.394 2.063 . . . . 0.0 110.427 173.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 10.2 m -141.71 146.67 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 123.068 0.547 . . . . 0.0 110.07 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.9 tt0 -105.67 118.63 37.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.8 172.0 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.82 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.1 p -148.49 166.07 29.31 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 87.51 22.81 42.16 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.158 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 50.3 tp -72.98 -28.64 62.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.139 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 64.23 20.01 12.01 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.279 1.031 . . . . 0.0 110.213 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 455' ' ' THR . 33.2 t70 -149.03 179.39 7.91 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.47 114.9 65.8 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 118.415 0.552 . . . . 0.0 110.395 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.21 157.63 23.08 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.05 1.833 . . . . 0.0 111.091 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -124.6 137.91 54.35 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-O 121.529 0.681 . . . . 0.0 110.59 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.32 139.83 50.05 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.944 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.81 89.46 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.476 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 2.5 t70 -85.13 -170.87 3.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.476 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.3 OUTLIER -137.75 148.87 45.97 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.09 0.471 . . . . 0.0 109.903 -174.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.7 p90 -139.4 162.7 34.39 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.356 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.09 116.06 16.56 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.115 0.483 . . . . 0.0 109.87 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 494' ' ' PHE . 62.2 t . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 121.689 0.757 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -63.1 -41.21 99.32 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.649 1.18 . . . . 0.0 109.553 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -75.45 -19.8 59.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.655 0.741 . . . . 0.0 110.496 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.54 -44.07 21.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 108.877 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -70.56 -19.74 62.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.538 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' GLN . . . . . 0.477 ' OE1' ' HD3' ' A' ' 445' ' ' LYS . 45.0 tp60 -64.17 -40.67 96.62 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.613 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 40.0 mm -76.23 -35.27 27.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 CA-C-N 115.078 -0.964 . . . . 0.0 113.325 175.914 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 419' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 441' ' ' ALA . 18.7 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.2 162.75 12.31 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.24 140.22 41.8 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.13 139.61 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.26 -39.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.27 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.22 158.45 44.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.62 135.32 14.45 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 177.52 8.36 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 123.582 0.551 . . . . 0.0 109.84 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.8 149.0 22.16 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.094 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.04 127.95 45.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -32.97 74.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.21 -39.27 2.3 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.641 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -87.85 -20.2 26.37 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.697 0.284 . . . . 0.0 111.717 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.24 -166.48 23.22 Favored Glycine 0 C--O 1.222 -0.633 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.84 117.01 3.66 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.589 2.193 . . . . 0.0 111.063 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.57 153.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.467 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -147.88 123.95 10.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.926 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 5.9 m -96.32 126.39 41.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.462 HD21 HD12 ' A' ' 444' ' ' LEU . 0.0 OUTLIER -134.97 173.43 11.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 121.04 0.448 . . . . 0.0 111.208 -177.476 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.7 tm? -116.52 107.58 14.93 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -74.69 119.58 22.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.274 0.559 . . . . 0.0 112.063 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -124.39 -16.65 6.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -69.21 -28.0 65.98 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.673 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 175.01 -96.07 0.1 Allowed Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.103 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 501' ' ' LYS . 40.2 m -149.2 143.92 26.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.655 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.79 136.24 49.43 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 25.7 ttpt -147.23 150.57 35.13 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 34.1 m -69.69 131.04 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.167 0.508 . . . . 0.0 110.042 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.48 -10.46 61.18 Favored Glycine 0 N--CA 1.417 -2.586 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.415 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.518 ' OD2' ' HE2' ' A' ' 445' ' ' LYS . 17.2 m-20 -89.19 146.2 35.77 Favored Pre-proline 0 C--O 1.252 1.191 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.085 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 3.8 Cg_exo -75.36 148.27 33.72 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.33 2.02 . . . . 0.0 111.702 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.27 153.45 37.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.682 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.07 107.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.88 162.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . -39.85 108.7 0.1 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.263 0.483 . . . . 0.0 113.191 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.3 m 70.78 -25.34 0.16 Allowed 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 126.523 1.929 . . . . 0.0 115.198 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.422 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.1 m -119.6 132.82 55.8 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 120.955 -1.091 . . . . 0.0 112.295 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -111.46 165.44 11.98 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -169.8 -164.04 24.85 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -137.89 135.84 36.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 444' ' ' LEU . 38.6 t -69.99 118.48 14.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 120.905 0.383 . . . . 0.0 111.548 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -88.29 -54.86 3.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.149 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -133.19 146.37 51.45 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.655 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.6 tpp -115.54 116.69 28.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.24 132.13 60.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -103.7 178.22 4.62 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.945 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.27 -29.83 25.01 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.323 1.449 . . . . 0.0 112.985 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 47.6 t -78.52 -17.2 56.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.034 0.445 . . . . 0.0 110.494 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.74 56.69 Favored Glycine 0 CA--C 1.501 -0.814 0 O-C-N 122.013 -0.43 . . . . 0.0 112.157 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -92.08 149.19 21.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 120.722 0.296 . . . . 0.0 111.607 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -75.33 129.78 37.95 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.763 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.4 m -137.33 -176.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -111.54 -24.68 9.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.129 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -149.02 157.57 43.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.84 136.01 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 122.979 0.512 . . . . 0.0 110.189 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.0 167.86 38.48 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.482 ' HA ' HG13 ' A' ' 439' ' ' VAL . 38.6 Cg_endo -63.04 153.02 76.41 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.02 2.48 . . . . 0.0 112.925 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.1 m 71.61 21.63 4.33 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.649 1.18 . . . . 0.0 111.714 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 24.9 ttt -121.0 137.07 26.13 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.84 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 6.2 Cg_exo -78.61 126.84 7.66 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.84 2.36 . . . . 0.0 111.64 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 473' ' ' ALA . 13.4 m -143.78 155.93 16.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 122.516 0.326 . . . . 0.0 110.536 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 480' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 436' ' ' THR . 44.3 tt0 -116.11 115.43 26.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.32 177.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.035 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.0 p -152.44 166.68 31.2 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.91 20.35 24.1 Favored Glycine 0 C--N 1.294 -1.797 0 O-C-N 123.823 0.702 . . . . 0.0 114.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 43.3 tp -85.18 -33.37 22.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 7.6 t60 60.82 23.59 13.57 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.346 1.459 . . . . 0.0 110.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.422 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.2 t70 -144.82 -179.91 6.9 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.18 112.49 56.48 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -78.19 166.2 24.88 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.961 1.774 . . . . 0.0 110.41 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 492' ' ' ASP . 5.5 tp-100 -120.09 132.81 55.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.785 0.802 . . . . 0.0 110.587 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.53 121.46 18.74 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.032 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.45 -0.25 59.76 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 489' ' ' GLN . 3.4 t70 -80.28 -167.43 1.32 Allowed 'General case' 0 C--O 1.247 0.93 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ARG . . . . . 0.494 ' HD3' ' N ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -137.76 129.71 28.76 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.385 0.612 . . . . 0.0 110.422 -172.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.33 158.95 29.9 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.715 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.8 ttt -118.4 123.23 44.75 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 441' ' ' ALA . 2.5 p . . . . . 0 C--N 1.299 -1.593 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 504' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.188 -2.156 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 501' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 443' ' ' THR . 64.7 mttp -62.97 -45.32 93.0 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.297 0.57 . . . . 0.0 112.174 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -74.82 -27.51 60.32 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.75 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.13 31.75 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 500' ' ' GLU . 3.9 ptp180 -64.66 -23.22 67.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.87 -32.79 72.22 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.208 1.004 . . . . 0.0 109.028 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 60.6 mt -87.31 -44.89 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.564 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.269 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.151 178.893 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -125.72 170.86 17.58 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.8 m -114.65 139.74 49.4 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.37 127.91 38.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.07 -37.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.83 154.96 26.97 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.58 139.13 25.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' LYS . . . . . 0.486 ' CD ' HG23 ' A' ' 434' ' ' VAL . 0.0 OUTLIER -156.99 176.85 12.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.41 150.09 22.98 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.88 119.48 32.76 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.551 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -50.85 -25.46 4.54 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.24 -36.28 1.23 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.119 -1.038 . . . . 0.0 113.646 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -90.08 -15.09 32.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 122.398 -0.472 . . . . 0.0 111.333 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 91.68 -144.93 17.45 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.02 116.42 4.14 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.388 2.059 . . . . 0.0 111.879 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.486 HG23 ' CD ' ' A' ' 426' ' ' LYS . 2.9 m -121.14 123.92 71.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 124.532 1.133 . . . . 0.0 108.943 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -130.18 125.22 34.45 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.175 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.11 122.2 40.96 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.5 pp -132.3 173.18 11.54 Favored 'General case' 0 C--N 1.257 -3.417 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 476' ' ' SER . 4.5 tt -124.17 110.63 14.92 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -69.12 121.63 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.806 0.812 . . . . 0.0 111.761 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -122.2 -16.03 7.55 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.655 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.0 -3.83 55.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.61 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 149.84 -103.56 0.25 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 119.943 -1.123 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.8 m -142.51 130.44 21.77 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.478 ' CD1' HD11 ' A' ' 437' ' ' LEU . 2.9 tt -107.26 138.47 43.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -145.94 151.94 38.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.866 0.757 . . . . 0.0 110.946 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' VAL . . . . . 0.594 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.9 m -62.77 128.29 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.331 0.586 . . . . 0.0 111.123 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.59 54.0 Favored Glycine 0 N--CA 1.428 -1.865 0 C-N-CA 119.845 -1.169 . . . . 0.0 114.219 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 445' ' ' LYS 0.254 2.2 p30 -101.17 149.58 36.4 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 118.904 1.352 . . . . 0.0 112.55 177.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 449' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 73.2 Cg_endo -78.37 124.83 6.67 Favored 'Trans proline' 0 C--N 1.364 1.393 0 C-N-CA 122.881 2.387 . . . . 0.0 113.04 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.39 151.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.364 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.03 120.61 65.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.24 111.36 26.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.68 -113.83 6.23 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.235 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 17.5 p -104.06 2.92 32.68 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.889 0.376 . . . . 0.0 111.53 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.465 HG21 ' CB ' ' A' ' 486' ' ' ASP . 25.3 m -124.78 151.33 45.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.685 0.278 . . . . 0.0 110.692 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -127.56 144.34 51.08 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -147.26 -164.36 11.12 Favored Glycine 0 C--N 1.287 -2.149 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 53.7 ttt180 -135.39 134.67 39.95 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.526 HG11 ' HE2' ' A' ' 462' ' ' MET . 38.5 t -66.67 121.58 16.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -86.88 -61.24 1.77 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.005 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.13 155.25 51.03 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 123.892 0.877 . . . . 0.0 109.091 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.526 ' HE2' HG11 ' A' ' 459' ' ' VAL . 36.4 tpp -123.68 117.83 25.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.27 132.01 70.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.3 p30 -96.65 175.03 6.53 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.617 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.16 -27.35 61.83 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.53 0.732 . . . . 0.0 112.884 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.8 t -79.42 -11.03 59.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 96.55 6.0 58.69 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.134 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ARG . . . . . 0.494 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.6 mpt_? -87.75 130.79 34.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.625 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.39 127.27 32.59 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 462' ' ' MET . 15.3 m -134.46 178.57 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -103.34 -35.4 8.42 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.647 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.65 162.16 33.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.905 0.383 . . . . 0.0 111.434 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -129.65 129.49 44.36 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.213 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.25 163.99 34.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 439' ' ' VAL . 36.4 Cg_endo -65.26 152.37 82.36 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.402 2.068 . . . . 0.0 112.409 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.625 ' HA ' HD21 ' A' ' 438' ' ' LEU . 23.0 t 74.43 15.34 3.47 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.415 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 42.1 ttm -113.14 134.81 21.77 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 5.9 Cg_exo -81.21 126.09 5.45 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.675 2.25 . . . . 0.0 110.882 173.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 479' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.4 m -137.86 142.49 35.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.216 0.532 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -91.25 112.2 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.47 167.37 2.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.17 0.51 . . . . 0.0 109.652 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.3 29.37 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 483' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 94.27 12.87 55.67 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.512 177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.05 -31.85 61.39 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t60 61.73 20.52 11.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 111.499 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ASP . . . . . 0.465 ' CB ' HG21 ' A' ' 455' ' ' THR . 4.1 t70 -149.26 -179.54 7.13 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 11.8 p -90.15 120.4 69.2 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-O 121.003 0.43 . . . . 0.0 110.369 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 488' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.2 Cg_endo -88.01 172.05 5.49 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.064 1.843 . . . . 0.0 111.425 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -128.53 131.07 48.25 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.71 33.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.85 -0.4 59.21 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.383 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -89.36 -178.35 5.59 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 152.55 24.17 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 494' ' ' PHE . . . . . 0.647 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.6 p90 -141.59 154.54 45.49 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.0 ttp -126.26 121.41 32.6 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 C--N 1.301 -1.54 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.35 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.213 -0.863 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -68.77 -39.59 80.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.106 0.479 . . . . 0.0 111.374 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -80.24 -39.57 28.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.57 -52.44 61.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -67.84 -15.79 63.79 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.389 0.676 . . . . 0.0 111.591 -174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -80.95 -33.87 33.62 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.411 0.624 . . . . 0.0 109.375 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.83 -54.73 7.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.351 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.447 -179.6 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.993 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.9 m -89.11 89.46 7.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 69.64 -63.39 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.808 1.243 . . . . 0.0 112.606 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 60.2 mtt 73.51 100.32 0.07 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.033 1.333 . . . . 0.0 109.649 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.13 123.66 21.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.868 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.54 119.29 19.4 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -148.37 -71.18 0.21 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 125.006 1.322 . . . . 0.0 107.742 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -176.48 100.03 0.06 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 62.7 tp -107.38 107.91 19.02 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.4 121.38 14.73 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 123.532 0.52 . . . . 0.0 110.047 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' MET . . . . . 0.595 ' HB2' ' CD ' ' A' ' 498' ' ' GLU . 25.8 ptt? -163.05 133.3 4.48 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.436 ' HA ' ' HE3' ' A' ' 445' ' ' LYS . 54.4 mt -143.14 -66.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -170.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 401' ' ' ILE . 80.1 mt -127.68 162.1 27.35 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.12 174.9 10.16 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 123.269 0.356 . . . . 0.0 110.976 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 33.7 t -119.82 -75.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.998 0.427 . . . . 0.0 110.478 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 3.3 m -142.86 96.98 3.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 497' ' ' PHE . 28.3 mm-40 -98.14 114.21 26.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -142.0 22.23 2.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.039 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.02 151.39 23.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.03 117.16 28.89 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.589 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.51 -35.04 21.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 68.42 95.59 0.07 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 125.737 1.615 . . . . 0.0 110.95 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -146.59 -44.21 0.19 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.054 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -125.25 146.59 54.58 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.8 -27.55 21.35 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.643 2.229 . . . . 0.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.11 -61.66 2.39 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.392 0.615 . . . . 0.0 109.815 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.409 ' HB2' HG13 ' A' ' 419' ' ' VAL . 58.7 mtt180 -134.23 150.04 51.01 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -82.11 25.23 0.6 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 495' ' ' MET . . . -169.43 82.54 0.13 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.315 1.046 . . . . 0.0 109.193 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 416' ' ' ARG . 4.9 m -154.89 175.92 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 C-N-CA 124.047 0.939 . . . . 0.0 108.982 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -149.26 -179.35 25.06 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 p -117.38 143.12 46.31 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.313 0.578 . . . . 0.0 112.187 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.9 137.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.4 pt -93.18 -38.46 9.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -154.33 147.34 24.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.63 134.36 13.74 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -159.15 175.75 13.08 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -97.24 146.56 24.98 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -120.24 123.32 42.94 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.543 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.79 -10.03 3.44 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.08 -44.62 0.56 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.023 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -82.81 -25.39 32.74 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 122.859 0.464 . . . . 0.0 110.847 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.15 -166.58 15.48 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.75 116.41 4.09 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 121.84 1.693 . . . . 0.0 110.307 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 482' ' ' THR . 22.5 m -113.05 144.65 20.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-O 121.204 0.526 . . . . 0.0 109.939 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.71 111.98 9.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -85.04 120.9 27.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.0 pp -140.15 173.11 11.84 Favored 'General case' 0 C--N 1.278 -2.516 0 O-C-N 122.281 -0.262 . . . . 0.0 111.521 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.42 107.81 16.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.3 p -67.16 116.69 6.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.49 -15.64 6.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.509 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.31 -17.28 56.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.066 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.6 -107.83 0.33 Allowed Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 96.6 m -131.92 137.48 48.0 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.476 ' HG ' HG11 ' A' ' 496' ' ' VAL . 0.5 OUTLIER -109.84 127.18 54.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.602 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.7 ttpm? -131.71 158.28 41.55 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.431 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.8 m -71.19 137.13 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 O-C-N 121.777 -0.577 . . . . 0.0 110.384 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.17 -8.05 60.61 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.604 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 5.8 m-20 -68.5 136.86 90.78 Favored Pre-proline 0 CA--C 1.494 -1.202 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 55.1 Cg_endo -81.4 106.43 1.71 Allowed 'Trans proline' 0 N--CA 1.429 -2.29 0 C-N-CA 122.117 1.878 . . . . 0.0 107.544 171.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.618 HG22 HG22 ' A' ' 496' ' ' VAL . 2.8 pp -108.23 139.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.175 -170.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 58.5 t -110.39 113.99 45.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.24 112.0 38.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.08 -97.36 0.65 Allowed Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.85 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.0 t -131.74 3.95 4.18 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 120.963 0.411 . . . . 0.0 110.233 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.454 HG21 ' CB ' ' A' ' 486' ' ' ASP . 96.2 m -116.46 141.64 47.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 44.5 p90 -114.97 151.03 34.84 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -153.81 -164.3 12.59 Favored Glycine 0 C--N 1.296 -1.664 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 448' ' ' ASP . 19.9 ttm180 -134.58 127.43 31.23 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 482' ' ' THR . 60.9 t -58.88 115.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.72 0.638 . . . . 0.0 111.536 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -84.33 -59.27 2.44 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.0 151.22 48.87 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.549 0.739 . . . . 0.0 109.451 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 469' ' ' ARG . 54.7 tpp -122.49 117.33 25.69 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.3 127.91 75.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -96.45 -176.76 3.73 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.16 -173.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -48.54 -37.06 16.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 126.825 2.05 . . . . 0.0 113.114 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.0 m -88.71 -6.73 57.25 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.33 15.18 48.55 Favored Glycine 0 CA--C 1.496 -1.11 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.13 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.47 ' HB2' HD21 ' A' ' 464' ' ' ASN . 0.1 OUTLIER -100.4 135.17 42.26 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.086 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 462' ' ' MET . 6.6 tpt180 -68.89 130.99 44.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 462' ' ' MET . 14.0 m -139.71 -177.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.172 0.295 . . . . 0.0 110.681 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 472' ' ' GLU . 0.8 OUTLIER -106.32 -34.34 7.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 471' ' ' LYS . 32.8 tt0 -148.13 135.27 20.32 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.641 -172.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -128.84 144.74 51.25 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 171.11 31.96 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.233 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.506 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.5 Cg_endo -63.44 156.67 55.02 Favored 'Trans proline' 0 C--O 1.247 0.931 0 C-N-CA 122.969 2.446 . . . . 0.0 112.598 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 44.3 m 71.98 12.32 6.07 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.218 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.0 ttp -118.88 129.73 25.23 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.2 Cg_exo -67.48 127.22 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.694 2.263 . . . . 0.0 111.108 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 473' ' ' ALA . 24.5 m -139.85 154.96 24.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 39.4 tt0 -115.7 119.21 35.33 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -98.19 173.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.969 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.465 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.2 p -149.38 167.63 25.63 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.62 31.42 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.452 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 53.9 tp -81.22 -30.89 34.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.648 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 61.46 20.58 11.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.351 1.46 . . . . 0.0 111.345 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.454 ' CB ' HG21 ' A' ' 455' ' ' THR . 34.5 t70 -147.81 175.09 11.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.42 114.76 53.83 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 118.983 0.811 . . . . 0.0 112.318 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.75 146.61 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.686 1.59 . . . . 0.0 110.25 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.37 139.58 50.68 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.08 131.6 43.86 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.091 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.38 -0.12 68.05 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.091 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.56 ' OD1' ' HD2' ' A' ' 493' ' ' ARG . 1.6 t0 -85.02 -173.63 4.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.6 ' H ' ' HD2' ' A' ' 493' ' ' ARG . 0.9 OUTLIER -130.0 133.85 47.04 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.485 -175.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 40.5 p90 -127.15 150.23 49.59 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 418' ' ' ALA . 54.2 ttp -119.98 115.81 24.5 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.822 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 450' ' ' ILE . 26.3 t -137.04 104.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 406' ' ' GLU . 14.9 p90 -153.95 124.29 7.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.595 ' CD ' ' HB2' ' A' ' 400' ' ' MET . 15.5 pt-20 -138.04 -57.02 0.66 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 163.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.405 ' N ' ' HG3' ' A' ' 498' ' ' GLU . 15.0 t70 47.94 -92.94 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.116 1.766 . . . . 0.0 114.406 168.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.91 -10.66 59.69 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 122.12 -0.363 . . . . 0.0 111.872 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 498' ' ' GLU . 34.0 tptt -47.37 -54.15 11.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 112.144 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.47 -34.92 41.05 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.241 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.57 73.04 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 122.006 0.908 . . . . 0.0 108.885 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 511' ' ' ALA . 63.9 ttt180 -61.03 -37.62 83.22 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 125.675 1.59 . . . . 0.0 110.289 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -63.62 -45.32 90.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.798 0.332 . . . . 0.0 110.251 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 80.1 mt -67.67 -34.21 66.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.06 22.72 6.74 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -85.69 -44.29 12.69 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.402 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -93.61 -175.73 3.86 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -72.76 123.61 23.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 504' ' ' ARG . . . -146.98 -77.64 0.17 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 170.34 93.85 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.91 1.284 . . . . 0.0 108.228 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -82.21 145.88 29.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 . . . . . 0 C--N 1.276 -2.609 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.929 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.389 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 23.1 t 68.48 -176.44 0.2 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.278 1.031 . . . . 0.0 109.623 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.443 ' O ' ' HG2' ' A' ' 393' ' ' MET . 71.6 m-70 73.25 -57.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.14 1.376 . . . . 0.0 111.402 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 392' ' ' HIS . 21.0 ptp 64.8 -26.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 128.022 2.529 . . . . 0.0 114.49 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 84.8 mt -81.74 -10.2 59.43 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.121 0.486 . . . . 0.0 109.964 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -88.44 135.44 33.47 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -136.13 170.77 15.49 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.27 107.54 18.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 95.9 mt 71.68 98.35 0.07 Allowed 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.607 1.192 . . . . 0.0 111.247 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.44 -5.34 52.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.807 0.813 . . . . 0.0 109.232 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -152.44 168.86 24.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 26.1 pt -73.43 157.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.91 -47.71 50.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.639 0.733 . . . . 0.0 111.246 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.61 162.69 18.73 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.345 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.08 -69.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 22.7 t -178.63 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.52 104.08 4.86 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.702 0.763 . . . . 0.0 111.181 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -166.11 106.01 0.68 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -118.81 140.6 49.69 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.189 0.519 . . . . 0.0 111.732 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -150.66 132.17 14.77 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.69 -18.35 21.39 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -170.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.98 75.09 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.127 0.892 . . . . 0.0 109.05 -174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -137.59 26.16 2.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.357 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -142.56 109.95 5.72 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.632 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.66 -20.1 18.06 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.557 2.171 . . . . 0.0 113.334 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.83 98.66 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 416' ' ' ARG . 4.5 mmp_? -96.17 79.62 3.19 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.661 0.744 . . . . 0.0 112.628 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -133.72 -86.32 0.43 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -155.14 79.31 1.05 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 495' ' ' MET . 10.9 m -155.39 164.17 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 124.72 1.208 . . . . 0.0 108.04 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -139.63 -178.13 16.36 Favored Glycine 0 C--N 1.295 -1.697 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 26.7 m -124.22 143.8 50.32 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.4 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.045 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.7 pt -91.7 -35.19 6.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.423 ' HG3' ' OG1' ' A' ' 436' ' ' THR . 9.8 pt-20 -159.21 148.66 18.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.22 130.54 12.06 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 177.46 10.71 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -174.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 427' ' ' LEU . 2.0 pt? -94.72 150.12 20.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.84 135.09 50.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.29 -18.2 59.08 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.834 -174.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -114.82 -36.31 1.28 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.549 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.52 -30.48 19.3 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.418 -0.46 . . . . 0.0 111.796 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.67 -152.28 17.7 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 482' ' ' THR . 14.4 Cg_exo -71.67 116.33 4.66 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.725 1.617 . . . . 0.0 110.017 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.93 124.06 68.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.63 0.729 . . . . 0.0 111.537 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -123.08 112.18 17.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.889 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 424' ' ' GLU . 1.2 m -83.59 115.45 22.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.2 pp -132.21 170.85 14.44 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.898 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.467 ' O ' ' HG3' ' A' ' 440' ' ' GLN . 2.1 tm? -117.03 106.13 13.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -64.64 117.7 5.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-O 121.827 0.823 . . . . 0.0 112.346 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 438' ' ' LEU . 72.1 mt-30 -123.66 -15.46 7.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.698 -175.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.579 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -78.28 -14.99 59.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.831 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 153.97 -108.05 0.35 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 27.2 m -128.8 142.5 50.96 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.554 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.13 135.98 53.22 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.3 ttpt -146.0 150.83 36.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 33.5 m -70.74 134.23 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.235 0.541 . . . . 0.0 110.707 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 105.2 -21.19 36.11 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.488 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 43.8 m-20 -79.47 146.44 65.85 Favored Pre-proline 0 C--O 1.251 1.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 458' ' ' ARG . 10.7 Cg_endo -77.8 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.114 1.876 . . . . 0.0 111.179 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.58 152.03 30.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.67 121.9 48.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-O 121.195 0.521 . . . . 0.0 109.64 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.462 ' HB ' ' CB ' ' A' ' 494' ' ' PHE . 2.5 p -143.78 133.45 20.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.644 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.75 33.82 88.26 Favored Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.261 26.7 p 62.05 1.76 0.71 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.928 1.691 . . . . 0.0 114.306 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 39.0 m -98.38 141.15 31.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -120.18 151.37 39.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.171 -1.011 . . . . 0.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.25 14.04 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 449' ' ' PRO . 32.7 ttp180 -127.76 146.65 50.52 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.521 HG11 ' HE2' ' A' ' 462' ' ' MET . 45.9 t -74.08 120.17 22.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -92.63 -45.16 8.21 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.782 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -144.04 152.56 41.17 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.554 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -122.47 117.59 26.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.94 133.81 65.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.542 HD21 ' HB2' ' A' ' 468' ' ' ARG . 4.7 p30 -101.63 172.77 6.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.816 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.67 -26.1 61.2 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.335 1.054 . . . . 0.0 113.061 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.7 m -86.02 -2.22 58.1 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 122.099 -0.375 . . . . 0.0 111.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 93.92 1.98 64.98 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.413 170.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.8 mpt_? -86.35 131.83 34.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.597 -0.301 . . . . 0.0 110.439 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -77.85 129.63 35.64 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.08 176.04 9.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 -8.35 10.38 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.736 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -151.65 139.4 19.81 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.55 131.55 29.73 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.74 166.9 31.73 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.439 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 439' ' ' VAL . 17.7 Cg_endo -58.05 149.81 68.86 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 123.252 2.635 . . . . 0.0 112.175 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 43.4 t 77.55 6.44 2.92 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.917 0.887 . . . . 0.0 112.133 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 39.5 ttp -110.26 127.09 27.62 Favored Pre-proline 0 N--CA 1.439 -0.993 0 O-C-N 121.403 -0.811 . . . . 0.0 111.417 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.8 Cg_endo -74.15 126.59 10.62 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.627 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 17.4 m -141.17 152.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.327 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 35.4 mt-10 -99.62 123.1 43.57 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.5 pt -97.58 164.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 4.1 p -145.77 158.38 43.86 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 100.9 12.48 36.96 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.919 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.31 -36.58 71.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 67.33 21.43 9.81 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.731 1.612 . . . . 0.0 109.873 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.451 ' CB ' HG21 ' A' ' 455' ' ' THR . 6.7 t70 -145.63 -179.05 6.42 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.29 110.05 48.36 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 123.405 0.441 . . . . 0.0 110.982 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 36.2 Cg_endo -82.73 148.49 13.98 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.931 1.754 . . . . 0.0 110.561 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -111.29 135.98 51.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.024 0.44 . . . . 0.0 111.958 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.87 127.26 32.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.99 -0.24 66.69 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.866 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.2 t70 -88.41 -172.13 3.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.0 OUTLIER -128.31 139.0 52.65 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -171.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 46.7 p90 -127.63 159.69 33.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.01 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' MET . . . . . 0.414 ' HB2' HG12 ' A' ' 419' ' ' VAL . 28.1 ttt -132.44 130.68 40.88 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.579 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.0 p -87.42 138.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -93.86 122.02 35.91 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -91.51 -83.47 0.28 Allowed 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.516 -173.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.521 ' H ' ' HG3' ' A' ' 498' ' ' GLU . 34.0 t70 67.45 -55.61 0.46 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 127.133 2.173 . . . . 0.0 114.625 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -65.78 -35.82 81.79 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -62.27 -52.97 61.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.903 -170.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 499' ' ' ASP . 21.9 pttp -61.22 -40.72 95.05 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.282 0.363 . . . . 0.0 110.257 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.05 60.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.104 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -60.29 -38.11 82.61 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.961 0.904 . . . . 0.0 110.928 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -69.84 -34.62 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.645 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.65 -23.21 14.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.655 0.741 . . . . 0.0 110.116 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.74 29.4 9.27 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -95.18 -50.39 5.07 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.728 0.811 . . . . 0.0 109.045 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -82.47 101.02 10.41 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -106.2 -47.32 3.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.864 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 512' ' ' GLN . . . 72.02 116.98 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.659 1.225 . . . . 0.0 108.971 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 511' ' ' ALA . 15.1 pt20 68.64 168.06 0.27 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 127.102 2.161 . . . . 0.0 111.095 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -109.39 164.29 12.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.688 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.568 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 40.0 m -85.31 15.82 4.09 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 117.432 0.616 . . . . 0.0 111.849 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 31.8 m170 63.57 46.67 4.1 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.328 1.061 . . . . 0.0 109.986 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 59.5 ttp -92.12 96.82 10.54 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.546 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 394' ' ' LEU . 2.3 pt? -111.68 139.32 47.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.27 -164.13 0.23 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.746 0.654 . . . . 0.0 110.353 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -114.76 99.5 7.55 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.87 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 61.8 tp 68.52 109.78 0.05 OUTLIER 'General case' 0 C--O 1.245 0.822 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.89 114.47 27.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.58 -32.43 62.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.06 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 93.1 mmm 64.98 82.21 0.19 Allowed 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 110.929 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.447 HG13 HD22 ' A' ' 402' ' ' LEU . 10.9 tp -113.6 142.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 401' ' ' ILE . 3.8 mm? 61.55 -93.31 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.145 0.578 . . . . 0.0 111.332 -174.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 406' ' ' GLU . 95.6 mt -151.07 -57.45 0.16 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 124.228 1.011 . . . . 0.0 108.882 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 81.0 t 71.8 -63.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.194 1.798 . . . . 0.0 111.106 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 74.3 m -128.44 -1.15 5.6 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 403' ' ' LEU . 16.7 mm-40 -85.01 105.45 15.78 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 22.8 mmt -95.57 -16.99 21.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.309 0.576 . . . . 0.0 110.178 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.35 117.91 13.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.037 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . 0.25 6.1 pt-20 -157.72 85.32 0.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.295 1.045 . . . . 0.0 111.439 171.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 411' ' ' LYS . 4.3 pp -92.99 -38.83 11.45 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.504 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.47 ' N ' HD12 ' A' ' 410' ' ' LEU . 82.3 mttt 69.5 -67.82 0.21 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 126.343 1.857 . . . . 0.0 110.648 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 414' ' ' PRO . . . -176.18 93.51 0.05 Allowed 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -108.67 93.16 11.48 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 412' ' ' ALA . 26.4 Cg_endo -103.34 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.859 3.039 . . . . 0.0 115.028 -170.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -75.47 110.13 9.59 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 72.51 -64.1 0.41 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.693 1.597 . . . . 0.0 109.046 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -168.34 -39.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -165.42 139.18 4.63 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.591 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 30.4 m -143.77 172.96 5.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.99 162.02 13.29 Favored Glycine 0 C--N 1.279 -2.62 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 m -117.01 138.76 51.36 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.88 139.45 17.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 18.2 pt -99.3 -39.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 490' ' ' ALA . 8.5 pt-20 -153.39 152.29 30.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.22 134.34 29.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.69 177.39 10.91 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.311 0.577 . . . . 0.0 111.185 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.97 145.08 26.19 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.771 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 10.4 t70 -128.02 129.16 46.25 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -75.55 -11.23 59.98 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -175.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -119.34 -35.64 0.92 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.478 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.0 mtp180 -94.08 -15.22 24.94 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.844 0.458 . . . . 0.0 111.028 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 88.15 -154.1 25.08 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -60.27 116.16 3.13 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.108 1.872 . . . . 0.0 111.173 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.8 137.18 53.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.434 0.635 . . . . 0.0 110.377 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -131.4 114.62 15.19 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.104 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -83.39 119.44 24.64 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.482 HD22 ' CE1' ' A' ' 494' ' ' PHE . 1.6 pp -135.73 173.07 12.12 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -120.01 112.41 19.12 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -75.77 125.2 35.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.526 0.679 . . . . 0.0 111.799 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 26.1 mt-30 -124.03 -15.11 6.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.937 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -97.3 6.31 48.55 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 147.62 -125.77 2.22 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.15 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.7 m -116.39 141.63 47.92 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.73 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.77 119.25 36.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.65 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -130.02 155.14 46.61 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.494 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.0 m -67.06 132.16 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.84 -7.09 48.76 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.916 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 498' ' ' GLU . 13.7 m-20 -73.88 135.02 77.68 Favored Pre-proline 0 C--O 1.25 1.089 0 CA-C-N 117.555 0.678 . . . . 0.0 111.932 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.32 119.15 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.629 2.219 . . . . 0.0 109.306 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.07 159.81 29.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.73 115.59 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 494' ' ' PHE . 16.6 t -128.38 124.17 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 56.98 42.35 92.78 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.264 6.6 t 60.39 4.09 0.65 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.549 2.34 . . . . 0.0 113.436 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.462 HG21 ' CB ' ' A' ' 486' ' ' ASP . 22.4 m -96.53 135.62 38.18 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -111.5 151.65 28.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.604 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.95 -163.97 19.29 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -134.62 137.21 43.48 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 444' ' ' LEU . 48.7 t -66.69 119.36 11.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.184 0.516 . . . . 0.0 112.097 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -81.54 -60.59 2.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.92 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -136.2 152.05 50.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.73 ' HE1' HD22 ' A' ' 444' ' ' LEU . 41.2 tpp -115.23 117.07 29.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 469' ' ' ARG . 11.9 t -122.88 126.49 73.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.444 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -92.81 174.77 7.08 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.625 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.21 -27.82 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.949 0.9 . . . . 0.0 113.144 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.5 m -78.81 -12.1 60.01 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.756 0.312 . . . . 0.0 111.0 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 98.41 8.32 54.95 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.93 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -97.0 128.81 44.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 463' ' ' VAL . 3.8 tmm_? -84.77 124.33 31.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.43 -174.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -99.31 -31.85 11.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.11 156.67 40.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.304 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.53 42.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -100.58 177.04 28.0 Favored Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.44 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.7 Cg_endo -59.76 155.37 43.6 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.971 2.447 . . . . 0.0 112.641 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 47.6 m 70.81 16.94 6.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.955 0.902 . . . . 0.0 112.144 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 45.5 ttm -117.81 136.68 23.8 Favored Pre-proline 0 C--N 1.316 -0.861 0 O-C-N 122.007 -0.433 . . . . 0.0 111.185 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.1 Cg_endo -82.57 125.85 4.5 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.234 1.956 . . . . 0.0 110.884 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 464' ' ' ASN . 16.9 m -143.22 156.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.0 mt-10 -105.0 126.55 52.18 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 50.0 pt -97.95 170.4 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 1.2 p -150.42 167.46 27.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.75 13.89 62.05 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.914 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.63 -32.54 64.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.9 t60 67.45 19.85 9.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.076 1.75 . . . . 0.0 109.788 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.462 ' CB ' HG21 ' A' ' 455' ' ' THR . 7.3 t70 -148.39 -179.98 7.36 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.9 t -120.42 113.41 33.68 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.46 175.38 10.24 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.773 2.315 . . . . 0.0 111.509 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -111.03 148.0 33.54 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 424' ' ' GLU . . . -70.22 138.84 52.05 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.255 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.85 -0.23 86.26 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.18 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.613 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 4.5 t70 -83.96 -165.34 1.11 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.613 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -138.59 148.98 44.78 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.688 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.482 ' CE1' HD22 ' A' ' 437' ' ' LEU . 15.0 p90 -139.56 156.19 47.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.833 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.1 ttt -118.86 127.39 53.46 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.8 p -101.65 136.44 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -150.65 133.47 15.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.441 ' HA ' ' OD1' ' A' ' 448' ' ' ASP . 8.2 tp10 -76.42 148.07 37.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.893 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.46 -55.06 38.06 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 124.217 1.007 . . . . 0.0 110.882 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.56 -34.55 78.51 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.563 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -72.53 -38.63 67.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.607 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.49 -46.78 88.84 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.611 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.94 -45.03 94.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.449 ' HA ' ' HB3' ' A' ' 508' ' ' GLU . 37.2 ttm180 -58.94 -36.03 74.1 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 125.374 1.469 . . . . 0.0 111.757 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -34.14 59.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.9 mm -80.18 -54.06 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -171.83 9.55 0.04 OUTLIER Glycine 0 C--N 1.32 -0.316 0 C-N-CA 118.695 -1.717 . . . . 0.0 115.052 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.449 ' HB3' ' HA ' ' A' ' 504' ' ' ARG . 5.4 tp10 -83.04 -29.09 29.12 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.84 -0.744 . . . . 0.0 108.998 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 504' ' ' ARG . . . 59.68 -163.17 0.24 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.552 0.741 . . . . 0.0 109.557 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -74.96 -29.93 61.06 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.204 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . 65.22 74.55 0.38 Allowed 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.487 1.115 . . . . 0.0 112.661 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -160.56 162.08 32.81 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -169.83 105.8 0.34 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.76 0.79 . . . . 0.0 109.568 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.779 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.252 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.5 m -78.26 91.99 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -128.73 86.01 2.4 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.563 0.697 . . . . 0.0 110.876 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -94.41 3.96 54.48 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.166 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.19 13.74 1.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.436 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.95 105.58 17.67 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -101.71 13.14 35.77 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.355 0.598 . . . . 0.0 111.288 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.36 -36.2 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.0 tp 72.71 -76.78 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.606 1.163 . . . . 0.0 111.983 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 52.24 70.52 0.55 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.742 0.817 . . . . 0.0 109.0 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 52.8 ttm -77.86 89.13 4.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.716 0.77 . . . . 0.0 112.06 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 50.0 mm -95.69 -65.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 84.3 mt 61.97 177.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.165 1.386 . . . . 0.0 112.622 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 95.2 mt 63.97 89.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.409 1.084 . . . . 0.0 111.811 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.75 1.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 50.8 m -111.6 -8.18 14.24 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.454 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -145.46 64.78 1.25 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.773 0.797 . . . . 0.0 111.466 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.7 170.32 8.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.05 117.79 30.18 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 411' ' ' LYS . 7.8 tp10 -97.54 106.16 18.43 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 413' ' ' ASN . 2.2 pt? -131.03 3.36 4.38 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.757 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.517 ' HG2' ' OE2' ' A' ' 409' ' ' GLU . 23.5 pttm -102.02 -35.51 8.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.411 0.624 . . . . 0.0 109.807 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -104.23 -23.47 13.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.046 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 410' ' ' LEU . 21.2 m-80 -123.31 121.83 26.88 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.952 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.92 -12.85 10.68 Favored 'Trans proline' 0 C--N 1.329 -0.456 0 C-N-CA 122.084 1.856 . . . . 0.0 112.921 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.494 ' HB2' HG21 ' A' ' 419' ' ' VAL . 11.3 m120 -81.41 -7.78 59.63 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.823 -172.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.91 176.58 0.26 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 52.42 -112.91 0.71 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.328 1.451 . . . . 0.0 112.933 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 441' ' ' ALA . . . -127.17 104.48 7.99 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 415' ' ' ASN . 2.5 m -149.18 162.78 4.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -129.47 178.37 17.43 Favored Glycine 0 C--N 1.298 -1.554 0 C-N-CA 119.233 -1.46 . . . . 0.0 112.542 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.84 145.16 45.89 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 123.335 0.654 . . . . 0.0 111.107 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 30.0 t -86.55 134.06 28.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 436' ' ' THR . 17.2 pt -94.26 -33.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.31 149.13 20.56 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.58 131.27 18.93 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.78 177.98 4.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.89 152.85 21.77 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -126.62 119.32 26.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -58.11 -19.55 33.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -112.53 -38.78 1.28 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.784 -1.198 . . . . 0.0 112.839 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.57 -32.59 19.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.37 -155.53 16.17 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.56 116.38 4.38 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.075 1.85 . . . . 0.0 110.068 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 32.4 m -116.3 143.94 25.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.793 0.806 . . . . 0.0 111.684 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -133.17 112.03 11.4 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.488 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 423' ' ' ILE . 2.7 m -87.55 115.36 24.92 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.646 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.4 pp -132.86 171.37 14.0 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 476' ' ' SER . 2.4 tm? -113.33 106.38 14.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -70.3 108.84 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.352 1.072 . . . . 0.0 111.928 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -115.0 -15.94 11.71 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.18 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.441 ' HA ' ' HB1' ' A' ' 418' ' ' ALA . . . -77.64 -4.12 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.906 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.31 -95.67 0.19 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.218 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.9 m -142.05 139.61 32.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -114.47 135.57 53.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -147.75 164.3 34.01 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 28.6 m -70.62 138.12 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 121.734 0.778 . . . . 0.0 112.134 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.28 -10.62 65.4 Favored Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.207 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 51.1 m-20 -76.66 131.76 73.37 Favored Pre-proline 0 C--O 1.245 0.848 0 CA-C-N 117.651 0.725 . . . . 0.0 111.536 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 4.9 Cg_exo -77.42 107.68 2.44 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.681 2.254 . . . . 0.0 109.26 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -112.48 161.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.898 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.56 114.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.444 HG23 HD13 ' A' ' 450' ' ' ILE . 61.7 t -120.34 112.42 36.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.55 -115.61 7.52 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.8 p -107.34 7.02 28.94 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.997 0.427 . . . . 0.0 111.259 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 486' ' ' ASP . 90.0 m -121.59 129.53 52.9 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.781 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -111.31 151.99 27.74 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -165.66 -164.27 20.77 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.593 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 56.7 ttp180 -131.91 128.72 39.15 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 482' ' ' THR . 40.1 t -61.28 122.86 12.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 123.859 0.724 . . . . 0.0 111.767 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -95.71 -56.93 2.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.31 52.28 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.6 tpp -115.37 117.68 31.09 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 16.8 t -116.36 139.6 42.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -105.43 171.97 7.04 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.095 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.6 -25.89 54.02 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 41.2 m -77.09 -11.71 59.85 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.011 -0.43 . . . . 0.0 110.954 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.74 -4.64 56.41 Favored Glycine 0 CA--C 1.496 -1.12 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.484 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -91.89 140.26 29.85 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.4 tmm_? -86.44 138.01 32.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 16.7 m -136.17 -173.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 124.41 1.084 . . . . 0.0 108.493 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -119.34 -17.07 8.91 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.113 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 445' ' ' LYS . 34.0 tt0 -149.19 152.25 35.72 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.44 135.36 30.25 Favored 'General case' 0 C--O 1.25 1.11 0 O-C-N 123.536 0.522 . . . . 0.0 110.876 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -86.45 168.43 40.19 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.641 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 439' ' ' VAL . 37.0 Cg_endo -64.26 154.99 68.0 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 122.941 2.427 . . . . 0.0 113.729 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 438' ' ' LEU . 34.1 m 70.17 16.55 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.016 1.326 . . . . 0.0 112.19 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.6 ttp -117.0 130.07 24.87 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.475 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 11.2 Cg_endo -72.68 126.12 11.16 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.27 1.98 . . . . 0.0 111.788 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.72 155.05 22.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.672 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 463' ' ' VAL . 43.5 mt-10 -108.64 113.63 26.78 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 124.516 1.127 . . . . 0.0 108.575 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.8 pt -98.13 172.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.805 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.6 p -146.45 163.03 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 107.29 11.56 25.34 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.972 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.4 mt -83.71 -27.29 29.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.706 0.289 . . . . 0.0 111.749 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 60.27 19.26 8.73 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.61 1.164 . . . . 0.0 110.518 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 455' ' ' THR . 34.4 t70 -149.26 174.39 12.44 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.22 112.26 52.37 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.92 2.413 . . . . 0.0 111.37 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -105.31 132.43 51.51 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.484 0.659 . . . . 0.0 111.656 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.03 28.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 101.63 -5.11 54.16 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.24 -177.48 6.25 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.09 143.66 44.41 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.656 0.782 . . . . 0.0 110.758 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.646 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 50.1 p90 -136.83 163.16 31.3 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.5 ttm -130.17 115.88 17.65 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.851 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' A' ' 444' ' ' LEU . 74.6 t -101.05 106.88 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -151.39 123.05 7.97 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.836 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -179.25 4.89 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 167.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -158.75 -52.43 0.06 Allowed 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.651 0.738 . . . . 0.0 109.921 -165.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 49.3 mt-10 -71.68 -33.69 69.04 Favored 'General case' 0 C--O 1.182 -2.458 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.401 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -62.42 -39.12 92.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.74 0.781 . . . . 0.0 111.141 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.12 -41.2 86.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.914 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 508' ' ' GLU . . . -79.65 -25.92 41.22 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.159 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 28.7 ttt180 -70.76 -29.06 65.17 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.74 1.216 . . . . 0.0 110.014 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -65.2 -34.52 78.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.033 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 70.9 mt -79.08 -35.02 17.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 108.11 28.06 4.83 Favored Glycine 0 N--CA 1.419 -2.437 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.272 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.431 ' HG3' ' HB1' ' A' ' 503' ' ' ALA . 12.7 pt-20 -114.68 -32.04 5.97 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.566 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 64.44 -74.52 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.116 1.366 . . . . 0.0 113.084 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -72.56 93.37 1.58 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -89.15 92.47 9.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -101.87 132.78 47.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.305 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -147.18 134.32 20.46 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.015 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 66.0 m 70.05 135.74 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.463 1.105 . . . . 0.0 112.493 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -115.22 134.91 54.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.323 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -114.57 -49.38 2.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.599 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 63.97 -175.06 0.16 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 124.226 0.954 . . . . 0.0 111.858 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.4 t70 68.52 -82.49 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.436 1.494 . . . . 0.0 111.745 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -87.82 95.41 10.08 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 74.68 153.03 0.14 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.414 1.085 . . . . 0.0 111.605 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.23 152.08 35.57 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -77.26 131.03 37.97 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 50.5 ttm -79.4 -38.85 33.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 109.814 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.4 111.34 23.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.66 172.16 10.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 tp 72.7 -62.7 0.46 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.152 1.381 . . . . 0.0 111.065 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 7.5 p -178.92 -47.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 124.645 1.178 . . . . 0.0 108.275 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 50.7 m -163.76 155.08 16.45 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.39 102.93 6.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 96.1 mmm -61.14 -35.82 78.12 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.893 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -135.88 118.55 16.03 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.71 139.75 26.75 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.054 0.454 . . . . 0.0 110.66 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 5.55 37.24 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -80.86 -11.05 59.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.621 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -87.55 5.34 39.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.725 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 75.21 126.19 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.038 1.335 . . . . 0.0 110.424 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.44 -13.46 37.58 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.08 2.52 . . . . 0.0 113.731 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -86.93 -170.01 2.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -72.29 175.02 6.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -85.0 8.25 18.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.241 0.544 . . . . 0.0 111.017 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -82.85 6.24 19.05 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.204 0.526 . . . . 0.0 110.547 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.01 179.93 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 123.887 0.875 . . . . 0.0 108.807 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -147.8 -175.35 20.46 Favored Glycine 0 C--N 1.299 -1.508 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 6.6 m -123.76 141.96 51.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.098 0.449 . . . . 0.0 109.891 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.87 138.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.4 pt -94.19 -42.22 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.779 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.77 146.72 27.34 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.71 19.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 177.44 4.34 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.98 150.78 20.05 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.043 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -127.46 129.84 48.18 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -67.21 -16.87 64.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.7 -53.78 0.55 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.93 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.72 -29.25 64.33 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.49 0.662 . . . . 0.0 110.15 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 434' ' ' VAL . . . 104.16 -179.42 24.89 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 486' ' ' ASP . 35.6 Cg_exo -49.73 119.55 4.87 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.341 2.027 . . . . 0.0 111.179 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 432' ' ' GLY . 21.0 m -117.98 158.81 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.444 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -150.76 113.38 4.69 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.095 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 m -90.47 119.84 31.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -134.63 173.3 11.82 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.54 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.6 tm? -117.07 106.16 13.06 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.8 p -78.71 123.41 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.415 0.626 . . . . 0.0 112.506 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -124.09 -16.31 6.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.403 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -63.82 -16.99 62.64 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.541 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.89 -92.79 0.11 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.433 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.3 m -148.1 141.86 25.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.729 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.22 117.76 34.94 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.8 ttpm? -125.62 153.46 43.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.2 m -71.02 139.02 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.775 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 101.75 -10.23 57.3 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.405 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 66.1 m-20 -82.08 138.19 46.01 Favored Pre-proline 0 C--O 1.244 0.789 0 CA-C-N 117.271 0.535 . . . . 0.0 111.846 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 18.5 Cg_endo -83.68 106.87 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.542 2.161 . . . . 0.0 110.161 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -108.4 162.98 6.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.034 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 6.9 p -133.18 125.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.67 125.5 70.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.64 -103.12 1.13 Allowed Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 19.6 m -126.33 0.24 7.02 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.739 0.78 . . . . 0.0 109.662 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 74.7 m -116.23 146.01 42.68 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.491 -0.755 . . . . 0.0 111.158 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 54.7 p90 -119.24 159.89 23.23 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -164.81 -164.44 20.14 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 35.3 ttm-85 -135.43 130.03 34.16 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 482' ' ' THR . 38.2 t -64.46 120.78 12.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.69 0.757 . . . . 0.0 112.858 -172.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -85.33 -60.28 2.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.812 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.8 160.75 37.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.921 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.729 ' HE1' HD22 ' A' ' 444' ' ' LEU . 36.7 tpp -130.69 117.51 19.56 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.16 138.78 53.72 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.0 p30 -103.62 176.48 5.14 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.932 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -51.33 -38.39 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.517 1.136 . . . . 0.0 111.783 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.0 m -76.74 -5.9 49.98 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.01 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.44 2.64 63.5 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.38 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.477 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.9 mpt_? -88.67 128.63 35.6 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.755 0.312 . . . . 0.0 110.365 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -84.31 134.15 34.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.1 176.15 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -96.52 -35.51 11.09 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.962 0.411 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.75 151.43 28.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.304 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.91 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.135 0.574 . . . . 0.0 109.755 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.77 179.29 42.87 Favored Glycine 0 N--CA 1.439 -1.148 0 O-C-N 123.534 0.521 . . . . 0.0 112.327 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.411 ' HA ' HG13 ' A' ' 439' ' ' VAL . 65.1 Cg_endo -71.72 161.01 46.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.696 2.264 . . . . 0.0 112.689 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 438' ' ' LEU . 18.7 m 67.25 23.14 9.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.406 1.082 . . . . 0.0 110.591 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.0 ttt -125.86 137.62 30.43 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.884 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 5.7 Cg_exo -83.21 125.75 4.1 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.0 m -142.69 151.66 17.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.248 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.7 tt0 -108.63 119.05 38.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.5 pt -98.15 172.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.262 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.6 p -148.9 157.24 43.28 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.823 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.49 4.96 Favored Glycine 0 C--N 1.308 -0.988 0 O-C-N 123.566 0.541 . . . . 0.0 112.379 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.27 -31.65 11.95 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.76 21.16 11.22 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.992 1.317 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 433' ' ' PRO . 38.1 t70 -147.78 167.43 24.72 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 4.8 p -94.75 115.93 65.85 Favored Pre-proline 0 C--N 1.287 -2.117 0 CA-C-O 121.035 0.445 . . . . 0.0 110.762 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.9 Cg_endo -84.97 173.7 7.88 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.617 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -122.47 136.63 54.93 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.962 0.411 . . . . 0.0 111.383 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.85 140.6 51.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.922 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.51 89.38 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.585 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.84 -176.4 4.43 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 6.3 mpt_? -113.14 150.4 32.26 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.241 0.543 . . . . 0.0 110.196 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.2 p90 -139.54 165.13 28.07 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.14 131.99 45.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 444' ' ' LEU . 84.5 t -129.08 138.14 55.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -133.92 123.2 24.27 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -92.94 -41.86 9.79 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.785 0.802 . . . . 0.0 109.387 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 15.2 t70 73.36 -76.87 0.06 Allowed 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 126.505 1.922 . . . . 0.0 112.79 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 503' ' ' ALA . 0.0 OUTLIER -74.47 -27.24 60.5 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -165.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.455 ' HB2' ' HG3' ' A' ' 498' ' ' GLU . 6.7 mmmm -56.36 -42.48 77.87 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.277 0.361 . . . . 0.0 110.363 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -80.82 -37.38 30.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 500' ' ' GLU . . . -54.64 -56.6 17.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.23 0.612 . . . . 0.0 111.425 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -72.73 -19.49 61.37 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.394 0.616 . . . . 0.0 111.296 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 501' ' ' LYS . 47.6 tt0 -81.21 -31.05 34.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.01 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 83.3 mt -87.29 -53.89 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 151.79 32.56 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.237 -1.459 . . . . 0.0 114.173 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -66.42 -38.83 88.32 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -131.57 115.86 16.66 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -104.0 -56.52 2.18 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.645 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -86.45 -40.7 15.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -172.49 170.73 4.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -89.99 -20.38 23.35 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.208 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 124.564 1.146 . . . . 0.0 109.845 -176.753 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.492 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 25.5 m -127.43 -61.15 1.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -94.5 74.66 3.81 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 56.9 ttp -100.92 106.82 18.19 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.287 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 94.3 mt -98.45 157.77 16.0 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.68 -23.99 45.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -85.61 105.19 16.0 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.527 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 98.0 mt -126.49 118.13 24.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.71 -25.51 44.67 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 66.67 102.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.87 1.268 . . . . 0.0 112.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 64.4 mtt -116.81 142.82 46.43 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.906 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 52.6 mt 60.75 79.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.274 1.03 . . . . 0.0 110.152 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.16 88.38 4.19 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.9 99.46 3.26 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.91 -13.19 8.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.724 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 13.8 m -82.86 95.67 8.01 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.589 0.709 . . . . 0.0 110.57 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.42 -64.76 1.04 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.278 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 16.6 tpt 71.97 -14.12 0.54 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.334 1.454 . . . . 0.0 112.312 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.98 123.28 26.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 111.54 22.2 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.2 tp -132.69 14.21 4.42 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.958 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 61.37 85.43 0.12 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.828 -173.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -75.15 97.3 3.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -45.49 123.45 5.74 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 124.671 1.188 . . . . 0.0 111.766 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.83 -49.82 7.68 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 111.258 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 418' ' ' ALA . 14.7 m120 -90.72 74.57 6.62 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.0 117.48 5.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.396 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 75.39 7.83 3.95 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.674 1.59 . . . . 0.0 112.206 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 415' ' ' ASN . . . -111.46 -6.76 14.4 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.915 -0.491 . . . . 0.0 110.469 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 415' ' ' ASN . 30.3 m -147.99 175.28 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -141.84 -178.35 17.87 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.3 m -124.21 138.97 54.34 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.64 138.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 436' ' ' THR . 24.7 pt -89.13 -44.3 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.045 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 7.4 pt-20 -155.45 157.42 36.95 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.05 136.98 32.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 177.74 5.54 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.18 152.48 21.08 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.344 0.593 . . . . 0.0 110.047 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -122.76 118.28 27.68 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.466 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.2 -19.37 13.44 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.31 -41.32 1.79 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.642 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.55 -37.25 19.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 110.817 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.63 -146.42 18.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.53 116.51 4.27 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.507 2.138 . . . . 0.0 111.331 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 482' ' ' THR . 27.4 m -119.81 158.6 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.2 121.77 13.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 480' ' ' GLU . 1.6 m -92.55 117.65 30.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.613 HD23 ' CZ ' ' A' ' 494' ' ' PHE . 0.0 OUTLIER -133.75 168.87 17.92 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.506 -177.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -114.86 106.35 14.07 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -72.72 117.08 15.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.779 0.799 . . . . 0.0 112.494 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.41 -15.96 9.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.123 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.68 60.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.802 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 498' ' ' GLU . . . 155.63 -106.92 0.3 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 90.1 m -134.74 133.69 40.2 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.559 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -101.9 126.02 48.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.1 ttpt -140.09 145.71 37.98 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -64.93 145.58 13.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.368 0.604 . . . . 0.0 112.449 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 -21.87 42.52 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.419 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 0.3 OUTLIER -94.7 144.03 27.21 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 26.1 Cg_exo -66.55 136.69 43.7 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.914 2.409 . . . . 0.0 111.346 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 452' ' ' VAL . 2.7 pp -131.5 161.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.262 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.22 116.19 47.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.48 HG23 HD13 ' A' ' 450' ' ' ILE . 85.0 t -128.58 122.62 57.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' GLY . . . . . 0.513 ' HA2' ' OD1' ' A' ' 492' ' ' ASP . . . 60.89 36.63 92.39 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 121.18 -0.534 . . . . 0.0 111.966 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.295 8.3 p 60.97 8.93 2.08 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.498 HG21 ' CB ' ' A' ' 486' ' ' ASP . 87.0 m -102.81 139.41 38.42 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -111.65 146.77 36.87 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.493 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -152.6 -167.86 15.94 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.67 135.92 47.27 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.561 HG11 ' HE2' ' A' ' 462' ' ' MET . 46.2 t -73.73 117.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 123.404 0.44 . . . . 0.0 110.292 -176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.97 -56.22 3.42 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -130.63 153.76 48.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.561 ' HE2' HG11 ' A' ' 459' ' ' VAL . 39.5 tpp -121.09 120.02 34.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.87 139.13 51.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 5.5 p30 -97.02 174.53 6.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.12 -25.88 67.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 44.0 m -78.83 -19.8 51.21 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.189 0.519 . . . . 0.0 111.102 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.88 2.21 Favored Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.191 165.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.468 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 25.8 ttm180 -120.27 136.5 54.65 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.021 -1.59 . . . . 0.0 109.941 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -79.77 132.05 36.06 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.16 0.913 . . . . 0.0 110.728 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.29 -32.0 8.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.138 0.494 . . . . 0.0 110.284 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.04 163.95 37.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.388 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.64 38.45 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.09 172.31 38.19 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.555 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.498 ' HA ' HG13 ' A' ' 439' ' ' VAL . 35.6 Cg_endo -65.79 158.55 53.11 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.9 m 70.54 16.83 6.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.598 1.159 . . . . 0.0 111.362 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 25.1 ttt -117.04 137.53 23.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.677 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 1.9 Cg_endo -82.06 126.15 4.93 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.417 2.078 . . . . 0.0 111.298 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.57 158.0 16.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.334 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 37.8 mt-10 -111.62 121.24 44.61 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.7 pt -98.44 172.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.773 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.447 ' CG2' HG12 ' A' ' 434' ' ' VAL . 3.1 p -147.43 163.19 37.29 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.65 7.73 58.79 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.159 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.89 -39.05 64.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.22 30.41 19.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.003 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 455' ' ' THR . 35.2 t70 -140.77 179.67 6.57 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.58 109.73 47.27 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 118.317 0.508 . . . . 0.0 109.939 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 1.2 Cg_endo -80.58 164.19 21.15 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 121.602 1.535 . . . . 0.0 109.73 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -131.4 140.06 49.57 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-O 121.318 0.58 . . . . 0.0 110.458 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -71.11 132.08 44.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.285 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 88.24 0.61 82.57 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.968 -1.111 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.595 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.6 t70 -88.41 -173.26 4.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.595 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -128.4 153.54 46.96 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.156 0.503 . . . . 0.0 111.0 -171.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.613 ' CZ ' HD23 ' A' ' 437' ' ' LEU . 44.2 p90 -145.65 165.7 27.96 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.105 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.3 ttt -133.15 123.44 25.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' CD1' ' A' ' 494' ' ' PHE . 84.0 t -109.0 136.72 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.47 122.55 32.07 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.544 0.688 . . . . 0.0 112.072 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.438 ' HB3' ' HD3' ' A' ' 501' ' ' LYS . 8.9 tp10 -92.77 155.85 17.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.49 -65.73 0.51 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 7.1 pt-20 -66.39 -36.1 82.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.491 0.662 . . . . 0.0 110.984 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 61.6 mtpt -66.49 -37.7 85.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.562 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 506' ' ' ILE . 87.8 tttt -77.79 -40.0 42.09 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.035 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.22 86.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.481 0.657 . . . . 0.0 110.924 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 508' ' ' GLU . 28.3 ttm180 -58.5 -38.83 78.47 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.835 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -74.32 -35.43 63.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.534 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 502' ' ' LYS . 75.7 mt -64.68 -38.42 82.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.724 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 157.48 -11.56 0.25 Allowed Glycine 0 N--CA 1.421 -2.31 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.117 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 504' ' ' ARG . 29.8 tt0 -88.14 63.95 7.49 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.682 1.23 . . . . 0.0 108.796 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.6 15.24 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.981 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -110.99 -173.26 2.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -84.23 25.01 0.89 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.012 0.434 . . . . 0.0 111.729 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -132.02 109.17 9.83 Favored 'General case' 0 CA--C 1.491 -1.294 0 C-N-CA 123.583 0.753 . . . . 0.0 110.864 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -127.54 21.23 6.58 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.614 1.197 . . . . 0.0 108.118 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 N--CA 1.422 -1.84 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.126 -179.603 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.475 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 45.6 m -150.2 163.73 37.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -113.77 98.06 6.79 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.407 0.622 . . . . 0.0 111.915 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 97.0 mmm -120.83 32.18 6.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.849 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 32.3 tp 66.94 20.48 10.49 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.319 1.048 . . . . 0.0 111.176 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -80.35 -40.24 27.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.624 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -63.26 -59.83 4.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.14 150.71 52.03 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.27 -45.34 5.91 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 56.04 -103.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.238 1.415 . . . . 0.0 111.652 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 70.8 mtm -147.25 114.0 6.07 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.75 103.73 14.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 80.2 mt -87.5 129.78 34.95 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.176 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.02 110.03 13.68 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.62 -3.28 10.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.241 0.544 . . . . 0.0 109.902 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.9 m -91.83 120.05 32.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.746 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -55.33 125.34 20.36 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.139 0.976 . . . . 0.0 111.416 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 1.9 mmt -73.92 146.32 44.07 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.083 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.54 117.15 24.42 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.05 86.52 6.6 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.359 1.076 . . . . 0.0 110.571 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -169.32 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 476' ' ' SER . 23.4 pttm -140.37 113.14 8.13 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.365 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -170.86 159.57 6.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -155.5 100.87 2.23 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.97 -68.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.071 1.847 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 57.64 -71.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.782 1.633 . . . . 0.0 111.189 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 417' ' ' ARG . 89.1 mtt180 -111.54 -92.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 416' ' ' ARG . 0.0 OUTLIER -137.84 93.39 2.77 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . 61.45 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.854 1.346 . . . . 0.0 113.655 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.38 175.62 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -126.41 171.07 18.17 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.1 m -121.86 139.94 53.01 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 34.1 t -84.61 134.78 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.93 -38.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.196 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.33 132.05 12.32 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -166.33 175.48 8.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -82.62 142.75 31.5 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.992 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.46 122.56 48.05 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.515 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.21 -16.33 43.88 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.09 -36.15 1.05 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.508 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -93.76 -15.25 25.37 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 94.13 -167.56 27.91 Favored Glycine 0 C--O 1.206 -1.597 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.32 116.46 3.2 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.207 1.938 . . . . 0.0 111.06 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.75 145.36 21.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-O 121.292 0.568 . . . . 0.0 111.043 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.79 114.92 8.32 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.36 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 480' ' ' GLU . 6.7 m -87.04 127.56 35.1 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -141.6 169.87 16.79 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.543 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -118.44 109.48 16.29 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -78.06 122.51 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.572 0.701 . . . . 0.0 112.293 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -123.92 -13.4 7.37 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.38 -19.82 41.84 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.03 -171.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 167.53 -118.32 0.78 Allowed Glycine 0 N--CA 1.414 -2.77 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.024 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.3 m -130.85 120.82 24.23 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.654 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -98.18 123.19 42.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 24.6 ttpt -137.87 153.12 49.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -70.78 141.25 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.372 0.606 . . . . 0.0 112.554 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.39 87.14 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.403 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.32 139.63 21.66 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.16 134.7 47.0 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.085 2.523 . . . . 0.0 113.192 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -134.22 162.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.651 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 121.42 49.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 450' ' ' ILE . 59.9 t -128.45 119.25 49.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.99 96.9 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 123.474 0.484 . . . . 0.0 112.069 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.304 35.0 p 66.82 -6.34 0.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.83 1.652 . . . . 0.0 115.027 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.0 m -90.94 140.92 29.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -110.78 155.48 22.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.688 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -161.47 -164.33 16.15 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 40.9 ttm180 -135.7 131.66 35.94 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 446' ' ' VAL . 35.2 t -67.96 114.06 4.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -79.22 -56.55 4.27 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.732 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.65 148.93 46.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.654 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.9 tpp -114.69 116.97 29.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.4 136.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.43 178.01 5.01 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.792 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.14 -34.76 58.18 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.157 0.983 . . . . 0.0 112.375 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.6 m -83.88 -4.03 58.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.53 62.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.97 171.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.46 136.9 37.72 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -90.07 128.65 36.35 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.46 -175.37 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.428 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.53 -36.26 6.25 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.79 148.3 35.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.631 -174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.39 142.15 39.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.51 176.26 36.62 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.447 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.5 Cg_endo -64.28 155.44 65.47 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.494 ' HB3' ' HE3' ' A' ' 411' ' ' LYS . 70.8 m 70.23 22.04 5.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.383 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.8 ttt -120.52 133.74 24.08 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.244 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 4.9 Cg_exo -79.2 126.5 7.01 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.866 2.377 . . . . 0.0 110.718 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.48 155.01 14.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.49 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 436' ' ' THR . 33.4 mt-10 -106.72 116.63 32.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -98.19 168.25 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.2 p -147.77 165.81 29.42 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 98.93 13.49 39.77 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.597 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.56 -28.3 33.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 58.11 25.48 12.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.141 1.376 . . . . 0.0 110.944 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 455' ' ' THR . 11.2 t70 -147.53 -179.61 6.99 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.21 105.1 51.32 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.69 170.88 19.29 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.939 1.759 . . . . 0.0 111.144 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -111.92 141.01 46.1 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.76 21.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.03 59.25 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.905 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.44 174.62 10.48 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 141.93 43.31 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.394 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -133.77 158.33 43.61 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.9 ttt -132.37 131.27 41.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.159 0.504 . . . . 0.0 109.801 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 99.3 t -123.84 107.48 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -125.99 121.95 34.52 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.9 OUTLIER -121.86 -42.08 2.42 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.826 -175.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 21.6 t70 50.13 -87.09 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 127.928 2.491 . . . . 0.0 112.764 -174.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -49.15 -42.66 40.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.392 1.877 . . . . 0.0 111.964 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 86.7 mttt -62.84 -47.04 85.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.815 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -79.97 -29.01 39.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.036 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.1 -47.03 86.45 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -57.22 -39.55 75.69 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.957 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 81.5 mm-40 -64.32 -44.82 90.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.239 0.337 . . . . 0.0 110.633 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.96 -38.84 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.612 0.72 . . . . 0.0 110.345 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 114.89 23.25 4.7 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.334 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -88.52 -44.41 10.7 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.578 0.704 . . . . 0.0 109.556 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -124.86 93.86 4.02 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-O 121.432 0.634 . . . . 0.0 109.425 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -116.43 -60.76 1.82 Allowed 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -156.35 127.46 6.97 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.11 138.6 58.53 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -133.41 151.52 51.83 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 C--N 1.286 -2.164 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.306 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.977 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 53.3 p -90.81 -19.28 23.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.245 1.022 . . . . 0.0 111.353 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -83.47 68.58 9.81 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.896 0.855 . . . . 0.0 110.373 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 26.7 ptm -173.23 26.59 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.633 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.0 -56.15 2.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.093 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.66 111.69 18.17 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 60.88 72.12 0.53 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.941 0.877 . . . . 0.0 109.217 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.45 4.32 54.16 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.863 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.76 -67.38 0.43 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.2 -176.54 5.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 23.4 ptp -111.34 145.2 39.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.631 0.253 . . . . 0.0 111.549 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 11.1 tt -69.78 144.56 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.264 0.626 . . . . 0.0 110.518 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.03 -177.14 4.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.08 0.466 . . . . 0.0 110.666 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.0 mt -85.1 160.42 19.97 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.71 12.04 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 26.0 t 69.46 98.62 0.06 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.902 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -84.42 -28.26 27.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.865 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 74.3 mtp 60.81 -170.47 0.15 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 111.668 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -127.96 115.21 18.18 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 61.12 125.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.607 1.163 . . . . 0.0 111.135 -171.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 410' ' ' LEU . 1.9 pt? -117.04 -9.47 11.08 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp 52.7 32.85 12.71 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.476 0.485 . . . . 0.0 112.198 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -75.8 -58.98 2.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.675 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.433 ' HB2' ' OG1' ' A' ' 421' ' ' THR . 9.3 t-20 -142.95 137.91 15.39 Favored Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.016 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.9 -20.4 58.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.931 2.42 . . . . 0.0 113.35 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -119.49 -57.48 1.98 Allowed 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.018 -0.426 . . . . 0.0 110.707 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 66.27 17.74 10.78 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.408 1.083 . . . . 0.0 112.174 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -105.01 -54.71 2.44 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.944 -1.097 . . . . 0.0 112.901 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -107.11 8.06 29.98 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.617 0.723 . . . . 0.0 109.924 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.71 172.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.72 -179.04 19.19 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 413' ' ' ASN . 61.1 m -126.36 144.34 50.85 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.324 0.583 . . . . 0.0 110.535 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 425' ' ' ALA . 43.1 t -80.13 132.87 30.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.9 pt -86.7 -39.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.65 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.51 146.42 22.37 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.489 ' HB2' HG11 ' A' ' 422' ' ' VAL . . . -149.86 146.51 27.15 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -173.85 177.15 2.49 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.3 pt? -85.39 148.73 25.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.98 131.1 51.13 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.982 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -74.28 -15.7 60.96 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.625 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -91.3 -58.53 1.45 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.935 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -95.81 -42.47 8.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.144 0.472 . . . . 0.0 112.056 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 135.35 -135.89 8.16 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.53 116.05 4.38 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.971 1.78 . . . . 0.0 110.708 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.47 142.63 33.9 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 CA-C-O 121.38 0.609 . . . . 0.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -139.94 113.42 8.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.871 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.64 120.82 27.49 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -135.88 173.44 11.71 Favored 'General case' 0 C--N 1.273 -2.743 0 O-C-N 122.188 -0.32 . . . . 0.0 111.756 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -121.39 106.3 11.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.8 p -74.35 121.85 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.634 0.73 . . . . 0.0 112.891 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -125.38 -15.97 6.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.772 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 496' ' ' VAL . . . -73.24 -9.51 58.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.407 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.02 -97.01 0.16 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.887 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.3 m -144.51 139.64 28.36 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -111.05 115.52 29.59 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -131.75 154.22 49.28 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.486 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -70.46 146.14 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.778 0.799 . . . . 0.0 112.774 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 502' ' ' LYS . . . 97.23 -10.61 65.49 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.577 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 499' ' ' ASP . 1.1 m-20 -96.56 153.43 38.82 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.04 134.64 6.17 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 C-N-CA 122.401 2.068 . . . . 0.0 112.501 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.2 150.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.9 p -121.28 122.49 67.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.43 108.75 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.91 -90.96 0.22 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.233 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.7 t -118.25 -19.78 8.83 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.887 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 486' ' ' ASP . 29.6 m -105.68 137.92 42.74 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.364 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 51.1 p90 -114.82 148.5 38.41 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.066 0.46 . . . . 0.0 110.858 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -155.73 -164.93 13.71 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -126.6 143.13 51.32 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.445 HG11 ' HE2' ' A' ' 462' ' ' MET . 32.6 t -73.21 113.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.487 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -88.69 -59.28 2.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.98 148.43 50.09 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 40.0 tpp -114.74 117.78 31.75 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.97 157.65 22.25 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 44.4 p30 -108.18 -176.68 3.12 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.548 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.1 -25.29 61.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.375 0.607 . . . . 0.0 110.251 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.1 m -81.89 -13.27 57.8 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.36 6.61 50.61 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.435 ' HB2' HD21 ' A' ' 464' ' ' ASN . 10.8 mpt_? -88.97 140.78 29.08 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -101.58 126.58 48.42 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 462' ' ' MET . 31.0 m -131.54 -175.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.63 -23.13 8.87 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -154.17 137.28 15.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.13 147.67 32.76 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.658 0.383 . . . . 0.0 110.694 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -95.3 179.82 36.45 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.44 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.415 ' HA ' HG13 ' A' ' 439' ' ' VAL . 55.5 Cg_endo -68.56 160.51 49.03 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.921 2.414 . . . . 0.0 113.463 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.423 ' HA ' HD11 ' A' ' 438' ' ' LEU . 36.8 m 65.4 29.64 11.31 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.236 1.017 . . . . 0.0 110.704 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.2 ttt -131.59 131.01 22.57 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.502 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.3 Cg_endo -78.03 125.17 7.09 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.653 1.569 . . . . 0.0 111.884 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.4 m -137.66 158.48 34.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.585 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 33.3 tt0 -121.48 114.78 21.73 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.7 pt -97.74 170.78 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.561 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 5.3 p -147.96 160.44 42.82 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.85 7.51 38.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.096 -1.05 . . . . 0.0 114.332 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.47 -30.91 64.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.182 0.491 . . . . 0.0 109.938 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 23.5 t60 64.3 21.45 12.52 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.959 1.304 . . . . 0.0 110.73 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.433 ' CB ' HG21 ' A' ' 455' ' ' THR . 14.8 t70 -147.68 179.6 7.58 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.61 111.15 64.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-O 121.645 0.736 . . . . 0.0 111.251 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.11 161.43 18.0 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.203 1.936 . . . . 0.0 111.193 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -114.93 148.03 39.21 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-O 121.284 0.564 . . . . 0.0 109.487 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.07 128.55 36.32 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.626 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.4 64.05 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.002 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.76 178.63 7.21 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.527 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -122.91 130.52 52.95 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 44.8 p90 -122.99 151.77 41.53 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 121.26 0.552 . . . . 0.0 110.235 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.7 ttm -121.62 116.67 25.02 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 441' ' ' ALA . 92.7 t -88.74 110.56 21.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -115.86 162.6 17.09 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.849 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 55.4 tt0 68.06 -111.36 0.12 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.501 1.12 . . . . 0.0 111.95 -174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 19.6 t70 65.05 -55.23 0.31 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.019 1.327 . . . . 0.0 112.277 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 6.9 pt-20 -57.05 -38.35 73.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.238 1.415 . . . . 0.0 113.03 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 48.3 mmtm -64.12 -49.66 71.31 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.346 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 447' ' ' GLY . 61.9 mttp -68.25 -35.24 77.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.81 -57.07 12.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.784 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 508' ' ' GLU . 63.8 ttt180 -58.69 -40.2 82.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 111.861 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.09 -25.23 65.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.28 . . . . 0.0 111.705 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 502' ' ' LYS . 42.0 mm -78.36 -51.47 17.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 158.42 -12.28 0.23 Allowed Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.654 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 504' ' ' ARG . 33.4 tt0 62.66 0.21 0.63 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.564 1.946 . . . . 0.0 113.524 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -99.83 -74.1 0.61 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.494 -0.754 . . . . 0.0 112.551 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 510' ' ' ARG . 66.7 mtt180 64.08 -68.11 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.491 1.516 . . . . 0.0 112.316 -175.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -171.05 -61.58 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.773 1.229 . . . . 0.0 108.169 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -136.26 110.58 8.44 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.285 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 178.2 153.65 0.33 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.719 1.207 . . . . 0.0 108.009 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 . . . . . 0 C--N 1.282 -2.346 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.311 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 10.8 m -93.87 126.48 39.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -124.12 -73.31 0.64 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 14.0 tpt 162.44 -58.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -110.91 114.86 28.52 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 170.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.59 -33.55 9.97 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 -168.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 35.8 t60 75.24 -49.0 0.64 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.333 1.053 . . . . 0.0 111.01 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 399' ' ' GLU . 7.0 mp -77.82 150.4 34.24 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.5 mp 74.28 -25.92 0.19 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.563 1.145 . . . . 0.0 111.611 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 397' ' ' LEU . 37.5 mt-10 -85.26 127.06 34.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 88.0 mtp 73.27 173.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 50.7 mm 64.06 92.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 67.9 mt -76.4 17.81 0.35 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.684 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.69 23.5 13.77 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.422 0.689 . . . . 0.0 109.558 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 98.9 t 77.22 -39.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.073 1.349 . . . . 0.0 113.311 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 19.4 m 79.53 115.46 0.06 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.572 1.549 . . . . 0.0 108.615 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 406' ' ' GLU . 0.1 OUTLIER -85.41 164.18 18.06 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.974 -175.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 56.9 ttp -90.57 84.44 5.93 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.79 117.1 24.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -94.97 154.98 16.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.71 -16.74 5.65 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.006 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -21.45 4.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -116.36 175.46 5.55 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -122.41 109.36 33.02 Favored Pre-proline 0 C--N 1.275 -2.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.14 -4.82 11.19 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.784 2.322 . . . . 0.0 113.809 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.508 ' O ' HG22 ' A' ' 419' ' ' VAL . 66.4 t30 -123.0 30.64 6.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.281 1.039 . . . . 0.0 108.387 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -57.74 20.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 127.888 2.475 . . . . 0.0 115.543 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -129.61 -18.82 3.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.724 -0.61 . . . . 0.0 111.254 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -123.57 2.63 8.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.089 0.471 . . . . 0.0 110.747 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 415' ' ' ASN . 35.4 m -147.87 168.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.03 -178.29 18.27 Favored Glycine 0 C--N 1.289 -2.04 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.9 m -120.69 141.69 50.17 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 117.812 0.806 . . . . 0.0 109.507 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.23 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 436' ' ' THR . 14.8 pt -94.35 -34.7 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.318 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.402 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 11.8 pt-20 -157.4 147.85 21.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.48 17.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 178.15 2.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.14 151.97 29.5 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.728 0.775 . . . . 0.0 111.445 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.07 -17.7 59.53 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.27 -36.35 2.71 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.058 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -95.81 -29.01 14.46 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.065 0.459 . . . . 0.0 110.891 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 110.28 -149.33 17.54 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.516 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 13.8 Cg_exo -68.85 115.65 4.06 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.809 1.673 . . . . 0.0 109.217 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.98 137.53 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 122.309 1.052 . . . . 0.0 112.621 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.91 15.23 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.485 HG22 HD11 ' A' ' 423' ' ' ILE . 3.3 m -88.72 123.09 32.82 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -140.36 170.99 14.78 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.474 -173.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 476' ' ' SER . 0.8 OUTLIER -118.91 106.42 12.47 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.63 121.95 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.631 . . . . 0.0 112.229 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -120.84 -15.12 8.4 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.689 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.8 -7.54 59.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.659 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.73 -110.79 0.46 Allowed Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.348 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.4 m -139.9 139.78 36.29 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -112.7 126.41 55.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -174.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 8.2 ttpt -136.83 150.83 48.54 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 110.223 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.2 m -68.5 146.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.471 0.653 . . . . 0.0 112.193 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.7 -3.44 84.97 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.768 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.46 139.31 19.99 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.39 133.56 19.37 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.449 2.099 . . . . 0.0 113.281 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 14.3 pt -126.25 172.46 13.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.22 122.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 494' ' ' PHE . 44.4 t -122.8 105.29 15.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.61 -118.92 14.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.4 p -102.38 -3.5 26.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 486' ' ' ASP . 87.1 m -104.07 129.52 51.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -123.53 167.39 13.96 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 122.032 -0.417 . . . . 0.0 109.88 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.26 -164.61 37.07 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -115.07 143.33 45.37 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.36 124.43 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.448 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.1 tmt_? -93.79 -58.89 2.13 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.19 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.89 148.47 50.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 444' ' ' LEU . 50.4 tpp -119.15 117.25 28.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.82 125.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.45 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.1 p30 -95.1 176.26 6.31 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.325 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.44 -23.17 62.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 113.083 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.4 m -77.83 -16.34 58.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.04 32.37 8.47 Favored Glycine 0 CA--C 1.486 -1.743 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.562 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.45 ' HB2' HD21 ' A' ' 464' ' ' ASN . 80.9 mtt180 -116.9 126.65 53.3 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -81.45 123.45 28.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.61 -174.46 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -98.68 -34.06 10.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.892 0.377 . . . . 0.0 109.986 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.67 166.1 31.39 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.941 0.401 . . . . 0.0 111.38 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.69 150.51 34.46 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.745 0.818 . . . . 0.0 109.089 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -96.39 -179.96 35.04 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.166 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HA ' HG13 ' A' ' 439' ' ' VAL . 51.4 Cg_endo -67.06 161.9 40.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.814 2.343 . . . . 0.0 112.066 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.422 ' HA ' HD11 ' A' ' 438' ' ' LEU 0.258 51.9 p 66.47 6.79 4.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.775 1.63 . . . . 0.0 113.516 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 40.0 ttm -107.98 136.92 19.7 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.232 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.4 Cg_endo -82.34 126.62 4.9 Favored 'Trans proline' 0 C--O 1.252 1.187 0 C-N-CA 122.46 2.107 . . . . 0.0 110.6 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 473' ' ' ALA . 20.0 m -137.33 155.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.194 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.09 115.74 30.7 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.7 pt -97.93 167.95 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 7.8 p -150.1 166.49 29.63 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.43 -15.68 19.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.877 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.76 -40.32 91.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.998 0.427 . . . . 0.0 110.802 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.516 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 72.1 t60 61.83 20.12 11.17 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.578 1.551 . . . . 0.0 110.627 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.425 ' HB2' HG21 ' A' ' 455' ' ' THR . 10.5 m-20 -142.38 167.21 22.63 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.6 p -110.05 119.76 46.41 Favored Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.882 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.73 176.52 7.69 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.194 2.596 . . . . 0.0 110.604 175.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -102.05 140.15 36.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.36 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -67.18 124.53 23.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.7 -0.36 57.94 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.478 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.39 176.93 8.73 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.45 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 1.4 mpt_? -118.77 124.83 48.22 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.387 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 31.8 p90 -119.96 148.84 43.04 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 53.2 ttp -118.51 127.01 53.23 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 494' ' ' PHE . 59.0 t -125.37 107.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.245 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -125.23 122.84 38.15 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 172.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 501' ' ' LYS . 81.3 tt0 -73.18 131.63 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.035 0.921 . . . . 0.0 111.995 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 502' ' ' LYS . 23.6 t70 -62.9 -41.85 99.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 42.0 mt-10 -73.24 -15.5 61.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.688 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 498' ' ' GLU . 12.6 mptt -77.91 -39.06 44.2 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 499' ' ' ASP . 23.1 ttpp -58.42 -47.94 82.29 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.98 88.06 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.804 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 3.4 tmt_? -58.82 -43.11 90.55 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.738 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -75.13 -35.36 61.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.89 -30.52 14.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.472 0.653 . . . . 0.0 109.907 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 104.32 32.09 4.4 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.561 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.64 -23.63 15.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -99.0 165.64 11.65 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.916 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.99 95.38 10.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.599 0.714 . . . . 0.0 111.733 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -93.35 -4.47 51.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.729 0.776 . . . . 0.0 109.584 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -139.33 157.11 46.46 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.812 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -85.11 139.03 32.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.581 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.95 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 11.1 p -73.9 -26.55 60.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -113.09 81.34 1.48 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.425 ' HA ' ' CE ' ' A' ' 393' ' ' MET . 3.0 mmt 50.97 -102.54 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.93 139.11 54.4 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.608 0.718 . . . . 0.0 112.773 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -140.97 10.91 2.19 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 39.5 m80 63.47 85.63 0.13 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.567 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 44.7 tp -71.52 93.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.752 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.02 122.69 44.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.39 -45.91 16.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.037 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -115.66 107.27 14.89 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 13.5 mt -117.13 27.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 9.3 mp 73.58 174.02 0.28 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.119 1.368 . . . . 0.0 110.742 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.87 89.55 3.07 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.5 m -81.8 -24.74 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.7 m 69.03 -86.18 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.849 -1.978 . . . . 0.0 116.033 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.74 -177.99 6.54 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.464 -167.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 13.1 tpt 72.13 -81.14 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 111.599 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -106.79 133.22 51.78 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.122 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -75.42 149.92 38.45 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 93.0 mt -127.14 75.62 1.59 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.365 0.602 . . . . 0.0 110.746 -174.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -106.64 142.13 36.79 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.543 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 414' ' ' PRO . . . 172.14 -167.17 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.7 ' OD1' ' HB3' ' A' ' 441' ' ' ALA 0.254 1.8 m-20 -78.56 -9.91 0.15 Allowed Pre-proline 0 CA--C 1.582 2.186 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 413' ' ' ASN . 28.8 Cg_endo -64.89 29.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.492 2.128 . . . . 0.0 112.946 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 413' ' ' ASN . 25.9 t-20 -96.58 153.09 18.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -83.52 22.63 1.03 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -165.79 -27.87 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.125 0.488 . . . . 0.0 109.784 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.98 31.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.375 0.607 . . . . 0.0 112.236 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 4.8 m -154.17 -178.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.878 0 C-N-CA 128.72 2.808 . . . . 0.0 104.786 175.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -114.89 172.2 14.09 Favored Glycine 1 N--CA 1.385 -4.705 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.2 p -131.18 141.99 50.15 Favored 'General case' 0 C--N 1.245 -3.937 0 O-C-N 124.225 0.603 . . . . 0.0 110.903 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 53.7 t -89.13 130.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 436' ' ' THR . 13.9 pt -89.8 -38.82 11.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.698 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -154.74 154.45 32.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -139.99 139.19 35.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.35 177.92 3.94 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.514 0.673 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -88.24 149.45 23.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.875 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.6 129.9 46.56 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 173.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.412 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -68.86 -20.85 64.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -104.66 -40.6 2.15 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.723 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.497 ' HB3' HG21 ' A' ' 482' ' ' THR . 91.8 mtm180 -94.94 -22.76 17.77 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.5 -159.69 21.11 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.64 116.4 3.17 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.28 1.987 . . . . 0.0 111.095 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 482' ' ' THR . 34.6 m -118.17 154.39 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.8 116.34 12.86 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 480' ' ' GLU . 2.2 m -85.3 116.69 23.79 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 0.9 OUTLIER -134.18 170.91 14.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.23 108.03 12.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.56 122.05 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.398 0.618 . . . . 0.0 110.913 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 45.7 mt-30 -120.28 -21.42 6.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.7 ' HB3' ' OD1' ' A' ' 413' ' ' ASN . . . -97.1 -8.9 29.12 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 113.956 -3.098 . . . . 0.0 114.666 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . -164.94 -110.09 0.23 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 118.255 -1.926 . . . . 0.0 113.299 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.1 m -147.94 138.08 22.78 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.474 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -108.23 130.91 55.13 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.0 ttpt -146.02 151.74 38.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.512 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 26.9 m -67.22 146.96 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.91 -17.21 59.12 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.55 -1.204 . . . . 0.0 114.117 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -111.09 152.9 44.02 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.167 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 33.0 Cg_endo -64.15 147.47 91.37 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.342 2.695 . . . . 0.0 113.689 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.55 158.86 16.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 124.969 1.308 . . . . 0.0 108.455 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.51 118.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.66 107.66 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.1 -111.28 3.83 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.063 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.4 p -104.4 -4.14 23.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.148 0.579 . . . . 0.0 111.672 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.432 HG21 ' CB ' ' A' ' 486' ' ' ASP . 65.1 m -125.92 141.89 51.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 120.945 0.403 . . . . 0.0 110.943 -175.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -118.05 154.48 31.97 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -160.56 -164.22 15.17 Favored Glycine 0 C--N 1.282 -2.427 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 35.1 ttm180 -126.71 136.67 52.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.63 HG11 ' HE2' ' A' ' 462' ' ' MET . 26.2 t -73.69 111.69 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.532 0.52 . . . . 0.0 110.612 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -83.36 -50.51 8.27 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.855 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.31 144.92 42.86 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.63 ' HE2' HG11 ' A' ' 459' ' ' VAL . 41.5 tpp -115.06 117.2 29.89 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.05 126.73 68.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 6.2 p30 -87.13 177.86 7.07 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.831 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.01 -30.62 36.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.1 m -76.16 -26.17 55.99 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.899 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.12 38.64 3.28 Favored Glycine 0 CA--C 1.475 -2.46 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.649 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 69.7 ttt180 -119.63 127.37 52.86 Favored 'General case' 0 N--CA 1.404 -2.748 0 CA-C-N 112.171 -2.015 . . . . 0.0 105.977 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -81.32 129.83 34.78 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.93 -178.72 2.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -111.45 -28.56 8.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.878 0.371 . . . . 0.0 111.368 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 445' ' ' LYS . 12.1 pt-20 -150.67 168.22 25.0 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -147.45 134.33 20.18 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.57 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.85 176.6 53.34 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 439' ' ' VAL . 56.1 Cg_endo -68.2 156.22 66.55 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.028 1.819 . . . . 0.0 112.754 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.8 t 77.85 -0.34 2.72 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.15 1.38 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.428 ' HG2' HG13 ' A' ' 479' ' ' VAL . 33.6 ttm -98.93 133.66 22.1 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -84.92 126.0 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.374 2.05 . . . . 0.0 112.083 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 477' ' ' MET . 16.5 m -140.74 155.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' A' ' 436' ' ' THR . 37.4 mt-10 -107.3 118.96 38.09 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 45.4 pt -98.02 170.01 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.083 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 431' ' ' ARG . 3.0 p -146.3 156.57 43.45 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 109.26 22.17 6.95 Favored Glycine 0 N--CA 1.427 -1.964 0 O-C-N 124.081 0.863 . . . . 0.0 113.807 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.95 -38.31 16.77 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 60.09 21.97 11.2 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.279 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.432 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.7 t0 -139.33 179.96 6.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 5.9 p -90.19 114.69 61.87 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-O 121.304 0.573 . . . . 0.0 111.487 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.68 168.43 8.33 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -129.48 131.93 46.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.773 0.321 . . . . 0.0 111.36 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.46 134.91 46.92 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.97 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 91.01 -5.0 81.88 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.24 -179.09 7.13 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -109.82 141.35 42.61 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 8.7 p90 -128.84 153.3 47.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.86 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' MET . . . . . 0.684 ' HA ' ' CB ' ' A' ' 413' ' ' ASN . 44.0 ttp -122.5 117.0 24.9 Favored 'General case' 0 C--N 1.248 -3.821 0 C-N-CA 125.399 1.48 . . . . 0.0 110.582 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.684 ' H ' ' CG ' ' A' ' 413' ' ' ASN . 0.5 OUTLIER -86.91 144.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.316 174.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -97.67 167.47 10.94 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.32 0.581 . . . . 0.0 110.83 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.565 ' HB3' ' HE2' ' A' ' 501' ' ' LYS . 33.3 tt0 -74.16 138.85 44.09 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.401 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.51 -45.67 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.203 1.001 . . . . 0.0 111.195 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.37 -5.43 52.24 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 498' ' ' GLU . 7.2 tppt? -57.65 -34.46 69.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.369 0.668 . . . . 0.0 111.135 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 506' ' ' ILE . 13.1 mmmm -60.89 -51.59 68.64 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.683 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.31 99.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.9 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 501' ' ' LYS . 21.9 tpp180 -50.2 -54.22 22.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.456 1.502 . . . . 0.0 109.239 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.62 -39.86 89.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.901 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 502' ' ' LYS . 50.9 mm -75.68 -53.9 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.598 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -152.44 -11.02 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 118.931 -1.604 . . . . 0.0 115.794 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 504' ' ' ARG . 18.9 mm-40 -89.15 14.14 11.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 118.403 1.101 . . . . 0.0 113.441 -173.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -107.29 -67.56 0.95 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.907 0.385 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 53.71 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.57 1.548 . . . . 0.0 113.812 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -87.95 -26.05 22.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -96.45 85.73 3.99 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.806 0.336 . . . . 0.0 110.67 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -160.87 40.54 0.16 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.365 0.602 . . . . 0.0 111.11 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.247 0.956 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.141 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.2 p -86.23 103.8 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 121.375 0.607 . . . . 0.0 111.902 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -98.15 -6.79 30.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.868 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 34.4 tpp 71.01 117.34 0.04 OUTLIER 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.032 0.933 . . . . 0.0 111.227 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 396' ' ' HIS . 77.0 mt -81.66 -14.95 56.0 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.103 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.5 t70 60.17 78.05 0.29 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.438 1.095 . . . . 0.0 110.43 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 394' ' ' LEU . 7.4 p-80 -160.15 19.82 0.15 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.699 -173.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.27 26.49 2.18 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.3 0.571 . . . . 0.0 111.792 -173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.27 -70.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.202 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 50.7 -87.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.412 1.085 . . . . 0.0 113.705 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 86.2 mtp -73.32 -30.41 63.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 0.0 110.049 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 43.0 pt -102.17 17.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.431 0.634 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.92 -23.14 62.2 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.479 1.133 . . . . 0.0 108.415 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.05 98.52 6.53 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.182 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.84 -28.05 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.838 0.828 . . . . 0.0 109.223 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 51.2 m -114.84 141.38 47.98 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.88 123.96 22.01 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 22.1 ttt -85.56 92.01 8.41 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.749 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.38 145.06 30.79 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -106.28 -177.14 3.28 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.16 -13.58 38.74 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.648 0.737 . . . . 0.0 109.723 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt 72.23 97.82 0.07 Allowed 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.041 1.736 . . . . 0.0 112.907 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 414' ' ' PRO . . . -94.76 -159.7 0.73 Allowed 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -104.61 98.09 13.97 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 412' ' ' ALA . 81.7 Cg_endo -97.05 17.99 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.527 2.818 . . . . 0.0 112.807 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -80.21 105.87 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.417 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 72.11 -35.9 0.34 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 81.93 129.04 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.777 1.631 . . . . 0.0 109.697 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . 69.95 67.39 0.23 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.356 1.063 . . . . 0.0 109.72 -174.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.8 m -142.35 -178.89 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 113.628 -1.624 . . . . 0.0 106.951 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -138.08 176.31 20.8 Favored Glycine 0 C--N 1.293 -1.856 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.722 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 19.2 m -120.82 141.99 50.03 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.6 138.57 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.41 -39.02 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 10.9 pt-20 -153.62 148.86 26.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.79 131.4 12.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.5 178.46 1.96 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.95 149.23 29.46 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.234 0.54 . . . . 0.0 110.151 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -126.7 122.56 35.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.565 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.4 -17.09 52.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -178.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.26 -42.88 1.13 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -84.51 -31.63 24.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.68 -158.08 14.56 Favored Glycine 0 C--N 1.314 -0.639 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.56 116.25 4.14 Favored 'Trans proline' 0 C--O 1.244 0.8 0 CA-C-N 120.047 1.924 . . . . 0.0 108.949 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.44 150.94 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.943 0.878 . . . . 0.0 112.386 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -141.56 111.52 6.71 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.519 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -88.22 122.86 32.25 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -139.21 173.2 11.8 Favored 'General case' 0 C--N 1.272 -2.77 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.425 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -117.24 106.01 12.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -73.48 119.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 112.143 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 77.6 mt-30 -124.28 -15.03 6.84 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.865 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -76.24 -15.57 60.0 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.189 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 166.98 -100.93 0.17 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.3 m -144.93 144.15 30.92 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.642 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -108.65 129.75 55.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 448' ' ' ASP . 18.0 ttpt -138.81 148.39 43.71 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.8 m -70.76 141.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.21 0.529 . . . . 0.0 111.058 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.14 83.8 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.601 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 445' ' ' LYS . 1.2 t70 -94.9 130.71 32.11 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.57 123.22 10.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.284 1.989 . . . . 0.0 109.755 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -127.45 162.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 122.639 0.376 . . . . 0.0 110.498 -175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.4 p -129.35 122.56 56.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 450' ' ' ILE . 46.2 t -134.25 125.33 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.14 97.29 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.999 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 2.3 m 65.07 9.51 5.56 Favored 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 124.905 1.282 . . . . 0.0 112.758 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 59.7 m -113.23 137.48 51.42 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 17.3 p90 -111.55 150.87 29.39 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.097 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -157.15 -164.11 13.26 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -134.06 129.53 36.18 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 462' ' ' MET . 47.5 t -62.16 114.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.432 0.458 . . . . 0.0 111.58 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -81.3 -55.19 4.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.259 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.51 152.64 51.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.642 ' HE1' HD22 ' A' ' 444' ' ' LEU . 51.1 tpp -115.01 117.57 30.98 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.74 136.52 53.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -99.38 -179.22 4.15 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.463 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.08 -29.57 60.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.8 m -74.86 -25.29 58.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.028 0.442 . . . . 0.0 110.378 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.75 30.02 6.3 Favored Glycine 0 CA--C 1.5 -0.899 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.588 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 464' ' ' ASN . 79.8 mtt180 -115.77 144.45 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -76.58 129.79 36.94 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 124.239 0.962 . . . . 0.0 110.329 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.8 m -135.87 -178.25 2.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -115.72 -23.74 8.55 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.08 143.77 19.48 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -173.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.48 146.82 32.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.78 177.35 40.21 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.678 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HA ' HG13 ' A' ' 439' ' ' VAL . 54.7 Cg_endo -65.07 161.26 37.81 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 123.167 2.578 . . . . 0.0 113.666 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.449 ' HA ' HD11 ' A' ' 438' ' ' LEU . 20.4 t 67.74 16.77 9.78 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 125.124 1.37 . . . . 0.0 111.076 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 23.8 ttt -120.16 133.92 24.0 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -72.73 125.88 10.92 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.559 2.172 . . . . 0.0 112.129 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 8.3 m -141.81 159.38 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.64 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 30.1 tt0 -122.35 115.81 22.94 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.8 172.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.655 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.6 p -149.08 167.16 26.61 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.23 33.37 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.779 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.36 -33.37 25.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 70.6 t60 64.93 21.31 12.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.859 1.663 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -145.91 179.6 7.35 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.7 t -121.67 109.65 34.18 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 118.389 0.541 . . . . 0.0 109.544 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.0 175.57 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.894 2.396 . . . . 0.0 110.952 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -118.59 148.32 42.8 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.25 0.547 . . . . 0.0 112.052 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -68.95 141.93 54.83 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.829 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.38 0.03 89.88 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.091 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -92.56 -179.21 5.12 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.34 145.2 43.39 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.308 0.575 . . . . 0.0 110.653 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -132.14 159.15 39.78 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.6 ttt -132.15 118.03 19.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.235 0.54 . . . . 0.0 109.814 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.06 106.91 21.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -100.03 121.56 41.57 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.562 ' OE1' ' HB2' ' A' ' 501' ' ' LYS . 2.4 tt0 -100.48 148.54 24.64 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.502 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.77 -49.89 3.85 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.238 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.04 -16.11 63.89 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.305 0.574 . . . . 0.0 112.253 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.562 ' HB2' ' OE1' ' A' ' 498' ' ' GLU . 65.0 tttm -62.49 -51.36 67.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.493 ' HB2' ' HZ2' ' A' ' 502' ' ' LYS . 10.3 mtmp? -64.2 -40.74 96.72 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.519 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.21 40.41 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 123.379 0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.01 -39.75 86.89 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.68 -46.74 71.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.786 0.327 . . . . 0.0 111.558 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.85 -32.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.292 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.39 28.62 5.4 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.81 -41.37 16.16 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 61.31 -174.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.839 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -160.2 163.28 33.73 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -89.55 99.09 12.16 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -74.34 145.89 43.5 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.184 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -149.41 7.21 0.67 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.265 1.026 . . . . 0.0 111.222 -175.484 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.615 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.5 p -155.43 164.16 39.08 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 27.8 m80 64.12 39.16 7.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 124.076 0.86 . . . . 0.0 110.718 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 25.2 mmt -117.21 -44.33 2.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.017 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 394' ' ' LEU . 1.9 pt? -129.74 31.39 4.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.68 -156.99 0.67 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.001 -1.908 . . . . 0.0 107.839 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -136.74 146.17 45.49 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.76 115.14 16.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 401' ' ' ILE . 50.1 tp -118.63 -50.96 2.4 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.713 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 69.7 112.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.191 . . . . 0.0 109.451 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 21.0 mmt 65.74 81.72 0.2 Allowed 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.176 0.989 . . . . 0.0 109.958 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.443 ' HA ' HD23 ' A' ' 398' ' ' LEU . 68.1 mt -71.68 128.06 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.403 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.9 137.57 57.84 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.92 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 405' ' ' SER . 52.0 tp 73.89 119.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 O-C-N 125.035 1.46 . . . . 0.0 110.07 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 406' ' ' GLU . 12.9 p -66.6 -11.4 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.359 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.446 ' H ' ' HG ' ' A' ' 403' ' ' LEU . 15.9 m 72.89 -4.68 2.08 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.413 1.485 . . . . 0.0 112.461 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLU . . . . . 0.504 ' H ' HG13 ' A' ' 404' ' ' VAL . 0.5 OUTLIER 64.62 104.35 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 110.819 178.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 55.2 ttp -142.97 22.46 1.92 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.001 -167.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -86.07 83.65 7.71 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.926 0.869 . . . . 0.0 110.784 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.0 pp -129.98 17.28 5.65 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.472 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -88.14 89.01 7.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -151.62 27.86 0.64 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -141.04 92.05 8.7 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.484 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -101.12 20.07 0.24 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.372 2.715 . . . . 0.0 111.721 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.37 -66.49 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.553 ' HD2' ' SD ' ' A' ' 495' ' ' MET . 43.2 ttm180 -130.64 -85.13 0.52 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.439 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -173.09 -68.76 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -85.72 85.55 7.4 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 16.4 m -142.21 179.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.49 169.22 25.57 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.3 m -119.06 141.93 48.3 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.59 137.13 22.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.1 pt -89.53 -39.83 12.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.844 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.442 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 9.6 pt-20 -159.39 148.52 18.23 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.3 144.2 33.15 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -170.07 176.02 4.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.9 pt? -84.46 142.06 30.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.55 120.45 37.53 Favored 'General case' 0 C--N 1.255 -3.51 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.43 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.58 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.35 -17.08 6.74 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.26 -40.85 0.85 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.355 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -88.4 -16.05 33.91 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 90.86 -158.92 26.34 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -59.79 116.45 3.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 121.894 1.729 . . . . 0.0 110.363 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.436 HG12 ' CG2' ' A' ' 482' ' ' THR . 33.3 m -122.54 163.86 20.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -147.76 112.2 5.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.323 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.87 117.28 24.63 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.694 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.8 pp -132.92 173.14 11.71 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -173.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -119.48 105.72 11.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -75.56 121.57 27.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.636 0.731 . . . . 0.0 112.189 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 37.8 mt-30 -124.04 -14.26 7.13 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.401 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.47 61.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.187 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 152.04 -104.71 0.27 Allowed Glycine 0 N--CA 1.411 -2.981 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.823 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 6.8 m -130.82 136.5 48.74 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -111.39 124.06 51.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.545 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 2.4 ttpm? -134.07 157.24 46.64 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.522 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 27.7 m -67.64 126.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.24 0.543 . . . . 0.0 109.987 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 110.91 -11.1 29.63 Favored Glycine 0 C--N 1.306 -1.137 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 445' ' ' LYS . 1.0 OUTLIER -71.0 131.2 87.45 Favored Pre-proline 0 C--O 1.247 0.938 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -79.44 112.38 2.97 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 122.239 1.959 . . . . 0.0 108.935 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.24 149.28 14.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.216 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 40.5 t -122.85 115.03 44.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.562 HG12 ' CB ' ' A' ' 494' ' ' PHE . 30.0 m -120.31 116.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.11 0.481 . . . . 0.0 109.723 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.94 -96.62 0.16 Allowed Glycine 0 C--N 1.307 -1.068 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.345 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 30.9 p -118.26 -7.21 10.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 122.734 0.413 . . . . 0.0 111.205 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.505 HG21 ' CB ' ' A' ' 486' ' ' ASP . 21.1 m -113.67 145.84 40.71 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.201 -0.312 . . . . 0.0 110.899 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -120.72 156.25 32.19 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.22 -168.51 27.49 Favored Glycine 0 C--N 1.295 -1.733 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.305 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -127.66 132.6 49.68 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 444' ' ' LEU . 51.1 t -65.75 121.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.586 0.554 . . . . 0.0 110.735 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -91.4 -52.26 4.88 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.672 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.15 150.37 50.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.552 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.1 tpp -115.1 117.11 29.64 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 9.4 t -120.35 141.42 40.72 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 3.4 p30 -108.63 175.06 5.6 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.193 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.71 -25.86 55.47 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.075 0.95 . . . . 0.0 113.087 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.3 t -78.19 -10.66 59.74 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.222 0.534 . . . . 0.0 110.097 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.99 8.16 61.94 Favored Glycine 0 CA--C 1.491 -1.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.83 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -96.79 129.69 44.17 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.558 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.0 tmm_? -86.65 129.99 34.66 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.12 -174.21 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.236 0.614 . . . . 0.0 109.907 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -98.04 -36.12 10.21 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 122.96 0.504 . . . . 0.0 111.404 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -156.0 151.74 27.29 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.535 -172.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -142.91 150.23 39.5 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 123.924 0.765 . . . . 0.0 109.549 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.11 179.53 39.46 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.352 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 439' ' ' VAL . 59.9 Cg_endo -70.83 161.42 46.13 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 123.052 2.501 . . . . 0.0 113.888 -175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 438' ' ' LEU . 50.2 m 68.83 18.63 8.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.834 1.254 . . . . 0.0 111.116 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.4 ttt -122.23 133.98 24.6 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.561 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 46.5 Cg_endo -77.55 125.9 7.9 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 122.293 1.995 . . . . 0.0 112.577 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 16.1 m -141.11 157.83 22.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.19 117.51 29.77 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -97.68 168.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.859 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.436 ' CG2' HG12 ' A' ' 434' ' ' VAL . 6.0 p -146.74 165.66 28.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.574 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.45 20.53 22.24 Favored Glycine 0 C--N 1.296 -1.684 0 O-C-N 123.929 0.768 . . . . 0.0 112.576 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 41.6 tp -85.34 -39.35 17.75 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 64.41 21.44 12.48 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.776 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.505 ' CB ' HG21 ' A' ' 455' ' ' THR . 15.0 t70 -138.92 179.24 6.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 38.0 t -111.47 107.08 57.04 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 118.214 0.461 . . . . 0.0 111.175 -173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -85.84 174.7 6.36 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.556 2.171 . . . . 0.0 111.61 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.71 145.53 50.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.922 0.392 . . . . 0.0 110.701 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -66.69 128.62 36.95 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.571 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.28 60.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.123 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.48 179.18 6.06 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.333 0.587 . . . . 0.0 110.591 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 0.4 OUTLIER -114.73 129.2 56.65 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.179 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 45.8 p90 -131.87 158.95 40.0 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.671 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' MET . . . . . 0.553 ' SD ' ' HD2' ' A' ' 416' ' ' ARG . 27.0 ttt -131.44 134.45 46.22 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.311 174.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.496 HG11 ' HG ' ' A' ' 444' ' ' LEU . 58.1 t -119.26 107.77 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -150.65 122.62 8.19 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 500' ' ' GLU . 43.9 tt0 -105.91 141.28 37.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 502' ' ' LYS . 17.5 t70 -68.17 -38.84 82.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 498' ' ' GLU . 48.5 mt-10 -68.75 -21.16 64.38 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.284 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.3 -43.66 73.34 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 502' ' ' LYS . 33.8 ttpt -61.22 -46.22 91.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.93 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.8 92.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.727 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -63.74 -34.72 78.51 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.781 0.832 . . . . 0.0 111.24 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.7 -38.77 91.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.75 -42.95 77.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 119.05 9.89 8.54 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.503 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -63.3 -37.76 88.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.72 61.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.056 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -129.64 20.33 5.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.795 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -118.34 -9.58 10.37 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.332 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.04 154.82 29.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -154.71 143.71 20.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.29 -2.004 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 m -79.07 -29.06 43.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 59.26 85.71 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -70.47 113.37 7.53 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 77.26 156.38 0.17 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.895 1.278 . . . . 0.0 110.337 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -47.34 46.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.192 0.52 . . . . 0.0 110.738 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -135.08 144.2 47.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 40.6 tp 63.5 82.23 0.19 Allowed 'General case' 0 C--O 1.246 0.88 0 O-C-N 124.52 1.138 . . . . 0.0 109.027 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.8 pp -84.86 166.56 16.77 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.8 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -84.79 146.56 27.3 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.737 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -81.37 -36.7 29.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 15.5 tt -157.8 147.74 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.932 0.396 . . . . 0.0 110.368 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.0 mp -89.49 155.97 18.95 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.89 168.8 18.77 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.166 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.59 -18.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 49.7 m -83.05 94.62 7.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.53 122.45 16.32 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.265 -175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -95.68 -17.67 21.11 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.37 118.24 33.41 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.901 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.19 144.04 29.66 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 22.5 tp -151.77 7.98 0.49 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.052 0.453 . . . . 0.0 111.115 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -88.0 -39.44 14.68 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.199 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -78.64 -40.63 33.68 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.436 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.436 HD21 HG23 ' A' ' 419' ' ' VAL . 13.6 t-20 -145.9 134.91 11.17 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.28 -4.29 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.0 2.467 . . . . 0.0 114.269 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -121.88 158.98 27.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.53 -16.59 41.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.784 0.326 . . . . 0.0 110.359 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -71.55 166.98 20.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 112.131 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -86.87 94.19 9.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.4 m -146.91 178.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -124.22 169.75 16.33 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.8 m -115.99 139.54 50.16 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.24 133.91 28.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 12.6 pt -91.94 -39.8 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.884 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.87 153.76 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.42 29.95 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -165.63 176.34 8.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.6 pt? -94.83 148.23 22.51 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.44 121.94 32.16 Favored 'General case' 0 N--CA 1.391 -3.412 0 C-N-CA 116.929 -1.908 . . . . 0.0 109.697 167.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.9 -22.58 62.57 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.026 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.8 -51.99 0.82 Allowed Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.702 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.68 -26.56 57.74 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 122.935 0.494 . . . . 0.0 111.379 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 107.79 -163.74 12.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 25.2 Cg_exo -69.21 115.56 4.07 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 121.914 1.743 . . . . 0.0 108.215 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.448 ' HB ' ' CG ' ' A' ' 480' ' ' GLU . 28.3 m -124.46 162.79 25.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -154.39 114.82 3.92 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.603 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 119.64 25.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.0 OUTLIER -136.24 173.48 11.66 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.2 tm? -122.61 107.98 12.59 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.4 p -73.98 119.85 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 111.751 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 40.5 mt-30 -123.59 -15.81 6.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.794 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.565 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -92.23 2.17 56.77 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 158.87 -125.67 1.55 Allowed Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.185 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.3 m -129.83 134.19 47.39 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.641 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -104.6 133.2 49.86 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.629 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 2.1 ttpm? -148.29 159.66 43.76 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -68.06 136.27 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.159 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.59 -2.83 60.8 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.403 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 67.8 m-20 -92.76 132.77 30.51 Favored Pre-proline 0 C--O 1.25 1.115 0 CA-C-N 117.317 0.559 . . . . 0.0 110.003 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 2.5 Cg_endo -80.35 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.08 1.853 . . . . 0.0 111.762 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.92 172.65 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.25 124.29 18.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.178 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.4 111.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.32 11.13 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.1 m -99.15 -4.45 32.15 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.32 0.581 . . . . 0.0 110.3 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 486' ' ' ASP . 48.9 m -102.86 136.32 42.9 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.602 -0.686 . . . . 0.0 112.053 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.75 161.88 16.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -177.3 -169.33 38.31 Favored Glycine 0 CA--C 1.475 -2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.488 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 55.2 ttp180 -130.6 137.71 49.77 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.431 HG11 ' HE2' ' A' ' 462' ' ' MET . 49.0 t -65.99 116.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.04 0.448 . . . . 0.0 111.824 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -79.43 -60.07 2.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -143.49 160.25 40.93 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.641 ' HE1' HD22 ' A' ' 444' ' ' LEU . 35.6 tpp -121.48 134.65 55.07 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 480' ' ' GLU . 6.1 t -117.24 142.09 32.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.478 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.0 p30 -103.62 179.73 4.19 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.178 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.42 -29.25 48.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.612 1.165 . . . . 0.0 112.94 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 -6.85 58.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.0 4.13 63.38 Favored Glycine 0 N--CA 1.466 0.654 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.255 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.478 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.0 mpt_? -93.09 156.93 16.56 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.407 ' NH1' HG22 ' A' ' 463' ' ' VAL . 20.2 tpp180 -75.41 132.88 41.17 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.824 0.85 . . . . 0.0 110.97 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.3 175.59 5.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.76 -28.89 3.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.719 0.295 . . . . 0.0 111.673 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 445' ' ' LYS . 30.7 mt-10 -123.6 141.17 52.27 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.44 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -139.29 126.01 20.73 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.54 161.36 40.61 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.488 ' HA ' HG13 ' A' ' 439' ' ' VAL . 19.3 Cg_endo -59.67 150.75 74.72 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.931 2.421 . . . . 0.0 113.031 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 438' ' ' LEU . 22.2 m 75.77 4.45 3.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.351 1.46 . . . . 0.0 112.268 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 47.0 ttp -103.86 136.11 19.25 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 122.275 -0.266 . . . . 0.0 110.953 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.6 Cg_exo -76.77 126.2 8.67 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.423 2.082 . . . . 0.0 111.326 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 473' ' ' ALA . 12.7 m -142.06 159.02 20.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 463' ' ' VAL . 37.7 tt0 -117.56 124.94 49.91 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.45 172.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.725 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.9 p -151.22 161.99 41.7 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 112.73 8.11 21.13 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.941 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 58.2 mt -89.95 -40.33 12.43 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.478 -0.425 . . . . 0.0 110.166 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' HIS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 16.4 t-80 58.17 21.29 7.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 111.07 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.495 ' HB3' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -126.74 -178.89 4.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.27 110.09 46.37 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 4.6 Cg_endo -84.24 156.42 12.84 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.178 1.919 . . . . 0.0 109.988 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -121.29 134.8 55.17 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -69.17 124.5 23.98 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.141 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.04 -0.37 56.19 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.62 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.01 178.51 8.12 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.859 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -110.44 130.07 55.63 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 32.5 p90 -125.86 154.86 42.08 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.123 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 59.6 ttp -119.28 127.13 52.94 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 441' ' ' ALA . 10.6 p -86.76 123.76 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -127.82 122.07 31.74 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.43 -161.89 0.81 Allowed 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.54 -68.34 0.84 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.207 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -52.46 -34.69 50.06 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.4 -44.76 70.78 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.501 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 506' ' ' ILE . 60.4 mttp -79.96 -30.57 39.83 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.141 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.7 88.98 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 508' ' ' GLU . 42.9 ttp180 -59.36 -41.88 90.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.488 0.661 . . . . 0.0 109.983 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -68.8 -29.86 68.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.6 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 502' ' ' LYS . 85.1 mt -83.5 -52.16 13.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.895 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -169.13 -17.44 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 119.411 -1.376 . . . . 0.0 113.552 -173.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 504' ' ' ARG . 7.6 tp10 -81.7 57.04 3.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.655 1.217 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -126.99 118.83 25.27 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.853 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -85.18 92.61 8.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.08 0.943 . . . . 0.0 109.662 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -73.33 95.11 2.12 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.782 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -131.34 86.0 2.32 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -154.13 119.1 5.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.194 -176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 C--N 1.284 -2.263 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.92 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 19.2 m -83.67 -17.24 42.12 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -76.67 -34.03 58.26 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.702 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 87.7 mtp 63.87 -179.98 0.16 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.793 1.237 . . . . 0.0 112.774 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.5 pp -118.76 27.2 9.04 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.103 0.954 . . . . 0.0 109.663 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.02 -50.15 67.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.559 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -144.87 112.62 6.28 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 125.102 1.361 . . . . 0.0 107.332 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.43 -58.94 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.7 mp -125.84 -67.81 0.86 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 42.42 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.787 2.035 . . . . 0.0 115.81 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -83.53 26.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.679 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.9 -39.54 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.03 137.47 53.07 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.95 105.49 15.76 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.429 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 78.0 t -70.89 -53.87 20.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 22.6 t 57.7 84.72 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.017 0.927 . . . . 0.0 112.144 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -81.67 -68.9 0.65 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 27.0 ttt 41.1 83.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.693 1.597 . . . . 0.0 112.436 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -130.52 161.32 31.74 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.137 -173.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -70.1 109.41 4.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.21 -20.28 20.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -123.01 -74.11 0.63 Allowed 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.62 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 179.06 133.19 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 125.171 1.388 . . . . 0.0 107.977 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.462 ' OD1' ' HB2' ' A' ' 493' ' ' ARG . 51.7 m-80 85.32 125.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 125.797 1.639 . . . . 0.0 110.333 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -69.67 -44.15 2.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.598 1.532 . . . . 0.0 110.674 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 95.02 4.52 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.084 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -76.63 92.42 3.5 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.535 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -125.88 -86.77 0.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -116.62 75.98 1.0 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.85 166.17 3.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -140.16 -175.16 14.23 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.055 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.7 p -125.57 145.13 50.26 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 124.156 0.983 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 37.7 t -87.73 134.01 28.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.76 -39.69 12.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.506 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 8.5 pt-20 -158.31 149.43 20.84 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.35 149.13 34.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.519 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -172.65 177.1 3.02 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -95.26 146.72 24.15 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -123.38 120.57 33.41 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -55.84 -18.77 9.5 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -107.62 -42.57 1.44 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.403 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -81.2 -34.25 32.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.728 0.299 . . . . 0.0 111.489 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.09 -145.85 17.98 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.32 115.99 4.24 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 121.86 1.706 . . . . 0.0 108.648 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 18.1 m -116.09 153.53 17.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.259 0.552 . . . . 0.0 111.134 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -144.91 112.74 6.32 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.482 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.62 114.91 22.98 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.9 pp -132.95 173.27 11.58 Favored 'General case' 0 C--N 1.266 -3.022 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.007 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.92 106.78 14.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -65.94 114.85 3.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.421 1.105 . . . . 0.0 111.943 -176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.63 -14.33 7.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.08 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.431 ' CB ' ' H ' ' A' ' 496' ' ' VAL . . . -85.24 0.29 52.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.829 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 140.85 -115.27 1.02 Allowed Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 144.53 49.35 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.512 ' CD1' HD11 ' A' ' 437' ' ' LEU . 0.9 OUTLIER -125.82 120.23 29.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.2 ttpm? -138.38 161.71 36.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.566 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.6 m -66.09 130.67 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.557 0.694 . . . . 0.0 111.443 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.12 50.98 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.851 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 67.5 m-20 -88.32 147.17 39.5 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.959 0.379 . . . . 0.0 110.788 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -81.74 131.86 7.38 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.391 2.061 . . . . 0.0 110.731 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 496' ' ' VAL . 2.9 pp -125.79 140.46 48.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.478 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.84 111.62 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.41 138.22 26.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.74 26.09 74.73 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.33 -0.938 . . . . 0.0 110.875 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 65.0 p 63.68 7.05 2.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.166 1.786 . . . . 0.0 113.036 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.441 HG21 ' CB ' ' A' ' 486' ' ' ASP . 88.2 m -107.34 146.36 31.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -122.68 151.86 41.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.633 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -154.09 -164.3 12.66 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.534 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 47.7 ttp180 -131.49 137.15 48.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.153 0.477 . . . . 0.0 110.005 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 482' ' ' THR . 28.3 t -67.9 123.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 122.688 0.395 . . . . 0.0 111.314 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -98.81 -51.04 4.01 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.767 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.81 153.86 51.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.468 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.1 tpp -122.5 121.47 36.64 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 469' ' ' ARG . 13.4 t -127.85 148.6 32.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.538 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.9 p30 -109.27 179.46 4.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.736 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -58.97 -32.19 69.42 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.7 t -78.61 -9.12 59.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.311 0.577 . . . . 0.0 110.401 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.41 63.04 Favored Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.787 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.538 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.2 mpt_? -73.38 116.86 14.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.406 ' HG2' HG22 ' A' ' 463' ' ' VAL . 4.0 tmm_? -81.09 133.48 35.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.11 -173.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 123.844 0.858 . . . . 0.0 108.791 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -117.39 -20.46 9.1 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.147 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.37 147.35 33.3 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.421 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -145.68 139.14 26.34 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.208 0.603 . . . . 0.0 110.169 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -97.92 167.1 22.75 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.9 Cg_endo -58.63 150.66 68.26 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.09 2.527 . . . . 0.0 112.878 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 32.6 m 75.32 17.83 2.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.431 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.5 ttt -117.16 136.36 23.36 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.12 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 3.6 Cg_exo -80.55 126.77 6.17 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.201 1.934 . . . . 0.0 110.933 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.3 m -142.36 149.87 19.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.005 0.431 . . . . 0.0 110.865 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.4 tt0 -108.67 112.56 24.95 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.6 pt -99.84 172.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.576 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.453 ' CG2' HG12 ' A' ' 434' ' ' VAL . 5.5 p -145.33 157.55 44.02 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 113.23 4.44 23.83 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.16 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 51.2 tp -73.3 -37.58 66.16 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.483 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 64.62 24.14 12.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.278 1.431 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.441 ' CB ' HG21 ' A' ' 455' ' ' THR . 37.5 t70 -144.93 171.62 14.19 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.85 109.23 47.64 Favored Pre-proline 0 C--N 1.291 -1.956 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.44 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.02 174.52 4.56 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.595 2.197 . . . . 0.0 111.783 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -129.94 150.78 51.08 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.116 0.484 . . . . 0.0 111.327 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -63.74 130.03 42.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.346 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.28 58.83 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.749 -1.215 . . . . 0.0 111.588 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 493' ' ' ARG . 7.3 t70 -86.29 -166.63 1.6 Allowed 'General case' 0 C--O 1.248 0.974 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.462 ' HB2' ' OD1' ' A' ' 413' ' ' ASN . 0.1 OUTLIER -131.24 136.89 48.61 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.295 -169.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 38.4 p90 -136.74 158.53 44.23 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.824 0.821 . . . . 0.0 111.758 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.2 ttp -134.05 119.53 19.08 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.862 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 450' ' ' ILE . 83.1 t -108.64 136.77 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.74 122.7 30.19 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.472 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -70.0 -48.57 57.61 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.676 -174.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 27.4 t70 60.53 -58.0 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.844 1.658 . . . . 0.0 115.166 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -13.25 62.27 Favored 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -70.19 -47.0 63.45 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -61.33 -37.71 84.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.207 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.58 64.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.901 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.463 ' HA ' ' H ' ' A' ' 508' ' ' GLU . 36.6 ttm105 -55.44 -40.29 71.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 123.891 0.876 . . . . 0.0 112.274 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -59.01 -31.8 69.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.967 0.792 . . . . 0.0 111.147 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.63 -9.0 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.451 0.7 . . . . 0.0 110.219 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 108.48 37.93 2.01 Favored Glycine 0 C--N 1.32 -0.342 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.463 ' H ' ' HA ' ' A' ' 504' ' ' ARG . 41.5 mt-10 54.87 35.51 24.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.782 1.633 . . . . 0.0 113.221 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -79.44 105.11 10.51 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.884 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -108.1 140.13 41.74 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.433 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -68.46 -77.86 0.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.428 0.455 . . . . 0.0 111.947 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -150.75 93.78 2.0 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.356 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 178.28 107.88 0.03 OUTLIER 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.481 1.112 . . . . 0.0 110.465 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 . . . . . 0 C--N 1.296 -1.754 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.97 179.832 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.396 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 32.4 t -63.87 106.98 1.11 Allowed 'General case' 0 C--O 1.253 1.237 0 C-N-CA 123.388 0.675 . . . . 0.0 110.711 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 55.32 -108.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.409 1.084 . . . . 0.0 110.015 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 72.6 mtm -142.55 13.98 1.96 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 pp -108.1 2.99 23.41 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.02 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 123.16 17.94 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.639 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -124.1 24.14 8.26 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 121.363 0.601 . . . . 0.0 109.723 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.3 mp -89.62 73.35 7.72 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.861 0.839 . . . . 0.0 109.896 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 47.2 tp -94.65 90.82 6.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.94 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.0 -44.2 55.4 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.233 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -138.1 138.76 39.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.93 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 6.9 tp -120.3 125.7 74.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 31.1 tp 68.87 12.46 8.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.583 1.153 . . . . 0.0 110.458 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.0 tp -93.86 -50.07 5.52 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.0 t 57.48 24.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 122.185 0.993 . . . . 0.0 111.232 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 16.8 m -80.57 67.6 6.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.907 0.86 . . . . 0.0 110.508 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.53 16.46 0.9 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.357 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 42.8 ttm -99.88 -65.49 0.96 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.156 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.93 140.04 48.07 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -101.37 122.82 44.43 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.195 0.521 . . . . 0.0 110.946 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.51 -32.87 71.99 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.557 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 88.7 tttt 60.34 83.01 0.15 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.568 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -83.65 -34.92 24.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -139.03 142.23 32.63 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.209 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.37 -22.59 24.94 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.443 2.096 . . . . 0.0 110.137 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -81.61 146.19 30.22 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.917 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -114.81 -126.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 69.78 -74.82 0.08 Allowed 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.905 0.882 . . . . 0.0 109.599 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 495' ' ' MET . . . 177.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.984 1.314 . . . . 0.0 108.291 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 9.7 m -146.39 169.61 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 122.679 0.392 . . . . 0.0 110.551 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -151.43 -174.68 22.48 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 18.8 m -127.89 143.87 51.1 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 117.049 0.424 . . . . 0.0 110.558 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.64 136.38 22.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.0 pt -89.77 -43.21 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.687 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.01 155.75 37.51 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.093 0.473 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -134.2 129.83 36.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 427' ' ' LEU . 0.3 OUTLIER -134.8 159.53 41.06 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -170.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.49 ' N ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -94.68 139.64 30.95 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 9.9 t70 -127.66 117.62 22.31 Favored 'General case' 0 C--N 1.261 -3.25 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.69 -26.15 65.34 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.24 -37.95 1.73 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.9 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.48 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.1 mtp180 -86.51 -24.37 25.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.14 -166.91 19.09 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -58.11 116.11 3.01 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.529 2.153 . . . . 0.0 111.049 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 482' ' ' THR . 20.1 m -114.94 136.62 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.341 0.591 . . . . 0.0 110.508 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -126.75 124.66 40.24 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.381 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 2.0 m -98.7 118.78 36.2 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 170.14 15.31 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -118.44 105.29 11.53 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 475' ' ' PRO . 3.3 p -71.14 118.6 16.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.708 0.766 . . . . 0.0 112.197 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 47.0 mt-30 -123.3 -16.22 6.96 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.468 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.4 31.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.957 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 145.81 -89.89 0.16 Allowed Glycine 0 C--O 1.212 -1.244 0 C-N-CA 119.019 -1.562 . . . . 0.0 113.219 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 56.3 m -146.64 146.89 30.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.537 HD22 ' HE1' ' A' ' 462' ' ' MET . 2.2 tt -128.23 115.58 18.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 0.0 OUTLIER -135.81 158.9 43.26 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 120.708 0.29 . . . . 0.0 110.847 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.7 m -61.81 133.71 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.89 0.376 . . . . 0.0 110.119 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.82 4.04 56.95 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.259 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 33.7 m-20 -86.36 127.91 59.29 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.997 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 5.5 Cg_exo -77.18 106.65 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.814 1.676 . . . . 0.0 108.073 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 456' ' ' TYR . 2.9 pp -104.9 140.84 21.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.035 -172.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.34 119.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.472 HG12 ' CB ' ' A' ' 494' ' ' PHE . 8.5 m -125.27 133.94 68.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' GLY . . . . . 0.451 ' HA2' ' NH1' ' A' ' 493' ' ' ARG . . . 57.97 -100.17 0.14 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.515 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 7.0 p -131.54 10.86 4.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.639 0.776 . . . . 0.0 110.895 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.514 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.3 m -119.7 144.8 47.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.777 0.322 . . . . 0.0 110.282 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 52.8 p90 -120.5 150.85 40.18 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -150.36 -170.68 17.86 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -134.82 127.89 31.68 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.73 118.23 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.15 -52.82 3.87 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.1 35.86 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.537 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -133.18 117.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.78 131.43 72.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.88 177.74 5.8 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.369 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.73 -30.55 33.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.37 1.068 . . . . 0.0 113.148 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.2 t -76.95 -16.14 59.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.078 0.466 . . . . 0.0 110.483 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.64 15.09 47.8 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.23 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -99.87 133.82 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.541 -0.33 . . . . 0.0 110.184 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.4 tpt85 -73.16 126.06 29.16 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.181 0.926 . . . . 0.0 108.981 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 462' ' ' MET . 30.6 m -135.66 -177.2 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 471' ' ' LYS . 0.0 OUTLIER -120.9 -12.71 8.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.947 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.68 152.18 33.58 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.04 145.96 31.68 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 123.719 0.637 . . . . 0.0 109.866 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -94.84 173.91 32.48 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.477 ' HA ' HG13 ' A' ' 439' ' ' VAL . 58.5 Cg_endo -69.57 156.66 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.637 2.224 . . . . 0.0 113.378 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 438' ' ' LEU . 12.1 t 72.08 16.51 5.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.022 1.329 . . . . 0.0 110.892 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 34.8 ttp -119.76 129.53 25.31 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.638 -0.664 . . . . 0.0 112.069 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.77 125.93 12.71 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.777 2.318 . . . . 0.0 112.345 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 436' ' ' THR . 6.0 m -140.41 151.74 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.163 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 40.8 tt0 -112.42 112.78 24.58 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.3 pt -98.23 170.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.699 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.482 HG23 HG12 ' A' ' 434' ' ' VAL . 0.2 OUTLIER -150.72 150.1 30.63 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 109.72 31.94 3.04 Favored Glycine 0 C--N 1.304 -1.25 0 O-C-N 123.742 0.651 . . . . 0.0 113.295 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 457' ' ' GLY . 54.9 tp -82.94 -35.84 25.68 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.0 t60 65.4 27.72 11.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.185 1.394 . . . . 0.0 109.404 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.514 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.3 t0 -148.01 -179.95 7.29 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.91 108.97 44.06 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.77 158.1 56.59 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.902 1.735 . . . . 0.0 110.733 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -126.48 131.35 51.66 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.391 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -72.48 135.66 45.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.295 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.44 89.35 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.664 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 1.6 t70 -84.7 -172.69 4.31 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.496 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.1 OUTLIER -129.16 150.92 50.34 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.742 -173.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 452' ' ' VAL . 40.7 p90 -140.28 168.68 19.25 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 418' ' ' ALA . 52.3 ttp -134.02 115.98 14.97 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 444' ' ' LEU . 61.7 t -121.72 106.06 17.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -131.63 122.95 26.85 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.708 ' HG3' ' H ' ' A' ' 501' ' ' LYS . 10.1 tp10 -78.23 142.91 37.55 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 122.338 1.065 . . . . 0.0 111.284 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -102.43 -40.28 6.78 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.833 -175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.46 -25.0 59.13 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.841 -0.537 . . . . 0.0 112.444 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.708 ' H ' ' HG3' ' A' ' 498' ' ' GLU . 48.3 mtpt -72.48 -38.97 68.06 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.486 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -70.88 -26.64 63.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.855 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.67 50.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.39 -45.76 55.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.579 1.552 . . . . 0.0 110.32 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.62 -36.21 75.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.2 -10.96 11.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.432 0.634 . . . . 0.0 109.838 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 101.45 28.26 6.82 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.893 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 62.7 31.31 16.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.831 1.3 . . . . 0.0 109.932 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.85 -8.63 57.01 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.878 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -96.73 104.39 16.38 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.47 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -98.75 -17.31 18.58 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -114.03 135.11 54.37 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.333 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -77.74 -43.13 31.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--N 1.319 -0.754 0 C-N-CA 123.439 0.695 . . . . 0.0 109.986 -178.5 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.858 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 36.4 m 64.96 114.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.574 1.149 . . . . 0.0 111.228 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -78.01 70.87 4.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.424 1.107 . . . . 0.0 112.616 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 26.0 ptm -153.12 9.89 0.44 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.205 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.66 101.62 14.31 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.967 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.78 115.28 15.3 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -65.39 123.39 19.49 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.616 0.722 . . . . 0.0 112.544 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.1 mp -75.23 165.1 25.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.274 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.48 88.19 6.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.574 0.702 . . . . 0.0 110.14 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -86.14 176.29 8.06 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.614 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 23.1 ptp -78.38 153.74 31.34 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 34.8 pt -73.89 127.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.88 131.59 35.26 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.482 -173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.1 -23.7 23.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 58.0 t 63.74 89.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.71 1.204 . . . . 0.0 110.036 -177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 20.3 m -144.56 150.2 37.11 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.215 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 142.14 31.49 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.014 0.435 . . . . 0.0 111.924 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 27.1 ttt -101.91 13.37 34.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.593 1.187 . . . . 0.0 108.031 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.47 156.61 19.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.217 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.98 -73.59 0.28 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 411' ' ' LYS . 3.5 pp -179.99 -30.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.796 0.838 . . . . 0.0 110.994 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 410' ' ' LEU . 0.9 OUTLIER -86.59 -76.08 0.36 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 179.43 130.71 0.08 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 71.02 104.89 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 125.103 1.361 . . . . 0.0 111.333 171.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.47 -27.51 23.01 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.491 2.128 . . . . 0.0 113.501 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.564 HD21 ' HB3' ' A' ' 418' ' ' ALA . 30.3 t-20 -86.35 -58.61 2.56 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 65.48 9.8 6.09 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.455 1.502 . . . . 0.0 114.061 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 441' ' ' ALA . 55.5 ttt180 -131.18 -54.61 1.04 Allowed 'General case' 0 C--O 1.204 -1.324 0 O-C-N 121.391 -0.818 . . . . 0.0 111.027 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.564 ' HB3' HD21 ' A' ' 415' ' ' ASN . . . -82.59 5.46 20.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.924 0.392 . . . . 0.0 111.69 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.35 155.34 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -117.74 178.59 17.01 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.6 m -122.02 139.09 54.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 52.1 t -82.51 135.07 25.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 11.3 pt -93.73 -37.05 7.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.905 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 12.6 pt-20 -156.7 148.14 22.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.46 136.76 17.6 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 176.43 8.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.44 145.92 24.23 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.69 122.81 33.91 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.527 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.13 -13.4 58.01 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -109.67 -46.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.401 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.49 -40.59 42.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 109.605 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 121.7 -176.45 16.38 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.45 116.13 3.07 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.141 1.894 . . . . 0.0 109.445 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 482' ' ' THR . 29.1 m -121.94 146.56 26.88 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.391 0.615 . . . . 0.0 112.229 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -137.53 119.14 14.95 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.3 m -88.22 125.06 34.44 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.91 168.05 20.67 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.399 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.83 105.9 12.43 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 475' ' ' PRO . 4.3 p -70.84 121.21 20.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.836 0.827 . . . . 0.0 111.529 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -121.84 -20.5 6.38 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 417' ' ' ARG . . . -81.63 -11.41 59.12 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -170.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 165.13 -111.38 0.46 Allowed Glycine 0 N--CA 1.416 -2.663 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.86 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 24.7 m -137.16 133.75 35.59 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.7 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.7 OUTLIER -101.28 115.79 31.32 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.0 OUTLIER -129.04 150.99 50.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.4 m -71.0 141.32 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.257 0.551 . . . . 0.0 111.297 177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.38 8.6 70.91 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.792 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -101.07 128.17 30.15 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 6.8 Cg_exo -72.38 120.81 6.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.46 HG22 HG22 ' A' ' 496' ' ' VAL . 18.9 pt -114.36 160.63 13.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.404 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.44 127.25 59.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 494' ' ' PHE . 3.0 m -127.22 128.19 70.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 55.47 -97.09 0.04 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 121.597 -0.335 . . . . 0.0 113.595 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 8.9 t -127.84 11.33 6.63 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.072 0.463 . . . . 0.0 110.623 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.477 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.2 m -124.21 150.12 45.61 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -127.92 162.1 27.53 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -173.91 -165.09 30.06 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -135.61 134.77 39.66 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 482' ' ' THR . 31.0 t -70.2 122.58 22.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 123.369 0.418 . . . . 0.0 110.352 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -93.09 -56.74 2.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.651 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.45 146.62 50.02 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.7 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.5 tpp -121.8 117.47 26.62 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.17 136.74 49.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.87 174.18 5.99 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.046 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.53 -29.82 38.55 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.602 1.161 . . . . 0.0 113.491 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 68.7 m -77.17 -11.81 59.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.821 -0.55 . . . . 0.0 111.33 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.77 -11.56 59.25 Favored Glycine 0 CA--C 1.494 -1.273 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.785 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -77.7 137.09 38.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.006 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.16 127.48 34.29 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.2 m -126.39 174.52 10.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.558 -172.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -102.74 -35.24 8.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 151.25 37.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.483 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.408 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -139.17 145.22 39.09 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.43 174.14 37.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.994 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.2 Cg_endo -64.51 158.6 48.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 38.6 m 68.67 17.0 8.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.521 0.728 . . . . 0.0 112.39 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.5 ttp -122.6 127.14 25.91 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.156 -0.34 . . . . 0.0 110.927 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.79 126.38 13.88 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 121.99 1.793 . . . . 0.0 111.72 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.408 HG11 ' CB ' ' A' ' 473' ' ' ALA . 17.6 m -139.12 167.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.514 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 34.4 tt0 -125.33 118.3 25.64 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -98.52 173.02 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.472 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.1 p -152.77 155.04 36.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.399 1.08 . . . . 0.0 108.352 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.18 8.15 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 172.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.21 -31.14 38.69 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 63.51 21.36 12.71 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.823 1.249 . . . . 0.0 109.263 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.477 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -140.79 -179.77 6.24 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.67 107.63 58.7 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-O 121.538 0.685 . . . . 0.0 111.779 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.45 167.92 14.98 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.019 1.812 . . . . 0.0 110.059 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' GLN . . . . . 0.606 ' HB2' ' OD2' ' A' ' 492' ' ' ASP . 21.9 mt-30 -134.8 154.2 51.71 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.109 -0.369 . . . . 0.0 110.356 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -70.97 133.42 46.36 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.2 -11.39 63.73 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.116 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 489' ' ' GLN . 4.3 m-20 -79.5 164.61 23.78 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.779 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 5.9 mpt_? -113.11 128.75 56.58 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.488 ' CB ' HG12 ' A' ' 452' ' ' VAL . 53.9 p90 -118.94 155.73 30.81 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.3 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 51.6 ttm -121.03 116.29 24.77 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.172 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 450' ' ' ILE . 46.7 t -123.65 105.05 15.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -114.53 151.31 33.55 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.451 ' CD ' ' HB3' ' A' ' 501' ' ' LYS . 3.2 pt-20 54.36 -160.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.901 1.68 . . . . 0.0 110.118 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.6 t70 178.47 -49.79 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 125.279 1.432 . . . . 0.0 108.214 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -77.76 -28.77 50.7 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-N 114.149 -1.387 . . . . 0.0 114.348 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 0.1 OUTLIER -63.86 -54.11 40.07 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.633 0.652 . . . . 0.0 110.899 -174.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 506' ' ' ILE . 10.8 ptpp? -65.28 -35.35 80.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.074 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.55 77.64 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.848 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -55.61 -50.17 70.85 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.127 1.371 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 12.0 mm100 -70.08 -26.31 63.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.926 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 502' ' ' LYS . 44.6 mm -74.06 -41.65 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 167.92 -14.95 0.07 OUTLIER Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.827 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.99 43.79 0.96 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 122.683 1.23 . . . . 0.0 110.321 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -91.77 10.53 28.08 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.392 1.092 . . . . 0.0 108.592 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -90.09 96.62 10.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.411 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.12 34.2 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -85.11 91.39 8.1 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.89 24.98 2.36 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 . . . . . 0 N--CA 1.416 -2.133 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.002 -178.084 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.851 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 39.4 m -91.58 102.81 15.46 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 117.016 0.408 . . . . 0.0 110.312 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 72.98 128.71 0.04 OUTLIER 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.333 1.453 . . . . 0.0 112.498 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 398' ' ' LEU . 50.7 ttm -75.34 81.29 2.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.044 0.926 . . . . 0.0 109.606 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 90.9 mt -108.27 -83.73 0.54 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -108.34 8.61 27.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -115.45 105.24 12.59 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.299 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 89.4 mt 62.02 -169.54 0.18 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 124.853 1.346 . . . . 0.0 112.209 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' A' ' 399' ' ' GLU . 19.7 tp -163.76 -173.18 3.14 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 102.303 -3.221 . . . . 0.0 102.303 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.47 ' H ' ' HG ' ' A' ' 398' ' ' LEU . 43.9 tt0 -66.98 99.79 0.68 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 119.537 1.062 . . . . 0.0 111.261 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 13.0 tpt 72.72 -55.23 0.68 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.782 1.633 . . . . 0.0 112.737 177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 24.9 pt -139.61 174.75 8.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 123.778 0.831 . . . . 0.0 108.805 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 398' ' ' LEU . 3.8 mm? -91.97 172.13 8.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 67.9 mt -84.96 -178.43 6.83 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 27.9 m -78.63 37.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.595 0.758 . . . . 0.0 112.123 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 49.4 m 63.18 82.02 0.19 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.732 1.213 . . . . 0.0 111.499 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -98.85 132.85 43.88 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.71 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 24.9 ptp -74.04 113.32 11.08 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.533 0.682 . . . . 0.0 110.737 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.58 135.86 46.21 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 411' ' ' LYS . 0.7 OUTLIER -133.86 144.32 48.84 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 76.1 mt -128.72 4.65 5.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.446 ' H ' ' CD ' ' A' ' 409' ' ' GLU . 99.0 mttt -111.76 31.82 5.9 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.991 0.424 . . . . 0.0 111.781 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 73.78 -6.19 1.85 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 176.92 126.98 0.18 Allowed Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.96 -19.12 66.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.108 2.539 . . . . 0.0 113.117 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -95.56 169.2 10.2 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -78.38 178.21 7.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.22 57.71 1.49 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.014 0.911 . . . . 0.0 110.22 173.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -125.77 2.81 7.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 17.5 m -147.45 161.66 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.35 176.48 17.88 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.0 m -127.2 139.6 52.83 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 42.7 t -83.58 137.29 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -97.54 -37.55 6.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.232 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 436' ' ' THR . 0.2 OUTLIER -152.35 166.07 33.0 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.39 128.59 17.72 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.54 146.85 30.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.67 144.71 26.51 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.299 0.571 . . . . 0.0 109.885 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.24 129.48 50.86 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.545 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -64.0 -19.98 65.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.466 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -111.61 -48.42 0.69 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.878 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -74.68 -26.94 60.18 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 123.594 0.758 . . . . 0.0 110.59 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 98.98 -158.91 20.14 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.25 116.46 3.51 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.567 2.178 . . . . 0.0 111.084 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 482' ' ' THR . 15.1 m -121.33 157.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -148.26 120.37 8.29 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.54 ' HB ' ' HG3' ' A' ' 424' ' ' GLU . 3.4 m -82.74 123.67 29.53 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 478' ' ' PRO . 1.3 pp -133.03 173.3 11.57 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -119.44 110.99 17.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -75.5 122.58 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.763 0.792 . . . . 0.0 111.24 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 18.8 mt-30 -123.83 -14.45 7.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.095 -174.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.671 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -96.36 8.42 44.02 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.049 0.452 . . . . 0.0 110.133 -173.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.62 -126.55 2.92 Favored Glycine 0 N--CA 1.403 -3.513 0 C-N-CA 120.033 -1.08 . . . . 0.0 111.347 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.3 m -115.62 142.7 46.38 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.646 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.4 OUTLIER -111.45 117.69 33.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.541 ' HB3' ' OD2' ' A' ' 448' ' ' ASP . 12.3 ttpt -122.86 148.36 45.51 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.02 123.88 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.413 0.625 . . . . 0.0 109.768 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 109.5 -8.51 32.52 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.125 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.541 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 42.7 m-20 -90.32 146.02 33.82 Favored Pre-proline 0 C--O 1.25 1.081 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.448 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 4.0 Cg_exo -77.03 145.37 24.71 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.536 2.157 . . . . 0.0 111.391 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 13.8 pt -136.44 156.88 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.345 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.74 115.34 44.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.0 115.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.38 -102.56 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 12.6 t -127.9 8.23 6.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 486' ' ' ASP . 26.6 m -115.76 145.02 43.16 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.618 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -127.95 158.77 36.93 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -173.05 -164.3 28.2 Favored Glycine 0 C--N 1.29 -2.015 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -125.48 134.68 51.97 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.467 HG21 ' CD2' ' A' ' 444' ' ' LEU . 41.6 t -72.15 123.47 26.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -95.79 -50.38 4.93 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.693 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.05 159.66 32.19 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.646 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.9 tpp -130.8 117.33 19.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.79 128.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.634 HD21 ' HB2' ' A' ' 468' ' ' ARG . 8.8 p30 -92.9 -175.71 3.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.227 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.94 -20.26 66.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 112.402 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 31.5 t -84.21 -20.31 32.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.71 40.62 5.26 Favored Glycine 0 CA--C 1.488 -1.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.706 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.634 ' HB2' HD21 ' A' ' 464' ' ' ASN . 85.2 mtt180 -118.34 129.88 55.69 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 2.3 tmm_? -80.17 129.51 34.55 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.4 m -130.55 -179.23 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 120.583 0.23 . . . . 0.0 110.385 -176.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -98.97 -35.98 9.89 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.231 0.612 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -157.74 147.59 20.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.017 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -134.7 142.99 46.95 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.059 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.04 173.85 45.18 Favored Glycine 0 N--CA 1.442 -0.928 0 O-C-N 123.717 0.636 . . . . 0.0 112.304 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.9 Cg_endo -64.98 156.52 62.07 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.551 2.168 . . . . 0.0 113.23 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.462 ' HA ' HD11 ' A' ' 438' ' ' LEU . 28.3 m 72.54 10.85 5.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.439 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.1 ttt -111.08 138.26 21.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.5 Cg_exo -83.91 126.34 3.88 Favored 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.925 2.416 . . . . 0.0 112.001 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.7 151.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.171 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.7 mt-10 -96.82 129.19 44.29 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -100.87 170.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.479 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.7 p -151.07 158.86 44.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 124.237 1.015 . . . . 0.0 108.503 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.12 8.15 Favored Glycine 0 N--CA 1.422 -2.277 0 O-C-N 124.059 0.849 . . . . 0.0 114.428 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.57 -36.39 13.72 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.1 t60 64.62 20.95 12.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.357 1.463 . . . . 0.0 108.423 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.487 ' CB ' HG21 ' A' ' 455' ' ' THR . 30.9 t70 -135.9 173.52 11.62 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.12 103.6 36.06 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 118.094 0.406 . . . . 0.0 110.008 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.61 174.97 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.814 2.343 . . . . 0.0 111.124 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -111.17 145.56 38.43 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.308 0.575 . . . . 0.0 111.365 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -64.02 127.62 32.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.185 173.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.67 -3.48 56.15 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.609 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.18 178.11 8.44 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.751 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.61 140.73 48.91 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 124.105 0.962 . . . . 0.0 108.779 -175.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.05 155.18 49.68 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.998 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 49.7 ttp -122.02 120.34 34.09 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.671 HG12 ' HB3' ' A' ' 441' ' ' ALA . 7.0 p -95.47 143.07 12.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -101.74 120.54 40.52 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.513 ' OE2' ' HG2' ' A' ' 501' ' ' LYS . 37.4 tt0 -81.02 137.54 36.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 123.548 0.53 . . . . 0.0 110.888 -174.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.97 -58.2 8.57 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 124.719 1.207 . . . . 0.0 111.778 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.2 -20.91 62.22 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.139 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.513 ' HG2' ' OE2' ' A' ' 498' ' ' GLU . 41.9 mmtm -68.88 -49.24 59.93 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -69.2 -40.6 77.92 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.572 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.92 88.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -73.71 -16.1 61.2 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.878 0.471 . . . . 0.0 111.033 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.6 -28.65 61.0 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 2.4 mp -86.93 -34.96 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 129.44 20.22 1.42 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.466 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 54.56 21.17 3.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.398 1.479 . . . . 0.0 112.932 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -152.09 171.48 17.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.55 179.75 4.15 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -69.65 -41.39 75.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 62.95 84.69 0.14 Allowed 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.521 1.138 . . . . 0.0 108.937 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -72.91 114.07 10.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.626 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.127 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 39.2 m -75.52 -30.4 59.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.955 0.378 . . . . 0.0 111.66 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 63.86 17.38 10.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.829 0.852 . . . . 0.0 111.91 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 28.1 ttt -98.1 86.67 3.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.23 117.28 27.02 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.79 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.22 137.04 32.67 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -90.48 92.68 8.98 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.721 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.05 132.0 20.24 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 398' ' ' LEU . 2.8 pp -168.22 125.37 1.09 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.795 0.685 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -78.66 111.01 14.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 73.1 mtm -78.37 93.0 4.63 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 58.4 mt -76.7 -46.87 30.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 60.3 tp -101.64 139.3 37.48 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.592 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.71 168.06 11.47 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.71 70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.64 1.21 . . . . 0.0 108.05 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 17.1 m -143.38 99.18 3.39 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -91.72 116.16 28.65 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -133.27 124.55 27.54 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 411' ' ' LYS . 1.9 mp0 -91.3 147.62 22.92 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.716 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -48.32 7.77 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 59.6 tp -116.7 -12.62 10.85 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 408' ' ' GLU . 58.2 tttp 75.88 -38.6 0.35 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.417 1.887 . . . . 0.0 112.84 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -87.28 83.71 7.33 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.343 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 58.62 103.46 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 0.0 114.118 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -86.09 -17.61 3.78 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.055 1.837 . . . . 0.0 113.076 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -96.78 -35.51 10.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.235 0.541 . . . . 0.0 111.064 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 416' ' ' ARG 0.273 14.4 mmt180 69.85 -44.73 0.56 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 174.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -107.75 -6.64 16.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 118.49 0.587 . . . . 0.0 112.272 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -92.9 -25.33 18.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.262 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 441' ' ' ALA . 15.9 m -144.86 162.03 13.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.52 166.11 12.82 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.12 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.6 m -114.2 143.01 45.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.11 131.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.1 pt -88.75 -36.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.747 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -160.11 153.36 21.99 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.38 143.33 23.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.478 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -163.49 175.73 10.44 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.2 pt? -85.07 143.38 28.91 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -126.41 129.77 49.41 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.04 -24.68 67.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.743 -178.2 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -97.32 -47.63 2.16 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.723 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HB3' HG21 ' A' ' 482' ' ' THR . 25.3 mmt180 -91.4 -33.43 15.25 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.24 -134.56 12.23 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.83 115.96 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.679 1.74 . . . . 0.0 110.782 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.478 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 25.3 m -118.2 148.26 21.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -143.54 114.24 7.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.2 m -85.58 116.91 24.15 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.4 pp -132.89 171.54 13.79 Favored 'General case' 0 C--N 1.279 -2.476 0 O-C-N 122.205 -0.309 . . . . 0.0 111.795 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.51 106.37 11.73 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.4 ' HB ' HD12 ' A' ' 444' ' ' LEU . 7.2 p -78.83 123.89 36.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.241 0.544 . . . . 0.0 112.009 -177.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -124.72 -15.88 6.38 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -77.84 -15.29 59.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.03 -0.987 . . . . 0.0 113.34 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 169.97 -102.26 0.18 Allowed Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.051 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 32.5 m -148.04 131.94 17.11 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 462' ' ' MET . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.013 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.616 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.1 ttpt -148.3 153.23 38.39 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.616 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 28.2 m -71.24 134.7 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.25 0.547 . . . . 0.0 110.746 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.05 8.44 72.24 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.79 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.8 132.86 20.51 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 123.92 11.77 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.779 2.32 . . . . 0.0 111.495 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.73 151.7 26.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.452 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.95 123.12 70.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 494' ' ' PHE . 4.1 m -128.0 135.13 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 54.89 -100.44 0.08 OUTLIER Glycine 0 CA--C 1.533 1.164 0 N-CA-C 114.221 0.448 . . . . 0.0 114.221 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 42.2 p -121.94 4.54 9.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 122.652 0.381 . . . . 0.0 111.239 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 486' ' ' ASP . 44.3 m -125.36 145.62 49.96 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.835 0.35 . . . . 0.0 111.419 -173.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.0 144.38 48.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -149.74 -175.54 22.07 Favored Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -124.77 126.9 46.38 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 482' ' ' THR . 48.3 t -63.62 132.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.938 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -97.62 -59.42 1.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -122.6 167.79 12.97 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.72 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.8 tpp -143.23 117.14 9.36 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.74 132.03 72.03 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -98.71 -179.77 4.41 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.006 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.38 -30.15 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.065 0.946 . . . . 0.0 112.539 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 28.3 m -80.7 -13.18 59.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.188 -0.32 . . . . 0.0 111.445 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 95.95 7.96 58.31 Favored Glycine 0 CA--C 1.501 -0.795 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.206 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -91.72 138.94 31.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.567 -0.317 . . . . 0.0 110.336 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 462' ' ' MET . 9.2 tpt180 -74.22 131.33 41.12 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.39 174.49 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.9 -36.16 8.74 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.086 0.469 . . . . 0.0 110.02 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.83 151.98 49.75 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.851 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -137.81 137.48 38.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.022 0.529 . . . . 0.0 109.597 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 169.17 30.19 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.89 151.93 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 31.1 t 75.44 15.71 2.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.139 1.376 . . . . 0.0 110.637 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 44.1 ttm -113.71 135.11 21.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.062 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.7 Cg_exo -79.53 126.23 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.394 2.063 . . . . 0.0 110.427 173.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 10.2 m -141.71 146.67 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 123.068 0.547 . . . . 0.0 110.07 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.9 tt0 -105.67 118.63 37.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.8 172.0 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.82 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.1 p -148.49 166.07 29.31 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 87.51 22.81 42.16 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.158 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 50.3 tp -72.98 -28.64 62.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.139 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 64.23 20.01 12.01 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.279 1.031 . . . . 0.0 110.213 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 455' ' ' THR . 33.2 t70 -149.03 179.39 7.91 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.47 114.9 65.8 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 118.415 0.552 . . . . 0.0 110.395 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.21 157.63 23.08 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.05 1.833 . . . . 0.0 111.091 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -124.6 137.91 54.35 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-O 121.529 0.681 . . . . 0.0 110.59 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.32 139.83 50.05 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.944 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.81 89.46 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.476 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 2.5 t70 -85.13 -170.87 3.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.476 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.3 OUTLIER -137.75 148.87 45.97 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.09 0.471 . . . . 0.0 109.903 -174.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.7 p90 -139.4 162.7 34.39 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.356 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.09 116.06 16.56 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.115 0.483 . . . . 0.0 109.87 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 494' ' ' PHE . 62.2 t -115.73 103.71 15.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 172.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -152.14 130.89 12.38 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 501' ' ' LYS . 11.2 tp10 -176.11 137.31 0.31 Allowed 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.142 166.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 502' ' ' LYS . 34.0 t70 -87.71 -50.05 6.74 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.45 -18.28 61.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.689 0.757 . . . . 0.0 110.531 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 498' ' ' GLU . 17.4 tptp -63.1 -41.21 99.32 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.649 1.18 . . . . 0.0 109.553 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 499' ' ' ASP . 22.0 pttm -75.45 -19.8 59.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.655 0.741 . . . . 0.0 110.496 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.54 -44.07 21.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 108.877 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.45 ' HA ' ' HG3' ' A' ' 508' ' ' GLU . 39.8 ttm180 -70.56 -19.74 62.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.538 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' GLN . . . . . 0.477 ' OE1' ' HD3' ' A' ' 445' ' ' LYS . 45.0 tp60 -64.17 -40.67 96.62 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.613 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 40.0 mm -76.23 -35.27 27.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 129.18 20.75 1.4 Allowed Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.078 -0.964 . . . . 0.0 113.325 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 504' ' ' ARG . 43.7 mt-10 60.22 27.55 17.07 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.484 1.114 . . . . 0.0 111.024 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 178.84 166.7 0.9 Allowed 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -71.28 139.44 49.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -71.11 93.6 1.06 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -114.83 170.0 8.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -86.28 -43.29 13.04 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 . . . . . 0 N--CA 1.427 -1.575 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.411 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.24 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.2 m -94.14 169.74 10.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -68.5 -40.46 80.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 57.6 mtt -97.36 120.66 38.13 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.56 133.06 37.26 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.101 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.82 103.44 15.33 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -105.15 9.44 34.18 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.712 0.768 . . . . 0.0 111.195 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 52.1 mt -148.6 104.66 3.51 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 114.189 -1.368 . . . . 0.0 107.4 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.77 134.54 37.01 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -82.32 -0.6 46.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.419 0.628 . . . . 0.0 111.307 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -139.66 95.03 2.85 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 8.9 tp -153.2 -33.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.5 -169.04 2.11 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 7.1 mp 69.04 169.78 0.29 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.683 0.754 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.01 -31.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.796 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 18.1 m -68.04 101.28 1.1 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.245 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -74.06 78.67 1.72 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 122.488 1.137 . . . . 0.0 111.626 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 63.1 mtm -88.83 -16.8 31.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.281 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.17 151.69 38.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.43 123.47 25.36 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 123.469 0.481 . . . . 0.0 110.265 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.73 6.94 4.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -102.4 7.89 40.3 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.414 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -85.0 100.57 11.75 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 74.87 150.76 0.13 Allowed Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.733 1.213 . . . . 0.0 113.695 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -69.81 -38.32 7.83 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.379 2.053 . . . . 0.0 112.16 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.608 ' HB2' HG22 ' A' ' 419' ' ' VAL . 13.3 m120 -84.12 -37.32 22.13 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 75.32 -43.99 0.52 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 114.111 174.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -104.7 -40.08 6.12 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.407 0.549 . . . . 0.0 112.333 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -77.05 4.77 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 415' ' ' ASN . 18.7 m -146.08 156.37 12.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.2 162.75 12.31 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.24 140.22 41.8 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.13 139.61 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.26 -39.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.27 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.22 158.45 44.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.62 135.32 14.45 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 177.52 8.36 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 123.582 0.551 . . . . 0.0 109.84 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.8 149.0 22.16 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.094 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.04 127.95 45.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -32.97 74.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.21 -39.27 2.3 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.641 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -87.85 -20.2 26.37 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.697 0.284 . . . . 0.0 111.717 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.24 -166.48 23.22 Favored Glycine 0 C--O 1.222 -0.633 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.84 117.01 3.66 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.589 2.193 . . . . 0.0 111.063 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.57 153.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.467 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -147.88 123.95 10.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.926 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 5.9 m -96.32 126.39 41.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.462 HD21 HD12 ' A' ' 444' ' ' LEU . 0.0 OUTLIER -134.97 173.43 11.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 121.04 0.448 . . . . 0.0 111.208 -177.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.7 tm? -116.52 107.58 14.93 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -74.69 119.58 22.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.274 0.559 . . . . 0.0 112.063 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -124.39 -16.65 6.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -69.21 -28.0 65.98 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.673 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' GLY . . . . . 0.486 ' HA3' ' OE2' ' A' ' 498' ' ' GLU . . . 175.01 -96.07 0.1 Allowed Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.103 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 501' ' ' LYS . 40.2 m -149.2 143.92 26.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.655 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.79 136.24 49.43 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 25.7 ttpt -147.23 150.57 35.13 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 34.1 m -69.69 131.04 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.167 0.508 . . . . 0.0 110.042 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.48 -10.46 61.18 Favored Glycine 0 N--CA 1.417 -2.586 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.415 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.518 ' OD2' ' HE2' ' A' ' 445' ' ' LYS . 17.2 m-20 -89.19 146.2 35.77 Favored Pre-proline 0 C--O 1.252 1.191 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.085 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 3.8 Cg_exo -75.36 148.27 33.72 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.33 2.02 . . . . 0.0 111.702 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.27 153.45 37.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.682 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.07 107.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.88 162.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . -39.85 108.7 0.1 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.263 0.483 . . . . 0.0 113.191 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.3 m 70.78 -25.34 0.16 Allowed 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 126.523 1.929 . . . . 0.0 115.198 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.422 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.1 m -119.6 132.82 55.8 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 120.955 -1.091 . . . . 0.0 112.295 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -111.46 165.44 11.98 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -169.8 -164.04 24.85 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -137.89 135.84 36.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 444' ' ' LEU . 38.6 t -69.99 118.48 14.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 120.905 0.383 . . . . 0.0 111.548 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -88.29 -54.86 3.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.149 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -133.19 146.37 51.45 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.655 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.6 tpp -115.54 116.69 28.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.24 132.13 60.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -103.7 178.22 4.62 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.945 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.27 -29.83 25.01 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.323 1.449 . . . . 0.0 112.985 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 47.6 t -78.52 -17.2 56.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.034 0.445 . . . . 0.0 110.494 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.74 56.69 Favored Glycine 0 CA--C 1.501 -0.814 0 O-C-N 122.013 -0.43 . . . . 0.0 112.157 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -92.08 149.19 21.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 120.722 0.296 . . . . 0.0 111.607 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -75.33 129.78 37.95 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.763 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.4 m -137.33 -176.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -111.54 -24.68 9.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.129 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -149.02 157.57 43.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.84 136.01 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 122.979 0.512 . . . . 0.0 110.189 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.0 167.86 38.48 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.482 ' HA ' HG13 ' A' ' 439' ' ' VAL . 38.6 Cg_endo -63.04 153.02 76.41 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.02 2.48 . . . . 0.0 112.925 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.1 m 71.61 21.63 4.33 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.649 1.18 . . . . 0.0 111.714 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 24.9 ttt -121.0 137.07 26.13 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.84 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 6.2 Cg_exo -78.61 126.84 7.66 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.84 2.36 . . . . 0.0 111.64 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 473' ' ' ALA . 13.4 m -143.78 155.93 16.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 122.516 0.326 . . . . 0.0 110.536 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 480' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 436' ' ' THR . 44.3 tt0 -116.11 115.43 26.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.32 177.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.035 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.0 p -152.44 166.68 31.2 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.91 20.35 24.1 Favored Glycine 0 C--N 1.294 -1.797 0 O-C-N 123.823 0.702 . . . . 0.0 114.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 43.3 tp -85.18 -33.37 22.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 7.6 t60 60.82 23.59 13.57 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.346 1.459 . . . . 0.0 110.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.422 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.2 t70 -144.82 -179.91 6.9 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.18 112.49 56.48 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -78.19 166.2 24.88 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.961 1.774 . . . . 0.0 110.41 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 492' ' ' ASP . 5.5 tp-100 -120.09 132.81 55.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.785 0.802 . . . . 0.0 110.587 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.53 121.46 18.74 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.032 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.45 -0.25 59.76 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 489' ' ' GLN . 3.4 t70 -80.28 -167.43 1.32 Allowed 'General case' 0 C--O 1.247 0.93 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ARG . . . . . 0.494 ' HD3' ' N ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -137.76 129.71 28.76 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.385 0.612 . . . . 0.0 110.422 -172.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.33 158.95 29.9 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.715 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.8 ttt -118.4 123.23 44.75 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 441' ' ' ALA . 2.5 p -87.21 143.99 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -108.23 122.06 46.16 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.818 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.488 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -150.79 -162.86 1.64 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.488 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 16.8 t70 -160.72 -63.61 0.06 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 500' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -61.81 -36.91 82.51 Favored 'General case' 0 C--O 1.188 -2.156 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.819 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 501' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 443' ' ' THR . 64.7 mttp -62.97 -45.32 93.0 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.297 0.57 . . . . 0.0 112.174 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -74.82 -27.51 60.32 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.75 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.13 31.75 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 500' ' ' GLU . 3.9 ptp180 -64.66 -23.22 67.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.87 -32.79 72.22 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.208 1.004 . . . . 0.0 109.028 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 60.6 mt -87.31 -44.89 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.564 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 162.87 -6.93 0.08 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 75.16 -28.77 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.457 2.303 . . . . 0.0 111.779 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -76.04 -28.03 57.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.361 1.077 . . . . 0.0 108.712 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -102.28 146.04 28.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . 68.19 27.64 6.7 Favored 'General case' 0 C--O 1.253 1.257 0 O-C-N 124.397 1.061 . . . . 0.0 110.156 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 513' ' ' ARG . 18.4 tt0 -81.89 161.42 23.14 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.878 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 512' ' ' GLN . 4.6 ptm180 -92.88 163.37 13.73 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--N 1.261 -3.242 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.125 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.538 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 12.5 p -151.35 32.92 0.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -93.53 -82.21 0.35 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.996 -0.44 . . . . 0.0 111.567 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -65.69 0.88 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.102 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 50.7 tp -97.82 72.34 2.25 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.21 1.005 . . . . 0.0 108.994 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -126.94 9.15 6.85 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.963 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -85.21 103.86 14.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.494 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 399' ' ' GLU . 84.5 mt -79.7 -35.97 38.22 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.869 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 86.4 mt 72.43 -35.85 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.09 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 397' ' ' LEU . 38.4 tt0 -66.19 111.32 3.37 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 170.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 24.4 mmt -96.8 145.65 25.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.67 -22.01 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 98.8 mt -74.97 137.02 41.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.24 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 67.7 mt 70.69 -143.58 0.07 Allowed 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.642 1.214 . . . . 0.0 109.464 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 40.6 t 70.6 18.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 123.592 1.663 . . . . 0.0 108.142 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 34.4 t -176.52 169.13 2.65 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 77.33 6.87 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.764 1.269 . . . . 0.0 109.403 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 26.5 ttt -92.03 98.94 11.87 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.411 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -106.93 118.71 37.42 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.425 -174.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 410' ' ' LEU . 1.3 pt-20 -94.38 -88.21 0.25 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.494 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' A' ' 409' ' ' GLU . 49.1 tp -131.91 79.95 1.89 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 411' ' ' LYS . 35.1 ttpt -126.04 112.53 15.99 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.08 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.67 -29.42 8.72 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -125.67 139.54 34.34 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.95 -29.07 49.67 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.02 102.67 13.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -53.88 109.7 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.346 1.058 . . . . 0.0 112.098 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 63.3 8.83 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.794 1.237 . . . . 0.0 113.19 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -98.24 -5.06 33.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.095 0.474 . . . . 0.0 111.436 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -151.25 167.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -125.72 170.86 17.58 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.8 m -114.65 139.74 49.4 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.37 127.91 38.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.07 -37.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.83 154.96 26.97 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.58 139.13 25.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' LYS . . . . . 0.486 ' CD ' HG23 ' A' ' 434' ' ' VAL . 0.0 OUTLIER -156.99 176.85 12.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.41 150.09 22.98 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.88 119.48 32.76 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -50.85 -25.46 4.54 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.24 -36.28 1.23 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.119 -1.038 . . . . 0.0 113.646 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -90.08 -15.09 32.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 122.398 -0.472 . . . . 0.0 111.333 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 91.68 -144.93 17.45 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.02 116.42 4.14 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.388 2.059 . . . . 0.0 111.879 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.486 HG23 ' CD ' ' A' ' 426' ' ' LYS . 2.9 m -121.14 123.92 71.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 124.532 1.133 . . . . 0.0 108.943 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -130.18 125.22 34.45 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.175 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.11 122.2 40.96 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.5 pp -132.3 173.18 11.54 Favored 'General case' 0 C--N 1.257 -3.417 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 476' ' ' SER . 4.5 tt -124.17 110.63 14.92 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -69.12 121.63 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.806 0.812 . . . . 0.0 111.761 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -122.2 -16.03 7.55 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.655 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.0 -3.83 55.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.61 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 149.84 -103.56 0.25 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 119.943 -1.123 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.8 m -142.51 130.44 21.77 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.478 ' CD1' HD11 ' A' ' 437' ' ' LEU . 2.9 tt -107.26 138.47 43.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -145.94 151.94 38.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.866 0.757 . . . . 0.0 110.946 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' VAL . . . . . 0.594 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.9 m -62.77 128.29 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.331 0.586 . . . . 0.0 111.123 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.59 54.0 Favored Glycine 0 N--CA 1.428 -1.865 0 C-N-CA 119.845 -1.169 . . . . 0.0 114.219 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 445' ' ' LYS 0.254 2.2 p30 -101.17 149.58 36.4 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 118.904 1.352 . . . . 0.0 112.55 177.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 73.2 Cg_endo -78.37 124.83 6.67 Favored 'Trans proline' 0 C--N 1.364 1.393 0 C-N-CA 122.881 2.387 . . . . 0.0 113.04 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.39 151.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.364 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.03 120.61 65.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.24 111.36 26.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.68 -113.83 6.23 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.235 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 17.5 p -104.06 2.92 32.68 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.889 0.376 . . . . 0.0 111.53 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.465 HG21 ' CB ' ' A' ' 486' ' ' ASP . 25.3 m -124.78 151.33 45.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.685 0.278 . . . . 0.0 110.692 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -127.56 144.34 51.08 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -147.26 -164.36 11.12 Favored Glycine 0 C--N 1.287 -2.149 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 53.7 ttt180 -135.39 134.67 39.95 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.526 HG11 ' HE2' ' A' ' 462' ' ' MET . 38.5 t -66.67 121.58 16.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -86.88 -61.24 1.77 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.005 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.13 155.25 51.03 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 123.892 0.877 . . . . 0.0 109.091 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.526 ' HE2' HG11 ' A' ' 459' ' ' VAL . 36.4 tpp -123.68 117.83 25.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.27 132.01 70.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.3 p30 -96.65 175.03 6.53 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.617 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.16 -27.35 61.83 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.53 0.732 . . . . 0.0 112.884 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.8 t -79.42 -11.03 59.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 96.55 6.0 58.69 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.134 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ARG . . . . . 0.494 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.6 mpt_? -87.75 130.79 34.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.625 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.39 127.27 32.59 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 462' ' ' MET . 15.3 m -134.46 178.57 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -103.34 -35.4 8.42 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.647 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.65 162.16 33.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.905 0.383 . . . . 0.0 111.434 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -129.65 129.49 44.36 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.213 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.25 163.99 34.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 439' ' ' VAL . 36.4 Cg_endo -65.26 152.37 82.36 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.402 2.068 . . . . 0.0 112.409 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.625 ' HA ' HD21 ' A' ' 438' ' ' LEU . 23.0 t 74.43 15.34 3.47 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.415 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 42.1 ttm -113.14 134.81 21.77 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 5.9 Cg_exo -81.21 126.09 5.45 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.675 2.25 . . . . 0.0 110.882 173.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.4 m -137.86 142.49 35.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.216 0.532 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -91.25 112.2 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.47 167.37 2.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.17 0.51 . . . . 0.0 109.652 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.3 29.37 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 94.27 12.87 55.67 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.512 177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.05 -31.85 61.39 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t60 61.73 20.52 11.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 111.499 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ASP . . . . . 0.465 ' CB ' HG21 ' A' ' 455' ' ' THR . 4.1 t70 -149.26 -179.54 7.13 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 11.8 p -90.15 120.4 69.2 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-O 121.003 0.43 . . . . 0.0 110.369 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 488' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.2 Cg_endo -88.01 172.05 5.49 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.064 1.843 . . . . 0.0 111.425 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -128.53 131.07 48.25 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.71 33.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.85 -0.4 59.21 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.383 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -89.36 -178.35 5.59 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 152.55 24.17 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 494' ' ' PHE . . . . . 0.647 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.6 p90 -141.59 154.54 45.49 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.0 ttp -126.26 121.41 32.6 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.49 114.58 47.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.407 ' HD1' ' N ' ' A' ' 498' ' ' GLU . 0.3 OUTLIER -139.69 132.02 28.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 498' ' ' GLU . . . . . 0.407 ' N ' ' HD1' ' A' ' 497' ' ' PHE . 9.6 tp10 -67.0 141.37 57.6 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 123.724 0.64 . . . . 0.0 110.043 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -62.68 -61.21 2.58 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 125.242 1.417 . . . . 0.0 110.478 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.2 -28.72 70.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.376 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -68.77 -39.59 80.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.106 0.479 . . . . 0.0 111.374 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -80.24 -39.57 28.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.57 -52.44 61.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 508' ' ' GLU . 37.6 ttp180 -67.84 -15.79 63.79 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.389 0.676 . . . . 0.0 111.591 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -80.95 -33.87 33.62 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.411 0.624 . . . . 0.0 109.375 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.83 -54.73 7.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.351 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -164.64 3.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.447 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 35.7 tt0 75.58 -39.99 0.4 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.869 2.068 . . . . 0.0 111.347 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -91.39 -32.03 15.81 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.615 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -99.02 132.68 44.15 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.128 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -106.8 -179.09 3.84 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -164.45 107.05 0.89 Allowed 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -90.41 -37.31 14.05 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 128.593 2.757 . . . . 0.0 105.374 178.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 CA--C 1.501 -0.938 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -149.26 -179.35 25.06 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 p -117.38 143.12 46.31 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.313 0.578 . . . . 0.0 112.187 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.9 137.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.4 pt -93.18 -38.46 9.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -154.33 147.34 24.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.63 134.36 13.74 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -159.15 175.75 13.08 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -97.24 146.56 24.98 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -120.24 123.32 42.94 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.543 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.79 -10.03 3.44 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.08 -44.62 0.56 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.023 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -82.81 -25.39 32.74 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 122.859 0.464 . . . . 0.0 110.847 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.15 -166.58 15.48 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.75 116.41 4.09 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 121.84 1.693 . . . . 0.0 110.307 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 482' ' ' THR . 22.5 m -113.05 144.65 20.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-O 121.204 0.526 . . . . 0.0 109.939 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.71 111.98 9.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -85.04 120.9 27.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.0 pp -140.15 173.11 11.84 Favored 'General case' 0 C--N 1.278 -2.516 0 O-C-N 122.281 -0.262 . . . . 0.0 111.521 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.42 107.81 16.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.3 p -67.16 116.69 6.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.49 -15.64 6.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.509 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.31 -17.28 56.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.066 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.6 -107.83 0.33 Allowed Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 96.6 m -131.92 137.48 48.0 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.476 ' HG ' HG11 ' A' ' 496' ' ' VAL . 0.5 OUTLIER -109.84 127.18 54.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.602 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.7 ttpm? -131.71 158.28 41.55 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.431 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.8 m -71.19 137.13 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 O-C-N 121.777 -0.577 . . . . 0.0 110.384 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.17 -8.05 60.61 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.604 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 5.8 m-20 -68.5 136.86 90.78 Favored Pre-proline 0 CA--C 1.494 -1.202 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 55.1 Cg_endo -81.4 106.43 1.71 Allowed 'Trans proline' 0 N--CA 1.429 -2.29 0 C-N-CA 122.117 1.878 . . . . 0.0 107.544 171.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.618 HG22 HG22 ' A' ' 496' ' ' VAL . 2.8 pp -108.23 139.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.175 -170.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 58.5 t -110.39 113.99 45.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.24 112.0 38.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.08 -97.36 0.65 Allowed Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.85 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.0 t -131.74 3.95 4.18 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 120.963 0.411 . . . . 0.0 110.233 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.454 HG21 ' CB ' ' A' ' 486' ' ' ASP . 96.2 m -116.46 141.64 47.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 44.5 p90 -114.97 151.03 34.84 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -153.81 -164.3 12.59 Favored Glycine 0 C--N 1.296 -1.664 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 448' ' ' ASP . 19.9 ttm180 -134.58 127.43 31.23 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 482' ' ' THR . 60.9 t -58.88 115.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.72 0.638 . . . . 0.0 111.536 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -84.33 -59.27 2.44 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.0 151.22 48.87 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.549 0.739 . . . . 0.0 109.451 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 469' ' ' ARG . 54.7 tpp -122.49 117.33 25.69 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.3 127.91 75.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -96.45 -176.76 3.73 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.16 -173.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -48.54 -37.06 16.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 126.825 2.05 . . . . 0.0 113.114 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.0 m -88.71 -6.73 57.25 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.33 15.18 48.55 Favored Glycine 0 CA--C 1.496 -1.11 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.13 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.47 ' HB2' HD21 ' A' ' 464' ' ' ASN . 0.1 OUTLIER -100.4 135.17 42.26 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.086 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 462' ' ' MET . 6.6 tpt180 -68.89 130.99 44.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 462' ' ' MET . 14.0 m -139.71 -177.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.172 0.295 . . . . 0.0 110.681 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 472' ' ' GLU . 0.8 OUTLIER -106.32 -34.34 7.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 471' ' ' LYS . 32.8 tt0 -148.13 135.27 20.32 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.641 -172.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -128.84 144.74 51.25 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 171.11 31.96 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.233 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.506 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.5 Cg_endo -63.44 156.67 55.02 Favored 'Trans proline' 0 C--O 1.247 0.931 0 C-N-CA 122.969 2.446 . . . . 0.0 112.598 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 44.3 m 71.98 12.32 6.07 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.218 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.0 ttp -118.88 129.73 25.23 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.2 Cg_exo -67.48 127.22 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.694 2.263 . . . . 0.0 111.108 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 473' ' ' ALA . 24.5 m -139.85 154.96 24.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 39.4 tt0 -115.7 119.21 35.33 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -98.19 173.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.969 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.465 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.2 p -149.38 167.63 25.63 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.62 31.42 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.452 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 53.9 tp -81.22 -30.89 34.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.648 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 61.46 20.58 11.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.351 1.46 . . . . 0.0 111.345 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.454 ' CB ' HG21 ' A' ' 455' ' ' THR . 34.5 t70 -147.81 175.09 11.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.42 114.76 53.83 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 118.983 0.811 . . . . 0.0 112.318 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.75 146.61 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.686 1.59 . . . . 0.0 110.25 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.37 139.58 50.68 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.08 131.6 43.86 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.091 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.38 -0.12 68.05 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.091 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.56 ' OD1' ' HD2' ' A' ' 493' ' ' ARG . 1.6 t0 -85.02 -173.63 4.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.6 ' H ' ' HD2' ' A' ' 493' ' ' ARG . 0.9 OUTLIER -130.0 133.85 47.04 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.485 -175.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 40.5 p90 -127.15 150.23 49.59 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 54.2 ttp -119.98 115.81 24.5 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.822 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 450' ' ' ILE . 26.3 t . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.214 -0.768 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -47.37 -54.15 11.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 112.144 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.47 -34.92 41.05 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.241 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.57 73.04 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 122.006 0.908 . . . . 0.0 108.885 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -61.03 -37.62 83.22 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 125.675 1.59 . . . . 0.0 110.289 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -63.62 -45.32 90.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.798 0.332 . . . . 0.0 110.251 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 80.1 mt -67.67 -34.21 66.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.152 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -177.559 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 495' ' ' MET . 10.9 m . . . . . 0 CA--C 1.51 -0.576 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -139.63 -178.13 16.36 Favored Glycine 0 C--N 1.295 -1.697 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 26.7 m -124.22 143.8 50.32 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.4 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.045 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.7 pt -91.7 -35.19 6.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.423 ' HG3' ' OG1' ' A' ' 436' ' ' THR . 9.8 pt-20 -159.21 148.66 18.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.22 130.54 12.06 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 177.46 10.71 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -174.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 427' ' ' LEU . 2.0 pt? -94.72 150.12 20.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.84 135.09 50.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.29 -18.2 59.08 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.834 -174.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -114.82 -36.31 1.28 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.549 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.52 -30.48 19.3 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.418 -0.46 . . . . 0.0 111.796 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.67 -152.28 17.7 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 482' ' ' THR . 14.4 Cg_exo -71.67 116.33 4.66 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.725 1.617 . . . . 0.0 110.017 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.93 124.06 68.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.63 0.729 . . . . 0.0 111.537 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -123.08 112.18 17.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.889 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 424' ' ' GLU . 1.2 m -83.59 115.45 22.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.2 pp -132.21 170.85 14.44 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.898 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.467 ' O ' ' HG3' ' A' ' 440' ' ' GLN . 2.1 tm? -117.03 106.13 13.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -64.64 117.7 5.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-O 121.827 0.823 . . . . 0.0 112.346 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 438' ' ' LEU . 72.1 mt-30 -123.66 -15.46 7.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.698 -175.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.579 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -78.28 -14.99 59.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.831 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 153.97 -108.05 0.35 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 27.2 m -128.8 142.5 50.96 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.554 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.13 135.98 53.22 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.3 ttpt -146.0 150.83 36.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 33.5 m -70.74 134.23 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.235 0.541 . . . . 0.0 110.707 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 105.2 -21.19 36.11 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.488 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 43.8 m-20 -79.47 146.44 65.85 Favored Pre-proline 0 C--O 1.251 1.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 458' ' ' ARG . 10.7 Cg_endo -77.8 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.114 1.876 . . . . 0.0 111.179 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.58 152.03 30.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.67 121.9 48.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-O 121.195 0.521 . . . . 0.0 109.64 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.462 ' HB ' ' CB ' ' A' ' 494' ' ' PHE . 2.5 p -143.78 133.45 20.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.644 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.75 33.82 88.26 Favored Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.261 26.7 p 62.05 1.76 0.71 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.928 1.691 . . . . 0.0 114.306 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 39.0 m -98.38 141.15 31.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -120.18 151.37 39.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.171 -1.011 . . . . 0.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.25 14.04 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 449' ' ' PRO . 32.7 ttp180 -127.76 146.65 50.52 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.521 HG11 ' HE2' ' A' ' 462' ' ' MET . 45.9 t -74.08 120.17 22.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -92.63 -45.16 8.21 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.782 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -144.04 152.56 41.17 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.554 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -122.47 117.59 26.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.94 133.81 65.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.542 HD21 ' HB2' ' A' ' 468' ' ' ARG . 4.7 p30 -101.63 172.77 6.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.816 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.67 -26.1 61.2 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.335 1.054 . . . . 0.0 113.061 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.7 m -86.02 -2.22 58.1 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 122.099 -0.375 . . . . 0.0 111.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 93.92 1.98 64.98 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.413 170.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.8 mpt_? -86.35 131.83 34.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.597 -0.301 . . . . 0.0 110.439 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -77.85 129.63 35.64 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.08 176.04 9.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 -8.35 10.38 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.736 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -151.65 139.4 19.81 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.55 131.55 29.73 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.74 166.9 31.73 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.439 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 439' ' ' VAL . 17.7 Cg_endo -58.05 149.81 68.86 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 123.252 2.635 . . . . 0.0 112.175 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 43.4 t 77.55 6.44 2.92 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.917 0.887 . . . . 0.0 112.133 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 39.5 ttp -110.26 127.09 27.62 Favored Pre-proline 0 N--CA 1.439 -0.993 0 O-C-N 121.403 -0.811 . . . . 0.0 111.417 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.8 Cg_endo -74.15 126.59 10.62 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.627 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 17.4 m -141.17 152.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.327 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 35.4 mt-10 -99.62 123.1 43.57 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.5 pt -97.58 164.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 4.1 p -145.77 158.38 43.86 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 100.9 12.48 36.96 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.919 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.31 -36.58 71.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 67.33 21.43 9.81 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.731 1.612 . . . . 0.0 109.873 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.451 ' CB ' HG21 ' A' ' 455' ' ' THR . 6.7 t70 -145.63 -179.05 6.42 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.29 110.05 48.36 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 123.405 0.441 . . . . 0.0 110.982 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 36.2 Cg_endo -82.73 148.49 13.98 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.931 1.754 . . . . 0.0 110.561 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -111.29 135.98 51.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.024 0.44 . . . . 0.0 111.958 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.87 127.26 32.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.99 -0.24 66.69 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.866 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.2 t70 -88.41 -172.13 3.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.0 OUTLIER -128.31 139.0 52.65 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -171.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 46.7 p90 -127.63 159.69 33.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.01 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . 0.414 ' HB2' HG12 ' A' ' 419' ' ' VAL . 28.1 ttt -132.44 130.68 40.88 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.579 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.0 p . . . . . 0 N--CA 1.426 -1.657 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 . . . . . 0 C--O 1.199 -1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -62.27 -52.97 61.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.903 -170.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.22 -40.72 95.05 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.282 0.363 . . . . 0.0 110.257 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.05 60.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.104 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -60.29 -38.11 82.61 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.961 0.904 . . . . 0.0 110.928 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -69.84 -34.62 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.645 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.65 -23.21 14.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.655 0.741 . . . . 0.0 110.116 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.086 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -177.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.591 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 30.4 m . . . . . 0 CA--C 1.498 -1.041 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.99 162.02 13.29 Favored Glycine 0 C--N 1.279 -2.62 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 m -117.01 138.76 51.36 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.88 139.45 17.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 18.2 pt -99.3 -39.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 490' ' ' ALA . 8.5 pt-20 -153.39 152.29 30.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.22 134.34 29.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.69 177.39 10.91 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.311 0.577 . . . . 0.0 111.185 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.97 145.08 26.19 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.771 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 10.4 t70 -128.02 129.16 46.25 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -75.55 -11.23 59.98 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -175.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -119.34 -35.64 0.92 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.478 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.0 mtp180 -94.08 -15.22 24.94 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.844 0.458 . . . . 0.0 111.028 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 88.15 -154.1 25.08 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -60.27 116.16 3.13 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.108 1.872 . . . . 0.0 111.173 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.8 137.18 53.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.434 0.635 . . . . 0.0 110.377 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -131.4 114.62 15.19 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.104 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -83.39 119.44 24.64 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.482 HD22 ' CE1' ' A' ' 494' ' ' PHE . 1.6 pp -135.73 173.07 12.12 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -120.01 112.41 19.12 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -75.77 125.2 35.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.526 0.679 . . . . 0.0 111.799 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 72.6 mt-30 -124.03 -15.11 6.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.937 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -97.3 6.31 48.55 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 147.62 -125.77 2.22 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.15 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.7 m -116.39 141.63 47.92 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.73 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.77 119.25 36.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.4 ttpm? -130.02 155.14 46.61 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.494 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.0 m -67.06 132.16 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.84 -7.09 48.76 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.916 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 445' ' ' LYS . 13.7 m-20 -73.88 135.02 77.68 Favored Pre-proline 0 C--O 1.25 1.089 0 CA-C-N 117.555 0.678 . . . . 0.0 111.932 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.32 119.15 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.629 2.219 . . . . 0.0 109.306 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.07 159.81 29.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.73 115.59 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 494' ' ' PHE . 16.6 t -128.38 124.17 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 56.98 42.35 92.78 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.264 6.6 t 60.39 4.09 0.65 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.549 2.34 . . . . 0.0 113.436 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.462 HG21 ' CB ' ' A' ' 486' ' ' ASP . 22.4 m -96.53 135.62 38.18 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -111.5 151.65 28.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.604 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.95 -163.97 19.29 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -134.62 137.21 43.48 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 444' ' ' LEU . 48.7 t -66.69 119.36 11.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.184 0.516 . . . . 0.0 112.097 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -81.54 -60.59 2.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.92 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -136.2 152.05 50.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.73 ' HE1' HD22 ' A' ' 444' ' ' LEU . 41.2 tpp -115.23 117.07 29.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 469' ' ' ARG . 11.9 t -122.88 126.49 73.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.444 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -92.81 174.77 7.08 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.625 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.21 -27.82 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.949 0.9 . . . . 0.0 113.144 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.5 m -78.81 -12.1 60.01 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.756 0.312 . . . . 0.0 111.0 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 98.41 8.32 54.95 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.93 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -97.0 128.81 44.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 463' ' ' VAL . 3.8 tmm_? -84.77 124.33 31.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.43 -174.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -99.31 -31.85 11.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.11 156.67 40.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.304 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.53 42.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -100.58 177.04 28.0 Favored Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.44 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.7 Cg_endo -59.76 155.37 43.6 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.971 2.447 . . . . 0.0 112.641 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 47.6 m 70.81 16.94 6.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.955 0.902 . . . . 0.0 112.144 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 45.5 ttm -117.81 136.68 23.8 Favored Pre-proline 0 C--N 1.316 -0.861 0 O-C-N 122.007 -0.433 . . . . 0.0 111.185 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.1 Cg_endo -82.57 125.85 4.5 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.234 1.956 . . . . 0.0 110.884 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 464' ' ' ASN . 16.9 m -143.22 156.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.0 mt-10 -105.0 126.55 52.18 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 50.0 pt -97.95 170.4 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 1.2 p -150.42 167.46 27.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.75 13.89 62.05 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.914 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.63 -32.54 64.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.9 t60 67.45 19.85 9.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.076 1.75 . . . . 0.0 109.788 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.462 ' CB ' HG21 ' A' ' 455' ' ' THR . 7.3 t70 -148.39 -179.98 7.36 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.9 t -120.42 113.41 33.68 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.46 175.38 10.24 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.773 2.315 . . . . 0.0 111.509 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -111.03 148.0 33.54 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 424' ' ' GLU . . . -70.22 138.84 52.05 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.255 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.85 -0.23 86.26 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.18 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.613 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 4.5 t70 -83.96 -165.34 1.11 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.613 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -138.59 148.98 44.78 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.688 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.482 ' CE1' HD22 ' A' ' 437' ' ' LEU . 15.0 p90 -139.56 156.19 47.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.833 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.1 ttt -118.86 127.39 53.46 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.8 p . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.719 0 CA-C-O 121.096 0.474 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -72.53 -38.63 67.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.607 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.49 -46.78 88.84 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.611 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.94 -45.03 94.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -58.94 -36.03 74.1 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 125.374 1.469 . . . . 0.0 111.757 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -34.14 59.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.9 mm -80.18 -54.06 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.316 0 C-N-CA 118.695 -1.717 . . . . 0.0 115.052 -178.378 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.503 -0.85 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -129.47 178.37 17.43 Favored Glycine 0 C--N 1.298 -1.554 0 C-N-CA 119.233 -1.46 . . . . 0.0 112.542 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.84 145.16 45.89 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 123.335 0.654 . . . . 0.0 111.107 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 30.0 t -86.55 134.06 28.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 436' ' ' THR . 17.2 pt -94.26 -33.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.31 149.13 20.56 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.58 131.27 18.93 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.78 177.98 4.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.89 152.85 21.77 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -126.62 119.32 26.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -58.11 -19.55 33.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -112.53 -38.78 1.28 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.784 -1.198 . . . . 0.0 112.839 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.57 -32.59 19.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.37 -155.53 16.17 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.56 116.38 4.38 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.075 1.85 . . . . 0.0 110.068 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 32.4 m -116.3 143.94 25.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.793 0.806 . . . . 0.0 111.684 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -133.17 112.03 11.4 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.488 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 423' ' ' ILE . 2.7 m -87.55 115.36 24.92 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.646 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.4 pp -132.86 171.37 14.0 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 476' ' ' SER . 2.4 tm? -113.33 106.38 14.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -70.3 108.84 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.352 1.072 . . . . 0.0 111.928 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -115.0 -15.94 11.71 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.18 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -77.64 -4.12 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.906 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.31 -95.67 0.19 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.218 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.9 m -142.05 139.61 32.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -114.47 135.57 53.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -147.75 164.3 34.01 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 28.6 m -70.62 138.12 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 121.734 0.778 . . . . 0.0 112.134 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.28 -10.62 65.4 Favored Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.207 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 51.1 m-20 -76.66 131.76 73.37 Favored Pre-proline 0 C--O 1.245 0.848 0 CA-C-N 117.651 0.725 . . . . 0.0 111.536 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 4.9 Cg_exo -77.42 107.68 2.44 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.681 2.254 . . . . 0.0 109.26 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -112.48 161.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.898 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.56 114.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.444 HG23 HD13 ' A' ' 450' ' ' ILE . 61.7 t -120.34 112.42 36.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.55 -115.61 7.52 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.8 p -107.34 7.02 28.94 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.997 0.427 . . . . 0.0 111.259 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 486' ' ' ASP . 90.0 m -121.59 129.53 52.9 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.781 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -111.31 151.99 27.74 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -165.66 -164.27 20.77 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.593 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 56.7 ttp180 -131.91 128.72 39.15 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 482' ' ' THR . 40.1 t -61.28 122.86 12.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 123.859 0.724 . . . . 0.0 111.767 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -95.71 -56.93 2.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.31 52.28 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.6 tpp -115.37 117.68 31.09 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 16.8 t -116.36 139.6 42.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -105.43 171.97 7.04 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.095 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.6 -25.89 54.02 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 41.2 m -77.09 -11.71 59.85 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.011 -0.43 . . . . 0.0 110.954 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.74 -4.64 56.41 Favored Glycine 0 CA--C 1.496 -1.12 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.484 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -91.89 140.26 29.85 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.4 tmm_? -86.44 138.01 32.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 16.7 m -136.17 -173.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 124.41 1.084 . . . . 0.0 108.493 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -119.34 -17.07 8.91 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.113 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 445' ' ' LYS . 34.0 tt0 -149.19 152.25 35.72 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.44 135.36 30.25 Favored 'General case' 0 C--O 1.25 1.11 0 O-C-N 123.536 0.522 . . . . 0.0 110.876 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -86.45 168.43 40.19 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.641 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 439' ' ' VAL . 37.0 Cg_endo -64.26 154.99 68.0 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 122.941 2.427 . . . . 0.0 113.729 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 438' ' ' LEU . 34.1 m 70.17 16.55 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.016 1.326 . . . . 0.0 112.19 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.6 ttp -117.0 130.07 24.87 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.475 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 11.2 Cg_endo -72.68 126.12 11.16 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.27 1.98 . . . . 0.0 111.788 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.72 155.05 22.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.672 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 463' ' ' VAL . 43.5 mt-10 -108.64 113.63 26.78 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 124.516 1.127 . . . . 0.0 108.575 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.8 pt -98.13 172.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.805 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.6 p -146.45 163.03 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 107.29 11.56 25.34 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.972 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.4 mt -83.71 -27.29 29.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.706 0.289 . . . . 0.0 111.749 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 60.27 19.26 8.73 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.61 1.164 . . . . 0.0 110.518 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 455' ' ' THR . 34.4 t70 -149.26 174.39 12.44 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.22 112.26 52.37 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.92 2.413 . . . . 0.0 111.37 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -105.31 132.43 51.51 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.484 0.659 . . . . 0.0 111.656 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.03 28.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 101.63 -5.11 54.16 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.24 -177.48 6.25 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.09 143.66 44.41 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.656 0.782 . . . . 0.0 110.758 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.646 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 50.1 p90 -136.83 163.16 31.3 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.5 ttm -130.17 115.88 17.65 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.851 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' A' ' 444' ' ' LEU . 74.6 t . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 49.3 mt-10 . . . . . 0 C--O 1.182 -2.458 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -62.42 -39.12 92.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.74 0.781 . . . . 0.0 111.141 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.12 -41.2 86.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.914 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.65 -25.92 41.22 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.159 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 28.7 ttt180 -70.76 -29.06 65.17 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.74 1.216 . . . . 0.0 110.014 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.2 -34.52 78.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.033 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 70.9 mt -79.08 -35.02 17.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.437 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.272 177.256 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -147.8 -175.35 20.46 Favored Glycine 0 C--N 1.299 -1.508 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 6.6 m -123.76 141.96 51.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.098 0.449 . . . . 0.0 109.891 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.87 138.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.4 pt -94.19 -42.22 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.779 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.77 146.72 27.34 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.71 19.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 177.44 4.34 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.98 150.78 20.05 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.043 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -127.46 129.84 48.18 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -67.21 -16.87 64.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.7 -53.78 0.55 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.93 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.72 -29.25 64.33 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.49 0.662 . . . . 0.0 110.15 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 434' ' ' VAL . . . 104.16 -179.42 24.89 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 486' ' ' ASP . 35.6 Cg_exo -49.73 119.55 4.87 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.341 2.027 . . . . 0.0 111.179 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 432' ' ' GLY . 21.0 m -117.98 158.81 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.444 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -150.76 113.38 4.69 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.095 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 m -90.47 119.84 31.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -134.63 173.3 11.82 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.54 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.6 tm? -117.07 106.16 13.06 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.8 p -78.71 123.41 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.415 0.626 . . . . 0.0 112.506 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -124.09 -16.31 6.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.403 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -63.82 -16.99 62.64 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.541 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.89 -92.79 0.11 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.433 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.3 m -148.1 141.86 25.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.729 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.22 117.76 34.94 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.8 ttpm? -125.62 153.46 43.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.2 m -71.02 139.02 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.775 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 101.75 -10.23 57.3 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.405 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 66.1 m-20 -82.08 138.19 46.01 Favored Pre-proline 0 C--O 1.244 0.789 0 CA-C-N 117.271 0.535 . . . . 0.0 111.846 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 18.5 Cg_endo -83.68 106.87 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.542 2.161 . . . . 0.0 110.161 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -108.4 162.98 6.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.034 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 6.9 p -133.18 125.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.67 125.5 70.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.64 -103.12 1.13 Allowed Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 19.6 m -126.33 0.24 7.02 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.739 0.78 . . . . 0.0 109.662 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 74.7 m -116.23 146.01 42.68 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.491 -0.755 . . . . 0.0 111.158 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 54.7 p90 -119.24 159.89 23.23 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -164.81 -164.44 20.14 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 35.3 ttm-85 -135.43 130.03 34.16 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 482' ' ' THR . 38.2 t -64.46 120.78 12.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.69 0.757 . . . . 0.0 112.858 -172.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -85.33 -60.28 2.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.812 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.8 160.75 37.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.921 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.729 ' HE1' HD22 ' A' ' 444' ' ' LEU . 36.7 tpp -130.69 117.51 19.56 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.16 138.78 53.72 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.0 p30 -103.62 176.48 5.14 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.932 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -51.33 -38.39 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.517 1.136 . . . . 0.0 111.783 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.0 m -76.74 -5.9 49.98 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.01 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.44 2.64 63.5 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.38 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.477 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.9 mpt_? -88.67 128.63 35.6 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.755 0.312 . . . . 0.0 110.365 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -84.31 134.15 34.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.1 176.15 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -96.52 -35.51 11.09 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.962 0.411 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.75 151.43 28.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.304 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.91 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.135 0.574 . . . . 0.0 109.755 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.77 179.29 42.87 Favored Glycine 0 N--CA 1.439 -1.148 0 O-C-N 123.534 0.521 . . . . 0.0 112.327 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.411 ' HA ' HG13 ' A' ' 439' ' ' VAL . 65.1 Cg_endo -71.72 161.01 46.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.696 2.264 . . . . 0.0 112.689 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 438' ' ' LEU . 18.7 m 67.25 23.14 9.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.406 1.082 . . . . 0.0 110.591 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.0 ttt -125.86 137.62 30.43 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.884 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 5.7 Cg_exo -83.21 125.75 4.1 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.0 m -142.69 151.66 17.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.248 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.7 tt0 -108.63 119.05 38.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.5 pt -98.15 172.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.262 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.6 p -148.9 157.24 43.28 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.823 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.49 4.96 Favored Glycine 0 C--N 1.308 -0.988 0 O-C-N 123.566 0.541 . . . . 0.0 112.379 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.27 -31.65 11.95 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.76 21.16 11.22 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.992 1.317 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 433' ' ' PRO . 38.1 t70 -147.78 167.43 24.72 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 4.8 p -94.75 115.93 65.85 Favored Pre-proline 0 C--N 1.287 -2.117 0 CA-C-O 121.035 0.445 . . . . 0.0 110.762 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.9 Cg_endo -84.97 173.7 7.88 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.617 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -122.47 136.63 54.93 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.962 0.411 . . . . 0.0 111.383 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.85 140.6 51.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.922 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.51 89.38 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.585 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.84 -176.4 4.43 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 6.3 mpt_? -113.14 150.4 32.26 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.241 0.543 . . . . 0.0 110.196 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.2 p90 -139.54 165.13 28.07 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.14 131.99 45.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 444' ' ' LEU . 84.5 t . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 503' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.968 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 505' ' ' GLN . 6.7 mmmm -56.36 -42.48 77.87 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.277 0.361 . . . . 0.0 110.363 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -80.82 -37.38 30.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 500' ' ' GLU . . . -54.64 -56.6 17.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.23 0.612 . . . . 0.0 111.425 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -72.73 -19.49 61.37 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.394 0.616 . . . . 0.0 111.296 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 501' ' ' LYS . 7.9 tt0 -81.21 -31.05 34.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.01 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 83.3 mt -87.29 -53.89 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.607 0 C-N-CA 119.237 -1.459 . . . . 0.0 114.173 179.278 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.504 -0.791 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -141.84 -178.35 17.87 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.3 m -124.21 138.97 54.34 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.64 138.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 436' ' ' THR . 24.7 pt -89.13 -44.3 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.045 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 7.4 pt-20 -155.45 157.42 36.95 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.05 136.98 32.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 177.74 5.54 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.18 152.48 21.08 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.344 0.593 . . . . 0.0 110.047 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -122.76 118.28 27.68 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.466 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.2 -19.37 13.44 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.31 -41.32 1.79 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.642 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.55 -37.25 19.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 110.817 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.63 -146.42 18.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.53 116.51 4.27 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.507 2.138 . . . . 0.0 111.331 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 482' ' ' THR . 27.4 m -119.81 158.6 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.2 121.77 13.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 480' ' ' GLU . 1.6 m -92.55 117.65 30.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.613 HD23 ' CZ ' ' A' ' 494' ' ' PHE . 0.0 OUTLIER -133.75 168.87 17.92 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.506 -177.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -114.86 106.35 14.07 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -72.72 117.08 15.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.779 0.799 . . . . 0.0 112.494 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.41 -15.96 9.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.123 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.68 60.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.802 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 155.63 -106.92 0.3 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 90.1 m -134.74 133.69 40.2 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.559 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -101.9 126.02 48.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.1 ttpt -140.09 145.71 37.98 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -64.93 145.58 13.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.368 0.604 . . . . 0.0 112.449 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 -21.87 42.52 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.419 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 0.3 OUTLIER -94.7 144.03 27.21 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 26.1 Cg_exo -66.55 136.69 43.7 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.914 2.409 . . . . 0.0 111.346 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 452' ' ' VAL . 2.7 pp -131.5 161.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.262 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.22 116.19 47.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.48 HG23 HD13 ' A' ' 450' ' ' ILE . 85.0 t -128.58 122.62 57.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . 0.513 ' HA2' ' OD1' ' A' ' 492' ' ' ASP . . . 60.89 36.63 92.39 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 121.18 -0.534 . . . . 0.0 111.966 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.295 8.3 p 60.97 8.93 2.08 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.498 HG21 ' CB ' ' A' ' 486' ' ' ASP . 87.0 m -102.81 139.41 38.42 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -111.65 146.77 36.87 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.493 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -152.6 -167.86 15.94 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.67 135.92 47.27 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.561 HG11 ' HE2' ' A' ' 462' ' ' MET . 46.2 t -73.73 117.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 123.404 0.44 . . . . 0.0 110.292 -176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.97 -56.22 3.42 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -130.63 153.76 48.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.561 ' HE2' HG11 ' A' ' 459' ' ' VAL . 39.5 tpp -121.09 120.02 34.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.87 139.13 51.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 5.5 p30 -97.02 174.53 6.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.12 -25.88 67.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 44.0 m -78.83 -19.8 51.21 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.189 0.519 . . . . 0.0 111.102 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.88 2.21 Favored Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.191 165.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.468 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 25.8 ttm180 -120.27 136.5 54.65 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.021 -1.59 . . . . 0.0 109.941 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -79.77 132.05 36.06 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.16 0.913 . . . . 0.0 110.728 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.29 -32.0 8.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.138 0.494 . . . . 0.0 110.284 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.04 163.95 37.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.388 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.64 38.45 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.09 172.31 38.19 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.555 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.498 ' HA ' HG13 ' A' ' 439' ' ' VAL . 35.6 Cg_endo -65.79 158.55 53.11 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.9 m 70.54 16.83 6.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.598 1.159 . . . . 0.0 111.362 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 25.1 ttt -117.04 137.53 23.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.677 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 1.9 Cg_endo -82.06 126.15 4.93 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.417 2.078 . . . . 0.0 111.298 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.57 158.0 16.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.334 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 37.8 mt-10 -111.62 121.24 44.61 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.7 pt -98.44 172.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.773 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.447 ' CG2' HG12 ' A' ' 434' ' ' VAL . 3.1 p -147.43 163.19 37.29 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.65 7.73 58.79 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.159 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.89 -39.05 64.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.22 30.41 19.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.003 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 455' ' ' THR . 35.2 t70 -140.77 179.67 6.57 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.58 109.73 47.27 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 118.317 0.508 . . . . 0.0 109.939 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 1.2 Cg_endo -80.58 164.19 21.15 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 121.602 1.535 . . . . 0.0 109.73 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -131.4 140.06 49.57 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-O 121.318 0.58 . . . . 0.0 110.458 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -71.11 132.08 44.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.285 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 88.24 0.61 82.57 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.968 -1.111 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.595 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.6 t70 -88.41 -173.26 4.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.595 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -128.4 153.54 46.96 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.156 0.503 . . . . 0.0 111.0 -171.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.613 ' CZ ' HD23 ' A' ' 437' ' ' LEU . 44.2 p90 -145.65 165.7 27.96 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.105 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.3 ttt -133.15 123.44 25.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' CD1' ' A' ' 494' ' ' PHE . 84.0 t . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 7.1 pt-20 . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.491 0.662 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 61.6 mtpt -66.49 -37.7 85.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.562 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 506' ' ' ILE . 87.8 tttt -77.79 -40.0 42.09 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.035 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.22 86.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.481 0.657 . . . . 0.0 110.924 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -58.5 -38.83 78.47 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.835 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -74.32 -35.43 63.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.534 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 502' ' ' LYS . 75.7 mt -64.68 -38.42 82.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.724 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.31 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.117 -179.423 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -126.41 171.07 18.17 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.1 m -121.86 139.94 53.01 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 34.1 t -84.61 134.78 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.93 -38.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.196 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.33 132.05 12.32 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -166.33 175.48 8.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -82.62 142.75 31.5 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.992 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.46 122.56 48.05 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.515 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.21 -16.33 43.88 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.09 -36.15 1.05 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.508 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -93.76 -15.25 25.37 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 94.13 -167.56 27.91 Favored Glycine 0 C--O 1.206 -1.597 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.32 116.46 3.2 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.207 1.938 . . . . 0.0 111.06 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.75 145.36 21.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-O 121.292 0.568 . . . . 0.0 111.043 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.79 114.92 8.32 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.36 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 480' ' ' GLU . 6.7 m -87.04 127.56 35.1 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -141.6 169.87 16.79 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.543 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -118.44 109.48 16.29 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -78.06 122.51 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.572 0.701 . . . . 0.0 112.293 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -123.92 -13.4 7.37 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.38 -19.82 41.84 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.03 -171.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 167.53 -118.32 0.78 Allowed Glycine 0 N--CA 1.414 -2.77 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.024 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.3 m -130.85 120.82 24.23 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.654 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -98.18 123.19 42.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 24.6 ttpt -137.87 153.12 49.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -70.78 141.25 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.372 0.606 . . . . 0.0 112.554 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.39 87.14 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.403 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.32 139.63 21.66 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.16 134.7 47.0 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.085 2.523 . . . . 0.0 113.192 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -134.22 162.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.651 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 121.42 49.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 450' ' ' ILE . 59.9 t -128.45 119.25 49.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.99 96.9 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 123.474 0.484 . . . . 0.0 112.069 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.304 35.0 p 66.82 -6.34 0.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.83 1.652 . . . . 0.0 115.027 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.0 m -90.94 140.92 29.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -110.78 155.48 22.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.688 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -161.47 -164.33 16.15 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 40.9 ttm180 -135.7 131.66 35.94 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 446' ' ' VAL . 35.2 t -67.96 114.06 4.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -79.22 -56.55 4.27 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.732 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.65 148.93 46.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.654 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.9 tpp -114.69 116.97 29.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.4 136.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.43 178.01 5.01 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.792 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.14 -34.76 58.18 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.157 0.983 . . . . 0.0 112.375 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.6 m -83.88 -4.03 58.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.53 62.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.97 171.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.46 136.9 37.72 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -90.07 128.65 36.35 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.46 -175.37 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.428 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.53 -36.26 6.25 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.79 148.3 35.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.631 -174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.39 142.15 39.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.51 176.26 36.62 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.447 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.5 Cg_endo -64.28 155.44 65.47 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 438' ' ' LEU . 70.8 m 70.23 22.04 5.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.383 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.8 ttt -120.52 133.74 24.08 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.244 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 4.9 Cg_exo -79.2 126.5 7.01 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.866 2.377 . . . . 0.0 110.718 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.48 155.01 14.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.49 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 436' ' ' THR . 33.4 mt-10 -106.72 116.63 32.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -98.19 168.25 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.2 p -147.77 165.81 29.42 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 98.93 13.49 39.77 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.597 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.56 -28.3 33.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 58.11 25.48 12.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.141 1.376 . . . . 0.0 110.944 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 455' ' ' THR . 11.2 t70 -147.53 -179.61 6.99 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.21 105.1 51.32 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.69 170.88 19.29 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.939 1.759 . . . . 0.0 111.144 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -111.92 141.01 46.1 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.76 21.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.03 59.25 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.905 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.44 174.62 10.48 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 141.93 43.31 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.394 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -133.77 158.33 43.61 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.9 ttt -132.37 131.27 41.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.159 0.504 . . . . 0.0 109.801 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 86.7 mttt -62.84 -47.04 85.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.815 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -79.97 -29.01 39.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.036 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.1 -47.03 86.45 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -57.22 -39.55 75.69 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.957 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 81.5 mm-40 -64.32 -44.82 90.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.239 0.337 . . . . 0.0 110.633 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.96 -38.84 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.612 0.72 . . . . 0.0 110.345 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.334 -177.581 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.508 -0.665 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.72 -179.04 19.19 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 61.1 m -126.36 144.34 50.85 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.324 0.583 . . . . 0.0 110.535 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 425' ' ' ALA . 43.1 t -80.13 132.87 30.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.9 pt -86.7 -39.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.65 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.51 146.42 22.37 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . 0.489 ' HB2' HG11 ' A' ' 422' ' ' VAL . . . -149.86 146.51 27.15 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -173.85 177.15 2.49 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.3 pt? -85.39 148.73 25.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.98 131.1 51.13 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.982 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -74.28 -15.7 60.96 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.625 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -91.3 -58.53 1.45 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.935 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -95.81 -42.47 8.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.144 0.472 . . . . 0.0 112.056 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 135.35 -135.89 8.16 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.53 116.05 4.38 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.971 1.78 . . . . 0.0 110.708 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.47 142.63 33.9 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 CA-C-O 121.38 0.609 . . . . 0.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -139.94 113.42 8.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.871 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.64 120.82 27.49 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -135.88 173.44 11.71 Favored 'General case' 0 C--N 1.273 -2.743 0 O-C-N 122.188 -0.32 . . . . 0.0 111.756 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -121.39 106.3 11.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.8 p -74.35 121.85 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.634 0.73 . . . . 0.0 112.891 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -125.38 -15.97 6.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.772 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 496' ' ' VAL . . . -73.24 -9.51 58.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.407 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.02 -97.01 0.16 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.887 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.3 m -144.51 139.64 28.36 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -111.05 115.52 29.59 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -131.75 154.22 49.28 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.486 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -70.46 146.14 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.778 0.799 . . . . 0.0 112.774 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 502' ' ' LYS . . . 97.23 -10.61 65.49 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.577 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.56 153.43 38.82 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.04 134.64 6.17 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 C-N-CA 122.401 2.068 . . . . 0.0 112.501 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.2 150.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.9 p -121.28 122.49 67.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.43 108.75 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.91 -90.96 0.22 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.233 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.7 t -118.25 -19.78 8.83 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.887 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 486' ' ' ASP . 29.6 m -105.68 137.92 42.74 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.364 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 51.1 p90 -114.82 148.5 38.41 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.066 0.46 . . . . 0.0 110.858 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -155.73 -164.93 13.71 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -126.6 143.13 51.32 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.445 HG11 ' HE2' ' A' ' 462' ' ' MET . 32.6 t -73.21 113.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.487 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -88.69 -59.28 2.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.98 148.43 50.09 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 40.0 tpp -114.74 117.78 31.75 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.97 157.65 22.25 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 44.4 p30 -108.18 -176.68 3.12 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.548 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.1 -25.29 61.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.375 0.607 . . . . 0.0 110.251 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.1 m -81.89 -13.27 57.8 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.36 6.61 50.61 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.435 ' HB2' HD21 ' A' ' 464' ' ' ASN . 10.8 mpt_? -88.97 140.78 29.08 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -101.58 126.58 48.42 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 462' ' ' MET . 31.0 m -131.54 -175.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.63 -23.13 8.87 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -154.17 137.28 15.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.13 147.67 32.76 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.658 0.383 . . . . 0.0 110.694 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -95.3 179.82 36.45 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.44 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.415 ' HA ' HG13 ' A' ' 439' ' ' VAL . 55.5 Cg_endo -68.56 160.51 49.03 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.921 2.414 . . . . 0.0 113.463 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.423 ' HA ' HD11 ' A' ' 438' ' ' LEU . 36.8 m 65.4 29.64 11.31 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.236 1.017 . . . . 0.0 110.704 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.2 ttt -131.59 131.01 22.57 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.502 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.3 Cg_endo -78.03 125.17 7.09 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.653 1.569 . . . . 0.0 111.884 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.4 m -137.66 158.48 34.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.585 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 33.3 tt0 -121.48 114.78 21.73 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.7 pt -97.74 170.78 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.561 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 5.3 p -147.96 160.44 42.82 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.85 7.51 38.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.096 -1.05 . . . . 0.0 114.332 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.47 -30.91 64.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.182 0.491 . . . . 0.0 109.938 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 23.5 t60 64.3 21.45 12.52 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.959 1.304 . . . . 0.0 110.73 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.433 ' CB ' HG21 ' A' ' 455' ' ' THR . 14.8 t70 -147.68 179.6 7.58 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.61 111.15 64.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-O 121.645 0.736 . . . . 0.0 111.251 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.11 161.43 18.0 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.203 1.936 . . . . 0.0 111.193 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -114.93 148.03 39.21 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-O 121.284 0.564 . . . . 0.0 109.487 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.07 128.55 36.32 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.626 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.4 64.05 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.002 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.76 178.63 7.21 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.527 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -122.91 130.52 52.95 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 44.8 p90 -122.99 151.77 41.53 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 121.26 0.552 . . . . 0.0 110.235 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.7 ttm -121.62 116.67 25.02 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 441' ' ' ALA . 92.7 t . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 6.9 pt-20 . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 48.3 mmtm -64.12 -49.66 71.31 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.346 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 447' ' ' GLY . 61.9 mttp -68.25 -35.24 77.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.81 -57.07 12.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.784 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -58.69 -40.2 82.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 111.861 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.09 -25.23 65.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.28 . . . . 0.0 111.705 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 502' ' ' LYS . 42.0 mm -78.36 -51.47 17.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.202 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.654 -179.31 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 494' ' ' PHE . 35.4 m . . . . . 0 N--CA 1.434 -1.225 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.03 -178.29 18.27 Favored Glycine 0 C--N 1.289 -2.04 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.9 m -120.69 141.69 50.17 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 117.812 0.806 . . . . 0.0 109.507 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.23 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 436' ' ' THR . 14.8 pt -94.35 -34.7 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.318 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.402 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 11.8 pt-20 -157.4 147.85 21.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.48 17.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 178.15 2.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.14 151.97 29.5 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.728 0.775 . . . . 0.0 111.445 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.07 -17.7 59.53 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.27 -36.35 2.71 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.058 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -95.81 -29.01 14.46 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.065 0.459 . . . . 0.0 110.891 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 110.28 -149.33 17.54 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.516 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 13.8 Cg_exo -68.85 115.65 4.06 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.809 1.673 . . . . 0.0 109.217 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.98 137.53 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 122.309 1.052 . . . . 0.0 112.621 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.91 15.23 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.485 HG22 HD11 ' A' ' 423' ' ' ILE . 3.3 m -88.72 123.09 32.82 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -140.36 170.99 14.78 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.474 -173.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 476' ' ' SER . 0.8 OUTLIER -118.91 106.42 12.47 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.63 121.95 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.631 . . . . 0.0 112.229 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -120.84 -15.12 8.4 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.689 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.8 -7.54 59.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.659 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.73 -110.79 0.46 Allowed Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.348 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.4 m -139.9 139.78 36.29 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -112.7 126.41 55.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -174.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 8.2 ttpt -136.83 150.83 48.54 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 110.223 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.2 m -68.5 146.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.471 0.653 . . . . 0.0 112.193 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.7 -3.44 84.97 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.768 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.46 139.31 19.99 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.39 133.56 19.37 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.449 2.099 . . . . 0.0 113.281 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 14.3 pt -126.25 172.46 13.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.22 122.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 494' ' ' PHE . 44.4 t -122.8 105.29 15.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.61 -118.92 14.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.4 p -102.38 -3.5 26.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 486' ' ' ASP . 87.1 m -104.07 129.52 51.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -123.53 167.39 13.96 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 122.032 -0.417 . . . . 0.0 109.88 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.26 -164.61 37.07 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -115.07 143.33 45.37 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.36 124.43 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.448 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.1 tmt_? -93.79 -58.89 2.13 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.19 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.89 148.47 50.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 444' ' ' LEU . 50.4 tpp -119.15 117.25 28.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.82 125.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.45 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.1 p30 -95.1 176.26 6.31 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.325 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.44 -23.17 62.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 113.083 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.4 m -77.83 -16.34 58.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.04 32.37 8.47 Favored Glycine 0 CA--C 1.486 -1.743 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.562 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.45 ' HB2' HD21 ' A' ' 464' ' ' ASN . 80.9 mtt180 -116.9 126.65 53.3 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -81.45 123.45 28.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.61 -174.46 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -98.68 -34.06 10.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.892 0.377 . . . . 0.0 109.986 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.67 166.1 31.39 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.941 0.401 . . . . 0.0 111.38 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.69 150.51 34.46 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.745 0.818 . . . . 0.0 109.089 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -96.39 -179.96 35.04 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.166 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HA ' HG13 ' A' ' 439' ' ' VAL . 51.4 Cg_endo -67.06 161.9 40.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.814 2.343 . . . . 0.0 112.066 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.422 ' HA ' HD11 ' A' ' 438' ' ' LEU 0.258 51.9 p 66.47 6.79 4.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.775 1.63 . . . . 0.0 113.516 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 40.0 ttm -107.98 136.92 19.7 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.232 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.4 Cg_endo -82.34 126.62 4.9 Favored 'Trans proline' 0 C--O 1.252 1.187 0 C-N-CA 122.46 2.107 . . . . 0.0 110.6 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 473' ' ' ALA . 20.0 m -137.33 155.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.194 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.09 115.74 30.7 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.7 pt -97.93 167.95 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 7.8 p -150.1 166.49 29.63 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.43 -15.68 19.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.877 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.76 -40.32 91.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.998 0.427 . . . . 0.0 110.802 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . 0.516 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 72.1 t60 61.83 20.12 11.17 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.578 1.551 . . . . 0.0 110.627 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.425 ' HB2' HG21 ' A' ' 455' ' ' THR . 10.5 m-20 -142.38 167.21 22.63 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.6 p -110.05 119.76 46.41 Favored Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.882 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.73 176.52 7.69 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.194 2.596 . . . . 0.0 110.604 175.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -102.05 140.15 36.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.36 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -67.18 124.53 23.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.7 -0.36 57.94 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.478 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.39 176.93 8.73 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.45 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 1.4 mpt_? -118.77 124.83 48.22 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.387 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 31.8 p90 -119.96 148.84 43.04 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 53.2 ttp -118.51 127.01 53.23 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 494' ' ' PHE . 59.0 t . . . . . 0 N--CA 1.433 -1.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.245 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 42.0 mt-10 . . . . . 0 N--CA 1.437 -1.114 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -77.91 -39.06 44.2 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.42 -47.94 82.29 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.98 88.06 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.804 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 3.4 tmt_? -58.82 -43.11 90.55 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.738 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -75.13 -35.36 61.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.89 -30.52 14.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.472 0.653 . . . . 0.0 109.907 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.561 -179.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 4.8 m . . . . . 0 CA--C 1.476 -1.878 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -114.89 172.2 14.09 Favored Glycine 1 N--CA 1.385 -4.705 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.2 p -131.18 141.99 50.15 Favored 'General case' 0 C--N 1.245 -3.937 0 O-C-N 124.225 0.603 . . . . 0.0 110.903 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 53.7 t -89.13 130.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 436' ' ' THR . 13.9 pt -89.8 -38.82 11.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.698 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -154.74 154.45 32.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -139.99 139.19 35.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.35 177.92 3.94 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.514 0.673 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -88.24 149.45 23.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.875 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.6 129.9 46.56 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 173.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.412 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -68.86 -20.85 64.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -104.66 -40.6 2.15 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.723 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.497 ' HB3' HG21 ' A' ' 482' ' ' THR . 91.8 mtm180 -94.94 -22.76 17.77 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.5 -159.69 21.11 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.64 116.4 3.17 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.28 1.987 . . . . 0.0 111.095 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 482' ' ' THR . 34.6 m -118.17 154.39 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.8 116.34 12.86 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 480' ' ' GLU . 2.2 m -85.3 116.69 23.79 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 0.9 OUTLIER -134.18 170.91 14.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.23 108.03 12.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.56 122.05 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.398 0.618 . . . . 0.0 110.913 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 45.7 mt-30 -120.28 -21.42 6.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -97.1 -8.9 29.12 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 113.956 -3.098 . . . . 0.0 114.666 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . -164.94 -110.09 0.23 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 118.255 -1.926 . . . . 0.0 113.299 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.1 m -147.94 138.08 22.78 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.474 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -108.23 130.91 55.13 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.0 ttpt -146.02 151.74 38.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.512 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 26.9 m -67.22 146.96 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.91 -17.21 59.12 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.55 -1.204 . . . . 0.0 114.117 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -111.09 152.9 44.02 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.167 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 33.0 Cg_endo -64.15 147.47 91.37 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.342 2.695 . . . . 0.0 113.689 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.55 158.86 16.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 124.969 1.308 . . . . 0.0 108.455 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.51 118.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.66 107.66 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.1 -111.28 3.83 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.063 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.4 p -104.4 -4.14 23.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.148 0.579 . . . . 0.0 111.672 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.432 HG21 ' CB ' ' A' ' 486' ' ' ASP . 65.1 m -125.92 141.89 51.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 120.945 0.403 . . . . 0.0 110.943 -175.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -118.05 154.48 31.97 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -160.56 -164.22 15.17 Favored Glycine 0 C--N 1.282 -2.427 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 35.1 ttm180 -126.71 136.67 52.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.63 HG11 ' HE2' ' A' ' 462' ' ' MET . 26.2 t -73.69 111.69 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.532 0.52 . . . . 0.0 110.612 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -83.36 -50.51 8.27 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.855 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.31 144.92 42.86 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.63 ' HE2' HG11 ' A' ' 459' ' ' VAL . 41.5 tpp -115.06 117.2 29.89 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.05 126.73 68.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 6.2 p30 -87.13 177.86 7.07 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.831 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.01 -30.62 36.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.1 m -76.16 -26.17 55.99 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.899 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.12 38.64 3.28 Favored Glycine 0 CA--C 1.475 -2.46 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.649 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 69.7 ttt180 -119.63 127.37 52.86 Favored 'General case' 0 N--CA 1.404 -2.748 0 CA-C-N 112.171 -2.015 . . . . 0.0 105.977 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -81.32 129.83 34.78 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.93 -178.72 2.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -111.45 -28.56 8.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.878 0.371 . . . . 0.0 111.368 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 445' ' ' LYS . 12.1 pt-20 -150.67 168.22 25.0 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -147.45 134.33 20.18 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.57 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.85 176.6 53.34 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 439' ' ' VAL . 56.1 Cg_endo -68.2 156.22 66.55 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.028 1.819 . . . . 0.0 112.754 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.8 t 77.85 -0.34 2.72 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.15 1.38 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.428 ' HG2' HG13 ' A' ' 479' ' ' VAL . 33.6 ttm -98.93 133.66 22.1 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -84.92 126.0 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.374 2.05 . . . . 0.0 112.083 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 477' ' ' MET . 16.5 m -140.74 155.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' A' ' 436' ' ' THR . 37.4 mt-10 -107.3 118.96 38.09 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 45.4 pt -98.02 170.01 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.083 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 431' ' ' ARG . 3.0 p -146.3 156.57 43.45 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 109.26 22.17 6.95 Favored Glycine 0 N--CA 1.427 -1.964 0 O-C-N 124.081 0.863 . . . . 0.0 113.807 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.95 -38.31 16.77 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 60.09 21.97 11.2 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.279 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.432 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.7 t0 -139.33 179.96 6.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 5.9 p -90.19 114.69 61.87 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-O 121.304 0.573 . . . . 0.0 111.487 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.68 168.43 8.33 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -129.48 131.93 46.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.773 0.321 . . . . 0.0 111.36 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.46 134.91 46.92 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.97 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 91.01 -5.0 81.88 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.24 -179.09 7.13 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -109.82 141.35 42.61 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 8.7 p90 -128.84 153.3 47.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.86 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 44.0 ttp -122.5 117.0 24.9 Favored 'General case' 0 C--N 1.248 -3.821 0 C-N-CA 125.399 1.48 . . . . 0.0 110.582 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.404 ' CG2' ' HG ' ' A' ' 444' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.43 -1.459 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.316 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.202 -1.398 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 504' ' ' ARG . 7.2 tppt? -57.65 -34.46 69.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.369 0.668 . . . . 0.0 111.135 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 506' ' ' ILE . 13.1 mmmm -60.89 -51.59 68.64 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.683 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.31 99.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.9 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 501' ' ' LYS . 21.9 tpp180 -50.2 -54.22 22.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.456 1.502 . . . . 0.0 109.239 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.62 -39.86 89.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.901 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 502' ' ' LYS . 50.9 mm -75.68 -53.9 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.598 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.013 0 C-N-CA 118.931 -1.604 . . . . 0.0 115.794 -176.605 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.8 m . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -138.08 176.31 20.8 Favored Glycine 0 C--N 1.293 -1.856 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.722 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 19.2 m -120.82 141.99 50.03 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.6 138.57 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.41 -39.02 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 10.9 pt-20 -153.62 148.86 26.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.79 131.4 12.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.5 178.46 1.96 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.95 149.23 29.46 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.234 0.54 . . . . 0.0 110.151 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -126.7 122.56 35.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.565 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.4 -17.09 52.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -178.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.26 -42.88 1.13 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -84.51 -31.63 24.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.68 -158.08 14.56 Favored Glycine 0 C--N 1.314 -0.639 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.56 116.25 4.14 Favored 'Trans proline' 0 C--O 1.244 0.8 0 CA-C-N 120.047 1.924 . . . . 0.0 108.949 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.44 150.94 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.943 0.878 . . . . 0.0 112.386 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -141.56 111.52 6.71 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.519 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -88.22 122.86 32.25 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -139.21 173.2 11.8 Favored 'General case' 0 C--N 1.272 -2.77 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.425 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -117.24 106.01 12.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -73.48 119.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 112.143 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 77.6 mt-30 -124.28 -15.03 6.84 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.865 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -76.24 -15.57 60.0 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.189 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 166.98 -100.93 0.17 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.3 m -144.93 144.15 30.92 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.642 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -108.65 129.75 55.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 448' ' ' ASP . 18.0 ttpt -138.81 148.39 43.71 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.8 m -70.76 141.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.21 0.529 . . . . 0.0 111.058 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.14 83.8 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.601 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 445' ' ' LYS . 1.2 t70 -94.9 130.71 32.11 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.57 123.22 10.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.284 1.989 . . . . 0.0 109.755 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -127.45 162.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 122.639 0.376 . . . . 0.0 110.498 -175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.4 p -129.35 122.56 56.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 450' ' ' ILE . 46.2 t -134.25 125.33 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.14 97.29 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.999 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 2.3 m 65.07 9.51 5.56 Favored 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 124.905 1.282 . . . . 0.0 112.758 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 59.7 m -113.23 137.48 51.42 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 17.3 p90 -111.55 150.87 29.39 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.097 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -157.15 -164.11 13.26 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -134.06 129.53 36.18 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 462' ' ' MET . 47.5 t -62.16 114.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.432 0.458 . . . . 0.0 111.58 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -81.3 -55.19 4.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.259 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.51 152.64 51.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.642 ' HE1' HD22 ' A' ' 444' ' ' LEU . 51.1 tpp -115.01 117.57 30.98 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.74 136.52 53.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -99.38 -179.22 4.15 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.463 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.08 -29.57 60.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.8 m -74.86 -25.29 58.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.028 0.442 . . . . 0.0 110.378 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.75 30.02 6.3 Favored Glycine 0 CA--C 1.5 -0.899 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.588 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 464' ' ' ASN . 79.8 mtt180 -115.77 144.45 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -76.58 129.79 36.94 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 124.239 0.962 . . . . 0.0 110.329 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.8 m -135.87 -178.25 2.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -115.72 -23.74 8.55 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.08 143.77 19.48 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -173.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.48 146.82 32.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.78 177.35 40.21 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.678 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HA ' HG13 ' A' ' 439' ' ' VAL . 54.7 Cg_endo -65.07 161.26 37.81 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 123.167 2.578 . . . . 0.0 113.666 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.449 ' HA ' HD11 ' A' ' 438' ' ' LEU . 20.4 t 67.74 16.77 9.78 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 125.124 1.37 . . . . 0.0 111.076 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 23.8 ttt -120.16 133.92 24.0 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -72.73 125.88 10.92 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.559 2.172 . . . . 0.0 112.129 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 8.3 m -141.81 159.38 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.64 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 30.1 tt0 -122.35 115.81 22.94 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.8 172.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.655 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.6 p -149.08 167.16 26.61 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.23 33.37 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.779 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.36 -33.37 25.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 70.6 t60 64.93 21.31 12.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.859 1.663 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -145.91 179.6 7.35 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.7 t -121.67 109.65 34.18 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 118.389 0.541 . . . . 0.0 109.544 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.0 175.57 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.894 2.396 . . . . 0.0 110.952 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -118.59 148.32 42.8 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.25 0.547 . . . . 0.0 112.052 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -68.95 141.93 54.83 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.829 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.38 0.03 89.88 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.091 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -92.56 -179.21 5.12 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.34 145.2 43.39 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.308 0.575 . . . . 0.0 110.653 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -132.14 159.15 39.78 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.6 ttt -132.15 118.03 19.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.235 0.54 . . . . 0.0 109.814 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 C--N 1.3 -1.557 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.118 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.305 0.574 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -62.49 -51.36 67.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -64.2 -40.74 96.72 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.519 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.21 40.41 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 123.379 0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.01 -39.75 86.89 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.68 -46.74 71.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.786 0.327 . . . . 0.0 111.558 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.85 -32.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.292 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.35 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -177.847 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 16.4 m . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.49 169.22 25.57 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.3 m -119.06 141.93 48.3 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.59 137.13 22.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.1 pt -89.53 -39.83 12.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.844 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.442 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 9.6 pt-20 -159.39 148.52 18.23 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.3 144.2 33.15 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -170.07 176.02 4.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.9 pt? -84.46 142.06 30.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.55 120.45 37.53 Favored 'General case' 0 C--N 1.255 -3.51 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.43 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.58 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.35 -17.08 6.74 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.26 -40.85 0.85 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.355 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -88.4 -16.05 33.91 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 90.86 -158.92 26.34 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -59.79 116.45 3.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 121.894 1.729 . . . . 0.0 110.363 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.436 HG12 ' CG2' ' A' ' 482' ' ' THR . 33.3 m -122.54 163.86 20.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -147.76 112.2 5.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.323 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.87 117.28 24.63 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.694 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.8 pp -132.92 173.14 11.71 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -173.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -119.48 105.72 11.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -75.56 121.57 27.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.636 0.731 . . . . 0.0 112.189 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 37.8 mt-30 -124.04 -14.26 7.13 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.401 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.47 61.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.187 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 152.04 -104.71 0.27 Allowed Glycine 0 N--CA 1.411 -2.981 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.823 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 6.8 m -130.82 136.5 48.74 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -111.39 124.06 51.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.522 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 2.4 ttpm? -134.07 157.24 46.64 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.522 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 27.7 m -67.64 126.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.24 0.543 . . . . 0.0 109.987 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 110.91 -11.1 29.63 Favored Glycine 0 C--N 1.306 -1.137 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 445' ' ' LYS . 1.0 OUTLIER -71.0 131.2 87.45 Favored Pre-proline 0 C--O 1.247 0.938 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -79.44 112.38 2.97 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 122.239 1.959 . . . . 0.0 108.935 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.24 149.28 14.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.216 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 40.5 t -122.85 115.03 44.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.562 HG12 ' CB ' ' A' ' 494' ' ' PHE . 30.0 m -120.31 116.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.11 0.481 . . . . 0.0 109.723 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.94 -96.62 0.16 Allowed Glycine 0 C--N 1.307 -1.068 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.345 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 30.9 p -118.26 -7.21 10.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 122.734 0.413 . . . . 0.0 111.205 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.505 HG21 ' CB ' ' A' ' 486' ' ' ASP . 21.1 m -113.67 145.84 40.71 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.201 -0.312 . . . . 0.0 110.899 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -120.72 156.25 32.19 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.22 -168.51 27.49 Favored Glycine 0 C--N 1.295 -1.733 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.305 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -127.66 132.6 49.68 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 444' ' ' LEU . 51.1 t -65.75 121.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.586 0.554 . . . . 0.0 110.735 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -91.4 -52.26 4.88 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.672 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.15 150.37 50.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.552 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.1 tpp -115.1 117.11 29.64 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 9.4 t -120.35 141.42 40.72 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 3.4 p30 -108.63 175.06 5.6 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.193 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.71 -25.86 55.47 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.075 0.95 . . . . 0.0 113.087 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.3 t -78.19 -10.66 59.74 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.222 0.534 . . . . 0.0 110.097 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.99 8.16 61.94 Favored Glycine 0 CA--C 1.491 -1.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.83 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -96.79 129.69 44.17 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.558 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.0 tmm_? -86.65 129.99 34.66 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.12 -174.21 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.236 0.614 . . . . 0.0 109.907 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -98.04 -36.12 10.21 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 122.96 0.504 . . . . 0.0 111.404 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -156.0 151.74 27.29 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.535 -172.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -142.91 150.23 39.5 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 123.924 0.765 . . . . 0.0 109.549 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.11 179.53 39.46 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.352 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 439' ' ' VAL . 59.9 Cg_endo -70.83 161.42 46.13 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 123.052 2.501 . . . . 0.0 113.888 -175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 438' ' ' LEU . 50.2 m 68.83 18.63 8.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.834 1.254 . . . . 0.0 111.116 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.4 ttt -122.23 133.98 24.6 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.561 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 46.5 Cg_endo -77.55 125.9 7.9 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 122.293 1.995 . . . . 0.0 112.577 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 16.1 m -141.11 157.83 22.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.19 117.51 29.77 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -97.68 168.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.859 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.436 ' CG2' HG12 ' A' ' 434' ' ' VAL . 6.0 p -146.74 165.66 28.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.574 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.45 20.53 22.24 Favored Glycine 0 C--N 1.296 -1.684 0 O-C-N 123.929 0.768 . . . . 0.0 112.576 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 41.6 tp -85.34 -39.35 17.75 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 64.41 21.44 12.48 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.776 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.505 ' CB ' HG21 ' A' ' 455' ' ' THR . 15.0 t70 -138.92 179.24 6.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 38.0 t -111.47 107.08 57.04 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 118.214 0.461 . . . . 0.0 111.175 -173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -85.84 174.7 6.36 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.556 2.171 . . . . 0.0 111.61 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.71 145.53 50.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.922 0.392 . . . . 0.0 110.701 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -66.69 128.62 36.95 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.571 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.28 60.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.123 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.48 179.18 6.06 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.333 0.587 . . . . 0.0 110.591 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 0.4 OUTLIER -114.73 129.2 56.65 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 45.8 p90 -131.87 158.95 40.0 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.671 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.0 ttt -131.44 134.45 46.22 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.311 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.496 HG11 ' HG ' ' A' ' 444' ' ' LEU . 58.1 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--O 1.218 -0.589 0 CA-C-O 120.573 0.225 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.3 -43.66 73.34 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 502' ' ' LYS . 33.8 ttpt -61.22 -46.22 91.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.93 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.8 92.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.727 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -63.74 -34.72 78.51 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.781 0.832 . . . . 0.0 111.24 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.7 -38.77 91.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.75 -42.95 77.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.503 179.329 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.4 m . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -124.22 169.75 16.33 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.8 m -115.99 139.54 50.16 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.24 133.91 28.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 12.6 pt -91.94 -39.8 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.884 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.87 153.76 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.42 29.95 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -165.63 176.34 8.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.6 pt? -94.83 148.23 22.51 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.44 121.94 32.16 Favored 'General case' 0 N--CA 1.391 -3.412 0 C-N-CA 116.929 -1.908 . . . . 0.0 109.697 167.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.9 -22.58 62.57 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.026 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.8 -51.99 0.82 Allowed Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.702 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.68 -26.56 57.74 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 122.935 0.494 . . . . 0.0 111.379 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 107.79 -163.74 12.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 25.2 Cg_exo -69.21 115.56 4.07 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 121.914 1.743 . . . . 0.0 108.215 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.448 ' HB ' ' CG ' ' A' ' 480' ' ' GLU . 28.3 m -124.46 162.79 25.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -154.39 114.82 3.92 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.603 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 119.64 25.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.0 OUTLIER -136.24 173.48 11.66 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.2 tm? -122.61 107.98 12.59 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.4 p -73.98 119.85 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 111.751 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 40.5 mt-30 -123.59 -15.81 6.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.794 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.565 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -92.23 2.17 56.77 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 158.87 -125.67 1.55 Allowed Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.185 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.3 m -129.83 134.19 47.39 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.641 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -104.6 133.2 49.86 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.629 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 2.1 ttpm? -148.29 159.66 43.76 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -68.06 136.27 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.159 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.59 -2.83 60.8 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.403 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 67.8 m-20 -92.76 132.77 30.51 Favored Pre-proline 0 C--O 1.25 1.115 0 CA-C-N 117.317 0.559 . . . . 0.0 110.003 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 2.5 Cg_endo -80.35 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.08 1.853 . . . . 0.0 111.762 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.92 172.65 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.25 124.29 18.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.178 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.4 111.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.32 11.13 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.1 m -99.15 -4.45 32.15 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.32 0.581 . . . . 0.0 110.3 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 486' ' ' ASP . 48.9 m -102.86 136.32 42.9 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.602 -0.686 . . . . 0.0 112.053 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.75 161.88 16.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -177.3 -169.33 38.31 Favored Glycine 0 CA--C 1.475 -2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.488 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 55.2 ttp180 -130.6 137.71 49.77 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.431 HG11 ' HE2' ' A' ' 462' ' ' MET . 49.0 t -65.99 116.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.04 0.448 . . . . 0.0 111.824 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -79.43 -60.07 2.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -143.49 160.25 40.93 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.641 ' HE1' HD22 ' A' ' 444' ' ' LEU . 35.6 tpp -121.48 134.65 55.07 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 480' ' ' GLU . 6.1 t -117.24 142.09 32.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.478 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.0 p30 -103.62 179.73 4.19 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.178 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.42 -29.25 48.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.612 1.165 . . . . 0.0 112.94 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 -6.85 58.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.0 4.13 63.38 Favored Glycine 0 N--CA 1.466 0.654 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.255 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.478 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.0 mpt_? -93.09 156.93 16.56 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.407 ' NH1' HG22 ' A' ' 463' ' ' VAL . 20.2 tpp180 -75.41 132.88 41.17 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.824 0.85 . . . . 0.0 110.97 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.3 175.59 5.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.76 -28.89 3.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.719 0.295 . . . . 0.0 111.673 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 445' ' ' LYS . 30.7 mt-10 -123.6 141.17 52.27 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.44 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -139.29 126.01 20.73 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.54 161.36 40.61 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.488 ' HA ' HG13 ' A' ' 439' ' ' VAL . 19.3 Cg_endo -59.67 150.75 74.72 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.931 2.421 . . . . 0.0 113.031 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 438' ' ' LEU . 22.2 m 75.77 4.45 3.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.351 1.46 . . . . 0.0 112.268 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 47.0 ttp -103.86 136.11 19.25 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 122.275 -0.266 . . . . 0.0 110.953 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.6 Cg_exo -76.77 126.2 8.67 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.423 2.082 . . . . 0.0 111.326 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 473' ' ' ALA . 12.7 m -142.06 159.02 20.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 463' ' ' VAL . 37.7 tt0 -117.56 124.94 49.91 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.45 172.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.725 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.9 p -151.22 161.99 41.7 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 112.73 8.11 21.13 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.941 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 58.2 mt -89.95 -40.33 12.43 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.478 -0.425 . . . . 0.0 110.166 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 16.4 t-80 58.17 21.29 7.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 111.07 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.495 ' HB3' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -126.74 -178.89 4.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.27 110.09 46.37 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 4.6 Cg_endo -84.24 156.42 12.84 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.178 1.919 . . . . 0.0 109.988 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -121.29 134.8 55.17 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -69.17 124.5 23.98 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.141 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.04 -0.37 56.19 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.62 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.01 178.51 8.12 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.859 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -110.44 130.07 55.63 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 32.5 p90 -125.86 154.86 42.08 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.123 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 59.6 ttp -119.28 127.13 52.94 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 441' ' ' ALA . 10.6 p . . . . . 0 N--CA 1.425 -1.679 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.4 -44.76 70.78 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.501 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 506' ' ' ILE . 60.4 mttp -79.96 -30.57 39.83 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.141 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.7 88.98 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -59.36 -41.88 90.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.488 0.661 . . . . 0.0 109.983 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -68.8 -29.86 68.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.6 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 502' ' ' LYS . 85.1 mt -83.5 -52.16 13.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.895 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 C-N-CA 119.411 -1.376 . . . . 0.0 113.552 -173.566 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.497 -1.096 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -140.16 -175.16 14.23 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.055 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.7 p -125.57 145.13 50.26 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 124.156 0.983 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 37.7 t -87.73 134.01 28.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.76 -39.69 12.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.506 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 8.5 pt-20 -158.31 149.43 20.84 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.35 149.13 34.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.519 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -172.65 177.1 3.02 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -95.26 146.72 24.15 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -123.38 120.57 33.41 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -55.84 -18.77 9.5 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -107.62 -42.57 1.44 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.403 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -81.2 -34.25 32.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.728 0.299 . . . . 0.0 111.489 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.09 -145.85 17.98 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.32 115.99 4.24 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 121.86 1.706 . . . . 0.0 108.648 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 18.1 m -116.09 153.53 17.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.259 0.552 . . . . 0.0 111.134 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -144.91 112.74 6.32 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.482 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.62 114.91 22.98 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.9 pp -132.95 173.27 11.58 Favored 'General case' 0 C--N 1.266 -3.022 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.007 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.92 106.78 14.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -65.94 114.85 3.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.421 1.105 . . . . 0.0 111.943 -176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.63 -14.33 7.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.08 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.431 ' CB ' ' H ' ' A' ' 496' ' ' VAL . . . -85.24 0.29 52.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.829 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 140.85 -115.27 1.02 Allowed Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 144.53 49.35 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.512 ' CD1' HD11 ' A' ' 437' ' ' LEU . 0.9 OUTLIER -125.82 120.23 29.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.2 ttpm? -138.38 161.71 36.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.566 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.6 m -66.09 130.67 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.557 0.694 . . . . 0.0 111.443 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.12 50.98 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.851 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 67.5 m-20 -88.32 147.17 39.5 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.959 0.379 . . . . 0.0 110.788 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -81.74 131.86 7.38 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.391 2.061 . . . . 0.0 110.731 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 496' ' ' VAL . 2.9 pp -125.79 140.46 48.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.478 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.84 111.62 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.41 138.22 26.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.74 26.09 74.73 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.33 -0.938 . . . . 0.0 110.875 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 65.0 p 63.68 7.05 2.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.166 1.786 . . . . 0.0 113.036 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.441 HG21 ' CB ' ' A' ' 486' ' ' ASP . 88.2 m -107.34 146.36 31.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -122.68 151.86 41.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.633 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -154.09 -164.3 12.66 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.534 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 47.7 ttp180 -131.49 137.15 48.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.153 0.477 . . . . 0.0 110.005 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 482' ' ' THR . 28.3 t -67.9 123.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 122.688 0.395 . . . . 0.0 111.314 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -98.81 -51.04 4.01 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.767 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.81 153.86 51.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.468 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.1 tpp -122.5 121.47 36.64 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 469' ' ' ARG . 13.4 t -127.85 148.6 32.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.538 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.9 p30 -109.27 179.46 4.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.736 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -58.97 -32.19 69.42 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.7 t -78.61 -9.12 59.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.311 0.577 . . . . 0.0 110.401 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.41 63.04 Favored Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.787 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.538 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.2 mpt_? -73.38 116.86 14.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.406 ' HG2' HG22 ' A' ' 463' ' ' VAL . 4.0 tmm_? -81.09 133.48 35.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.11 -173.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 123.844 0.858 . . . . 0.0 108.791 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -117.39 -20.46 9.1 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.147 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.37 147.35 33.3 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.421 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -145.68 139.14 26.34 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.208 0.603 . . . . 0.0 110.169 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -97.92 167.1 22.75 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.9 Cg_endo -58.63 150.66 68.26 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.09 2.527 . . . . 0.0 112.878 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 32.6 m 75.32 17.83 2.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.431 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.5 ttt -117.16 136.36 23.36 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.12 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 3.6 Cg_exo -80.55 126.77 6.17 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.201 1.934 . . . . 0.0 110.933 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.3 m -142.36 149.87 19.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.005 0.431 . . . . 0.0 110.865 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.4 tt0 -108.67 112.56 24.95 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.6 pt -99.84 172.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.576 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.453 ' CG2' HG12 ' A' ' 434' ' ' VAL . 5.5 p -145.33 157.55 44.02 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 113.23 4.44 23.83 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.16 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 51.2 tp -73.3 -37.58 66.16 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.483 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 64.62 24.14 12.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.278 1.431 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.441 ' CB ' HG21 ' A' ' 455' ' ' THR . 37.5 t70 -144.93 171.62 14.19 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.85 109.23 47.64 Favored Pre-proline 0 C--N 1.291 -1.956 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.44 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.02 174.52 4.56 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.595 2.197 . . . . 0.0 111.783 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -129.94 150.78 51.08 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.116 0.484 . . . . 0.0 111.327 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -63.74 130.03 42.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.346 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.28 58.83 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.749 -1.215 . . . . 0.0 111.588 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 493' ' ' ARG . 7.3 t70 -86.29 -166.63 1.6 Allowed 'General case' 0 C--O 1.248 0.974 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.443 ' H ' ' CG ' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -131.24 136.89 48.61 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.295 -169.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 38.4 p90 -136.74 158.53 44.23 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.824 0.821 . . . . 0.0 111.758 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.2 ttp -134.05 119.53 19.08 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.862 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 450' ' ' ILE . 83.1 t . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.21 -1.008 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -70.19 -47.0 63.45 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -61.33 -37.71 84.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.207 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.58 64.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.901 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -55.44 -40.29 71.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 123.891 0.876 . . . . 0.0 112.274 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.01 -31.8 69.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.967 0.792 . . . . 0.0 111.147 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.63 -9.0 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.451 0.7 . . . . 0.0 110.219 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.342 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.315 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 9.7 m . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 120.511 0.196 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -151.43 -174.68 22.48 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 18.8 m -127.89 143.87 51.1 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 117.049 0.424 . . . . 0.0 110.558 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.64 136.38 22.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.0 pt -89.77 -43.21 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.687 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.01 155.75 37.51 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.093 0.473 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -134.2 129.83 36.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 427' ' ' LEU . 0.3 OUTLIER -134.8 159.53 41.06 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -170.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.49 ' N ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -94.68 139.64 30.95 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 9.9 t70 -127.66 117.62 22.31 Favored 'General case' 0 C--N 1.261 -3.25 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.69 -26.15 65.34 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.24 -37.95 1.73 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.9 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.48 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.1 mtp180 -86.51 -24.37 25.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.14 -166.91 19.09 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -58.11 116.11 3.01 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.529 2.153 . . . . 0.0 111.049 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 482' ' ' THR . 20.1 m -114.94 136.62 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.341 0.591 . . . . 0.0 110.508 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -126.75 124.66 40.24 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.381 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 2.0 m -98.7 118.78 36.2 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 170.14 15.31 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -118.44 105.29 11.53 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 475' ' ' PRO . 3.3 p -71.14 118.6 16.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.708 0.766 . . . . 0.0 112.197 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 47.0 mt-30 -123.3 -16.22 6.96 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.468 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.4 31.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.957 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 145.81 -89.89 0.16 Allowed Glycine 0 C--O 1.212 -1.244 0 C-N-CA 119.019 -1.562 . . . . 0.0 113.219 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 56.3 m -146.64 146.89 30.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.537 HD22 ' HE1' ' A' ' 462' ' ' MET . 2.2 tt -128.23 115.58 18.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 0.0 OUTLIER -135.81 158.9 43.26 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 120.708 0.29 . . . . 0.0 110.847 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.7 m -61.81 133.71 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.89 0.376 . . . . 0.0 110.119 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.82 4.04 56.95 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.259 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 33.7 m-20 -86.36 127.91 59.29 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.997 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 5.5 Cg_exo -77.18 106.65 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.814 1.676 . . . . 0.0 108.073 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 456' ' ' TYR . 2.9 pp -104.9 140.84 21.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.035 -172.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.34 119.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.472 HG12 ' CB ' ' A' ' 494' ' ' PHE . 8.5 m -125.27 133.94 68.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . 0.451 ' HA2' ' NH1' ' A' ' 493' ' ' ARG . . . 57.97 -100.17 0.14 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.515 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 7.0 p -131.54 10.86 4.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.639 0.776 . . . . 0.0 110.895 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.514 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.3 m -119.7 144.8 47.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.777 0.322 . . . . 0.0 110.282 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 52.8 p90 -120.5 150.85 40.18 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -150.36 -170.68 17.86 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -134.82 127.89 31.68 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.73 118.23 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.15 -52.82 3.87 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.1 35.86 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.537 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -133.18 117.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.78 131.43 72.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.88 177.74 5.8 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.369 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.73 -30.55 33.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.37 1.068 . . . . 0.0 113.148 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.2 t -76.95 -16.14 59.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.078 0.466 . . . . 0.0 110.483 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.64 15.09 47.8 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.23 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -99.87 133.82 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.541 -0.33 . . . . 0.0 110.184 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.4 tpt85 -73.16 126.06 29.16 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.181 0.926 . . . . 0.0 108.981 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 462' ' ' MET . 30.6 m -135.66 -177.2 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 471' ' ' LYS . 0.0 OUTLIER -120.9 -12.71 8.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.947 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.68 152.18 33.58 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.04 145.96 31.68 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 123.719 0.637 . . . . 0.0 109.866 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -94.84 173.91 32.48 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.477 ' HA ' HG13 ' A' ' 439' ' ' VAL . 58.5 Cg_endo -69.57 156.66 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.637 2.224 . . . . 0.0 113.378 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 438' ' ' LEU . 12.1 t 72.08 16.51 5.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.022 1.329 . . . . 0.0 110.892 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 34.8 ttp -119.76 129.53 25.31 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.638 -0.664 . . . . 0.0 112.069 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.77 125.93 12.71 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.777 2.318 . . . . 0.0 112.345 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 436' ' ' THR . 6.0 m -140.41 151.74 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.163 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 40.8 tt0 -112.42 112.78 24.58 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.3 pt -98.23 170.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.699 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.482 HG23 HG12 ' A' ' 434' ' ' VAL . 0.2 OUTLIER -150.72 150.1 30.63 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 109.72 31.94 3.04 Favored Glycine 0 C--N 1.304 -1.25 0 O-C-N 123.742 0.651 . . . . 0.0 113.295 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 457' ' ' GLY . 54.9 tp -82.94 -35.84 25.68 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.0 t60 65.4 27.72 11.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.185 1.394 . . . . 0.0 109.404 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.514 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.3 t0 -148.01 -179.95 7.29 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.91 108.97 44.06 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.77 158.1 56.59 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.902 1.735 . . . . 0.0 110.733 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -126.48 131.35 51.66 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.391 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -72.48 135.66 45.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.295 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.44 89.35 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.664 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 1.6 t70 -84.7 -172.69 4.31 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.496 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.1 OUTLIER -129.16 150.92 50.34 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.742 -173.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 452' ' ' VAL . 40.7 p90 -140.28 168.68 19.25 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 52.3 ttp -134.02 115.98 14.97 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 444' ' ' LEU . 61.7 t . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -72.48 -38.97 68.06 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.486 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -70.88 -26.64 63.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.855 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.67 50.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.39 -45.76 55.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.579 1.552 . . . . 0.0 110.32 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.62 -36.21 75.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.2 -10.96 11.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.432 0.634 . . . . 0.0 109.838 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.417 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.893 -178.643 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -117.74 178.59 17.01 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.6 m -122.02 139.09 54.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 52.1 t -82.51 135.07 25.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 11.3 pt -93.73 -37.05 7.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.905 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 12.6 pt-20 -156.7 148.14 22.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.46 136.76 17.6 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 176.43 8.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.44 145.92 24.23 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.69 122.81 33.91 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.527 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.13 -13.4 58.01 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -109.67 -46.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.401 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.49 -40.59 42.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 109.605 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 121.7 -176.45 16.38 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.45 116.13 3.07 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.141 1.894 . . . . 0.0 109.445 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 482' ' ' THR . 29.1 m -121.94 146.56 26.88 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.391 0.615 . . . . 0.0 112.229 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -137.53 119.14 14.95 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.3 m -88.22 125.06 34.44 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.91 168.05 20.67 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.399 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.83 105.9 12.43 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 475' ' ' PRO . 4.3 p -70.84 121.21 20.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.836 0.827 . . . . 0.0 111.529 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -121.84 -20.5 6.38 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.63 -11.41 59.12 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 165.13 -111.38 0.46 Allowed Glycine 0 N--CA 1.416 -2.663 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.86 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 24.7 m -137.16 133.75 35.59 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.7 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.7 OUTLIER -101.28 115.79 31.32 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.0 OUTLIER -129.04 150.99 50.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.4 m -71.0 141.32 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.257 0.551 . . . . 0.0 111.297 177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.38 8.6 70.91 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.792 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -101.07 128.17 30.15 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 6.8 Cg_exo -72.38 120.81 6.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.46 HG22 HG22 ' A' ' 496' ' ' VAL . 18.9 pt -114.36 160.63 13.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.404 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.44 127.25 59.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 494' ' ' PHE . 3.0 m -127.22 128.19 70.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 55.47 -97.09 0.04 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 121.597 -0.335 . . . . 0.0 113.595 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 8.9 t -127.84 11.33 6.63 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.072 0.463 . . . . 0.0 110.623 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.477 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.2 m -124.21 150.12 45.61 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -127.92 162.1 27.53 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -173.91 -165.09 30.06 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -135.61 134.77 39.66 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 482' ' ' THR . 31.0 t -70.2 122.58 22.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 123.369 0.418 . . . . 0.0 110.352 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -93.09 -56.74 2.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.651 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.45 146.62 50.02 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.7 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.5 tpp -121.8 117.47 26.62 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.17 136.74 49.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.87 174.18 5.99 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.046 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.53 -29.82 38.55 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.602 1.161 . . . . 0.0 113.491 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 68.7 m -77.17 -11.81 59.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.821 -0.55 . . . . 0.0 111.33 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.77 -11.56 59.25 Favored Glycine 0 CA--C 1.494 -1.273 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.785 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -77.7 137.09 38.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.006 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.16 127.48 34.29 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.2 m -126.39 174.52 10.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.558 -172.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -102.74 -35.24 8.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 151.25 37.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.483 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.408 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -139.17 145.22 39.09 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.43 174.14 37.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.994 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.2 Cg_endo -64.51 158.6 48.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 38.6 m 68.67 17.0 8.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.521 0.728 . . . . 0.0 112.39 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.5 ttp -122.6 127.14 25.91 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.156 -0.34 . . . . 0.0 110.927 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.79 126.38 13.88 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 121.99 1.793 . . . . 0.0 111.72 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.408 HG11 ' CB ' ' A' ' 473' ' ' ALA . 17.6 m -139.12 167.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.514 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 34.4 tt0 -125.33 118.3 25.64 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -98.52 173.02 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.472 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.1 p -152.77 155.04 36.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.399 1.08 . . . . 0.0 108.352 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.18 8.15 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 172.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.21 -31.14 38.69 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 63.51 21.36 12.71 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.823 1.249 . . . . 0.0 109.263 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.477 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -140.79 -179.77 6.24 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.67 107.63 58.7 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-O 121.538 0.685 . . . . 0.0 111.779 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.45 167.92 14.98 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.019 1.812 . . . . 0.0 110.059 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . 0.606 ' HB2' ' OD2' ' A' ' 492' ' ' ASP . 21.9 mt-30 -134.8 154.2 51.71 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.109 -0.369 . . . . 0.0 110.356 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -70.97 133.42 46.36 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.2 -11.39 63.73 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.116 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 489' ' ' GLN . 4.3 m-20 -79.5 164.61 23.78 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.779 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 5.9 mpt_? -113.11 128.75 56.58 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.488 ' CB ' HG12 ' A' ' 452' ' ' VAL . 53.9 p90 -118.94 155.73 30.81 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.3 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 51.6 ttm -121.03 116.29 24.77 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.172 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 450' ' ' ILE . 46.7 t . . . . . 0 C--N 1.313 -0.995 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.197 -1.682 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 0.1 OUTLIER -63.86 -54.11 40.07 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.633 0.652 . . . . 0.0 110.899 -174.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 506' ' ' ILE . 10.8 ptpp? -65.28 -35.35 80.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.074 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.55 77.64 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.848 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -55.61 -50.17 70.85 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.127 1.371 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 12.0 mm100 -70.08 -26.31 63.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.926 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 502' ' ' LYS . 44.6 mm -74.06 -41.65 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.558 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.827 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 17.5 m . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.35 176.48 17.88 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.0 m -127.2 139.6 52.83 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 42.7 t -83.58 137.29 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -97.54 -37.55 6.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.232 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 436' ' ' THR . 0.2 OUTLIER -152.35 166.07 33.0 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.39 128.59 17.72 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.54 146.85 30.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.67 144.71 26.51 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.299 0.571 . . . . 0.0 109.885 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.24 129.48 50.86 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.545 ' H ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -64.0 -19.98 65.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -111.61 -48.42 0.69 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.878 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -74.68 -26.94 60.18 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 123.594 0.758 . . . . 0.0 110.59 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 98.98 -158.91 20.14 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.25 116.46 3.51 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.567 2.178 . . . . 0.0 111.084 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 482' ' ' THR . 15.1 m -121.33 157.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -148.26 120.37 8.29 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.54 ' HB ' ' HG3' ' A' ' 424' ' ' GLU . 3.4 m -82.74 123.67 29.53 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 478' ' ' PRO . 1.3 pp -133.03 173.3 11.57 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -119.44 110.99 17.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -75.5 122.58 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.763 0.792 . . . . 0.0 111.24 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 18.8 mt-30 -123.83 -14.45 7.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.095 -174.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.671 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -96.36 8.42 44.02 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.049 0.452 . . . . 0.0 110.133 -173.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.62 -126.55 2.92 Favored Glycine 0 N--CA 1.403 -3.513 0 C-N-CA 120.033 -1.08 . . . . 0.0 111.347 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.3 m -115.62 142.7 46.38 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.646 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.4 OUTLIER -111.45 117.69 33.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.541 ' HB3' ' OD2' ' A' ' 448' ' ' ASP . 12.3 ttpt -122.86 148.36 45.51 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.02 123.88 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.413 0.625 . . . . 0.0 109.768 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 109.5 -8.51 32.52 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.125 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.541 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 42.7 m-20 -90.32 146.02 33.82 Favored Pre-proline 0 C--O 1.25 1.081 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.448 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 4.0 Cg_exo -77.03 145.37 24.71 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.536 2.157 . . . . 0.0 111.391 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 13.8 pt -136.44 156.88 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.345 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.74 115.34 44.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.0 115.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.38 -102.56 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 12.6 t -127.9 8.23 6.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 486' ' ' ASP . 26.6 m -115.76 145.02 43.16 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.618 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -127.95 158.77 36.93 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -173.05 -164.3 28.2 Favored Glycine 0 C--N 1.29 -2.015 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -125.48 134.68 51.97 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.467 HG21 ' CD2' ' A' ' 444' ' ' LEU . 41.6 t -72.15 123.47 26.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -95.79 -50.38 4.93 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.693 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.05 159.66 32.19 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.646 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.9 tpp -130.8 117.33 19.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.79 128.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.634 HD21 ' HB2' ' A' ' 468' ' ' ARG . 8.8 p30 -92.9 -175.71 3.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.227 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.94 -20.26 66.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 112.402 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 31.5 t -84.21 -20.31 32.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.71 40.62 5.26 Favored Glycine 0 CA--C 1.488 -1.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.706 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.634 ' HB2' HD21 ' A' ' 464' ' ' ASN . 85.2 mtt180 -118.34 129.88 55.69 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 2.3 tmm_? -80.17 129.51 34.55 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.4 m -130.55 -179.23 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 120.583 0.23 . . . . 0.0 110.385 -176.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -98.97 -35.98 9.89 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.231 0.612 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -157.74 147.59 20.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.017 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -134.7 142.99 46.95 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.059 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.04 173.85 45.18 Favored Glycine 0 N--CA 1.442 -0.928 0 O-C-N 123.717 0.636 . . . . 0.0 112.304 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.9 Cg_endo -64.98 156.52 62.07 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.551 2.168 . . . . 0.0 113.23 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.462 ' HA ' HD11 ' A' ' 438' ' ' LEU . 28.3 m 72.54 10.85 5.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.439 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.1 ttt -111.08 138.26 21.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.5 Cg_exo -83.91 126.34 3.88 Favored 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.925 2.416 . . . . 0.0 112.001 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.7 151.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.171 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.7 mt-10 -96.82 129.19 44.29 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -100.87 170.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.479 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.7 p -151.07 158.86 44.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 124.237 1.015 . . . . 0.0 108.503 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.12 8.15 Favored Glycine 0 N--CA 1.422 -2.277 0 O-C-N 124.059 0.849 . . . . 0.0 114.428 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.57 -36.39 13.72 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.1 t60 64.62 20.95 12.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.357 1.463 . . . . 0.0 108.423 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.487 ' CB ' HG21 ' A' ' 455' ' ' THR . 30.9 t70 -135.9 173.52 11.62 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.12 103.6 36.06 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 118.094 0.406 . . . . 0.0 110.008 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.61 174.97 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.814 2.343 . . . . 0.0 111.124 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -111.17 145.56 38.43 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.308 0.575 . . . . 0.0 111.365 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -64.02 127.62 32.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.185 173.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.67 -3.48 56.15 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.609 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.18 178.11 8.44 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.751 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.61 140.73 48.91 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 124.105 0.962 . . . . 0.0 108.779 -175.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.05 155.18 49.68 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.998 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 49.7 ttp -122.02 120.34 34.09 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.671 HG12 ' HB3' ' A' ' 441' ' ' ALA . 7.0 p . . . . . 0 C--N 1.307 -1.26 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -68.88 -49.24 59.93 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -69.2 -40.6 77.92 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.572 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.92 88.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -73.71 -16.1 61.2 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.878 0.471 . . . . 0.0 111.033 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.6 -28.65 61.0 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 2.4 mp -86.93 -34.96 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.466 176.366 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 441' ' ' ALA . 15.9 m . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.52 166.11 12.82 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.12 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.6 m -114.2 143.01 45.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.11 131.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.1 pt -88.75 -36.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.747 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -160.11 153.36 21.99 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.38 143.33 23.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.478 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -163.49 175.73 10.44 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.2 pt? -85.07 143.38 28.91 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -126.41 129.77 49.41 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.04 -24.68 67.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.743 -178.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -97.32 -47.63 2.16 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.723 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HB3' HG21 ' A' ' 482' ' ' THR . 25.3 mmt180 -91.4 -33.43 15.25 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.24 -134.56 12.23 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.83 115.96 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.679 1.74 . . . . 0.0 110.782 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.478 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 25.3 m -118.2 148.26 21.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -143.54 114.24 7.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.2 m -85.58 116.91 24.15 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.4 pp -132.89 171.54 13.79 Favored 'General case' 0 C--N 1.279 -2.476 0 O-C-N 122.205 -0.309 . . . . 0.0 111.795 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.51 106.37 11.73 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.4 ' HB ' HD12 ' A' ' 444' ' ' LEU . 7.2 p -78.83 123.89 36.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.241 0.544 . . . . 0.0 112.009 -177.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -124.72 -15.88 6.38 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -77.84 -15.29 59.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.03 -0.987 . . . . 0.0 113.34 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 169.97 -102.26 0.18 Allowed Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.051 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 32.5 m -148.04 131.94 17.11 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 462' ' ' MET . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.616 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.1 ttpt -148.3 153.23 38.39 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.616 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 28.2 m -71.24 134.7 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.25 0.547 . . . . 0.0 110.746 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.05 8.44 72.24 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.79 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.8 132.86 20.51 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 123.92 11.77 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.779 2.32 . . . . 0.0 111.495 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.73 151.7 26.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.452 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.95 123.12 70.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 494' ' ' PHE . 4.1 m -128.0 135.13 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 54.89 -100.44 0.08 OUTLIER Glycine 0 CA--C 1.533 1.164 0 N-CA-C 114.221 0.448 . . . . 0.0 114.221 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 42.2 p -121.94 4.54 9.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 122.652 0.381 . . . . 0.0 111.239 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 486' ' ' ASP . 44.3 m -125.36 145.62 49.96 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.835 0.35 . . . . 0.0 111.419 -173.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.0 144.38 48.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -149.74 -175.54 22.07 Favored Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -124.77 126.9 46.38 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 482' ' ' THR . 48.3 t -63.62 132.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.938 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -97.62 -59.42 1.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -122.6 167.79 12.97 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.72 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.8 tpp -143.23 117.14 9.36 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.74 132.03 72.03 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -98.71 -179.77 4.41 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.006 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.38 -30.15 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.065 0.946 . . . . 0.0 112.539 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 28.3 m -80.7 -13.18 59.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.188 -0.32 . . . . 0.0 111.445 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 95.95 7.96 58.31 Favored Glycine 0 CA--C 1.501 -0.795 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.206 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -91.72 138.94 31.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.567 -0.317 . . . . 0.0 110.336 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 462' ' ' MET . 9.2 tpt180 -74.22 131.33 41.12 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.39 174.49 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.9 -36.16 8.74 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.086 0.469 . . . . 0.0 110.02 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.83 151.98 49.75 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.851 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -137.81 137.48 38.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.022 0.529 . . . . 0.0 109.597 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 169.17 30.19 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.89 151.93 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 31.1 t 75.44 15.71 2.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.139 1.376 . . . . 0.0 110.637 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 44.1 ttm -113.71 135.11 21.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.062 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.7 Cg_exo -79.53 126.23 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.394 2.063 . . . . 0.0 110.427 173.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 10.2 m -141.71 146.67 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 123.068 0.547 . . . . 0.0 110.07 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.9 tt0 -105.67 118.63 37.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.8 172.0 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.82 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.1 p -148.49 166.07 29.31 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 87.51 22.81 42.16 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.158 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 50.3 tp -72.98 -28.64 62.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.139 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 64.23 20.01 12.01 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.279 1.031 . . . . 0.0 110.213 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 455' ' ' THR . 33.2 t70 -149.03 179.39 7.91 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.47 114.9 65.8 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 118.415 0.552 . . . . 0.0 110.395 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.21 157.63 23.08 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.05 1.833 . . . . 0.0 111.091 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -124.6 137.91 54.35 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-O 121.529 0.681 . . . . 0.0 110.59 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.32 139.83 50.05 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.944 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.81 89.46 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.476 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 2.5 t70 -85.13 -170.87 3.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.476 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.3 OUTLIER -137.75 148.87 45.97 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.09 0.471 . . . . 0.0 109.903 -174.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.7 p90 -139.4 162.7 34.39 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.356 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.09 116.06 16.56 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.115 0.483 . . . . 0.0 109.87 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 494' ' ' PHE . 62.2 t . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 121.689 0.757 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -63.1 -41.21 99.32 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.649 1.18 . . . . 0.0 109.553 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -75.45 -19.8 59.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.655 0.741 . . . . 0.0 110.496 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.54 -44.07 21.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 108.877 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -70.56 -19.74 62.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.538 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . 0.477 ' OE1' ' HD3' ' A' ' 445' ' ' LYS . 45.0 tp60 -64.17 -40.67 96.62 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.613 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 40.0 mm -76.23 -35.27 27.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 CA-C-N 115.078 -0.964 . . . . 0.0 113.325 175.914 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 441' ' ' ALA . 18.7 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.2 162.75 12.31 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.24 140.22 41.8 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.13 139.61 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.26 -39.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.27 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.22 158.45 44.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.62 135.32 14.45 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 177.52 8.36 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 123.582 0.551 . . . . 0.0 109.84 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.8 149.0 22.16 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.094 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.04 127.95 45.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -32.97 74.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.21 -39.27 2.3 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.641 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -87.85 -20.2 26.37 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.697 0.284 . . . . 0.0 111.717 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.24 -166.48 23.22 Favored Glycine 0 C--O 1.222 -0.633 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.84 117.01 3.66 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.589 2.193 . . . . 0.0 111.063 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.57 153.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.467 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -147.88 123.95 10.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.926 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 5.9 m -96.32 126.39 41.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.462 HD21 HD12 ' A' ' 444' ' ' LEU . 0.0 OUTLIER -134.97 173.43 11.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 121.04 0.448 . . . . 0.0 111.208 -177.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.7 tm? -116.52 107.58 14.93 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -74.69 119.58 22.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.274 0.559 . . . . 0.0 112.063 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -124.39 -16.65 6.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -69.21 -28.0 65.98 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.673 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 175.01 -96.07 0.1 Allowed Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.103 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 501' ' ' LYS . 40.2 m -149.2 143.92 26.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.655 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.79 136.24 49.43 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 25.7 ttpt -147.23 150.57 35.13 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 34.1 m -69.69 131.04 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.167 0.508 . . . . 0.0 110.042 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.48 -10.46 61.18 Favored Glycine 0 N--CA 1.417 -2.586 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.415 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.518 ' OD2' ' HE2' ' A' ' 445' ' ' LYS . 17.2 m-20 -89.19 146.2 35.77 Favored Pre-proline 0 C--O 1.252 1.191 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.085 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 3.8 Cg_exo -75.36 148.27 33.72 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.33 2.02 . . . . 0.0 111.702 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.27 153.45 37.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.682 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.07 107.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.88 162.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . -39.85 108.7 0.1 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.263 0.483 . . . . 0.0 113.191 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.3 m 70.78 -25.34 0.16 Allowed 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 126.523 1.929 . . . . 0.0 115.198 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.422 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.1 m -119.6 132.82 55.8 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 120.955 -1.091 . . . . 0.0 112.295 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -111.46 165.44 11.98 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -169.8 -164.04 24.85 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -137.89 135.84 36.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 444' ' ' LEU . 38.6 t -69.99 118.48 14.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 120.905 0.383 . . . . 0.0 111.548 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -88.29 -54.86 3.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.149 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -133.19 146.37 51.45 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.655 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.6 tpp -115.54 116.69 28.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.24 132.13 60.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -103.7 178.22 4.62 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.945 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.27 -29.83 25.01 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.323 1.449 . . . . 0.0 112.985 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 47.6 t -78.52 -17.2 56.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.034 0.445 . . . . 0.0 110.494 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.74 56.69 Favored Glycine 0 CA--C 1.501 -0.814 0 O-C-N 122.013 -0.43 . . . . 0.0 112.157 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -92.08 149.19 21.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 120.722 0.296 . . . . 0.0 111.607 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -75.33 129.78 37.95 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.763 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.4 m -137.33 -176.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -111.54 -24.68 9.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.129 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -149.02 157.57 43.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.84 136.01 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 122.979 0.512 . . . . 0.0 110.189 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.0 167.86 38.48 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.482 ' HA ' HG13 ' A' ' 439' ' ' VAL . 38.6 Cg_endo -63.04 153.02 76.41 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.02 2.48 . . . . 0.0 112.925 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.1 m 71.61 21.63 4.33 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.649 1.18 . . . . 0.0 111.714 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 24.9 ttt -121.0 137.07 26.13 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.84 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 6.2 Cg_exo -78.61 126.84 7.66 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.84 2.36 . . . . 0.0 111.64 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 473' ' ' ALA . 13.4 m -143.78 155.93 16.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 122.516 0.326 . . . . 0.0 110.536 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 436' ' ' THR . 44.3 tt0 -116.11 115.43 26.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.32 177.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.035 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.0 p -152.44 166.68 31.2 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.91 20.35 24.1 Favored Glycine 0 C--N 1.294 -1.797 0 O-C-N 123.823 0.702 . . . . 0.0 114.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 43.3 tp -85.18 -33.37 22.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 7.6 t60 60.82 23.59 13.57 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.346 1.459 . . . . 0.0 110.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.422 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.2 t70 -144.82 -179.91 6.9 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.18 112.49 56.48 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -78.19 166.2 24.88 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.961 1.774 . . . . 0.0 110.41 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 492' ' ' ASP . 5.5 tp-100 -120.09 132.81 55.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.785 0.802 . . . . 0.0 110.587 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.53 121.46 18.74 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.032 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.45 -0.25 59.76 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 489' ' ' GLN . 3.4 t70 -80.28 -167.43 1.32 Allowed 'General case' 0 C--O 1.247 0.93 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . 0.494 ' HD3' ' N ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -137.76 129.71 28.76 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.385 0.612 . . . . 0.0 110.422 -172.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.33 158.95 29.9 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.715 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.8 ttt -118.4 123.23 44.75 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 441' ' ' ALA . 2.5 p . . . . . 0 C--N 1.299 -1.593 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 504' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.188 -2.156 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 443' ' ' THR . 64.7 mttp -62.97 -45.32 93.0 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.297 0.57 . . . . 0.0 112.174 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -74.82 -27.51 60.32 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.75 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.13 31.75 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 500' ' ' GLU . 3.9 ptp180 -64.66 -23.22 67.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.87 -32.79 72.22 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.208 1.004 . . . . 0.0 109.028 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 60.6 mt -87.31 -44.89 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.564 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.269 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.151 178.893 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -125.72 170.86 17.58 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.8 m -114.65 139.74 49.4 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.37 127.91 38.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.07 -37.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.83 154.96 26.97 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.58 139.13 25.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . 0.486 ' CD ' HG23 ' A' ' 434' ' ' VAL . 0.0 OUTLIER -156.99 176.85 12.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.41 150.09 22.98 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.88 119.48 32.76 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.551 ' N ' ' HE2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -50.85 -25.46 4.54 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.24 -36.28 1.23 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.119 -1.038 . . . . 0.0 113.646 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -90.08 -15.09 32.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 122.398 -0.472 . . . . 0.0 111.333 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 91.68 -144.93 17.45 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.02 116.42 4.14 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.388 2.059 . . . . 0.0 111.879 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.486 HG23 ' CD ' ' A' ' 426' ' ' LYS . 2.9 m -121.14 123.92 71.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 124.532 1.133 . . . . 0.0 108.943 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -130.18 125.22 34.45 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.175 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.11 122.2 40.96 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.5 pp -132.3 173.18 11.54 Favored 'General case' 0 C--N 1.257 -3.417 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 476' ' ' SER . 4.5 tt -124.17 110.63 14.92 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -69.12 121.63 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.806 0.812 . . . . 0.0 111.761 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -122.2 -16.03 7.55 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.655 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.0 -3.83 55.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.61 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 149.84 -103.56 0.25 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 119.943 -1.123 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.8 m -142.51 130.44 21.77 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.478 ' CD1' HD11 ' A' ' 437' ' ' LEU . 2.9 tt -107.26 138.47 43.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -145.94 151.94 38.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.866 0.757 . . . . 0.0 110.946 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . 0.594 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.9 m -62.77 128.29 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.331 0.586 . . . . 0.0 111.123 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.59 54.0 Favored Glycine 0 N--CA 1.428 -1.865 0 C-N-CA 119.845 -1.169 . . . . 0.0 114.219 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 445' ' ' LYS 0.254 2.2 p30 -101.17 149.58 36.4 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 118.904 1.352 . . . . 0.0 112.55 177.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 73.2 Cg_endo -78.37 124.83 6.67 Favored 'Trans proline' 0 C--N 1.364 1.393 0 C-N-CA 122.881 2.387 . . . . 0.0 113.04 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.39 151.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.364 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.03 120.61 65.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.24 111.36 26.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.68 -113.83 6.23 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.235 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 17.5 p -104.06 2.92 32.68 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.889 0.376 . . . . 0.0 111.53 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.465 HG21 ' CB ' ' A' ' 486' ' ' ASP . 25.3 m -124.78 151.33 45.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.685 0.278 . . . . 0.0 110.692 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -127.56 144.34 51.08 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -147.26 -164.36 11.12 Favored Glycine 0 C--N 1.287 -2.149 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 53.7 ttt180 -135.39 134.67 39.95 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.526 HG11 ' HE2' ' A' ' 462' ' ' MET . 38.5 t -66.67 121.58 16.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -86.88 -61.24 1.77 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.005 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.13 155.25 51.03 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 123.892 0.877 . . . . 0.0 109.091 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.526 ' HE2' HG11 ' A' ' 459' ' ' VAL . 36.4 tpp -123.68 117.83 25.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.27 132.01 70.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.3 p30 -96.65 175.03 6.53 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.617 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.16 -27.35 61.83 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.53 0.732 . . . . 0.0 112.884 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.8 t -79.42 -11.03 59.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 96.55 6.0 58.69 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.134 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ARG . . . . . 0.494 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.6 mpt_? -87.75 130.79 34.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.625 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.39 127.27 32.59 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 462' ' ' MET . 15.3 m -134.46 178.57 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -103.34 -35.4 8.42 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.647 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.65 162.16 33.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.905 0.383 . . . . 0.0 111.434 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -129.65 129.49 44.36 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.213 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.25 163.99 34.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 439' ' ' VAL . 36.4 Cg_endo -65.26 152.37 82.36 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.402 2.068 . . . . 0.0 112.409 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.625 ' HA ' HD21 ' A' ' 438' ' ' LEU . 23.0 t 74.43 15.34 3.47 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.415 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 42.1 ttm -113.14 134.81 21.77 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 5.9 Cg_exo -81.21 126.09 5.45 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.675 2.25 . . . . 0.0 110.882 173.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.4 m -137.86 142.49 35.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.216 0.532 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -91.25 112.2 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.47 167.37 2.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.17 0.51 . . . . 0.0 109.652 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.3 29.37 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 94.27 12.87 55.67 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.512 177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.05 -31.85 61.39 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t60 61.73 20.52 11.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 111.499 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ASP . . . . . 0.465 ' CB ' HG21 ' A' ' 455' ' ' THR . 4.1 t70 -149.26 -179.54 7.13 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 11.8 p -90.15 120.4 69.2 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-O 121.003 0.43 . . . . 0.0 110.369 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.2 Cg_endo -88.01 172.05 5.49 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.064 1.843 . . . . 0.0 111.425 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -128.53 131.07 48.25 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.71 33.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.85 -0.4 59.21 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.383 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -89.36 -178.35 5.59 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 152.55 24.17 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' PHE . . . . . 0.647 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.6 p90 -141.59 154.54 45.49 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.0 ttp -126.26 121.41 32.6 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 C--N 1.301 -1.54 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.35 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.213 -0.863 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -68.77 -39.59 80.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.106 0.479 . . . . 0.0 111.374 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -80.24 -39.57 28.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.57 -52.44 61.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -67.84 -15.79 63.79 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.389 0.676 . . . . 0.0 111.591 -174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -80.95 -33.87 33.62 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.411 0.624 . . . . 0.0 109.375 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.83 -54.73 7.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.351 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.447 -179.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.993 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 15.9 m -89.11 89.46 7.96 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 69.64 -63.39 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.808 1.243 . . . . 0.0 112.606 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 60.2 mtt 73.51 100.32 0.07 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.033 1.333 . . . . 0.0 109.649 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.13 123.66 21.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.868 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.54 119.29 19.4 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -148.37 -71.18 0.21 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 125.006 1.322 . . . . 0.0 107.742 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -176.48 100.03 0.06 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 62.7 tp -107.38 107.91 19.02 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.4 121.38 14.73 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 123.532 0.52 . . . . 0.0 110.047 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . 0.595 ' HB2' ' CD ' ' A' ' 498' ' ' GLU . 25.8 ptt? -163.05 133.3 4.48 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.436 ' HA ' ' HE3' ' A' ' 445' ' ' LYS . 54.4 mt -143.14 -66.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -170.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 401' ' ' ILE . 80.1 mt -127.68 162.1 27.35 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.12 174.9 10.16 Favored 'General case' 0 C--O 1.248 1.017 0 O-C-N 123.269 0.356 . . . . 0.0 110.976 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 33.7 t -119.82 -75.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.998 0.427 . . . . 0.0 110.478 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 3.3 m -142.86 96.98 3.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 497' ' ' PHE . 28.3 mm-40 -98.14 114.21 26.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -142.0 22.23 2.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.039 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.02 151.39 23.3 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.872 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.03 117.16 28.89 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.589 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.51 -35.04 21.4 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 68.42 95.59 0.07 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 125.737 1.615 . . . . 0.0 110.95 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -146.59 -44.21 0.19 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.054 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -125.25 146.59 54.58 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.8 -27.55 21.35 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.643 2.229 . . . . 0.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.11 -61.66 2.39 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.392 0.615 . . . . 0.0 109.815 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.409 ' HB2' HG13 ' A' ' 419' ' ' VAL . 58.7 mtt180 -134.23 150.04 51.01 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -82.11 25.23 0.6 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 495' ' ' MET . . . -169.43 82.54 0.13 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.315 1.046 . . . . 0.0 109.193 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 416' ' ' ARG . 4.9 m -154.89 175.92 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 C-N-CA 124.047 0.939 . . . . 0.0 108.982 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -149.26 -179.35 25.06 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 p -117.38 143.12 46.31 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.313 0.578 . . . . 0.0 112.187 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.9 137.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.4 pt -93.18 -38.46 9.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -154.33 147.34 24.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.63 134.36 13.74 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.425 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -159.15 175.75 13.08 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -97.24 146.56 24.98 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -120.24 123.32 42.94 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.543 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.79 -10.03 3.44 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.08 -44.62 0.56 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.023 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -82.81 -25.39 32.74 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 122.859 0.464 . . . . 0.0 110.847 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.15 -166.58 15.48 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.75 116.41 4.09 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 121.84 1.693 . . . . 0.0 110.307 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 482' ' ' THR . 22.5 m -113.05 144.65 20.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-O 121.204 0.526 . . . . 0.0 109.939 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.71 111.98 9.13 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -85.04 120.9 27.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.0 pp -140.15 173.11 11.84 Favored 'General case' 0 C--N 1.278 -2.516 0 O-C-N 122.281 -0.262 . . . . 0.0 111.521 -173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.42 107.81 16.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.3 p -67.16 116.69 6.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 CA-C-O 121.813 0.816 . . . . 0.0 111.099 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.49 -15.64 6.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.509 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -78.31 -17.28 56.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.066 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.6 -107.83 0.33 Allowed Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 96.6 m -131.92 137.48 48.0 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.476 ' HG ' HG11 ' A' ' 496' ' ' VAL . 0.5 OUTLIER -109.84 127.18 54.52 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.602 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.7 ttpm? -131.71 158.28 41.55 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.431 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.8 m -71.19 137.13 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 O-C-N 121.777 -0.577 . . . . 0.0 110.384 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.17 -8.05 60.61 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.604 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 5.8 m-20 -68.5 136.86 90.78 Favored Pre-proline 0 CA--C 1.494 -1.202 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 55.1 Cg_endo -81.4 106.43 1.71 Allowed 'Trans proline' 0 N--CA 1.429 -2.29 0 C-N-CA 122.117 1.878 . . . . 0.0 107.544 171.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.618 HG22 HG22 ' A' ' 496' ' ' VAL . 2.8 pp -108.23 139.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.175 -170.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 58.5 t -110.39 113.99 45.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.24 112.0 38.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.08 -97.36 0.65 Allowed Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.85 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.0 t -131.74 3.95 4.18 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 120.963 0.411 . . . . 0.0 110.233 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.454 HG21 ' CB ' ' A' ' 486' ' ' ASP . 96.2 m -116.46 141.64 47.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 44.5 p90 -114.97 151.03 34.84 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -153.81 -164.3 12.59 Favored Glycine 0 C--N 1.296 -1.664 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 448' ' ' ASP . 19.9 ttm180 -134.58 127.43 31.23 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 482' ' ' THR . 60.9 t -58.88 115.31 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.72 0.638 . . . . 0.0 111.536 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -84.33 -59.27 2.44 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.0 151.22 48.87 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.549 0.739 . . . . 0.0 109.451 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 469' ' ' ARG . 54.7 tpp -122.49 117.33 25.69 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.3 127.91 75.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -96.45 -176.76 3.73 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.16 -173.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -48.54 -37.06 16.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 126.825 2.05 . . . . 0.0 113.114 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.0 m -88.71 -6.73 57.25 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.33 15.18 48.55 Favored Glycine 0 CA--C 1.496 -1.11 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.13 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.47 ' HB2' HD21 ' A' ' 464' ' ' ASN . 0.1 OUTLIER -100.4 135.17 42.26 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.086 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 462' ' ' MET . 6.6 tpt180 -68.89 130.99 44.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 462' ' ' MET . 14.0 m -139.71 -177.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.172 0.295 . . . . 0.0 110.681 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 472' ' ' GLU . 0.8 OUTLIER -106.32 -34.34 7.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -176.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 471' ' ' LYS . 32.8 tt0 -148.13 135.27 20.32 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.641 -172.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -128.84 144.74 51.25 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 171.11 31.96 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.233 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.506 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.5 Cg_endo -63.44 156.67 55.02 Favored 'Trans proline' 0 C--O 1.247 0.931 0 C-N-CA 122.969 2.446 . . . . 0.0 112.598 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 44.3 m 71.98 12.32 6.07 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.218 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 42.0 ttp -118.88 129.73 25.23 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.2 Cg_exo -67.48 127.22 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.694 2.263 . . . . 0.0 111.108 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 473' ' ' ALA . 24.5 m -139.85 154.96 24.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 39.4 tt0 -115.7 119.21 35.33 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -98.19 173.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.969 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.465 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.2 p -149.38 167.63 25.63 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.62 31.42 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.452 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 53.9 tp -81.22 -30.89 34.08 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.648 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 61.46 20.58 11.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.351 1.46 . . . . 0.0 111.345 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.454 ' CB ' HG21 ' A' ' 455' ' ' THR . 34.5 t70 -147.81 175.09 11.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.42 114.76 53.83 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 118.983 0.811 . . . . 0.0 112.318 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -85.75 146.61 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.686 1.59 . . . . 0.0 110.25 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.37 139.58 50.68 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.08 131.6 43.86 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.091 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.38 -0.12 68.05 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.091 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.56 ' OD1' ' HD2' ' A' ' 493' ' ' ARG . 1.6 t0 -85.02 -173.63 4.83 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.6 ' H ' ' HD2' ' A' ' 493' ' ' ARG . 0.9 OUTLIER -130.0 133.85 47.04 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.485 -175.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 40.5 p90 -127.15 150.23 49.59 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 418' ' ' ALA . 54.2 ttp -119.98 115.81 24.5 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.822 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 450' ' ' ILE . 26.3 t -137.04 104.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 406' ' ' GLU . 14.9 p90 -153.95 124.29 7.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.595 ' CD ' ' HB2' ' A' ' 400' ' ' MET . 15.5 pt-20 -138.04 -57.02 0.66 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 163.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.405 ' N ' ' HG3' ' A' ' 498' ' ' GLU . 15.0 t70 47.94 -92.94 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.116 1.766 . . . . 0.0 114.406 168.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.91 -10.66 59.69 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 122.12 -0.363 . . . . 0.0 111.872 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 498' ' ' GLU . 34.0 tptt -47.37 -54.15 11.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 112.144 -170.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.47 -34.92 41.05 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.241 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.45 -50.57 73.04 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 122.006 0.908 . . . . 0.0 108.885 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 511' ' ' ALA . 63.9 ttt180 -61.03 -37.62 83.22 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 125.675 1.59 . . . . 0.0 110.289 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -63.62 -45.32 90.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.798 0.332 . . . . 0.0 110.251 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 80.1 mt -67.67 -34.21 66.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.06 22.72 6.74 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -85.69 -44.29 12.69 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.402 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -93.61 -175.73 3.86 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -72.76 123.61 23.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 504' ' ' ARG . . . -146.98 -77.64 0.17 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 170.34 93.85 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.91 1.284 . . . . 0.0 108.228 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -82.21 145.88 29.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 . . . . . 0 C--N 1.276 -2.609 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.389 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 23.1 t 68.48 -176.44 0.2 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.278 1.031 . . . . 0.0 109.623 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.443 ' O ' ' HG2' ' A' ' 393' ' ' MET . 71.6 m-70 73.25 -57.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.14 1.376 . . . . 0.0 111.402 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 392' ' ' HIS . 21.0 ptp 64.8 -26.69 0.09 Allowed 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 128.022 2.529 . . . . 0.0 114.49 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 84.8 mt -81.74 -10.2 59.43 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.121 0.486 . . . . 0.0 109.964 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -88.44 135.44 33.47 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -136.13 170.77 15.49 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.27 107.54 18.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 95.9 mt 71.68 98.35 0.07 Allowed 'General case' 0 C--O 1.241 0.615 0 O-C-N 124.607 1.192 . . . . 0.0 111.247 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.44 -5.34 52.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.807 0.813 . . . . 0.0 109.232 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -152.44 168.86 24.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 26.1 pt -73.43 157.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.91 -47.71 50.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.639 0.733 . . . . 0.0 111.246 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.61 162.69 18.73 Favored 'General case' 0 C--N 1.271 -2.848 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.345 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.08 -69.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 22.7 t -178.63 99.99 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.52 104.08 4.86 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.702 0.763 . . . . 0.0 111.181 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -166.11 106.01 0.68 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -118.81 140.6 49.69 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.189 0.519 . . . . 0.0 111.732 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -150.66 132.17 14.77 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.69 -18.35 21.39 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -170.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.98 75.09 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.127 0.892 . . . . 0.0 109.05 -174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -137.59 26.16 2.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.357 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -142.56 109.95 5.72 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.632 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.66 -20.1 18.06 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.557 2.171 . . . . 0.0 113.334 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.83 98.66 9.27 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 416' ' ' ARG . 4.5 mmp_? -96.17 79.62 3.19 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.661 0.744 . . . . 0.0 112.628 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -133.72 -86.32 0.43 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -155.14 79.31 1.05 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 495' ' ' MET . 10.9 m -155.39 164.17 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 124.72 1.208 . . . . 0.0 108.04 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -139.63 -178.13 16.36 Favored Glycine 0 C--N 1.295 -1.697 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.476 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 26.7 m -124.22 143.8 50.32 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.4 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.045 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.7 pt -91.7 -35.19 6.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.423 ' HG3' ' OG1' ' A' ' 436' ' ' THR . 9.8 pt-20 -159.21 148.66 18.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.22 130.54 12.06 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 177.46 10.71 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -174.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 427' ' ' LEU . 2.0 pt? -94.72 150.12 20.54 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -126.84 135.09 50.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.29 -18.2 59.08 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.834 -174.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -114.82 -36.31 1.28 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.549 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -88.52 -30.48 19.3 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.418 -0.46 . . . . 0.0 111.796 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.67 -152.28 17.7 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 482' ' ' THR . 14.4 Cg_exo -71.67 116.33 4.66 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.725 1.617 . . . . 0.0 110.017 175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.93 124.06 68.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.63 0.729 . . . . 0.0 111.537 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -123.08 112.18 17.45 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.889 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 424' ' ' GLU . 1.2 m -83.59 115.45 22.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.2 pp -132.21 170.85 14.44 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.898 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.467 ' O ' ' HG3' ' A' ' 440' ' ' GLN . 2.1 tm? -117.03 106.13 13.06 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -64.64 117.7 5.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-O 121.827 0.823 . . . . 0.0 112.346 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 438' ' ' LEU . 72.1 mt-30 -123.66 -15.46 7.01 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.698 -175.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.579 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -78.28 -14.99 59.19 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.831 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 153.97 -108.05 0.35 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 27.2 m -128.8 142.5 50.96 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.554 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.13 135.98 53.22 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.3 ttpt -146.0 150.83 36.76 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 33.5 m -70.74 134.23 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.235 0.541 . . . . 0.0 110.707 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 105.2 -21.19 36.11 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.488 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 43.8 m-20 -79.47 146.44 65.85 Favored Pre-proline 0 C--O 1.251 1.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 458' ' ' ARG . 10.7 Cg_endo -77.8 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.114 1.876 . . . . 0.0 111.179 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.58 152.03 30.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.67 121.9 48.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-O 121.195 0.521 . . . . 0.0 109.64 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.462 ' HB ' ' CB ' ' A' ' 494' ' ' PHE . 2.5 p -143.78 133.45 20.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.644 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.75 33.82 88.26 Favored Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.261 26.7 p 62.05 1.76 0.71 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.928 1.691 . . . . 0.0 114.306 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 39.0 m -98.38 141.15 31.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -120.18 151.37 39.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.171 -1.011 . . . . 0.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.25 14.04 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 449' ' ' PRO . 32.7 ttp180 -127.76 146.65 50.52 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.521 HG11 ' HE2' ' A' ' 462' ' ' MET . 45.9 t -74.08 120.17 22.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -92.63 -45.16 8.21 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.782 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -144.04 152.56 41.17 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.554 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -122.47 117.59 26.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.94 133.81 65.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.542 HD21 ' HB2' ' A' ' 468' ' ' ARG . 4.7 p30 -101.63 172.77 6.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 117.877 -1.529 . . . . 0.0 109.816 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.67 -26.1 61.2 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.335 1.054 . . . . 0.0 113.061 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.7 m -86.02 -2.22 58.1 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 122.099 -0.375 . . . . 0.0 111.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 93.92 1.98 64.98 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.413 170.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.542 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.8 mpt_? -86.35 131.83 34.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.597 -0.301 . . . . 0.0 110.439 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 21.6 tpp85 -77.85 129.63 35.64 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.08 176.04 9.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 -8.35 10.38 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.736 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -151.65 139.4 19.81 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.55 131.55 29.73 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.74 166.9 31.73 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.439 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 439' ' ' VAL . 17.7 Cg_endo -58.05 149.81 68.86 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 123.252 2.635 . . . . 0.0 112.175 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 43.4 t 77.55 6.44 2.92 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.917 0.887 . . . . 0.0 112.133 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 39.5 ttp -110.26 127.09 27.62 Favored Pre-proline 0 N--CA 1.439 -0.993 0 O-C-N 121.403 -0.811 . . . . 0.0 111.417 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.8 Cg_endo -74.15 126.59 10.62 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.752 2.301 . . . . 0.0 111.627 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 17.4 m -141.17 152.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.327 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 35.4 mt-10 -99.62 123.1 43.57 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.5 pt -97.58 164.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 4.1 p -145.77 158.38 43.86 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 100.9 12.48 36.96 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.919 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.31 -36.58 71.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 67.33 21.43 9.81 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.731 1.612 . . . . 0.0 109.873 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.451 ' CB ' HG21 ' A' ' 455' ' ' THR . 6.7 t70 -145.63 -179.05 6.42 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.29 110.05 48.36 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 123.405 0.441 . . . . 0.0 110.982 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 36.2 Cg_endo -82.73 148.49 13.98 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.931 1.754 . . . . 0.0 110.561 177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -111.29 135.98 51.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.024 0.44 . . . . 0.0 111.958 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.87 127.26 32.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 93.99 -0.24 66.69 Favored Glycine 0 C--N 1.313 -0.74 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.866 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.2 t70 -88.41 -172.13 3.64 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.0 OUTLIER -128.31 139.0 52.65 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -171.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 46.7 p90 -127.63 159.69 33.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.01 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . 0.414 ' HB2' HG12 ' A' ' 419' ' ' VAL . 28.1 ttt -132.44 130.68 40.88 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.579 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.0 p -87.42 138.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -93.86 122.02 35.91 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -91.51 -83.47 0.28 Allowed 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.516 -173.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.521 ' H ' ' HG3' ' A' ' 498' ' ' GLU . 34.0 t70 67.45 -55.61 0.46 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 127.133 2.173 . . . . 0.0 114.625 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -65.78 -35.82 81.79 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -62.27 -52.97 61.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.903 -170.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 499' ' ' ASP . 21.9 pttp -61.22 -40.72 95.05 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.282 0.363 . . . . 0.0 110.257 175.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.05 60.68 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.104 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -60.29 -38.11 82.61 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 123.961 0.904 . . . . 0.0 110.928 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -69.84 -34.62 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.645 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 81.8 mt -77.65 -23.21 14.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.655 0.741 . . . . 0.0 110.116 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.74 29.4 9.27 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -95.18 -50.39 5.07 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.728 0.811 . . . . 0.0 109.045 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -82.47 101.02 10.41 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -106.2 -47.32 3.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.864 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 512' ' ' GLN . . . 72.02 116.98 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.659 1.225 . . . . 0.0 108.971 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 511' ' ' ALA . 1.5 pt20 68.64 168.06 0.27 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 127.102 2.161 . . . . 0.0 111.095 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -109.39 164.29 12.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 514' ' ' GLN . 15.9 mt-30 . . . . . 0 C--N 1.29 -1.998 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.568 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 40.0 m -85.31 15.82 4.09 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 117.432 0.616 . . . . 0.0 111.849 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 31.8 m170 63.57 46.67 4.1 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.328 1.061 . . . . 0.0 109.986 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 59.5 ttp -92.12 96.82 10.54 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.546 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 394' ' ' LEU . 2.3 pt? -111.68 139.32 47.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.27 -164.13 0.23 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.746 0.654 . . . . 0.0 110.353 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -114.76 99.5 7.55 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.87 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 61.8 tp 68.52 109.78 0.05 OUTLIER 'General case' 0 C--O 1.245 0.822 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.89 114.47 27.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.58 -32.43 62.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.06 -175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 93.1 mmm 64.98 82.21 0.19 Allowed 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.204 1.002 . . . . 0.0 110.929 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.447 HG13 HD22 ' A' ' 402' ' ' LEU . 10.9 tp -113.6 142.51 25.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 401' ' ' ILE . 3.8 mm? 61.55 -93.31 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.145 0.578 . . . . 0.0 111.332 -174.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 406' ' ' GLU . 95.6 mt -151.07 -57.45 0.16 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 124.228 1.011 . . . . 0.0 108.882 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 81.0 t 71.8 -63.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.194 1.798 . . . . 0.0 111.106 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 74.3 m -128.44 -1.15 5.6 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 403' ' ' LEU . 16.7 mm-40 -85.01 105.45 15.78 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 22.8 mmt -95.57 -16.99 21.75 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.309 0.576 . . . . 0.0 110.178 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.35 117.91 13.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.037 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . 0.25 6.1 pt-20 -157.72 85.32 0.9 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.295 1.045 . . . . 0.0 111.439 171.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 411' ' ' LYS . 4.3 pp -92.99 -38.83 11.45 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.504 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.47 ' N ' HD12 ' A' ' 410' ' ' LEU . 82.3 mttt 69.5 -67.82 0.21 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 126.343 1.857 . . . . 0.0 110.648 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 414' ' ' PRO . . . -176.18 93.51 0.05 Allowed 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -108.67 93.16 11.48 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 412' ' ' ALA . 26.4 Cg_endo -103.34 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.859 3.039 . . . . 0.0 115.028 -170.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -75.47 110.13 9.59 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 72.51 -64.1 0.41 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.693 1.597 . . . . 0.0 109.046 -174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -168.34 -39.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -165.42 139.18 4.63 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.591 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 30.4 m -143.77 172.96 5.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 104.338 -2.467 . . . . 0.0 104.338 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.99 162.02 13.29 Favored Glycine 0 C--N 1.279 -2.62 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.9 m -117.01 138.76 51.36 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.88 139.45 17.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 18.2 pt -99.3 -39.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.356 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 490' ' ' ALA . 8.5 pt-20 -153.39 152.29 30.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.22 134.34 29.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.69 177.39 10.91 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.311 0.577 . . . . 0.0 111.185 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.97 145.08 26.19 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.771 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 10.4 t70 -128.02 129.16 46.25 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.644 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -75.55 -11.23 59.98 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -175.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -119.34 -35.64 0.92 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.478 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.0 mtp180 -94.08 -15.22 24.94 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.844 0.458 . . . . 0.0 111.028 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 88.15 -154.1 25.08 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -60.27 116.16 3.13 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.108 1.872 . . . . 0.0 111.173 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.8 137.18 53.62 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.434 0.635 . . . . 0.0 110.377 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -131.4 114.62 15.19 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.104 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -83.39 119.44 24.64 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.482 HD22 ' CE1' ' A' ' 494' ' ' PHE . 1.6 pp -135.73 173.07 12.12 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -120.01 112.41 19.12 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -75.77 125.2 35.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.526 0.679 . . . . 0.0 111.799 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 72.6 mt-30 -124.03 -15.11 6.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.937 -176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -97.3 6.31 48.55 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.153 0.501 . . . . 0.0 110.736 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 147.62 -125.77 2.22 Favored Glycine 0 N--CA 1.407 -3.263 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.15 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.7 m -116.39 141.63 47.92 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.73 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -113.77 119.25 36.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.65 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -130.02 155.14 46.61 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.494 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.0 m -67.06 132.16 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.84 -7.09 48.76 Favored Glycine 0 N--CA 1.425 -2.084 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.916 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 498' ' ' GLU . 13.7 m-20 -73.88 135.02 77.68 Favored Pre-proline 0 C--O 1.25 1.089 0 CA-C-N 117.555 0.678 . . . . 0.0 111.932 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.32 119.15 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.629 2.219 . . . . 0.0 109.306 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.07 159.81 29.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.73 115.59 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 494' ' ' PHE . 16.6 t -128.38 124.17 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 56.98 42.35 92.78 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.264 6.6 t 60.39 4.09 0.65 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.549 2.34 . . . . 0.0 113.436 -177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.462 HG21 ' CB ' ' A' ' 486' ' ' ASP . 22.4 m -96.53 135.62 38.18 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -111.5 151.65 28.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.604 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -164.95 -163.97 19.29 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -134.62 137.21 43.48 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 444' ' ' LEU . 48.7 t -66.69 119.36 11.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.184 0.516 . . . . 0.0 112.097 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -81.54 -60.59 2.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.92 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -136.2 152.05 50.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.73 ' HE1' HD22 ' A' ' 444' ' ' LEU . 41.2 tpp -115.23 117.07 29.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.415 HG22 ' HG2' ' A' ' 469' ' ' ARG . 11.9 t -122.88 126.49 73.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.444 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -92.81 174.77 7.08 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.625 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.21 -27.82 56.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.949 0.9 . . . . 0.0 113.144 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.5 m -78.81 -12.1 60.01 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.756 0.312 . . . . 0.0 111.0 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 98.41 8.32 54.95 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.93 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -97.0 128.81 44.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 463' ' ' VAL . 3.8 tmm_? -84.77 124.33 31.42 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.43 -174.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -99.31 -31.85 11.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.11 156.67 40.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.304 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.33 150.53 42.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -100.58 177.04 28.0 Favored Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.44 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.7 Cg_endo -59.76 155.37 43.6 Favored 'Trans proline' 0 C--O 1.247 0.952 0 C-N-CA 122.971 2.447 . . . . 0.0 112.641 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 47.6 m 70.81 16.94 6.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.955 0.902 . . . . 0.0 112.144 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 45.5 ttm -117.81 136.68 23.8 Favored Pre-proline 0 C--N 1.316 -0.861 0 O-C-N 122.007 -0.433 . . . . 0.0 111.185 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.1 Cg_endo -82.57 125.85 4.5 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.234 1.956 . . . . 0.0 110.884 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 464' ' ' ASN . 16.9 m -143.22 156.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.875 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.0 mt-10 -105.0 126.55 52.18 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 50.0 pt -97.95 170.4 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 1.2 p -150.42 167.46 27.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 88.75 13.89 62.05 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.914 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.63 -32.54 64.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 36.9 t60 67.45 19.85 9.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.076 1.75 . . . . 0.0 109.788 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.462 ' CB ' HG21 ' A' ' 455' ' ' THR . 7.3 t70 -148.39 -179.98 7.36 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.9 t -120.42 113.41 33.68 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.46 175.38 10.24 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.773 2.315 . . . . 0.0 111.509 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -111.03 148.0 33.54 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 424' ' ' GLU . . . -70.22 138.84 52.05 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.255 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.85 -0.23 86.26 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.18 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.613 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 4.5 t70 -83.96 -165.34 1.11 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.613 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -138.59 148.98 44.78 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.688 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.482 ' CE1' HD22 ' A' ' 437' ' ' LEU . 15.0 p90 -139.56 156.19 47.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.833 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.1 ttt -118.86 127.39 53.46 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 441' ' ' ALA . 4.8 p -101.65 136.44 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -150.65 133.47 15.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.441 ' HA ' ' OD1' ' A' ' 448' ' ' ASP . 8.2 tp10 -76.42 148.07 37.55 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.893 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.46 -55.06 38.06 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 124.217 1.007 . . . . 0.0 110.882 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.56 -34.55 78.51 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.563 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -72.53 -38.63 67.98 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.607 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -60.49 -46.78 88.84 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.611 174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.94 -45.03 94.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.142 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.449 ' HA ' ' HB3' ' A' ' 508' ' ' GLU . 37.2 ttm180 -58.94 -36.03 74.1 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 125.374 1.469 . . . . 0.0 111.757 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -34.14 59.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.9 mm -80.18 -54.06 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -171.83 9.55 0.04 OUTLIER Glycine 0 C--N 1.32 -0.316 0 C-N-CA 118.695 -1.717 . . . . 0.0 115.052 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.449 ' HB3' ' HA ' ' A' ' 504' ' ' ARG . 5.4 tp10 -83.04 -29.09 29.12 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.84 -0.744 . . . . 0.0 108.998 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 504' ' ' ARG . . . 59.68 -163.17 0.24 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.552 0.741 . . . . 0.0 109.557 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -74.96 -29.93 61.06 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.204 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . 65.22 74.55 0.38 Allowed 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.487 1.115 . . . . 0.0 112.661 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -160.56 162.08 32.81 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -169.83 105.8 0.34 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.76 0.79 . . . . 0.0 109.568 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.301 -1.506 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -178.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.252 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 16.5 m -78.26 91.99 4.45 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -128.73 86.01 2.4 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.563 0.697 . . . . 0.0 110.876 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -94.41 3.96 54.48 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.166 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.19 13.74 1.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.436 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.95 105.58 17.67 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -101.71 13.14 35.77 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.355 0.598 . . . . 0.0 111.288 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.36 -36.2 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.0 tp 72.71 -76.78 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.606 1.163 . . . . 0.0 111.983 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 52.24 70.52 0.55 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.742 0.817 . . . . 0.0 109.0 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 52.8 ttm -77.86 89.13 4.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.716 0.77 . . . . 0.0 112.06 -175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 50.0 mm -95.69 -65.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 84.3 mt 61.97 177.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.165 1.386 . . . . 0.0 112.622 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 95.2 mt 63.97 89.06 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.409 1.084 . . . . 0.0 111.811 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.75 1.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 50.8 m -111.6 -8.18 14.24 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.454 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -145.46 64.78 1.25 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.773 0.797 . . . . 0.0 111.466 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.7 170.32 8.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.05 117.79 30.18 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 411' ' ' LYS . 7.8 tp10 -97.54 106.16 18.43 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 413' ' ' ASN . 2.2 pt? -131.03 3.36 4.38 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.757 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.517 ' HG2' ' OE2' ' A' ' 409' ' ' GLU . 23.5 pttm -102.02 -35.51 8.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.411 0.624 . . . . 0.0 109.807 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -104.23 -23.47 13.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.046 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 410' ' ' LEU . 12.8 m120 -123.31 121.83 26.88 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.952 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.92 -12.85 10.68 Favored 'Trans proline' 0 C--N 1.329 -0.456 0 C-N-CA 122.084 1.856 . . . . 0.0 112.921 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.494 ' HB2' HG21 ' A' ' 419' ' ' VAL . 11.3 m120 -81.41 -7.78 59.63 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.823 -172.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.91 176.58 0.26 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 52.42 -112.91 0.71 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.328 1.451 . . . . 0.0 112.933 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 441' ' ' ALA . . . -127.17 104.48 7.99 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 415' ' ' ASN . 2.5 m -149.18 162.78 4.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -129.47 178.37 17.43 Favored Glycine 0 C--N 1.298 -1.554 0 C-N-CA 119.233 -1.46 . . . . 0.0 112.542 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.84 145.16 45.89 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 123.335 0.654 . . . . 0.0 111.107 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 30.0 t -86.55 134.06 28.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 436' ' ' THR . 17.2 pt -94.26 -33.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.31 149.13 20.56 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.58 131.27 18.93 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.78 177.98 4.23 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -87.89 152.85 21.77 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -126.62 119.32 26.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -58.11 -19.55 33.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -112.53 -38.78 1.28 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.784 -1.198 . . . . 0.0 112.839 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.57 -32.59 19.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.37 -155.53 16.17 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.56 116.38 4.38 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.075 1.85 . . . . 0.0 110.068 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 32.4 m -116.3 143.94 25.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.793 0.806 . . . . 0.0 111.684 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -133.17 112.03 11.4 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.488 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 423' ' ' ILE . 2.7 m -87.55 115.36 24.92 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.646 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.4 pp -132.86 171.37 14.0 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 476' ' ' SER . 2.4 tm? -113.33 106.38 14.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -70.3 108.84 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.352 1.072 . . . . 0.0 111.928 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -115.0 -15.94 11.71 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.18 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.441 ' HA ' ' HB1' ' A' ' 418' ' ' ALA . . . -77.64 -4.12 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.906 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.31 -95.67 0.19 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.218 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.9 m -142.05 139.61 32.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -114.47 135.57 53.96 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.4 ttpm? -147.75 164.3 34.01 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 28.6 m -70.62 138.12 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 121.734 0.778 . . . . 0.0 112.134 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.28 -10.62 65.4 Favored Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.207 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 51.1 m-20 -76.66 131.76 73.37 Favored Pre-proline 0 C--O 1.245 0.848 0 CA-C-N 117.651 0.725 . . . . 0.0 111.536 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 4.9 Cg_exo -77.42 107.68 2.44 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.681 2.254 . . . . 0.0 109.26 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -112.48 161.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.898 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.56 114.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.444 HG23 HD13 ' A' ' 450' ' ' ILE . 61.7 t -120.34 112.42 36.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.55 -115.61 7.52 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.8 p -107.34 7.02 28.94 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.997 0.427 . . . . 0.0 111.259 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 486' ' ' ASP . 90.0 m -121.59 129.53 52.9 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.781 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -111.31 151.99 27.74 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -165.66 -164.27 20.77 Favored Glycine 0 C--N 1.286 -2.199 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.593 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 56.7 ttp180 -131.91 128.72 39.15 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 482' ' ' THR . 40.1 t -61.28 122.86 12.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 123.859 0.724 . . . . 0.0 111.767 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -95.71 -56.93 2.52 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -132.94 148.31 52.28 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.6 tpp -115.37 117.68 31.09 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 16.8 t -116.36 139.6 42.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -105.43 171.97 7.04 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.095 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.6 -25.89 54.02 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 41.2 m -77.09 -11.71 59.85 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.011 -0.43 . . . . 0.0 110.954 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.74 -4.64 56.41 Favored Glycine 0 CA--C 1.496 -1.12 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.484 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -91.89 140.26 29.85 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.4 tmm_? -86.44 138.01 32.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 16.7 m -136.17 -173.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 124.41 1.084 . . . . 0.0 108.493 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -119.34 -17.07 8.91 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.113 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 445' ' ' LYS . 34.0 tt0 -149.19 152.25 35.72 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -141.44 135.36 30.25 Favored 'General case' 0 C--O 1.25 1.11 0 O-C-N 123.536 0.522 . . . . 0.0 110.876 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -86.45 168.43 40.19 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.641 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 439' ' ' VAL . 37.0 Cg_endo -64.26 154.99 68.0 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 122.941 2.427 . . . . 0.0 113.729 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.451 ' HA ' HD11 ' A' ' 438' ' ' LEU . 34.1 m 70.17 16.55 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.016 1.326 . . . . 0.0 112.19 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.6 ttp -117.0 130.07 24.87 Favored Pre-proline 0 N--CA 1.435 -1.21 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.475 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 11.2 Cg_endo -72.68 126.12 11.16 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.27 1.98 . . . . 0.0 111.788 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.72 155.05 22.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.672 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 463' ' ' VAL . 43.5 mt-10 -108.64 113.63 26.78 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 124.516 1.127 . . . . 0.0 108.575 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.8 pt -98.13 172.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.805 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.6 p -146.45 163.03 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 107.29 11.56 25.34 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.972 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.4 mt -83.71 -27.29 29.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.706 0.289 . . . . 0.0 111.749 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 60.27 19.26 8.73 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.61 1.164 . . . . 0.0 110.518 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.702 ' HB3' HG21 ' A' ' 455' ' ' THR . 34.4 t70 -149.26 174.39 12.44 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.22 112.26 52.37 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.92 2.413 . . . . 0.0 111.37 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -105.31 132.43 51.51 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.484 0.659 . . . . 0.0 111.656 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.03 28.4 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 101.63 -5.11 54.16 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.24 -177.48 6.25 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.44 ' HG3' ' ND2' ' A' ' 413' ' ' ASN . 6.4 mpt_? -114.09 143.66 44.41 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 123.656 0.782 . . . . 0.0 110.758 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.646 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 50.1 p90 -136.83 163.16 31.3 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.5 ttm -130.17 115.88 17.65 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.851 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' A' ' 444' ' ' LEU . 74.6 t -101.05 106.88 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -151.39 123.05 7.97 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.836 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -179.25 4.89 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 167.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -158.75 -52.43 0.06 Allowed 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.651 0.738 . . . . 0.0 109.921 -165.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 49.3 mt-10 -71.68 -33.69 69.04 Favored 'General case' 0 C--O 1.182 -2.458 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.401 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -62.42 -39.12 92.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.74 0.781 . . . . 0.0 111.141 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -67.12 -41.2 86.57 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.914 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 508' ' ' GLU . . . -79.65 -25.92 41.22 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.159 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 28.7 ttt180 -70.76 -29.06 65.17 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 124.74 1.216 . . . . 0.0 110.014 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.2 -34.52 78.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.033 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 70.9 mt -79.08 -35.02 17.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 108.11 28.06 4.83 Favored Glycine 0 N--CA 1.419 -2.437 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.272 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.431 ' HG3' ' HB1' ' A' ' 503' ' ' ALA . 12.7 pt-20 -114.68 -32.04 5.97 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.566 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 64.44 -74.52 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.116 1.366 . . . . 0.0 113.084 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -72.56 93.37 1.58 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -89.15 92.47 9.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -101.87 132.78 47.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.305 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -147.18 134.32 20.46 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.296 -1.756 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.015 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 66.0 m 70.05 135.74 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.463 1.105 . . . . 0.0 112.493 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -115.22 134.91 54.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.323 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -114.57 -49.38 2.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.599 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 63.97 -175.06 0.16 Allowed 'General case' 0 C--O 1.243 0.712 0 O-C-N 124.226 0.954 . . . . 0.0 111.858 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.4 t70 68.52 -82.49 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.436 1.494 . . . . 0.0 111.745 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -87.82 95.41 10.08 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 74.68 153.03 0.14 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.414 1.085 . . . . 0.0 111.605 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.23 152.08 35.57 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -77.26 131.03 37.97 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 50.5 ttm -79.4 -38.85 33.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 109.814 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 66.3 mt -91.4 111.34 23.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.66 172.16 10.43 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 tp 72.7 -62.7 0.46 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.152 1.381 . . . . 0.0 111.065 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 7.5 p -178.92 -47.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 124.645 1.178 . . . . 0.0 108.275 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 50.7 m -163.76 155.08 16.45 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.39 102.93 6.15 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 96.1 mmm -61.14 -35.82 78.12 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.893 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -135.88 118.55 16.03 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.523 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.71 139.75 26.75 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.054 0.454 . . . . 0.0 110.66 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 5.55 37.24 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -80.86 -11.05 59.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.621 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -87.55 5.34 39.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.725 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 75.21 126.19 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.038 1.335 . . . . 0.0 110.424 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.44 -13.46 37.58 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.08 2.52 . . . . 0.0 113.731 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -86.93 -170.01 2.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -72.29 175.02 6.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -85.0 8.25 18.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.241 0.544 . . . . 0.0 111.017 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -82.85 6.24 19.05 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.204 0.526 . . . . 0.0 110.547 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.01 179.93 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 123.887 0.875 . . . . 0.0 108.807 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -147.8 -175.35 20.46 Favored Glycine 0 C--N 1.299 -1.508 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 6.6 m -123.76 141.96 51.54 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.098 0.449 . . . . 0.0 109.891 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.87 138.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.4 pt -94.19 -42.22 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.779 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.77 146.72 27.34 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -150.88 138.71 19.88 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 177.44 4.34 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.98 150.78 20.05 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.043 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -127.46 129.84 48.18 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -67.21 -16.87 64.55 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.7 -53.78 0.55 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.93 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.72 -29.25 64.33 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.49 0.662 . . . . 0.0 110.15 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 434' ' ' VAL . . . 104.16 -179.42 24.89 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 486' ' ' ASP . 35.6 Cg_exo -49.73 119.55 4.87 Favored 'Trans proline' 0 C--O 1.252 1.224 0 C-N-CA 122.341 2.027 . . . . 0.0 111.179 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 432' ' ' GLY . 21.0 m -117.98 158.81 18.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.444 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -150.76 113.38 4.69 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.095 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 m -90.47 119.84 31.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -134.63 173.3 11.82 Favored 'General case' 0 C--N 1.264 -3.11 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.54 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.6 tm? -117.07 106.16 13.06 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.8 p -78.71 123.41 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.415 0.626 . . . . 0.0 112.506 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -124.09 -16.31 6.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.403 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -63.82 -16.99 62.64 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.541 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 160.89 -92.79 0.11 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.433 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.3 m -148.1 141.86 25.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.729 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.22 117.76 34.94 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.8 ttpm? -125.62 153.46 43.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.2 m -71.02 139.02 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.775 175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 101.75 -10.23 57.3 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.405 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 66.1 m-20 -82.08 138.19 46.01 Favored Pre-proline 0 C--O 1.244 0.789 0 CA-C-N 117.271 0.535 . . . . 0.0 111.846 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 18.5 Cg_endo -83.68 106.87 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.542 2.161 . . . . 0.0 110.161 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -108.4 162.98 6.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.034 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 6.9 p -133.18 125.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.67 125.5 70.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.64 -103.12 1.13 Allowed Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 19.6 m -126.33 0.24 7.02 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-O 121.739 0.78 . . . . 0.0 109.662 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 486' ' ' ASP . 74.7 m -116.23 146.01 42.68 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.491 -0.755 . . . . 0.0 111.158 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 54.7 p90 -119.24 159.89 23.23 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.757 0.313 . . . . 0.0 110.934 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -164.81 -164.44 20.14 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 35.3 ttm-85 -135.43 130.03 34.16 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 482' ' ' THR . 38.2 t -64.46 120.78 12.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.69 0.757 . . . . 0.0 112.858 -172.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -85.33 -60.28 2.08 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.812 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.8 160.75 37.2 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.921 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.729 ' HE1' HD22 ' A' ' 444' ' ' LEU . 36.7 tpp -130.69 117.51 19.56 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.16 138.78 53.72 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.0 p30 -103.62 176.48 5.14 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.932 -173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -51.33 -38.39 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.517 1.136 . . . . 0.0 111.783 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.0 m -76.74 -5.9 49.98 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.01 -175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.44 2.64 63.5 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.38 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.477 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.9 mpt_? -88.67 128.63 35.6 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 120.755 0.312 . . . . 0.0 110.365 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -84.31 134.15 34.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.1 176.15 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -96.52 -35.51 11.09 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.962 0.411 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.75 151.43 28.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.304 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -135.53 150.91 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.135 0.574 . . . . 0.0 109.755 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.77 179.29 42.87 Favored Glycine 0 N--CA 1.439 -1.148 0 O-C-N 123.534 0.521 . . . . 0.0 112.327 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.411 ' HA ' HG13 ' A' ' 439' ' ' VAL . 65.1 Cg_endo -71.72 161.01 46.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.696 2.264 . . . . 0.0 112.689 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 438' ' ' LEU . 18.7 m 67.25 23.14 9.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.406 1.082 . . . . 0.0 110.591 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.0 ttt -125.86 137.62 30.43 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.884 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 5.7 Cg_exo -83.21 125.75 4.1 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.0 m -142.69 151.66 17.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.248 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.7 tt0 -108.63 119.05 38.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.5 pt -98.15 172.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.262 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.6 p -148.9 157.24 43.28 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.823 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.49 4.96 Favored Glycine 0 C--N 1.308 -0.988 0 O-C-N 123.566 0.541 . . . . 0.0 112.379 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.27 -31.65 11.95 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.76 21.16 11.22 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.992 1.317 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 433' ' ' PRO . 38.1 t70 -147.78 167.43 24.72 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 4.8 p -94.75 115.93 65.85 Favored Pre-proline 0 C--N 1.287 -2.117 0 CA-C-O 121.035 0.445 . . . . 0.0 110.762 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.9 Cg_endo -84.97 173.7 7.88 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.617 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -122.47 136.63 54.93 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.962 0.411 . . . . 0.0 111.383 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -70.85 140.6 51.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.922 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.51 89.38 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.585 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -91.84 -176.4 4.43 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 6.3 mpt_? -113.14 150.4 32.26 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.241 0.543 . . . . 0.0 110.196 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.632 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.2 p90 -139.54 165.13 28.07 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 24.6 ttt -130.14 131.99 45.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 444' ' ' LEU . 84.5 t -129.08 138.14 55.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -133.92 123.2 24.27 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -92.94 -41.86 9.79 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.785 0.802 . . . . 0.0 109.387 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 15.2 t70 73.36 -76.87 0.06 Allowed 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 126.505 1.922 . . . . 0.0 112.79 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 503' ' ' ALA . 0.0 OUTLIER -74.47 -27.24 60.5 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -165.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.455 ' HB2' ' HG3' ' A' ' 498' ' ' GLU . 6.7 mmmm -56.36 -42.48 77.87 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.277 0.361 . . . . 0.0 110.363 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -80.82 -37.38 30.2 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 500' ' ' GLU . . . -54.64 -56.6 17.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 123.23 0.612 . . . . 0.0 111.425 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -72.73 -19.49 61.37 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.394 0.616 . . . . 0.0 111.296 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 501' ' ' LYS . 7.9 tt0 -81.21 -31.05 34.09 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.01 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 83.3 mt -87.29 -53.89 9.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 151.79 32.56 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.237 -1.459 . . . . 0.0 114.173 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -66.42 -38.83 88.32 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -131.57 115.86 16.66 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -104.0 -56.52 2.18 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.645 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -86.45 -40.7 15.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -172.49 170.73 4.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -89.99 -20.38 23.35 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.208 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 124.564 1.146 . . . . 0.0 109.845 -176.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.492 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 25.5 m -127.43 -61.15 1.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -94.5 74.66 3.81 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 56.9 ttp -100.92 106.82 18.19 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.287 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 94.3 mt -98.45 157.77 16.0 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.68 -23.99 45.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -85.61 105.19 16.0 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.527 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 98.0 mt -126.49 118.13 24.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.71 -25.51 44.67 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 66.67 102.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.87 1.268 . . . . 0.0 112.801 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 64.4 mtt -116.81 142.82 46.43 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.906 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 52.6 mt 60.75 79.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 124.274 1.03 . . . . 0.0 110.152 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.16 88.38 4.19 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.9 99.46 3.26 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.91 -13.19 8.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.724 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 13.8 m -82.86 95.67 8.01 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.589 0.709 . . . . 0.0 110.57 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.42 -64.76 1.04 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.278 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 16.6 tpt 71.97 -14.12 0.54 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.334 1.454 . . . . 0.0 112.312 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -76.98 123.28 26.1 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 111.54 22.2 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.2 tp -132.69 14.21 4.42 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.958 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 61.37 85.43 0.12 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.828 -173.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -75.15 97.3 3.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -45.49 123.45 5.74 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 124.671 1.188 . . . . 0.0 111.766 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.83 -49.82 7.68 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 111.258 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 418' ' ' ALA . 14.7 m120 -90.72 74.57 6.62 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.0 117.48 5.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.396 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 75.39 7.83 3.95 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.674 1.59 . . . . 0.0 112.206 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 415' ' ' ASN . . . -111.46 -6.76 14.4 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.915 -0.491 . . . . 0.0 110.469 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 415' ' ' ASN . 30.3 m -147.99 175.28 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -141.84 -178.35 17.87 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.3 m -124.21 138.97 54.34 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.64 138.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 436' ' ' THR . 24.7 pt -89.13 -44.3 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.045 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 7.4 pt-20 -155.45 157.42 36.95 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -141.05 136.98 32.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 177.74 5.54 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.18 152.48 21.08 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.344 0.593 . . . . 0.0 110.047 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -122.76 118.28 27.68 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.466 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.2 -19.37 13.44 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.31 -41.32 1.79 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.642 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.55 -37.25 19.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 110.817 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.63 -146.42 18.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.53 116.51 4.27 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.507 2.138 . . . . 0.0 111.331 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.447 HG12 ' CG2' ' A' ' 482' ' ' THR . 27.4 m -119.81 158.6 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 110.216 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.2 121.77 13.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 480' ' ' GLU . 1.6 m -92.55 117.65 30.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.613 HD23 ' CZ ' ' A' ' 494' ' ' PHE . 0.0 OUTLIER -133.75 168.87 17.92 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.506 -177.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -114.86 106.35 14.07 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.4 p -72.72 117.08 15.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.779 0.799 . . . . 0.0 112.494 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.41 -15.96 9.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.123 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.68 60.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.802 -173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 498' ' ' GLU . . . 155.63 -106.92 0.3 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 90.1 m -134.74 133.69 40.2 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.559 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -101.9 126.02 48.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.1 ttpt -140.09 145.71 37.98 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -64.93 145.58 13.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.368 0.604 . . . . 0.0 112.449 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 -21.87 42.52 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.419 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 0.3 OUTLIER -94.7 144.03 27.21 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 26.1 Cg_exo -66.55 136.69 43.7 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.914 2.409 . . . . 0.0 111.346 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 452' ' ' VAL . 2.7 pp -131.5 161.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.262 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.22 116.19 47.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.48 HG23 HD13 ' A' ' 450' ' ' ILE . 85.0 t -128.58 122.62 57.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . 0.513 ' HA2' ' OD1' ' A' ' 492' ' ' ASP . . . 60.89 36.63 92.39 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 121.18 -0.534 . . . . 0.0 111.966 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.295 8.3 p 60.97 8.93 2.08 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.498 HG21 ' CB ' ' A' ' 486' ' ' ASP . 87.0 m -102.81 139.41 38.42 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -111.65 146.77 36.87 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.493 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -152.6 -167.86 15.94 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.67 135.92 47.27 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.561 HG11 ' HE2' ' A' ' 462' ' ' MET . 46.2 t -73.73 117.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 123.404 0.44 . . . . 0.0 110.292 -176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.97 -56.22 3.42 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -130.63 153.76 48.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.561 ' HE2' HG11 ' A' ' 459' ' ' VAL . 39.5 tpp -121.09 120.02 34.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.87 139.13 51.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 5.5 p30 -97.02 174.53 6.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.12 -25.88 67.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 44.0 m -78.83 -19.8 51.21 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.189 0.519 . . . . 0.0 111.102 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.88 2.21 Favored Glycine 0 CA--C 1.48 -2.111 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.191 165.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.468 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 25.8 ttm180 -120.27 136.5 54.65 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.021 -1.59 . . . . 0.0 109.941 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -79.77 132.05 36.06 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 124.16 0.913 . . . . 0.0 110.728 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.29 -32.0 8.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.138 0.494 . . . . 0.0 110.284 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.04 163.95 37.57 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.388 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.64 38.45 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -90.09 172.31 38.19 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.555 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.498 ' HA ' HG13 ' A' ' 439' ' ' VAL . 35.6 Cg_endo -65.79 158.55 53.11 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.82 2.347 . . . . 0.0 112.493 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.9 m 70.54 16.83 6.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.598 1.159 . . . . 0.0 111.362 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 25.1 ttt -117.04 137.53 23.95 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.677 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 1.9 Cg_endo -82.06 126.15 4.93 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.417 2.078 . . . . 0.0 111.298 174.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.57 158.0 16.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.334 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 37.8 mt-10 -111.62 121.24 44.61 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.7 pt -98.44 172.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.773 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.447 ' CG2' HG12 ' A' ' 434' ' ' VAL . 3.1 p -147.43 163.19 37.29 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.65 7.73 58.79 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.159 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.89 -39.05 64.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 60.22 30.41 19.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.003 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 455' ' ' THR . 35.2 t70 -140.77 179.67 6.57 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.58 109.73 47.27 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 118.317 0.508 . . . . 0.0 109.939 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 1.2 Cg_endo -80.58 164.19 21.15 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 121.602 1.535 . . . . 0.0 109.73 176.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -131.4 140.06 49.57 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-O 121.318 0.58 . . . . 0.0 110.458 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -71.11 132.08 44.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.285 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 88.24 0.61 82.57 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.968 -1.111 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.595 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 3.6 t70 -88.41 -173.26 4.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.595 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.1 OUTLIER -128.4 153.54 46.96 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.156 0.503 . . . . 0.0 111.0 -171.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.613 ' CZ ' HD23 ' A' ' 437' ' ' LEU . 44.2 p90 -145.65 165.7 27.96 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.105 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.3 ttt -133.15 123.44 25.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' CD1' ' A' ' 494' ' ' PHE . 84.0 t -109.0 136.72 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.47 122.55 32.07 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.544 0.688 . . . . 0.0 112.072 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.438 ' HB3' ' HD3' ' A' ' 501' ' ' LYS . 8.9 tp10 -92.77 155.85 17.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.49 -65.73 0.51 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 7.1 pt-20 -66.39 -36.1 82.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.491 0.662 . . . . 0.0 110.984 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 61.6 mtpt -66.49 -37.7 85.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.562 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 506' ' ' ILE . 87.8 tttt -77.79 -40.0 42.09 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.035 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.22 86.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.481 0.657 . . . . 0.0 110.924 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 508' ' ' GLU . 28.3 ttm180 -58.5 -38.83 78.47 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.835 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -74.32 -35.43 63.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.534 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 502' ' ' LYS . 75.7 mt -64.68 -38.42 82.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.724 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 157.48 -11.56 0.25 Allowed Glycine 0 N--CA 1.421 -2.31 0 C-N-CA 120.087 -1.054 . . . . 0.0 112.117 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 504' ' ' ARG . 29.8 tt0 -88.14 63.95 7.49 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.682 1.23 . . . . 0.0 108.796 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.6 15.24 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.632 -1.622 . . . . 0.0 110.981 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -110.99 -173.26 2.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -84.23 25.01 0.89 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.012 0.434 . . . . 0.0 111.729 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -132.02 109.17 9.83 Favored 'General case' 0 CA--C 1.491 -1.294 0 C-N-CA 123.583 0.753 . . . . 0.0 110.864 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -127.54 21.23 6.58 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 122.614 1.197 . . . . 0.0 108.118 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 N--CA 1.422 -1.84 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.126 -179.603 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.475 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 45.6 m -150.2 163.73 37.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -113.77 98.06 6.79 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.407 0.622 . . . . 0.0 111.915 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 97.0 mmm -120.83 32.18 6.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.849 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 32.3 tp 66.94 20.48 10.49 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.319 1.048 . . . . 0.0 111.176 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -80.35 -40.24 27.0 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.624 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -63.26 -59.83 4.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.14 150.71 52.03 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.27 -45.34 5.91 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 56.04 -103.0 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.238 1.415 . . . . 0.0 111.652 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 70.8 mtm -147.25 114.0 6.07 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.75 103.73 14.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 80.2 mt -87.5 129.78 34.95 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.176 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.02 110.03 13.68 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.62 -3.28 10.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.241 0.544 . . . . 0.0 109.902 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.9 m -91.83 120.05 32.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.746 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -55.33 125.34 20.36 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.139 0.976 . . . . 0.0 111.416 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 1.9 mmt -73.92 146.32 44.07 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.083 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.54 117.15 24.42 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.05 86.52 6.6 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.359 1.076 . . . . 0.0 110.571 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -169.32 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 476' ' ' SER . 23.4 pttm -140.37 113.14 8.13 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.365 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -170.86 159.57 6.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -155.5 100.87 2.23 Favored Pre-proline 0 C--N 1.296 -1.731 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.97 -68.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.071 1.847 . . . . 0.0 113.336 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 57.64 -71.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.782 1.633 . . . . 0.0 111.189 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 417' ' ' ARG . 89.1 mtt180 -111.54 -92.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 416' ' ' ARG . 0.0 OUTLIER -137.84 93.39 2.77 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . 61.45 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.854 1.346 . . . . 0.0 113.655 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.38 175.62 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -126.41 171.07 18.17 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.1 m -121.86 139.94 53.01 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 34.1 t -84.61 134.78 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.93 -38.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.196 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.33 132.05 12.32 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -166.33 175.48 8.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -82.62 142.75 31.5 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.992 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -112.46 122.56 48.05 Favored 'General case' 0 C--N 1.264 -3.126 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.515 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.21 -16.33 43.88 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -117.09 -36.15 1.05 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.457 -1.354 . . . . 0.0 112.508 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -93.76 -15.25 25.37 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 94.13 -167.56 27.91 Favored Glycine 0 C--O 1.206 -1.597 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.32 116.46 3.2 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.207 1.938 . . . . 0.0 111.06 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.75 145.36 21.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.034 0 CA-C-O 121.292 0.568 . . . . 0.0 111.043 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -142.79 114.92 8.32 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.36 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 480' ' ' GLU . 6.7 m -87.04 127.56 35.1 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -141.6 169.87 16.79 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.543 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -118.44 109.48 16.29 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -78.06 122.51 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.572 0.701 . . . . 0.0 112.293 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -123.92 -13.4 7.37 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -81.38 -19.82 41.84 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.03 -171.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 167.53 -118.32 0.78 Allowed Glycine 0 N--CA 1.414 -2.77 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.024 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.3 m -130.85 120.82 24.23 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.654 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -98.18 123.19 42.12 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 24.6 ttpt -137.87 153.12 49.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.588 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.6 m -70.78 141.25 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.372 0.606 . . . . 0.0 112.554 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.92 4.39 87.14 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.403 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.32 139.63 21.66 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.16 134.7 47.0 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.085 2.523 . . . . 0.0 113.192 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -134.22 162.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.651 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.05 121.42 49.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 450' ' ' ILE . 59.9 t -128.45 119.25 49.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.99 96.9 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 123.474 0.484 . . . . 0.0 112.069 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . 0.304 35.0 p 66.82 -6.34 0.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.83 1.652 . . . . 0.0 115.027 -177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.0 m -90.94 140.92 29.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -110.78 155.48 22.46 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.688 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -161.47 -164.33 16.15 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 40.9 ttm180 -135.7 131.66 35.94 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 446' ' ' VAL . 35.2 t -67.96 114.06 4.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -79.22 -56.55 4.27 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.732 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.65 148.93 46.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.654 ' HE1' HD22 ' A' ' 444' ' ' LEU . 44.9 tpp -114.69 116.97 29.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.4 136.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.43 178.01 5.01 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.792 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.14 -34.76 58.18 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.157 0.983 . . . . 0.0 112.375 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.6 m -83.88 -4.03 58.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.13 -11.53 62.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.97 171.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.46 136.9 37.72 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 120.822 0.344 . . . . 0.0 110.432 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -90.07 128.65 36.35 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.46 -175.37 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.12 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.428 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.53 -36.26 6.25 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.79 148.3 35.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.631 -174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -138.39 142.15 39.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.51 176.26 36.62 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.447 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.5 Cg_endo -64.28 155.44 65.47 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.494 ' HB3' ' HE3' ' A' ' 411' ' ' LYS . 70.8 m 70.23 22.04 5.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.383 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.8 ttt -120.52 133.74 24.08 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.244 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 4.9 Cg_exo -79.2 126.5 7.01 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.866 2.377 . . . . 0.0 110.718 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.48 155.01 14.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.49 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 436' ' ' THR . 33.4 mt-10 -106.72 116.63 32.25 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -98.19 168.25 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.2 p -147.77 165.81 29.42 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 98.93 13.49 39.77 Favored Glycine 0 C--N 1.307 -1.031 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.597 177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.56 -28.3 33.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 58.11 25.48 12.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.141 1.376 . . . . 0.0 110.944 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 455' ' ' THR . 11.2 t70 -147.53 -179.61 6.99 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.21 105.1 51.32 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.69 170.88 19.29 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.939 1.759 . . . . 0.0 111.144 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -111.92 141.01 46.1 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.76 21.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.03 59.25 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.905 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.44 174.62 10.48 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.7 141.93 43.31 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.394 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -133.77 158.33 43.61 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.9 ttt -132.37 131.27 41.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.159 0.504 . . . . 0.0 109.801 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 99.3 t -123.84 107.48 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -125.99 121.95 34.52 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.9 OUTLIER -121.86 -42.08 2.42 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.826 -175.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 21.6 t70 50.13 -87.09 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 127.928 2.491 . . . . 0.0 112.764 -174.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -49.15 -42.66 40.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.392 1.877 . . . . 0.0 111.964 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 86.7 mttt -62.84 -47.04 85.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.815 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -79.97 -29.01 39.5 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.036 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.1 -47.03 86.45 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -57.22 -39.55 75.69 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.957 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 81.5 mm-40 -64.32 -44.82 90.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.239 0.337 . . . . 0.0 110.633 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.96 -38.84 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.612 0.72 . . . . 0.0 110.345 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 114.89 23.25 4.7 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.334 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -88.52 -44.41 10.7 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.578 0.704 . . . . 0.0 109.556 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -124.86 93.86 4.02 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-O 121.432 0.634 . . . . 0.0 109.425 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -116.43 -60.76 1.82 Allowed 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -156.35 127.46 6.97 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.11 138.6 58.53 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -133.41 151.52 51.83 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 C--N 1.286 -2.164 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.306 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.977 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 53.3 p -90.81 -19.28 23.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.245 1.022 . . . . 0.0 111.353 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -83.47 68.58 9.81 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.896 0.855 . . . . 0.0 110.373 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 26.7 ptm -173.23 26.59 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.633 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.0 -56.15 2.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.093 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.66 111.69 18.17 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 60.88 72.12 0.53 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.941 0.877 . . . . 0.0 109.217 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.45 4.32 54.16 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.863 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.76 -67.38 0.43 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.2 -176.54 5.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 23.4 ptp -111.34 145.2 39.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.631 0.253 . . . . 0.0 111.549 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 11.1 tt -69.78 144.56 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.264 0.626 . . . . 0.0 110.518 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.03 -177.14 4.62 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.08 0.466 . . . . 0.0 110.666 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.0 mt -85.1 160.42 19.97 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.71 12.04 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 26.0 t 69.46 98.62 0.06 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.902 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -84.42 -28.26 27.02 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.865 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 74.3 mtp 60.81 -170.47 0.15 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 111.668 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -127.96 115.21 18.18 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 61.12 125.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.607 1.163 . . . . 0.0 111.135 -171.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 410' ' ' LEU . 1.9 pt? -117.04 -9.47 11.08 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp 52.7 32.85 12.71 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.476 0.485 . . . . 0.0 112.198 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -75.8 -58.98 2.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.675 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.433 ' HB2' ' OG1' ' A' ' 421' ' ' THR . 9.3 t-20 -142.95 137.91 15.39 Favored Pre-proline 0 C--N 1.29 -1.981 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.016 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.9 -20.4 58.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.931 2.42 . . . . 0.0 113.35 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -119.49 -57.48 1.98 Allowed 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.018 -0.426 . . . . 0.0 110.707 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 19.5 ttp85 66.27 17.74 10.78 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.408 1.083 . . . . 0.0 112.174 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -105.01 -54.71 2.44 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.944 -1.097 . . . . 0.0 112.901 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -107.11 8.06 29.98 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.617 0.723 . . . . 0.0 109.924 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.71 172.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.72 -179.04 19.19 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 413' ' ' ASN . 61.1 m -126.36 144.34 50.85 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.324 0.583 . . . . 0.0 110.535 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 425' ' ' ALA . 43.1 t -80.13 132.87 30.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 14.9 pt -86.7 -39.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.65 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.51 146.42 22.37 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.489 ' HB2' HG11 ' A' ' 422' ' ' VAL . . . -149.86 146.51 27.15 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -173.85 177.15 2.49 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -177.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.3 pt? -85.39 148.73 25.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.98 131.1 51.13 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.982 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -74.28 -15.7 60.96 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.625 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -91.3 -58.53 1.45 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.935 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -95.81 -42.47 8.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.144 0.472 . . . . 0.0 112.056 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 135.35 -135.89 8.16 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.53 116.05 4.38 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 121.971 1.78 . . . . 0.0 110.708 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.47 142.63 33.9 Favored 'Isoleucine or valine' 0 C--O 1.249 1.072 0 CA-C-O 121.38 0.609 . . . . 0.0 110.901 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -139.94 113.42 8.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.871 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.64 120.82 27.49 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -135.88 173.44 11.71 Favored 'General case' 0 C--N 1.273 -2.743 0 O-C-N 122.188 -0.32 . . . . 0.0 111.756 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -121.39 106.3 11.32 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.8 p -74.35 121.85 26.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.634 0.73 . . . . 0.0 112.891 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -125.38 -15.97 6.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.772 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 496' ' ' VAL . . . -73.24 -9.51 58.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.407 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.02 -97.01 0.16 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.887 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.3 m -144.51 139.64 28.36 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.563 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -111.05 115.52 29.59 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -131.75 154.22 49.28 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.486 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -70.46 146.14 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.778 0.799 . . . . 0.0 112.774 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 502' ' ' LYS . . . 97.23 -10.61 65.49 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.577 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 499' ' ' ASP . 1.1 m-20 -96.56 153.43 38.82 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.04 134.64 6.17 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 C-N-CA 122.401 2.068 . . . . 0.0 112.501 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.2 150.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.9 p -121.28 122.49 67.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.43 108.75 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.91 -90.96 0.22 Allowed Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.233 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.7 t -118.25 -19.78 8.83 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.887 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 486' ' ' ASP . 29.6 m -105.68 137.92 42.74 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.364 -171.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 51.1 p90 -114.82 148.5 38.41 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.066 0.46 . . . . 0.0 110.858 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -155.73 -164.93 13.71 Favored Glycine 0 C--N 1.29 -2.026 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -126.6 143.13 51.32 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.445 HG11 ' HE2' ' A' ' 462' ' ' MET . 32.6 t -73.21 113.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.487 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -88.69 -59.28 2.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.98 148.43 50.09 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.563 ' HE1' HD22 ' A' ' 444' ' ' LEU . 40.0 tpp -114.74 117.78 31.75 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.97 157.65 22.25 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 44.4 p30 -108.18 -176.68 3.12 Favored 'General case' 0 C--N 1.269 -2.898 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.548 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.1 -25.29 61.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.375 0.607 . . . . 0.0 110.251 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.1 m -81.89 -13.27 57.8 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.36 6.61 50.61 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 114.969 0.747 . . . . 0.0 114.969 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.435 ' HB2' HD21 ' A' ' 464' ' ' ASN . 10.8 mpt_? -88.97 140.78 29.08 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -101.58 126.58 48.42 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 462' ' ' MET . 31.0 m -131.54 -175.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.63 -23.13 8.87 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -154.17 137.28 15.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.13 147.67 32.76 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.658 0.383 . . . . 0.0 110.694 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -95.3 179.82 36.45 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.44 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.415 ' HA ' HG13 ' A' ' 439' ' ' VAL . 55.5 Cg_endo -68.56 160.51 49.03 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.921 2.414 . . . . 0.0 113.463 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.423 ' HA ' HD11 ' A' ' 438' ' ' LEU . 36.8 m 65.4 29.64 11.31 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.236 1.017 . . . . 0.0 110.704 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.2 ttt -131.59 131.01 22.57 Favored Pre-proline 0 N--CA 1.425 -1.683 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.502 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 58.3 Cg_endo -78.03 125.17 7.09 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 121.653 1.569 . . . . 0.0 111.884 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 12.4 m -137.66 158.48 34.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.585 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 33.3 tt0 -121.48 114.78 21.73 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 47.7 pt -97.74 170.78 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.561 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 5.3 p -147.96 160.44 42.82 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.85 7.51 38.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.096 -1.05 . . . . 0.0 114.332 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.47 -30.91 64.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.182 0.491 . . . . 0.0 109.938 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 23.5 t60 64.3 21.45 12.52 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.959 1.304 . . . . 0.0 110.73 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.433 ' CB ' HG21 ' A' ' 455' ' ' THR . 14.8 t70 -147.68 179.6 7.58 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.61 111.15 64.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-O 121.645 0.736 . . . . 0.0 111.251 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.11 161.43 18.0 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.203 1.936 . . . . 0.0 111.193 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -114.93 148.03 39.21 Favored 'General case' 0 N--CA 1.402 -2.875 0 CA-C-O 121.284 0.564 . . . . 0.0 109.487 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.07 128.55 36.32 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.626 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 95.14 -0.4 64.05 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.002 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.76 178.63 7.21 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.527 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -122.91 130.52 52.95 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 44.8 p90 -122.99 151.77 41.53 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 121.26 0.552 . . . . 0.0 110.235 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 50.7 ttm -121.62 116.67 25.02 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 441' ' ' ALA . 92.7 t -88.74 110.56 21.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -115.86 162.6 17.09 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.849 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 55.4 tt0 68.06 -111.36 0.12 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.501 1.12 . . . . 0.0 111.95 -174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 19.6 t70 65.05 -55.23 0.31 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.019 1.327 . . . . 0.0 112.277 -174.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 501' ' ' LYS . 6.9 pt-20 -57.05 -38.35 73.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.238 1.415 . . . . 0.0 113.03 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 500' ' ' GLU . 48.3 mmtm -64.12 -49.66 71.31 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.346 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 447' ' ' GLY . 61.9 mttp -68.25 -35.24 77.6 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.81 -57.07 12.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.784 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 508' ' ' GLU . 63.8 ttt180 -58.69 -40.2 82.92 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 111.861 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.09 -25.23 65.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.28 . . . . 0.0 111.705 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 502' ' ' LYS . 42.0 mm -78.36 -51.47 17.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 158.42 -12.28 0.23 Allowed Glycine 0 N--CA 1.438 -1.202 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.654 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 504' ' ' ARG . 33.4 tt0 62.66 0.21 0.63 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.564 1.946 . . . . 0.0 113.524 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -99.83 -74.1 0.61 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.494 -0.754 . . . . 0.0 112.551 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 510' ' ' ARG . 66.7 mtt180 64.08 -68.11 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.491 1.516 . . . . 0.0 112.316 -175.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -171.05 -61.58 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.773 1.229 . . . . 0.0 108.169 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -136.26 110.58 8.44 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.285 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 178.2 153.65 0.33 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.719 1.207 . . . . 0.0 108.009 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 . . . . . 0 C--N 1.282 -2.346 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.311 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 10.8 m -93.87 126.48 39.09 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -124.12 -73.31 0.64 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 14.0 tpt 162.44 -58.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 93.4 mt -110.91 114.86 28.52 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 170.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -48.59 -33.55 9.97 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 -168.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 35.8 t60 75.24 -49.0 0.64 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.333 1.053 . . . . 0.0 111.01 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 399' ' ' GLU . 7.0 mp -77.82 150.4 34.24 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.5 mp 74.28 -25.92 0.19 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.563 1.145 . . . . 0.0 111.611 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 397' ' ' LEU . 37.5 mt-10 -85.26 127.06 34.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 88.0 mtp 73.27 173.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 50.7 mm 64.06 92.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 67.9 mt -76.4 17.81 0.35 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.684 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.69 23.5 13.77 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.422 0.689 . . . . 0.0 109.558 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 98.9 t 77.22 -39.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.073 1.349 . . . . 0.0 113.311 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 19.4 m 79.53 115.46 0.06 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.572 1.549 . . . . 0.0 108.615 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 406' ' ' GLU . 0.1 OUTLIER -85.41 164.18 18.06 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.974 -175.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 56.9 ttp -90.57 84.44 5.93 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -85.79 117.1 24.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -94.97 154.98 16.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 97.8 mt -125.71 -16.74 5.65 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.006 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -21.45 4.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -116.36 175.46 5.55 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -122.41 109.36 33.02 Favored Pre-proline 0 C--N 1.275 -2.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.14 -4.82 11.19 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.784 2.322 . . . . 0.0 113.809 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.508 ' O ' HG22 ' A' ' 419' ' ' VAL . 66.4 t30 -123.0 30.64 6.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.281 1.039 . . . . 0.0 108.387 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -57.74 20.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 127.888 2.475 . . . . 0.0 115.543 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -129.61 -18.82 3.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.724 -0.61 . . . . 0.0 111.254 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -123.57 2.63 8.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.089 0.471 . . . . 0.0 110.747 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 415' ' ' ASN . 35.4 m -147.87 168.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.03 -178.29 18.27 Favored Glycine 0 C--N 1.289 -2.04 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.9 m -120.69 141.69 50.17 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 117.812 0.806 . . . . 0.0 109.507 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.23 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 436' ' ' THR . 14.8 pt -94.35 -34.7 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.318 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.402 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 11.8 pt-20 -157.4 147.85 21.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.48 17.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.54 178.15 2.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.14 151.97 29.5 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.728 0.775 . . . . 0.0 111.445 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 167.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -76.07 -17.7 59.53 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -106.27 -36.35 2.71 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.058 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -95.81 -29.01 14.46 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.065 0.459 . . . . 0.0 110.891 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 110.28 -149.33 17.54 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.516 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 13.8 Cg_exo -68.85 115.65 4.06 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.809 1.673 . . . . 0.0 109.217 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.98 137.53 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 122.309 1.052 . . . . 0.0 112.621 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -126.08 111.91 15.23 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.485 HG22 HD11 ' A' ' 423' ' ' ILE . 3.3 m -88.72 123.09 32.82 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -140.36 170.99 14.78 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.474 -173.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 476' ' ' SER . 0.8 OUTLIER -118.91 106.42 12.47 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.63 121.95 27.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.631 . . . . 0.0 112.229 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -120.84 -15.12 8.4 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.689 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.8 -7.54 59.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.659 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 157.73 -110.79 0.46 Allowed Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.348 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.4 m -139.9 139.78 36.29 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.505 ' HB3' ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -112.7 126.41 55.36 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -174.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 8.2 ttpt -136.83 150.83 48.54 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 122.793 0.437 . . . . 0.0 110.223 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.2 m -68.5 146.42 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.471 0.653 . . . . 0.0 112.193 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.7 -3.44 84.97 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.768 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.46 139.31 19.99 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.39 133.56 19.37 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.449 2.099 . . . . 0.0 113.281 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 14.3 pt -126.25 172.46 13.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.22 122.11 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 494' ' ' PHE . 44.4 t -122.8 105.29 15.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 63.61 -118.92 14.68 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.4 p -102.38 -3.5 26.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 486' ' ' ASP . 87.1 m -104.07 129.52 51.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.117 0.484 . . . . 0.0 109.871 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -123.53 167.39 13.96 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 122.032 -0.417 . . . . 0.0 109.88 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.26 -164.61 37.07 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -115.07 143.33 45.37 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.36 124.43 33.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.448 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.1 tmt_? -93.79 -58.89 2.13 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.19 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -127.89 148.47 50.49 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 444' ' ' LEU . 50.4 tpp -119.15 117.25 28.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.82 125.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.45 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.1 p30 -95.1 176.26 6.31 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.325 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.44 -23.17 62.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.154 0.981 . . . . 0.0 113.083 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 17.4 m -77.83 -16.34 58.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.04 32.37 8.47 Favored Glycine 0 CA--C 1.486 -1.743 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.562 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.45 ' HB2' HD21 ' A' ' 464' ' ' ASN . 80.9 mtt180 -116.9 126.65 53.3 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -81.45 123.45 28.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.61 -174.46 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -98.68 -34.06 10.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.892 0.377 . . . . 0.0 109.986 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.67 166.1 31.39 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.941 0.401 . . . . 0.0 111.38 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.69 150.51 34.46 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.745 0.818 . . . . 0.0 109.089 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -96.39 -179.96 35.04 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.166 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HA ' HG13 ' A' ' 439' ' ' VAL . 51.4 Cg_endo -67.06 161.9 40.63 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.814 2.343 . . . . 0.0 112.066 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.422 ' HA ' HD11 ' A' ' 438' ' ' LEU 0.258 51.9 p 66.47 6.79 4.58 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.775 1.63 . . . . 0.0 113.516 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 40.0 ttm -107.98 136.92 19.7 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.232 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.4 Cg_endo -82.34 126.62 4.9 Favored 'Trans proline' 0 C--O 1.252 1.187 0 C-N-CA 122.46 2.107 . . . . 0.0 110.6 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 473' ' ' ALA . 20.0 m -137.33 155.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.194 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.09 115.74 30.7 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.7 pt -97.93 167.95 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 433' ' ' PRO . 7.8 p -150.1 166.49 29.63 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 114.43 -15.68 19.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.877 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.76 -40.32 91.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.998 0.427 . . . . 0.0 110.802 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.516 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 72.1 t60 61.83 20.12 11.17 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.578 1.551 . . . . 0.0 110.627 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.425 ' HB2' HG21 ' A' ' 455' ' ' THR . 10.5 m-20 -142.38 167.21 22.63 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.6 p -110.05 119.76 46.41 Favored Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.882 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.73 176.52 7.69 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.194 2.596 . . . . 0.0 110.604 175.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -102.05 140.15 36.72 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.36 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -67.18 124.53 23.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.7 -0.36 57.94 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.478 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.39 176.93 8.73 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.45 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 1.4 mpt_? -118.77 124.83 48.22 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.387 -174.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 31.8 p90 -119.96 148.84 43.04 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.774 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 53.2 ttp -118.51 127.01 53.23 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 494' ' ' PHE . 59.0 t -125.37 107.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.245 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -125.23 122.84 38.15 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 172.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 501' ' ' LYS . 81.3 tt0 -73.18 131.63 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.035 0.921 . . . . 0.0 111.995 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 502' ' ' LYS . 23.6 t70 -62.9 -41.85 99.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.0 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 504' ' ' ARG . 42.0 mt-10 -73.24 -15.5 61.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.688 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 498' ' ' GLU . 12.6 mptt -77.91 -39.06 44.2 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 499' ' ' ASP . 23.1 ttpp -58.42 -47.94 82.29 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.98 88.06 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.804 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 500' ' ' GLU . 3.4 tmt_? -58.82 -43.11 90.55 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.738 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -75.13 -35.36 61.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.89 -30.52 14.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.472 0.653 . . . . 0.0 109.907 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 104.32 32.09 4.4 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.561 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -97.64 -23.63 15.88 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -99.0 165.64 11.65 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.916 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.99 95.38 10.19 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.599 0.714 . . . . 0.0 111.733 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -93.35 -4.47 51.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.729 0.776 . . . . 0.0 109.584 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -139.33 157.11 46.46 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.812 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -85.11 139.03 32.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.95 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 11.1 p -73.9 -26.55 60.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 120.869 0.366 . . . . 0.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -113.09 81.34 1.48 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.425 ' HA ' ' CE ' ' A' ' 393' ' ' MET . 3.0 mmt 50.97 -102.54 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.93 139.11 54.4 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.608 0.718 . . . . 0.0 112.773 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -140.97 10.91 2.19 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 39.5 m80 63.47 85.63 0.13 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.567 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 44.7 tp -71.52 93.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.752 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.02 122.69 44.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.39 -45.91 16.91 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.037 -176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -115.66 107.27 14.89 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 13.5 mt -117.13 27.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 9.3 mp 73.58 174.02 0.28 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.119 1.368 . . . . 0.0 110.742 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.87 89.55 3.07 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.5 m -81.8 -24.74 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 15.7 m 69.03 -86.18 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 112.849 -1.978 . . . . 0.0 116.033 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.74 -177.99 6.54 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.464 -167.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 13.1 tpt 72.13 -81.14 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 111.599 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -106.79 133.22 51.78 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.122 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -75.42 149.92 38.45 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 93.0 mt -127.14 75.62 1.59 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.365 0.602 . . . . 0.0 110.746 -174.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -106.64 142.13 36.79 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.543 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 414' ' ' PRO . . . 172.14 -167.17 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.7 ' OD1' ' HB3' ' A' ' 441' ' ' ALA 0.254 1.8 m-20 -78.56 -9.91 0.15 Allowed Pre-proline 0 CA--C 1.582 2.186 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 413' ' ' ASN . 28.8 Cg_endo -64.89 29.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.492 2.128 . . . . 0.0 112.946 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 413' ' ' ASN . 25.9 t-20 -96.58 153.09 18.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -83.52 22.63 1.03 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -165.79 -27.87 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.125 0.488 . . . . 0.0 109.784 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.98 31.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.375 0.607 . . . . 0.0 112.236 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 4.8 m -154.17 -178.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.878 0 C-N-CA 128.72 2.808 . . . . 0.0 104.786 175.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -114.89 172.2 14.09 Favored Glycine 1 N--CA 1.385 -4.705 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.2 p -131.18 141.99 50.15 Favored 'General case' 0 C--N 1.245 -3.937 0 O-C-N 124.225 0.603 . . . . 0.0 110.903 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 53.7 t -89.13 130.12 39.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 436' ' ' THR . 13.9 pt -89.8 -38.82 11.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.698 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -154.74 154.45 32.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -139.99 139.19 35.99 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.35 177.92 3.94 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.514 0.673 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -88.24 149.45 23.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.875 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -128.6 129.9 46.56 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 173.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.412 ' H ' ' CD ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -68.86 -20.85 64.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -104.66 -40.6 2.15 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.723 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.497 ' HB3' HG21 ' A' ' 482' ' ' THR . 91.8 mtm180 -94.94 -22.76 17.77 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.5 -159.69 21.11 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.64 116.4 3.17 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.28 1.987 . . . . 0.0 111.095 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.451 HG12 ' CG2' ' A' ' 482' ' ' THR . 34.6 m -118.17 154.39 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -136.8 116.34 12.86 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 480' ' ' GLU . 2.2 m -85.3 116.69 23.79 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 0.9 OUTLIER -134.18 170.91 14.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.23 108.03 12.35 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -74.56 122.05 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.398 0.618 . . . . 0.0 110.913 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 45.7 mt-30 -120.28 -21.42 6.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.7 ' HB3' ' OD1' ' A' ' 413' ' ' ASN . . . -97.1 -8.9 29.12 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 113.956 -3.098 . . . . 0.0 114.666 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . -164.94 -110.09 0.23 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 118.255 -1.926 . . . . 0.0 113.299 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.1 m -147.94 138.08 22.78 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.474 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -108.23 130.91 55.13 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 13.0 ttpt -146.02 151.74 38.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.512 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 26.9 m -67.22 146.96 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.91 -17.21 59.12 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.55 -1.204 . . . . 0.0 114.117 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -111.09 152.9 44.02 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.167 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 33.0 Cg_endo -64.15 147.47 91.37 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.342 2.695 . . . . 0.0 113.689 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.55 158.86 16.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 124.969 1.308 . . . . 0.0 108.455 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.51 118.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.66 107.66 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.1 -111.28 3.83 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.063 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 11.4 p -104.4 -4.14 23.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.148 0.579 . . . . 0.0 111.672 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.432 HG21 ' CB ' ' A' ' 486' ' ' ASP . 65.1 m -125.92 141.89 51.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 120.945 0.403 . . . . 0.0 110.943 -175.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -118.05 154.48 31.97 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -160.56 -164.22 15.17 Favored Glycine 0 C--N 1.282 -2.427 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.441 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 35.1 ttm180 -126.71 136.67 52.76 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.63 HG11 ' HE2' ' A' ' 462' ' ' MET . 26.2 t -73.69 111.69 9.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 O-C-N 123.532 0.52 . . . . 0.0 110.612 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -83.36 -50.51 8.27 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.855 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -137.31 144.92 42.86 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.63 ' HE2' HG11 ' A' ' 459' ' ' VAL . 41.5 tpp -115.06 117.2 29.89 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.05 126.73 68.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 468' ' ' ARG . 6.2 p30 -87.13 177.86 7.07 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.831 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.01 -30.62 36.35 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 23.1 m -76.16 -26.17 55.99 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.899 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 101.12 38.64 3.28 Favored Glycine 0 CA--C 1.475 -2.46 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.649 ' HB3' ' ND2' ' A' ' 464' ' ' ASN . 69.7 ttt180 -119.63 127.37 52.86 Favored 'General case' 0 N--CA 1.404 -2.748 0 CA-C-N 112.171 -2.015 . . . . 0.0 105.977 -175.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -81.32 129.83 34.78 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.9 m -135.93 -178.72 2.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -111.45 -28.56 8.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.878 0.371 . . . . 0.0 111.368 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 445' ' ' LYS . 12.1 pt-20 -150.67 168.22 25.0 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -147.45 134.33 20.18 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.57 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.85 176.6 53.34 Favored Glycine 0 N--CA 1.426 -2.004 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 439' ' ' VAL . 56.1 Cg_endo -68.2 156.22 66.55 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.028 1.819 . . . . 0.0 112.754 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 18.8 t 77.85 -0.34 2.72 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.15 1.38 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.428 ' HG2' HG13 ' A' ' 479' ' ' VAL . 33.6 ttm -98.93 133.66 22.1 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -84.92 126.0 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.374 2.05 . . . . 0.0 112.083 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.428 HG13 ' HG2' ' A' ' 477' ' ' MET . 16.5 m -140.74 155.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HG2' HG23 ' A' ' 436' ' ' THR . 37.4 mt-10 -107.3 118.96 38.09 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 45.4 pt -98.02 170.01 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.083 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 431' ' ' ARG . 3.0 p -146.3 156.57 43.45 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 109.26 22.17 6.95 Favored Glycine 0 N--CA 1.427 -1.964 0 O-C-N 124.081 0.863 . . . . 0.0 113.807 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.95 -38.31 16.77 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 60.09 21.97 11.2 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.279 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.432 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.7 t0 -139.33 179.96 6.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 5.9 p -90.19 114.69 61.87 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-O 121.304 0.573 . . . . 0.0 111.487 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.68 168.43 8.33 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -129.48 131.93 46.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.773 0.321 . . . . 0.0 111.36 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.46 134.91 46.92 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.97 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 91.01 -5.0 81.88 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.24 -179.09 7.13 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -109.82 141.35 42.61 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 8.7 p90 -128.84 153.3 47.58 Favored 'General case' 0 C--N 1.278 -2.508 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.86 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . 0.684 ' HA ' ' CB ' ' A' ' 413' ' ' ASN . 44.0 ttp -122.5 117.0 24.9 Favored 'General case' 0 C--N 1.248 -3.821 0 C-N-CA 125.399 1.48 . . . . 0.0 110.582 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.684 ' H ' ' CG ' ' A' ' 413' ' ' ASN . 0.5 OUTLIER -86.91 144.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.316 174.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -97.67 167.47 10.94 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.32 0.581 . . . . 0.0 110.83 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.565 ' HB3' ' HE2' ' A' ' 501' ' ' LYS . 33.3 tt0 -74.16 138.85 44.09 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.401 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.51 -45.67 91.95 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.203 1.001 . . . . 0.0 111.195 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.37 -5.43 52.24 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 498' ' ' GLU . 7.2 tppt? -57.65 -34.46 69.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.369 0.668 . . . . 0.0 111.135 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 506' ' ' ILE . 13.1 mmmm -60.89 -51.59 68.64 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.683 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.31 99.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.9 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 501' ' ' LYS . 21.9 tpp180 -50.2 -54.22 22.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.456 1.502 . . . . 0.0 109.239 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -60.62 -39.86 89.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.901 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 502' ' ' LYS . 50.9 mm -75.68 -53.9 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.598 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -152.44 -11.02 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 118.931 -1.604 . . . . 0.0 115.794 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 504' ' ' ARG . 18.9 mm-40 -89.15 14.14 11.53 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 118.403 1.101 . . . . 0.0 113.441 -173.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -107.29 -67.56 0.95 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.907 0.385 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 53.71 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.57 1.548 . . . . 0.0 113.812 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -87.95 -26.05 22.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -96.45 85.73 3.99 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.806 0.336 . . . . 0.0 110.67 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -160.87 40.54 0.16 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.365 0.602 . . . . 0.0 111.11 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.247 0.956 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.141 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.083 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 2.2 p -86.23 103.8 15.19 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-O 121.375 0.607 . . . . 0.0 111.902 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -98.15 -6.79 30.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.868 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 34.4 tpp 71.01 117.34 0.04 OUTLIER 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.032 0.933 . . . . 0.0 111.227 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 396' ' ' HIS . 77.0 mt -81.66 -14.95 56.0 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.103 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.5 t70 60.17 78.05 0.29 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.438 1.095 . . . . 0.0 110.43 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 394' ' ' LEU . 1.6 p80 -160.15 19.82 0.15 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.699 -173.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.27 26.49 2.18 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.3 0.571 . . . . 0.0 111.792 -173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.27 -70.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.202 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 50.7 -87.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.412 1.085 . . . . 0.0 113.705 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 86.2 mtp -73.32 -30.41 63.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.873 0.368 . . . . 0.0 110.049 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 43.0 pt -102.17 17.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.431 0.634 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 49.6 tp -70.92 -23.14 62.2 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.479 1.133 . . . . 0.0 108.415 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.05 98.52 6.53 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 113.42 -1.718 . . . . 0.0 109.182 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.84 -28.05 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.838 0.828 . . . . 0.0 109.223 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 51.2 m -114.84 141.38 47.98 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.88 123.96 22.01 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 22.1 ttt -85.56 92.01 8.41 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.749 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.38 145.06 30.79 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -106.28 -177.14 3.28 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.16 -13.58 38.74 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.648 0.737 . . . . 0.0 109.723 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt 72.23 97.82 0.07 Allowed 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 126.041 1.736 . . . . 0.0 112.907 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 414' ' ' PRO . . . -94.76 -159.7 0.73 Allowed 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -104.61 98.09 13.97 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 412' ' ' ALA . 81.7 Cg_endo -97.05 17.99 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.527 2.818 . . . . 0.0 112.807 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -80.21 105.87 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.417 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 72.11 -35.9 0.34 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 81.93 129.04 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.777 1.631 . . . . 0.0 109.697 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . 69.95 67.39 0.23 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.356 1.063 . . . . 0.0 109.72 -174.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.8 m -142.35 -178.89 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 113.628 -1.624 . . . . 0.0 106.951 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -138.08 176.31 20.8 Favored Glycine 0 C--N 1.293 -1.856 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.722 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 19.2 m -120.82 141.99 50.03 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.6 138.57 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.41 -39.02 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 10.9 pt-20 -153.62 148.86 26.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -152.79 131.4 12.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.5 178.46 1.96 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.95 149.23 29.46 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.234 0.54 . . . . 0.0 110.151 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -126.7 122.56 35.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.565 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -61.4 -17.09 52.52 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -178.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.26 -42.88 1.13 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -84.51 -31.63 24.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.68 -158.08 14.56 Favored Glycine 0 C--N 1.314 -0.639 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.56 116.25 4.14 Favored 'Trans proline' 0 C--O 1.244 0.8 0 CA-C-N 120.047 1.924 . . . . 0.0 108.949 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.44 150.94 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.943 0.878 . . . . 0.0 112.386 -173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -141.56 111.52 6.71 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.519 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.6 m -88.22 122.86 32.25 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.8 pp -139.21 173.2 11.8 Favored 'General case' 0 C--N 1.272 -2.77 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.425 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -117.24 106.01 12.82 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 176.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.5 p -73.48 119.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.586 0.707 . . . . 0.0 112.143 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 77.6 mt-30 -124.28 -15.03 6.84 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.865 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -76.24 -15.57 60.0 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.189 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 166.98 -100.93 0.17 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.3 m -144.93 144.15 30.92 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.642 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -108.65 129.75 55.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 448' ' ' ASP . 18.0 ttpt -138.81 148.39 43.71 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 35.8 m -70.76 141.47 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.21 0.529 . . . . 0.0 111.058 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 86.76 3.14 83.8 Favored Glycine 0 N--CA 1.427 -1.959 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.601 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.457 ' HB2' ' HE2' ' A' ' 445' ' ' LYS . 1.2 t70 -94.9 130.71 32.11 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.57 123.22 10.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.284 1.989 . . . . 0.0 109.755 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 452' ' ' VAL . 2.8 pp -127.45 162.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 122.639 0.376 . . . . 0.0 110.498 -175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 456' ' ' TYR . 7.4 p -129.35 122.56 56.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 450' ' ' ILE . 46.2 t -134.25 125.33 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.19 39.14 97.29 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.999 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 2.3 m 65.07 9.51 5.56 Favored 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 124.905 1.282 . . . . 0.0 112.758 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 59.7 m -113.23 137.48 51.42 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 451' ' ' VAL . 17.3 p90 -111.55 150.87 29.39 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.097 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -157.15 -164.11 13.26 Favored Glycine 0 C--N 1.297 -1.586 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -134.06 129.53 36.18 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 462' ' ' MET . 47.5 t -62.16 114.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.432 0.458 . . . . 0.0 111.58 -175.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -81.3 -55.19 4.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.259 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.51 152.64 51.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.642 ' HE1' HD22 ' A' ' 444' ' ' LEU . 51.1 tpp -115.01 117.57 30.98 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 43.5 t -116.74 136.52 53.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.8 p30 -99.38 -179.22 4.15 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.463 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.08 -29.57 60.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 18.8 m -74.86 -25.29 58.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.028 0.442 . . . . 0.0 110.378 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.75 30.02 6.3 Favored Glycine 0 CA--C 1.5 -0.899 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.588 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 464' ' ' ASN . 79.8 mtt180 -115.77 144.45 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -76.58 129.79 36.94 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 124.239 0.962 . . . . 0.0 110.329 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.8 m -135.87 -178.25 2.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -115.72 -23.74 8.55 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -156.08 143.77 19.48 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -173.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -144.48 146.82 32.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.78 177.35 40.21 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.678 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HA ' HG13 ' A' ' 439' ' ' VAL . 54.7 Cg_endo -65.07 161.26 37.81 Favored 'Trans proline' 0 C--O 1.25 1.109 0 C-N-CA 123.167 2.578 . . . . 0.0 113.666 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.449 ' HA ' HD11 ' A' ' 438' ' ' LEU . 20.4 t 67.74 16.77 9.78 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 125.124 1.37 . . . . 0.0 111.076 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 23.8 ttt -120.16 133.92 24.0 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -72.73 125.88 10.92 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.559 2.172 . . . . 0.0 112.129 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 8.3 m -141.81 159.38 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.64 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 30.1 tt0 -122.35 115.81 22.94 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.8 172.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.655 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.6 p -149.08 167.16 26.61 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.23 33.37 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.779 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.36 -33.37 25.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 70.6 t60 64.93 21.31 12.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.859 1.663 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -145.91 179.6 7.35 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.7 t -121.67 109.65 34.18 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 118.389 0.541 . . . . 0.0 109.544 -175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.0 175.57 9.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.894 2.396 . . . . 0.0 110.952 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -118.59 148.32 42.8 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.25 0.547 . . . . 0.0 112.052 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -68.95 141.93 54.83 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.829 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.38 0.03 89.88 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.091 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -92.56 -179.21 5.12 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.34 145.2 43.39 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.308 0.575 . . . . 0.0 110.653 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.2 p90 -132.14 159.15 39.78 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 27.6 ttt -132.15 118.03 19.06 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.235 0.54 . . . . 0.0 109.814 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.06 106.91 21.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -100.03 121.56 41.57 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.562 ' OE1' ' HB2' ' A' ' 501' ' ' LYS . 2.4 tt0 -100.48 148.54 24.64 Favored 'General case' 0 N--CA 1.42 -1.942 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.502 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.77 -49.89 3.85 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.238 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.04 -16.11 63.89 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.305 0.574 . . . . 0.0 112.253 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.562 ' HB2' ' OE1' ' A' ' 498' ' ' GLU . 65.0 tttm -62.49 -51.36 67.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.493 ' HB2' ' HZ2' ' A' ' 502' ' ' LYS . 10.3 mtmp? -64.2 -40.74 96.72 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.519 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.21 40.41 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 123.379 0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -60.01 -39.75 86.89 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -67.68 -46.74 71.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.786 0.327 . . . . 0.0 111.558 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.85 -32.55 52.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.292 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.39 28.62 5.4 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.81 -41.37 16.16 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 61.31 -174.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.839 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -160.2 163.28 33.73 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -89.55 99.09 12.16 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.272 0.558 . . . . 0.0 110.568 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -74.34 145.89 43.5 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.184 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -149.41 7.21 0.67 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.265 1.026 . . . . 0.0 111.222 -175.484 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.615 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 31.5 p -155.43 164.16 39.08 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 27.8 m80 64.12 39.16 7.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 124.076 0.86 . . . . 0.0 110.718 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 25.2 mmt -117.21 -44.33 2.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.017 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 394' ' ' LEU . 1.9 pt? -129.74 31.39 4.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.68 -156.99 0.67 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.001 -1.908 . . . . 0.0 107.839 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -136.74 146.17 45.49 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.76 115.14 16.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 401' ' ' ILE . 50.1 tp -118.63 -50.96 2.4 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.713 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 69.7 112.16 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.676 1.191 . . . . 0.0 109.451 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 21.0 mmt 65.74 81.72 0.2 Allowed 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 122.176 0.989 . . . . 0.0 109.958 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.443 ' HA ' HD23 ' A' ' 398' ' ' LEU . 68.1 mt -71.68 128.06 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.403 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.9 137.57 57.84 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.92 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 405' ' ' SER . 52.0 tp 73.89 119.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 O-C-N 125.035 1.46 . . . . 0.0 110.07 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 406' ' ' GLU . 12.9 p -66.6 -11.4 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.359 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.446 ' H ' ' HG ' ' A' ' 403' ' ' LEU . 15.9 m 72.89 -4.68 2.08 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.413 1.485 . . . . 0.0 112.461 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . 0.504 ' H ' HG13 ' A' ' 404' ' ' VAL . 0.5 OUTLIER 64.62 104.35 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 110.819 178.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 55.2 ttp -142.97 22.46 1.92 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.001 -167.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -86.07 83.65 7.71 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.926 0.869 . . . . 0.0 110.784 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 2.0 pp -129.98 17.28 5.65 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.472 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -88.14 89.01 7.82 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -151.62 27.86 0.64 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -141.04 92.05 8.7 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.484 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -101.12 20.07 0.24 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.372 2.715 . . . . 0.0 111.721 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.37 -66.49 0.53 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.553 ' HD2' ' SD ' ' A' ' 495' ' ' MET . 43.2 ttm180 -130.64 -85.13 0.52 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.439 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -173.09 -68.76 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -85.72 85.55 7.4 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 16.4 m -142.21 179.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -142.49 169.22 25.57 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.3 m -119.06 141.93 48.3 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.59 137.13 22.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 24.1 pt -89.53 -39.83 12.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.844 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.442 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 9.6 pt-20 -159.39 148.52 18.23 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.3 144.2 33.15 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -170.07 176.02 4.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.9 pt? -84.46 142.06 30.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.55 120.45 37.53 Favored 'General case' 0 C--N 1.255 -3.51 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.43 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.58 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -56.35 -17.08 6.74 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.26 -40.85 0.85 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.355 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -88.4 -16.05 33.91 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 90.86 -158.92 26.34 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -59.79 116.45 3.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 121.894 1.729 . . . . 0.0 110.363 173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.436 HG12 ' CG2' ' A' ' 482' ' ' THR . 33.3 m -122.54 163.86 20.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -147.76 112.2 5.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.323 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.87 117.28 24.63 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.694 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.8 pp -132.92 173.14 11.71 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -173.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -119.48 105.72 11.53 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -75.56 121.57 27.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.636 0.731 . . . . 0.0 112.189 -175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 37.8 mt-30 -124.04 -14.26 7.13 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.401 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.47 61.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.187 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 152.04 -104.71 0.27 Allowed Glycine 0 N--CA 1.411 -2.981 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.823 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 6.8 m -130.82 136.5 48.74 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -111.39 124.06 51.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.545 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 2.4 ttpm? -134.07 157.24 46.64 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.522 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 27.7 m -67.64 126.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.24 0.543 . . . . 0.0 109.987 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 110.91 -11.1 29.63 Favored Glycine 0 C--N 1.306 -1.137 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 445' ' ' LYS . 1.0 OUTLIER -71.0 131.2 87.45 Favored Pre-proline 0 C--O 1.247 0.938 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -79.44 112.38 2.97 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 122.239 1.959 . . . . 0.0 108.935 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.24 149.28 14.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.216 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 494' ' ' PHE . 40.5 t -122.85 115.03 44.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.562 HG12 ' CB ' ' A' ' 494' ' ' PHE . 30.0 m -120.31 116.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.11 0.481 . . . . 0.0 109.723 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.94 -96.62 0.16 Allowed Glycine 0 C--N 1.307 -1.068 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.345 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 30.9 p -118.26 -7.21 10.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 122.734 0.413 . . . . 0.0 111.205 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.505 HG21 ' CB ' ' A' ' 486' ' ' ASP . 21.1 m -113.67 145.84 40.71 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.201 -0.312 . . . . 0.0 110.899 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -120.72 156.25 32.19 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -165.22 -168.51 27.49 Favored Glycine 0 C--N 1.295 -1.733 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.305 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -127.66 132.6 49.68 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 444' ' ' LEU . 51.1 t -65.75 121.14 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.586 0.554 . . . . 0.0 110.735 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -91.4 -52.26 4.88 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.672 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.15 150.37 50.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.552 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.1 tpp -115.1 117.11 29.64 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 469' ' ' ARG . 9.4 t -120.35 141.42 40.72 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 479' ' ' VAL . 3.4 p30 -108.63 175.06 5.6 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.193 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.71 -25.86 55.47 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.075 0.95 . . . . 0.0 113.087 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.3 t -78.19 -10.66 59.74 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.222 0.534 . . . . 0.0 110.097 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 92.99 8.16 61.94 Favored Glycine 0 CA--C 1.491 -1.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.83 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -96.79 129.69 44.17 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.558 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 463' ' ' VAL . 4.0 tmm_? -86.65 129.99 34.66 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.12 -174.21 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.236 0.614 . . . . 0.0 109.907 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -98.04 -36.12 10.21 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 122.96 0.504 . . . . 0.0 111.404 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -156.0 151.74 27.29 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.535 -172.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -142.91 150.23 39.5 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 123.924 0.765 . . . . 0.0 109.549 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.11 179.53 39.46 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.352 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 439' ' ' VAL . 59.9 Cg_endo -70.83 161.42 46.13 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 123.052 2.501 . . . . 0.0 113.888 -175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 438' ' ' LEU . 50.2 m 68.83 18.63 8.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.834 1.254 . . . . 0.0 111.116 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 21.4 ttt -122.23 133.98 24.6 Favored Pre-proline 0 N--CA 1.436 -1.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.561 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 46.5 Cg_endo -77.55 125.9 7.9 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 122.293 1.995 . . . . 0.0 112.577 176.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 464' ' ' ASN . 16.1 m -141.11 157.83 22.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -117.19 117.51 29.77 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.2 pt -97.68 168.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.859 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.436 ' CG2' HG12 ' A' ' 434' ' ' VAL . 6.0 p -146.74 165.66 28.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.574 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.45 20.53 22.24 Favored Glycine 0 C--N 1.296 -1.684 0 O-C-N 123.929 0.768 . . . . 0.0 112.576 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 41.6 tp -85.34 -39.35 17.75 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 64.41 21.44 12.48 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.776 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.505 ' CB ' HG21 ' A' ' 455' ' ' THR . 15.0 t70 -138.92 179.24 6.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 38.0 t -111.47 107.08 57.04 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 118.214 0.461 . . . . 0.0 111.175 -173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -85.84 174.7 6.36 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.556 2.171 . . . . 0.0 111.61 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.71 145.53 50.87 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.922 0.392 . . . . 0.0 110.701 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -66.69 128.62 36.95 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.571 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.28 60.67 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.123 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -76.48 179.18 6.06 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.333 0.587 . . . . 0.0 110.591 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 0.4 OUTLIER -114.73 129.2 56.65 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -173.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 45.8 p90 -131.87 158.95 40.0 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.671 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . 0.553 ' SD ' ' HD2' ' A' ' 416' ' ' ARG . 27.0 ttt -131.44 134.45 46.22 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.311 174.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.496 HG11 ' HG ' ' A' ' 444' ' ' LEU . 58.1 t -119.26 107.77 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -150.65 122.62 8.19 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 500' ' ' GLU . 43.9 tt0 -105.91 141.28 37.58 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 502' ' ' LYS . 17.5 t70 -68.17 -38.84 82.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 498' ' ' GLU . 48.5 mt-10 -68.75 -21.16 64.38 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.284 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.3 -43.66 73.34 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 502' ' ' LYS . 33.8 ttpt -61.22 -46.22 91.32 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.93 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.8 92.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.727 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -63.74 -34.72 78.51 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.781 0.832 . . . . 0.0 111.24 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.7 -38.77 91.74 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 48.8 mm -70.75 -42.95 77.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 119.05 9.89 8.54 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.503 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -63.3 -37.76 88.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.72 61.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.056 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -129.64 20.33 5.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.795 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -118.34 -9.58 10.37 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.332 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.04 154.82 29.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -154.71 143.71 20.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.29 -2.004 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 34.4 m -79.07 -29.06 43.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 59.26 85.71 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -70.47 113.37 7.53 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 77.26 156.38 0.17 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.895 1.278 . . . . 0.0 110.337 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -47.34 46.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.192 0.52 . . . . 0.0 110.738 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -135.08 144.2 47.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 40.6 tp 63.5 82.23 0.19 Allowed 'General case' 0 C--O 1.246 0.88 0 O-C-N 124.52 1.138 . . . . 0.0 109.027 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.8 pp -84.86 166.56 16.77 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.8 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -84.79 146.56 27.3 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.737 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -81.37 -36.7 29.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 15.5 tt -157.8 147.74 9.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.932 0.396 . . . . 0.0 110.368 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 5.0 mp -89.49 155.97 18.95 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.89 168.8 18.77 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.166 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.59 -18.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 49.7 m -83.05 94.62 7.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.53 122.45 16.32 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.265 -175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -95.68 -17.67 21.11 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -97.37 118.24 33.41 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.901 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.19 144.04 29.66 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 22.5 tp -151.77 7.98 0.49 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.052 0.453 . . . . 0.0 111.115 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -88.0 -39.44 14.68 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.199 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -78.64 -40.63 33.68 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.436 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.436 HD21 HG23 ' A' ' 419' ' ' VAL . 13.6 t-20 -145.9 134.91 11.17 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.28 -4.29 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.0 2.467 . . . . 0.0 114.269 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -121.88 158.98 27.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.53 -16.59 41.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.784 0.326 . . . . 0.0 110.359 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -71.55 166.98 20.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 112.131 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -86.87 94.19 9.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 15.4 m -146.91 178.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -124.22 169.75 16.33 Favored Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.8 m -115.99 139.54 50.16 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.24 133.91 28.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 12.6 pt -91.94 -39.8 11.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.884 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.87 153.76 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.42 29.95 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 427' ' ' LEU . 0.0 OUTLIER -165.63 176.34 8.16 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 1.6 pt? -94.83 148.23 22.51 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.44 121.94 32.16 Favored 'General case' 0 N--CA 1.391 -3.412 0 C-N-CA 116.929 -1.908 . . . . 0.0 109.697 167.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.9 -22.58 62.57 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.026 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.8 -51.99 0.82 Allowed Glycine 0 N--CA 1.411 -2.981 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.702 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -75.68 -26.56 57.74 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 122.935 0.494 . . . . 0.0 111.379 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 107.79 -163.74 12.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 485' ' ' HIS . 25.2 Cg_exo -69.21 115.56 4.07 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 121.914 1.743 . . . . 0.0 108.215 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.448 ' HB ' ' CG ' ' A' ' 480' ' ' GLU . 28.3 m -124.46 162.79 25.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -171.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -154.39 114.82 3.92 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.603 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 119.64 25.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.0 OUTLIER -136.24 173.48 11.66 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.2 tm? -122.61 107.98 12.59 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 475' ' ' PRO . 6.4 p -73.98 119.85 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 111.751 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 40.5 mt-30 -123.59 -15.81 6.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.794 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.565 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -92.23 2.17 56.77 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 158.87 -125.67 1.55 Allowed Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.185 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.3 m -129.83 134.19 47.39 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.641 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.6 OUTLIER -104.6 133.2 49.86 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.629 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 2.1 ttpm? -148.29 159.66 43.76 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.554 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 33.8 m -68.06 136.27 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.159 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.59 -2.83 60.8 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.403 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 67.8 m-20 -92.76 132.77 30.51 Favored Pre-proline 0 C--O 1.25 1.115 0 CA-C-N 117.317 0.559 . . . . 0.0 110.003 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 2.5 Cg_endo -80.35 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.08 1.853 . . . . 0.0 111.762 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 15.1 pt -96.92 172.65 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.25 124.29 18.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.178 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.4 111.96 30.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.32 11.13 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 22.1 m -99.15 -4.45 32.15 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.32 0.581 . . . . 0.0 110.3 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 486' ' ' ASP . 48.9 m -102.86 136.32 42.9 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.602 -0.686 . . . . 0.0 112.053 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.75 161.88 16.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -177.3 -169.33 38.31 Favored Glycine 0 CA--C 1.475 -2.457 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.488 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 55.2 ttp180 -130.6 137.71 49.77 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.431 HG11 ' HE2' ' A' ' 462' ' ' MET . 49.0 t -65.99 116.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 121.04 0.448 . . . . 0.0 111.824 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -79.43 -60.07 2.5 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -143.49 160.25 40.93 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.641 ' HE1' HD22 ' A' ' 444' ' ' LEU . 35.6 tpp -121.48 134.65 55.07 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 480' ' ' GLU . 6.1 t -117.24 142.09 32.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.478 HD21 ' HB2' ' A' ' 468' ' ' ARG . 7.0 p30 -103.62 179.73 4.19 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.178 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.42 -29.25 48.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.612 1.165 . . . . 0.0 112.94 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 -6.85 58.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.0 4.13 63.38 Favored Glycine 0 N--CA 1.466 0.654 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.255 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.478 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.0 mpt_? -93.09 156.93 16.56 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.407 ' NH1' HG22 ' A' ' 463' ' ' VAL . 20.2 tpp180 -75.41 132.88 41.17 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.824 0.85 . . . . 0.0 110.97 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.3 175.59 5.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.76 -28.89 3.19 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.719 0.295 . . . . 0.0 111.673 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 445' ' ' LYS . 30.7 mt-10 -123.6 141.17 52.27 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.44 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -139.29 126.01 20.73 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -82.54 161.36 40.61 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.488 ' HA ' HG13 ' A' ' 439' ' ' VAL . 19.3 Cg_endo -59.67 150.75 74.72 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.931 2.421 . . . . 0.0 113.031 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.503 ' HA ' HD11 ' A' ' 438' ' ' LEU . 22.2 m 75.77 4.45 3.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.351 1.46 . . . . 0.0 112.268 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 47.0 ttp -103.86 136.11 19.25 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 122.275 -0.266 . . . . 0.0 110.953 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 2.6 Cg_exo -76.77 126.2 8.67 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.423 2.082 . . . . 0.0 111.326 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 473' ' ' ALA . 12.7 m -142.06 159.02 20.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 463' ' ' VAL . 37.7 tt0 -117.56 124.94 49.91 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.9 pt -98.45 172.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.725 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 7.9 p -151.22 161.99 41.7 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 112.73 8.11 21.13 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.78 -1.2 . . . . 0.0 113.941 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 58.2 mt -89.95 -40.33 12.43 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.478 -0.425 . . . . 0.0 110.166 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 433' ' ' PRO . 16.4 t-80 58.17 21.29 7.89 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.873 1.269 . . . . 0.0 111.07 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.495 ' HB3' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -126.74 -178.89 4.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 56.8 t -94.27 110.09 46.37 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 486' ' ' ASP . 4.6 Cg_endo -84.24 156.42 12.84 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.178 1.919 . . . . 0.0 109.988 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -121.29 134.8 55.17 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.355 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -69.17 124.5 23.98 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.141 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.04 -0.37 56.19 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.62 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.01 178.51 8.12 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.859 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -110.44 130.07 55.63 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 32.5 p90 -125.86 154.86 42.08 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.123 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 59.6 ttp -119.28 127.13 52.94 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' A' ' 441' ' ' ALA . 10.6 p -86.76 123.76 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -127.82 122.07 31.74 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.43 -161.89 0.81 Allowed 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.54 -68.34 0.84 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.207 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -52.46 -34.69 50.06 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.609 1.336 . . . . 0.0 114.609 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.4 -44.76 70.78 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.501 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 506' ' ' ILE . 60.4 mttp -79.96 -30.57 39.83 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.141 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -66.39 -41.7 88.98 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.707 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 508' ' ' GLU . 42.9 ttp180 -59.36 -41.88 90.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.488 0.661 . . . . 0.0 109.983 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -68.8 -29.86 68.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.6 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 502' ' ' LYS . 85.1 mt -83.5 -52.16 13.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.895 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -169.13 -17.44 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 119.411 -1.376 . . . . 0.0 113.552 -173.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 504' ' ' ARG . 7.6 tp10 -81.7 57.04 3.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.655 1.217 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -126.99 118.83 25.27 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.853 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -85.18 92.61 8.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.08 0.943 . . . . 0.0 109.662 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -73.33 95.11 2.12 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.782 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -131.34 86.0 2.32 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -154.13 119.1 5.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.194 -176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 C--N 1.284 -2.263 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 19.2 m -83.67 -17.24 42.12 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -76.67 -34.03 58.26 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.702 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 87.7 mtp 63.87 -179.98 0.16 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.793 1.237 . . . . 0.0 112.774 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.5 pp -118.76 27.2 9.04 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.103 0.954 . . . . 0.0 109.663 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.02 -50.15 67.41 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.559 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -144.87 112.62 6.28 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 125.102 1.361 . . . . 0.0 107.332 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.43 -58.94 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.7 mp -125.84 -67.81 0.86 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 42.42 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.787 2.035 . . . . 0.0 115.81 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -83.53 26.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.679 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.9 -39.54 85.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.03 137.47 53.07 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.95 105.49 15.76 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.429 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 78.0 t -70.89 -53.87 20.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 22.6 t 57.7 84.72 0.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.017 0.927 . . . . 0.0 112.144 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -81.67 -68.9 0.65 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 27.0 ttt 41.1 83.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.693 1.597 . . . . 0.0 112.436 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -130.52 161.32 31.74 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.137 -173.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -70.1 109.41 4.57 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.21 -20.28 20.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -123.01 -74.11 0.63 Allowed 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.62 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 179.06 133.19 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 125.171 1.388 . . . . 0.0 107.977 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.462 ' OD1' ' HB2' ' A' ' 493' ' ' ARG . 51.7 m-80 85.32 125.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 125.797 1.639 . . . . 0.0 110.333 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -69.67 -44.15 2.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 121.598 1.532 . . . . 0.0 110.674 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -121.26 95.02 4.52 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.084 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -76.63 92.42 3.5 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.535 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -125.88 -86.77 0.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -116.62 75.98 1.0 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.85 166.17 3.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -140.16 -175.16 14.23 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.055 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.7 p -125.57 145.13 50.26 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 124.156 0.983 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 37.7 t -87.73 134.01 28.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 19.5 pt -89.76 -39.69 12.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.506 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 8.5 pt-20 -158.31 149.43 20.84 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -145.35 149.13 34.24 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.519 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -172.65 177.1 3.02 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -95.26 146.72 24.15 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -123.38 120.57 33.41 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.547 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -55.84 -18.77 9.5 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -107.62 -42.57 1.44 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.403 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -81.2 -34.25 32.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.728 0.299 . . . . 0.0 111.489 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.09 -145.85 17.98 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.32 115.99 4.24 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 121.86 1.706 . . . . 0.0 108.648 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.519 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 18.1 m -116.09 153.53 17.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.259 0.552 . . . . 0.0 111.134 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -144.91 112.74 6.32 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.482 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.62 114.91 22.98 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 494' ' ' PHE . 1.9 pp -132.95 173.27 11.58 Favored 'General case' 0 C--N 1.266 -3.022 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.007 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -114.92 106.78 14.56 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.1 p -65.94 114.85 3.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 122.421 1.105 . . . . 0.0 111.943 -176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -123.63 -14.33 7.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.08 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.431 ' CB ' ' H ' ' A' ' 496' ' ' VAL . . . -85.24 0.29 52.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.829 -175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 140.85 -115.27 1.02 Allowed Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 28.8 m -123.27 144.53 49.35 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.512 ' CD1' HD11 ' A' ' 437' ' ' LEU . 0.9 OUTLIER -125.82 120.23 29.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 445' ' ' LYS . 1.2 ttpm? -138.38 161.71 36.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.566 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 27.6 m -66.09 130.67 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.557 0.694 . . . . 0.0 111.443 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.12 50.98 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.851 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 67.5 m-20 -88.32 147.17 39.5 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.959 0.379 . . . . 0.0 110.788 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -81.74 131.86 7.38 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.391 2.061 . . . . 0.0 110.731 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 496' ' ' VAL . 2.9 pp -125.79 140.46 48.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.478 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 25.5 t -116.84 111.62 35.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.9 p -143.41 138.22 26.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.74 26.09 74.73 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.33 -0.938 . . . . 0.0 110.875 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 65.0 p 63.68 7.05 2.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.166 1.786 . . . . 0.0 113.036 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.441 HG21 ' CB ' ' A' ' 486' ' ' ASP . 88.2 m -107.34 146.36 31.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -122.68 151.86 41.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.633 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -154.09 -164.3 12.66 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.534 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 47.7 ttp180 -131.49 137.15 48.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.153 0.477 . . . . 0.0 110.005 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 482' ' ' THR . 28.3 t -67.9 123.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 122.688 0.395 . . . . 0.0 111.314 -177.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 460' ' ' ARG . 1.2 tmt_? -98.81 -51.04 4.01 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.767 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -134.81 153.86 51.86 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.468 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.1 tpp -122.5 121.47 36.64 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -177.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 469' ' ' ARG . 13.4 t -127.85 148.6 32.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.538 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.9 p30 -109.27 179.46 4.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.736 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -58.97 -32.19 69.42 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 22.7 t -78.61 -9.12 59.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.311 0.577 . . . . 0.0 110.401 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.41 63.04 Favored Glycine 0 CA--C 1.483 -1.953 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.787 172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.538 ' HB2' HD21 ' A' ' 464' ' ' ASN . 11.2 mpt_? -73.38 116.86 14.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.406 ' HG2' HG22 ' A' ' 463' ' ' VAL . 4.0 tmm_? -81.09 133.48 35.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.11 -173.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 123.844 0.858 . . . . 0.0 108.791 -174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -117.39 -20.46 9.1 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.147 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.37 147.35 33.3 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.421 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -145.68 139.14 26.34 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.208 0.603 . . . . 0.0 110.169 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -97.92 167.1 22.75 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 439' ' ' VAL . 18.9 Cg_endo -58.63 150.66 68.26 Favored 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 123.09 2.527 . . . . 0.0 112.878 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 32.6 m 75.32 17.83 2.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.431 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 24.5 ttt -117.16 136.36 23.36 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.12 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 3.6 Cg_exo -80.55 126.77 6.17 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.201 1.934 . . . . 0.0 110.933 174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.3 m -142.36 149.87 19.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.005 0.431 . . . . 0.0 110.865 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 31.4 tt0 -108.67 112.56 24.95 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.6 pt -99.84 172.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.576 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.453 ' CG2' HG12 ' A' ' 434' ' ' VAL . 5.5 p -145.33 157.55 44.02 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 113.23 4.44 23.83 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 119.586 -1.292 . . . . 0.0 114.16 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 51.2 tp -73.3 -37.58 66.16 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.483 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 64.62 24.14 12.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.278 1.431 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.441 ' CB ' HG21 ' A' ' 455' ' ' THR . 37.5 t70 -144.93 171.62 14.19 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 25.4 t -114.85 109.23 47.64 Favored Pre-proline 0 C--N 1.291 -1.956 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.44 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.02 174.52 4.56 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.595 2.197 . . . . 0.0 111.783 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -129.94 150.78 51.08 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.116 0.484 . . . . 0.0 111.327 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -63.74 130.03 42.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.346 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.28 58.83 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.749 -1.215 . . . . 0.0 111.588 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 493' ' ' ARG . 7.3 t70 -86.29 -166.63 1.6 Allowed 'General case' 0 C--O 1.248 0.974 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.462 ' HB2' ' OD1' ' A' ' 413' ' ' ASN . 0.1 OUTLIER -131.24 136.89 48.61 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.295 -169.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 437' ' ' LEU . 38.4 p90 -136.74 158.53 44.23 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.824 0.821 . . . . 0.0 111.758 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.2 ttp -134.05 119.53 19.08 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.862 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 450' ' ' ILE . 83.1 t -108.64 136.77 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -85.74 122.7 30.19 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.472 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -70.0 -48.57 57.61 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.676 -174.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 27.4 t70 60.53 -58.0 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.844 1.658 . . . . 0.0 115.166 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -13.25 62.27 Favored 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -70.19 -47.0 63.45 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -61.33 -37.71 84.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.207 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.22 -48.58 64.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.901 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.463 ' HA ' ' H ' ' A' ' 508' ' ' GLU . 36.6 ttm105 -55.44 -40.29 71.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 123.891 0.876 . . . . 0.0 112.274 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.01 -31.8 69.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.967 0.792 . . . . 0.0 111.147 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 46.0 mm -87.63 -9.0 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.451 0.7 . . . . 0.0 110.219 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 108.48 37.93 2.01 Favored Glycine 0 C--N 1.32 -0.342 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.463 ' H ' ' HA ' ' A' ' 504' ' ' ARG . 41.5 mt-10 54.87 35.51 24.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.782 1.633 . . . . 0.0 113.221 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -79.44 105.11 10.51 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.884 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -108.1 140.13 41.74 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.433 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -68.46 -77.86 0.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.428 0.455 . . . . 0.0 111.947 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -150.75 93.78 2.0 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.815 -0.754 . . . . 0.0 112.356 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 178.28 107.88 0.03 OUTLIER 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.481 1.112 . . . . 0.0 110.465 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 . . . . . 0 C--N 1.296 -1.754 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.97 179.832 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.396 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 32.4 t -63.87 106.98 1.11 Allowed 'General case' 0 C--O 1.253 1.237 0 C-N-CA 123.388 0.675 . . . . 0.0 110.711 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 55.32 -108.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.409 1.084 . . . . 0.0 110.015 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 72.6 mtm -142.55 13.98 1.96 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.4 pp -108.1 2.99 23.41 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.02 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.21 123.16 17.94 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.639 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -124.1 24.14 8.26 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 121.363 0.601 . . . . 0.0 109.723 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.3 mp -89.62 73.35 7.72 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.861 0.839 . . . . 0.0 109.896 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 47.2 tp -94.65 90.82 6.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.94 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.0 -44.2 55.4 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.233 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -138.1 138.76 39.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.93 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 6.9 tp -120.3 125.7 74.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 31.1 tp 68.87 12.46 8.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.583 1.153 . . . . 0.0 110.458 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.0 tp -93.86 -50.07 5.52 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.0 t 57.48 24.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 122.185 0.993 . . . . 0.0 111.232 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 16.8 m -80.57 67.6 6.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.907 0.86 . . . . 0.0 110.508 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -149.53 16.46 0.9 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.357 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 42.8 ttm -99.88 -65.49 0.96 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.156 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -112.93 140.04 48.07 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -101.37 122.82 44.43 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.195 0.521 . . . . 0.0 110.946 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.51 -32.87 71.99 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.557 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 88.7 tttt 60.34 83.01 0.15 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.568 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -83.65 -34.92 24.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -139.03 142.23 32.63 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.209 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.37 -22.59 24.94 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.443 2.096 . . . . 0.0 110.137 174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -81.61 146.19 30.22 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.917 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -114.81 -126.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 69.78 -74.82 0.08 Allowed 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.905 0.882 . . . . 0.0 109.599 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 495' ' ' MET . . . 177.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.984 1.314 . . . . 0.0 108.291 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 9.7 m -146.39 169.61 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 122.679 0.392 . . . . 0.0 110.551 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -151.43 -174.68 22.48 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 18.8 m -127.89 143.87 51.1 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 117.049 0.424 . . . . 0.0 110.558 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.64 136.38 22.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.0 pt -89.77 -43.21 14.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.687 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -153.01 155.75 37.51 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.093 0.473 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -134.2 129.83 36.33 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 427' ' ' LEU . 0.3 OUTLIER -134.8 159.53 41.06 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -170.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.49 ' N ' ' HG2' ' A' ' 426' ' ' LYS . 2.1 pt? -94.68 139.64 30.95 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 9.9 t70 -127.66 117.62 22.31 Favored 'General case' 0 C--N 1.261 -3.25 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -59.69 -26.15 65.34 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -110.24 -37.95 1.73 Allowed Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.9 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.48 ' HD3' ' OD2' ' A' ' 428' ' ' ASP . 42.1 mtp180 -86.51 -24.37 25.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.14 -166.91 19.09 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -58.11 116.11 3.01 Favored 'Trans proline' 0 C--O 1.25 1.088 0 C-N-CA 122.529 2.153 . . . . 0.0 111.049 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 482' ' ' THR . 20.1 m -114.94 136.62 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.341 0.591 . . . . 0.0 110.508 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -126.75 124.66 40.24 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.381 -177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 2.0 m -98.7 118.78 36.2 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.94 170.14 15.31 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.443 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.5 tm? -118.44 105.29 11.53 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 475' ' ' PRO . 3.3 p -71.14 118.6 16.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.708 0.766 . . . . 0.0 112.197 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 47.0 mt-30 -123.3 -16.22 6.96 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.468 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -76.22 -2.4 31.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.957 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 145.81 -89.89 0.16 Allowed Glycine 0 C--O 1.212 -1.244 0 C-N-CA 119.019 -1.562 . . . . 0.0 113.219 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 56.3 m -146.64 146.89 30.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.537 HD22 ' HE1' ' A' ' 462' ' ' MET . 2.2 tt -128.23 115.58 18.56 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 0.0 OUTLIER -135.81 158.9 43.26 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 120.708 0.29 . . . . 0.0 110.847 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 35.7 m -61.81 133.71 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 120.89 0.376 . . . . 0.0 110.119 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.82 4.04 56.95 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.259 -176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 449' ' ' PRO . 33.7 m-20 -86.36 127.91 59.29 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.997 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 5.5 Cg_exo -77.18 106.65 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.814 1.676 . . . . 0.0 108.073 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 456' ' ' TYR . 2.9 pp -104.9 140.84 21.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.035 -172.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.34 119.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.472 HG12 ' CB ' ' A' ' 494' ' ' PHE . 8.5 m -125.27 133.94 68.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . 0.451 ' HA2' ' NH1' ' A' ' 493' ' ' ARG . . . 57.97 -100.17 0.14 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.515 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 7.0 p -131.54 10.86 4.82 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.639 0.776 . . . . 0.0 110.895 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.514 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.3 m -119.7 144.8 47.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.777 0.322 . . . . 0.0 110.282 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 450' ' ' ILE . 52.8 p90 -120.5 150.85 40.18 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -150.36 -170.68 17.86 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -134.82 127.89 31.68 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.73 118.23 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.82 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.15 -52.82 3.87 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.1 35.86 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.537 ' HE1' HD22 ' A' ' 444' ' ' LEU . 38.5 tpp -133.18 117.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.78 131.43 72.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.681 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -94.88 177.74 5.8 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 118.986 -1.085 . . . . 0.0 109.369 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -52.73 -30.55 33.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.37 1.068 . . . . 0.0 113.148 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 29.2 t -76.95 -16.14 59.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.078 0.466 . . . . 0.0 110.483 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 94.64 15.09 47.8 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.23 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -99.87 133.82 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.541 -0.33 . . . . 0.0 110.184 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.4 tpt85 -73.16 126.06 29.16 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.181 0.926 . . . . 0.0 108.981 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 462' ' ' MET . 30.6 m -135.66 -177.2 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 471' ' ' LYS . 0.0 OUTLIER -120.9 -12.71 8.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.947 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.68 152.18 33.58 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -145.04 145.96 31.68 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 123.719 0.637 . . . . 0.0 109.866 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -94.84 173.91 32.48 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.477 ' HA ' HG13 ' A' ' 439' ' ' VAL . 58.5 Cg_endo -69.57 156.66 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.637 2.224 . . . . 0.0 113.378 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 438' ' ' LEU . 12.1 t 72.08 16.51 5.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.022 1.329 . . . . 0.0 110.892 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 34.8 ttp -119.76 129.53 25.31 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.638 -0.664 . . . . 0.0 112.069 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -69.77 125.93 12.71 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.777 2.318 . . . . 0.0 112.345 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 436' ' ' THR . 6.0 m -140.41 151.74 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.163 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 40.8 tt0 -112.42 112.78 24.58 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 48.3 pt -98.23 170.57 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.699 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.482 HG23 HG12 ' A' ' 434' ' ' VAL . 0.2 OUTLIER -150.72 150.1 30.63 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 109.72 31.94 3.04 Favored Glycine 0 C--N 1.304 -1.25 0 O-C-N 123.742 0.651 . . . . 0.0 113.295 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 457' ' ' GLY . 54.9 tp -82.94 -35.84 25.68 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 27.0 t60 65.4 27.72 11.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.185 1.394 . . . . 0.0 109.404 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.514 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.3 t0 -148.01 -179.95 7.29 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.91 108.97 44.06 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.77 158.1 56.59 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.902 1.735 . . . . 0.0 110.733 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -126.48 131.35 51.66 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.391 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -72.48 135.66 45.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.295 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 84.25 -0.44 89.35 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.664 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 1.6 t70 -84.7 -172.69 4.31 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.496 ' HD3' ' H ' ' A' ' 493' ' ' ARG . 0.1 OUTLIER -129.16 150.92 50.34 Favored 'General case' 0 C--N 1.273 -2.719 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.742 -173.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 452' ' ' VAL . 40.7 p90 -140.28 168.68 19.25 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 418' ' ' ALA . 52.3 ttp -134.02 115.98 14.97 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 444' ' ' LEU . 61.7 t -121.72 106.06 17.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -131.63 122.95 26.85 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.708 ' HG3' ' H ' ' A' ' 501' ' ' LYS . 10.1 tp10 -78.23 142.91 37.55 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-O 122.338 1.065 . . . . 0.0 111.284 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -102.43 -40.28 6.78 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.833 -175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.46 -25.0 59.13 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.841 -0.537 . . . . 0.0 112.444 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.708 ' H ' ' HG3' ' A' ' 498' ' ' GLU . 48.3 mtpt -72.48 -38.97 68.06 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.486 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -70.88 -26.64 63.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.855 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.67 50.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.39 -45.76 55.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.579 1.552 . . . . 0.0 110.32 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.62 -36.21 75.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.2 -10.96 11.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.432 0.634 . . . . 0.0 109.838 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 101.45 28.26 6.82 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.893 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 62.7 31.31 16.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.831 1.3 . . . . 0.0 109.932 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.85 -8.63 57.01 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.878 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -96.73 104.39 16.38 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.47 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -98.75 -17.31 18.58 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -114.03 135.11 54.37 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.333 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -77.74 -43.13 31.83 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--N 1.319 -0.754 0 C-N-CA 123.439 0.695 . . . . 0.0 109.986 -178.5 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.858 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 36.4 m 64.96 114.4 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.574 1.149 . . . . 0.0 111.228 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -78.01 70.87 4.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.424 1.107 . . . . 0.0 112.616 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 26.0 ptm -153.12 9.89 0.44 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.205 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.66 101.62 14.31 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.967 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -75.78 115.28 15.3 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -65.39 123.39 19.49 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.616 0.722 . . . . 0.0 112.544 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.1 mp -75.23 165.1 25.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.274 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.48 88.19 6.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.574 0.702 . . . . 0.0 110.14 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -86.14 176.29 8.06 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.614 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 23.1 ptp -78.38 153.74 31.34 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 34.8 pt -73.89 127.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.88 131.59 35.26 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.482 -173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.1 -23.7 23.62 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 58.0 t 63.74 89.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.71 1.204 . . . . 0.0 110.036 -177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 20.3 m -144.56 150.2 37.11 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.215 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.09 142.14 31.49 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.014 0.435 . . . . 0.0 111.924 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 27.1 ttt -101.91 13.37 34.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.593 1.187 . . . . 0.0 108.031 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.47 156.61 19.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.217 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.98 -73.59 0.28 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 411' ' ' LYS . 3.5 pp -179.99 -30.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.796 0.838 . . . . 0.0 110.994 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 410' ' ' LEU . 0.9 OUTLIER -86.59 -76.08 0.36 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 179.43 130.71 0.08 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 71.02 104.89 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 125.103 1.361 . . . . 0.0 111.333 171.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.47 -27.51 23.01 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.491 2.128 . . . . 0.0 113.501 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.564 HD21 ' HB3' ' A' ' 418' ' ' ALA . 30.3 t-20 -86.35 -58.61 2.56 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 65.48 9.8 6.09 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.455 1.502 . . . . 0.0 114.061 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 441' ' ' ALA . 55.5 ttt180 -131.18 -54.61 1.04 Allowed 'General case' 0 C--O 1.204 -1.324 0 O-C-N 121.391 -0.818 . . . . 0.0 111.027 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.564 ' HB3' HD21 ' A' ' 415' ' ' ASN . . . -82.59 5.46 20.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.924 0.392 . . . . 0.0 111.69 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.35 155.34 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -117.74 178.59 17.01 Favored Glycine 0 C--N 1.292 -1.871 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.6 m -122.02 139.09 54.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 52.1 t -82.51 135.07 25.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 11.3 pt -93.73 -37.05 7.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.905 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 490' ' ' ALA . 12.6 pt-20 -156.7 148.14 22.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.46 136.76 17.6 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 176.43 8.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.44 145.92 24.23 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.69 122.81 33.91 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.527 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.13 -13.4 58.01 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -109.67 -46.02 0.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.401 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.49 -40.59 42.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 109.605 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 121.7 -176.45 16.38 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.45 116.13 3.07 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 122.141 1.894 . . . . 0.0 109.445 171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 482' ' ' THR . 29.1 m -121.94 146.56 26.88 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 CA-C-O 121.391 0.615 . . . . 0.0 112.229 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -137.53 119.14 14.95 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.258 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.3 m -88.22 125.06 34.44 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.91 168.05 20.67 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.399 -173.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.83 105.9 12.43 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 475' ' ' PRO . 4.3 p -70.84 121.21 20.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.836 0.827 . . . . 0.0 111.529 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -121.84 -20.5 6.38 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.932 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 417' ' ' ARG . . . -81.63 -11.41 59.12 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -170.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 165.13 -111.38 0.46 Allowed Glycine 0 N--CA 1.416 -2.663 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.86 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 24.7 m -137.16 133.75 35.59 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.7 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.7 OUTLIER -101.28 115.79 31.32 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 446' ' ' VAL . 1.0 OUTLIER -129.04 150.99 50.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 445' ' ' LYS . 34.4 m -71.0 141.32 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 CA-C-O 121.257 0.551 . . . . 0.0 111.297 177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.38 8.6 70.91 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.792 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -101.07 128.17 30.15 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 6.8 Cg_exo -72.38 120.81 6.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.46 HG22 HG22 ' A' ' 496' ' ' VAL . 18.9 pt -114.36 160.63 13.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.404 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.44 127.25 59.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.488 HG12 ' CB ' ' A' ' 494' ' ' PHE . 3.0 m -127.22 128.19 70.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 55.47 -97.09 0.04 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 121.597 -0.335 . . . . 0.0 113.595 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 8.9 t -127.84 11.33 6.63 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.072 0.463 . . . . 0.0 110.623 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.477 HG21 ' CB ' ' A' ' 486' ' ' ASP . 91.2 m -124.21 150.12 45.61 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -127.92 162.1 27.53 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -173.91 -165.09 30.06 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -135.61 134.77 39.66 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 482' ' ' THR . 31.0 t -70.2 122.58 22.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 123.369 0.418 . . . . 0.0 110.352 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -93.09 -56.74 2.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.651 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.45 146.62 50.02 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.7 ' HE1' HD22 ' A' ' 444' ' ' LEU . 42.5 tpp -121.8 117.47 26.62 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.17 136.74 49.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.87 174.18 5.99 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.046 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.53 -29.82 38.55 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.602 1.161 . . . . 0.0 113.491 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 68.7 m -77.17 -11.81 59.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.821 -0.55 . . . . 0.0 111.33 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 100.77 -11.56 59.25 Favored Glycine 0 CA--C 1.494 -1.273 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.785 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -77.7 137.09 38.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.006 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.16 127.48 34.29 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.2 m -126.39 174.52 10.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.558 -172.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -102.74 -35.24 8.73 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 151.25 37.93 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.483 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.408 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -139.17 145.22 39.09 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -91.43 174.14 37.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.994 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 439' ' ' VAL . 36.2 Cg_endo -64.51 158.6 48.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 38.6 m 68.67 17.0 8.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.521 0.728 . . . . 0.0 112.39 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . . . . . . . . . 36.5 ttp -122.6 127.14 25.91 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.156 -0.34 . . . . 0.0 110.927 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.79 126.38 13.88 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 121.99 1.793 . . . . 0.0 111.72 176.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.408 HG11 ' CB ' ' A' ' 473' ' ' ALA . 17.6 m -139.12 167.39 20.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.514 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 34.4 tt0 -125.33 118.3 25.64 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 43.6 pt -98.52 173.02 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.472 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 3.1 p -152.77 155.04 36.41 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 124.399 1.08 . . . . 0.0 108.352 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.18 8.15 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 172.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.21 -31.14 38.69 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 63.51 21.36 12.71 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.823 1.249 . . . . 0.0 109.263 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.477 ' CB ' HG21 ' A' ' 455' ' ' THR . 5.4 t70 -140.79 -179.77 6.24 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.67 107.63 58.7 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-O 121.538 0.685 . . . . 0.0 111.779 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -82.45 167.92 14.98 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.019 1.812 . . . . 0.0 110.059 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . 0.606 ' HB2' ' OD2' ' A' ' 492' ' ' ASP . 21.9 mt-30 -134.8 154.2 51.71 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.109 -0.369 . . . . 0.0 110.356 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -70.97 133.42 46.36 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 98.2 -11.39 63.73 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.116 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 489' ' ' GLN . 4.3 m-20 -79.5 164.61 23.78 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.779 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 493' ' ' ARG . 5.9 mpt_? -113.11 128.75 56.58 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.488 ' CB ' HG12 ' A' ' 452' ' ' VAL . 53.9 p90 -118.94 155.73 30.81 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.3 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 51.6 ttm -121.03 116.29 24.77 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.172 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 450' ' ' ILE . 46.7 t -123.65 105.05 15.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -114.53 151.31 33.55 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.451 ' CD ' ' HB3' ' A' ' 501' ' ' LYS . 3.2 pt-20 54.36 -160.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.901 1.68 . . . . 0.0 110.118 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 18.6 t70 178.47 -49.79 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 125.279 1.432 . . . . 0.0 108.214 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -77.76 -28.77 50.7 Favored 'General case' 0 C--O 1.197 -1.682 0 CA-C-N 114.149 -1.387 . . . . 0.0 114.348 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 505' ' ' GLN . 0.1 OUTLIER -63.86 -54.11 40.07 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.633 0.652 . . . . 0.0 110.899 -174.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 506' ' ' ILE . 10.8 ptpp? -65.28 -35.35 80.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.074 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.55 77.64 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.848 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -55.61 -50.17 70.85 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.127 1.371 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 501' ' ' LYS . 12.0 mm100 -70.08 -26.31 63.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.926 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 502' ' ' LYS . 44.6 mm -74.06 -41.65 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 167.92 -14.95 0.07 OUTLIER Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.827 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.99 43.79 0.96 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 122.683 1.23 . . . . 0.0 110.321 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -91.77 10.53 28.08 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.392 1.092 . . . . 0.0 108.592 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -90.09 96.62 10.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.411 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.12 34.2 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -85.11 91.39 8.1 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -139.89 24.98 2.36 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 N--CA 1.416 -2.133 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.002 -178.084 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.851 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 39.4 m -91.58 102.81 15.46 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 117.016 0.408 . . . . 0.0 110.312 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 72.98 128.71 0.04 OUTLIER 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.333 1.453 . . . . 0.0 112.498 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 398' ' ' LEU . 50.7 ttm -75.34 81.29 2.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.044 0.926 . . . . 0.0 109.606 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 90.9 mt -108.27 -83.73 0.54 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -108.34 8.61 27.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -115.45 105.24 12.59 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.299 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 89.4 mt 62.02 -169.54 0.18 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 124.853 1.346 . . . . 0.0 112.209 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' A' ' 399' ' ' GLU . 19.7 tp -163.76 -173.18 3.14 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 102.303 -3.221 . . . . 0.0 102.303 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.47 ' H ' ' HG ' ' A' ' 398' ' ' LEU . 43.9 tt0 -66.98 99.79 0.68 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 119.537 1.062 . . . . 0.0 111.261 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 13.0 tpt 72.72 -55.23 0.68 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.782 1.633 . . . . 0.0 112.737 177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 24.9 pt -139.61 174.75 8.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 123.778 0.831 . . . . 0.0 108.805 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 398' ' ' LEU . 3.8 mm? -91.97 172.13 8.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 67.9 mt -84.96 -178.43 6.83 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 27.9 m -78.63 37.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.595 0.758 . . . . 0.0 112.123 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 49.4 m 63.18 82.02 0.19 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.732 1.213 . . . . 0.0 111.499 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -98.85 132.85 43.88 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.71 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 24.9 ptp -74.04 113.32 11.08 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.533 0.682 . . . . 0.0 110.737 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.58 135.86 46.21 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 411' ' ' LYS . 0.7 OUTLIER -133.86 144.32 48.84 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -175.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 76.1 mt -128.72 4.65 5.5 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.446 ' H ' ' CD ' ' A' ' 409' ' ' GLU . 99.0 mttt -111.76 31.82 5.9 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.991 0.424 . . . . 0.0 111.781 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . 73.78 -6.19 1.85 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 176.92 126.98 0.18 Allowed Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.96 -19.12 66.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.108 2.539 . . . . 0.0 113.117 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -95.56 169.2 10.2 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -78.38 178.21 7.87 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.22 57.71 1.49 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.014 0.911 . . . . 0.0 110.22 173.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -125.77 2.81 7.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 440' ' ' GLN . 17.5 m -147.45 161.66 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 175.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.35 176.48 17.88 Favored Glycine 0 C--N 1.291 -1.952 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 2.0 m -127.2 139.6 52.83 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 42.7 t -83.58 137.29 21.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 17.2 pt -97.54 -37.55 6.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.232 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 436' ' ' THR . 0.2 OUTLIER -152.35 166.07 33.0 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -144.39 128.59 17.72 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.54 146.85 30.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.67 144.71 26.51 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.299 0.571 . . . . 0.0 109.885 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.24 129.48 50.86 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.545 ' HE2' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -64.0 -19.98 65.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -111.61 -48.42 0.69 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.878 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -74.68 -26.94 60.18 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 123.594 0.758 . . . . 0.0 110.59 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 98.98 -158.91 20.14 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.25 116.46 3.51 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.567 2.178 . . . . 0.0 111.084 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 482' ' ' THR . 15.1 m -121.33 157.0 25.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -148.26 120.37 8.29 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.54 ' HB ' ' HG3' ' A' ' 424' ' ' GLU . 3.4 m -82.74 123.67 29.53 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 478' ' ' PRO . 1.3 pp -133.03 173.3 11.57 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.4 tm? -119.44 110.99 17.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -75.5 122.58 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.763 0.792 . . . . 0.0 111.24 -178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 419' ' ' VAL . 18.8 mt-30 -123.83 -14.45 7.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.095 -174.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.671 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -96.36 8.42 44.02 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.049 0.452 . . . . 0.0 110.133 -173.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 142.62 -126.55 2.92 Favored Glycine 0 N--CA 1.403 -3.513 0 C-N-CA 120.033 -1.08 . . . . 0.0 111.347 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.3 m -115.62 142.7 46.38 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.646 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.4 OUTLIER -111.45 117.69 33.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.541 ' HB3' ' OD2' ' A' ' 448' ' ' ASP . 12.3 ttpt -122.86 148.36 45.51 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 27.6 m -69.02 123.88 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.413 0.625 . . . . 0.0 109.768 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 109.5 -8.51 32.52 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.125 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.541 ' OD2' ' HB3' ' A' ' 445' ' ' LYS . 42.7 m-20 -90.32 146.02 33.82 Favored Pre-proline 0 C--O 1.25 1.081 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.448 177.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 4.0 Cg_exo -77.03 145.37 24.71 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.536 2.157 . . . . 0.0 111.391 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 13.8 pt -136.44 156.88 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.345 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.74 115.34 44.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.0 115.34 45.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.38 -102.56 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 12.6 t -127.9 8.23 6.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 486' ' ' ASP . 26.6 m -115.76 145.02 43.16 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.618 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -127.95 158.77 36.93 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -173.05 -164.3 28.2 Favored Glycine 0 C--N 1.29 -2.015 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -125.48 134.68 51.97 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.467 HG21 ' CD2' ' A' ' 444' ' ' LEU . 41.6 t -72.15 123.47 26.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -95.79 -50.38 4.93 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.693 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -126.05 159.66 32.19 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.646 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.9 tpp -130.8 117.33 19.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.79 128.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.634 HD21 ' HB2' ' A' ' 468' ' ' ARG . 8.8 p30 -92.9 -175.71 3.98 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.227 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.94 -20.26 66.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 112.402 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 31.5 t -84.21 -20.31 32.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 91.71 40.62 5.26 Favored Glycine 0 CA--C 1.488 -1.612 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.706 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.634 ' HB2' HD21 ' A' ' 464' ' ' ASN . 85.2 mtt180 -118.34 129.88 55.69 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 470' ' ' VAL . 2.3 tmm_? -80.17 129.51 34.55 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 469' ' ' ARG . 18.4 m -130.55 -179.23 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 120.583 0.23 . . . . 0.0 110.385 -176.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -98.97 -35.98 9.89 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.231 0.612 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -157.74 147.59 20.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.017 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -134.7 142.99 46.95 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.059 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.04 173.85 45.18 Favored Glycine 0 N--CA 1.442 -0.928 0 O-C-N 123.717 0.636 . . . . 0.0 112.304 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 439' ' ' VAL . 30.9 Cg_endo -64.98 156.52 62.07 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.551 2.168 . . . . 0.0 113.23 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.462 ' HA ' HD11 ' A' ' 438' ' ' LEU . 28.3 m 72.54 10.85 5.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.439 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 26.1 ttt -111.08 138.26 21.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 4.5 Cg_exo -83.91 126.34 3.88 Favored 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.925 2.416 . . . . 0.0 112.001 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.7 151.45 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.171 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 44.7 mt-10 -96.82 129.19 44.29 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 174.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -100.87 170.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.479 ' CG2' HG12 ' A' ' 434' ' ' VAL . 1.7 p -151.07 158.86 44.61 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 124.237 1.015 . . . . 0.0 108.503 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.12 8.15 Favored Glycine 0 N--CA 1.422 -2.277 0 O-C-N 124.059 0.849 . . . . 0.0 114.428 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.57 -36.39 13.72 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 38.1 t60 64.62 20.95 12.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.357 1.463 . . . . 0.0 108.423 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.487 ' CB ' HG21 ' A' ' 455' ' ' THR . 30.9 t70 -135.9 173.52 11.62 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.12 103.6 36.06 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 118.094 0.406 . . . . 0.0 110.008 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.61 174.97 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.814 2.343 . . . . 0.0 111.124 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -111.17 145.56 38.43 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.308 0.575 . . . . 0.0 111.365 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 424' ' ' GLU . . . -64.02 127.62 32.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.185 173.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 100.67 -3.48 56.15 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.609 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.18 178.11 8.44 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.751 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.61 140.73 48.91 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 124.105 0.962 . . . . 0.0 108.779 -175.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.05 155.18 49.68 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.998 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 49.7 ttp -122.02 120.34 34.09 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.671 HG12 ' HB3' ' A' ' 441' ' ' ALA . 7.0 p -95.47 143.07 12.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -101.74 120.54 40.52 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.513 ' OE2' ' HG2' ' A' ' 501' ' ' LYS . 37.4 tt0 -81.02 137.54 36.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 123.548 0.53 . . . . 0.0 110.888 -174.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.97 -58.2 8.57 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 124.719 1.207 . . . . 0.0 111.778 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.2 -20.91 62.22 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.139 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.513 ' HG2' ' OE2' ' A' ' 498' ' ' GLU . 41.9 mmtm -68.88 -49.24 59.93 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -69.2 -40.6 77.92 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.572 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -62.86 -37.92 88.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.699 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -73.71 -16.1 61.2 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 122.878 0.471 . . . . 0.0 111.033 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.6 -28.65 61.0 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 2.4 mp -86.93 -34.96 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 129.44 20.22 1.42 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.466 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 54.56 21.17 3.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.398 1.479 . . . . 0.0 112.932 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -152.09 171.48 17.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.55 179.75 4.15 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -69.65 -41.39 75.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 62.95 84.69 0.14 Allowed 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.521 1.138 . . . . 0.0 108.937 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -72.91 114.07 10.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.626 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.127 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 39.2 m -75.52 -30.4 59.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.955 0.378 . . . . 0.0 111.66 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 63.86 17.38 10.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.829 0.852 . . . . 0.0 111.91 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 28.1 ttt -98.1 86.67 3.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 89.1 mt -88.23 117.28 27.02 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.79 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.22 137.04 32.67 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -90.48 92.68 8.98 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.721 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.05 132.0 20.24 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 398' ' ' LEU . 2.8 pp -168.22 125.37 1.09 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.795 0.685 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -78.66 111.01 14.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 73.1 mtm -78.37 93.0 4.63 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 58.4 mt -76.7 -46.87 30.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 60.3 tp -101.64 139.3 37.48 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.592 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.71 168.06 11.47 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.71 70.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.64 1.21 . . . . 0.0 108.05 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 17.1 m -143.38 99.18 3.39 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -91.72 116.16 28.65 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -133.27 124.55 27.54 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.929 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 411' ' ' LYS . 1.9 mp0 -91.3 147.62 22.92 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.716 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -48.32 7.77 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 59.6 tp -116.7 -12.62 10.85 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.368 0.604 . . . . 0.0 109.99 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 408' ' ' GLU . 58.2 tttp 75.88 -38.6 0.35 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.417 1.887 . . . . 0.0 112.84 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -87.28 83.71 7.33 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.343 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 58.62 103.46 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 0.0 114.118 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -86.09 -17.61 3.78 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.055 1.837 . . . . 0.0 113.076 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -96.78 -35.51 10.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.235 0.541 . . . . 0.0 111.064 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 416' ' ' ARG 0.273 14.4 mmt180 69.85 -44.73 0.56 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 174.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -107.75 -6.64 16.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 118.49 0.587 . . . . 0.0 112.272 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -92.9 -25.33 18.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.606 0.717 . . . . 0.0 110.262 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 441' ' ' ALA . 15.9 m -144.86 162.03 13.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.52 166.11 12.82 Favored Glycine 0 C--N 1.292 -1.885 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.12 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 1.6 m -114.2 143.01 45.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.11 131.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 20.1 pt -88.75 -36.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.747 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -160.11 153.36 21.99 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.38 143.33 23.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.478 ' HD2' ' CG2' ' A' ' 434' ' ' VAL . 0.0 OUTLIER -163.49 175.73 10.44 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 426' ' ' LYS . 2.2 pt? -85.07 143.38 28.91 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -126.41 129.77 49.41 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -65.04 -24.68 67.55 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.743 -178.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -97.32 -47.63 2.16 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.723 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HB3' HG21 ' A' ' 482' ' ' THR . 25.3 mmt180 -91.4 -33.43 15.25 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.24 -134.56 12.23 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.83 115.96 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.679 1.74 . . . . 0.0 110.782 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.478 ' CG2' ' HD2' ' A' ' 426' ' ' LYS . 25.3 m -118.2 148.26 21.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -143.54 114.24 7.61 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.2 m -85.58 116.91 24.15 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 1.4 pp -132.89 171.54 13.79 Favored 'General case' 0 C--N 1.279 -2.476 0 O-C-N 122.205 -0.309 . . . . 0.0 111.795 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -120.51 106.37 11.73 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.4 ' HB ' HD12 ' A' ' 444' ' ' LEU . 7.2 p -78.83 123.89 36.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.241 0.544 . . . . 0.0 112.009 -177.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -124.72 -15.88 6.38 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.766 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 419' ' ' VAL . . . -77.84 -15.29 59.17 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.03 -0.987 . . . . 0.0 113.34 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 169.97 -102.26 0.18 Allowed Glycine 0 N--CA 1.436 -1.36 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.051 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 32.5 m -148.04 131.94 17.11 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.72 HD22 ' HE1' ' A' ' 462' ' ' MET . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -176.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.616 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 20.1 ttpt -148.3 153.23 38.39 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.616 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 28.2 m -71.24 134.7 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.25 0.547 . . . . 0.0 110.746 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 88.05 8.44 72.24 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.79 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.8 132.86 20.51 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.45 123.92 11.77 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.779 2.32 . . . . 0.0 111.495 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.73 151.7 26.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.452 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.95 123.12 70.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 494' ' ' PHE . 4.1 m -128.0 135.13 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 54.89 -100.44 0.08 OUTLIER Glycine 0 CA--C 1.533 1.164 0 N-CA-C 114.221 0.448 . . . . 0.0 114.221 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 42.2 p -121.94 4.54 9.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 122.652 0.381 . . . . 0.0 111.239 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 486' ' ' ASP . 44.3 m -125.36 145.62 49.96 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.835 0.35 . . . . 0.0 111.419 -173.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -122.0 144.38 48.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -149.74 -175.54 22.07 Favored Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -124.77 126.9 46.38 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 482' ' ' THR . 48.3 t -63.62 132.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.938 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -97.62 -59.42 1.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -122.6 167.79 12.97 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.72 ' HE1' HD22 ' A' ' 444' ' ' LEU . 39.8 tpp -143.23 117.14 9.36 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.74 132.03 72.03 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -98.71 -179.77 4.41 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.006 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.38 -30.15 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 124.065 0.946 . . . . 0.0 112.539 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 28.3 m -80.7 -13.18 59.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.188 -0.32 . . . . 0.0 111.445 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 95.95 7.96 58.31 Favored Glycine 0 CA--C 1.501 -0.795 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.206 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -91.72 138.94 31.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.567 -0.317 . . . . 0.0 110.336 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 462' ' ' MET . 9.2 tpt180 -74.22 131.33 41.12 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.39 174.49 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -101.9 -36.16 8.74 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.086 0.469 . . . . 0.0 110.02 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.83 151.98 49.75 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.851 -172.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . . . . . . . . . . . -137.81 137.48 38.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.022 0.529 . . . . 0.0 109.597 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -93.35 169.17 30.19 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.89 151.93 77.69 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.351 2.034 . . . . 0.0 112.346 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 31.1 t 75.44 15.71 2.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.139 1.376 . . . . 0.0 110.637 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 44.1 ttm -113.71 135.11 21.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.062 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 437' ' ' LEU . 2.7 Cg_exo -79.53 126.23 6.64 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.394 2.063 . . . . 0.0 110.427 173.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . . . . . . . . . 10.2 m -141.71 146.67 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 123.068 0.547 . . . . 0.0 110.07 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 435' ' ' ALA . 42.9 tt0 -105.67 118.63 37.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.3 pt -97.8 172.0 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.82 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 1.1 p -148.49 166.07 29.31 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 87.51 22.81 42.16 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.158 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 50.3 tp -72.98 -28.64 62.51 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.139 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 64.23 20.01 12.01 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 124.279 1.031 . . . . 0.0 110.213 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 455' ' ' THR . 33.2 t70 -149.03 179.39 7.91 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.47 114.9 65.8 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 118.415 0.552 . . . . 0.0 110.395 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.21 157.63 23.08 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.05 1.833 . . . . 0.0 111.091 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -124.6 137.91 54.35 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-O 121.529 0.681 . . . . 0.0 110.59 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.32 139.83 50.05 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.944 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.81 89.46 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.574 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.476 ' OD1' ' HD3' ' A' ' 493' ' ' ARG . 2.5 t70 -85.13 -170.87 3.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.476 ' HD3' ' OD1' ' A' ' 492' ' ' ASP . 0.3 OUTLIER -137.75 148.87 45.97 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 121.09 0.471 . . . . 0.0 109.903 -174.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 45.7 p90 -139.4 162.7 34.39 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.356 -174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.09 116.06 16.56 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.115 0.483 . . . . 0.0 109.87 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 494' ' ' PHE . 62.2 t -115.73 103.71 15.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 172.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -152.14 130.89 12.38 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 501' ' ' LYS . 11.2 tp10 -176.11 137.31 0.31 Allowed 'General case' 0 N--CA 1.412 -2.346 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.142 166.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 502' ' ' LYS . 34.0 t70 -87.71 -50.05 6.74 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.45 -18.28 61.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.689 0.757 . . . . 0.0 110.531 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 498' ' ' GLU . 17.4 tptp -63.1 -41.21 99.32 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.649 1.18 . . . . 0.0 109.553 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 499' ' ' ASP . 22.0 pttm -75.45 -19.8 59.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.655 0.741 . . . . 0.0 110.496 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -79.54 -44.07 21.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 108.877 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.45 ' HA ' ' HG3' ' A' ' 508' ' ' GLU . 39.8 ttm180 -70.56 -19.74 62.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.538 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . 0.477 ' OE1' ' HD3' ' A' ' 445' ' ' LYS . 45.0 tp60 -64.17 -40.67 96.62 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.613 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 40.0 mm -76.23 -35.27 27.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 129.18 20.75 1.4 Allowed Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.078 -0.964 . . . . 0.0 113.325 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 504' ' ' ARG . 43.7 mt-10 60.22 27.55 17.07 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.484 1.114 . . . . 0.0 111.024 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . 178.84 166.7 0.9 Allowed 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 103.832 -2.655 . . . . 0.0 103.832 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -71.28 139.44 49.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -71.11 93.6 1.06 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -114.83 170.0 8.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -86.28 -43.29 13.04 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 . . . . . 0 N--CA 1.427 -1.575 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.411 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.24 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 46.2 m -94.14 169.74 10.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -68.5 -40.46 80.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 57.6 mtt -97.36 120.66 38.13 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.56 133.06 37.26 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.101 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.82 103.44 15.33 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -105.15 9.44 34.18 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.712 0.768 . . . . 0.0 111.195 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 52.1 mt -148.6 104.66 3.51 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 114.189 -1.368 . . . . 0.0 107.4 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.77 134.54 37.01 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -82.32 -0.6 46.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.419 0.628 . . . . 0.0 111.307 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -139.66 95.03 2.85 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 8.9 tp -153.2 -33.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.5 -169.04 2.11 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 7.1 mp 69.04 169.78 0.29 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.683 0.754 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.01 -31.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.796 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 18.1 m -68.04 101.28 1.1 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.245 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -74.06 78.67 1.72 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 122.488 1.137 . . . . 0.0 111.626 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 63.1 mtm -88.83 -16.8 31.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.281 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.17 151.69 38.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.43 123.47 25.36 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 123.469 0.481 . . . . 0.0 110.265 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.73 6.94 4.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -102.4 7.89 40.3 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.414 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -85.0 100.57 11.75 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 74.87 150.76 0.13 Allowed Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.733 1.213 . . . . 0.0 113.695 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -69.81 -38.32 7.83 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.379 2.053 . . . . 0.0 112.16 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.608 ' HB2' HG22 ' A' ' 419' ' ' VAL . 13.3 m120 -84.12 -37.32 22.13 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 75.32 -43.99 0.52 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 114.111 174.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -104.7 -40.08 6.12 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.407 0.549 . . . . 0.0 112.333 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -77.05 4.77 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 415' ' ' ASN . 18.7 m -146.08 156.37 12.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -112.2 162.75 12.31 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.24 140.22 41.8 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.13 139.61 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.26 -39.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.27 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.22 158.45 44.18 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -153.62 135.32 14.45 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 177.52 8.36 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 123.582 0.551 . . . . 0.0 109.84 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.8 149.0 22.16 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.094 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.04 127.95 45.54 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -32.97 74.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -105.21 -39.27 2.3 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.641 -175.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 -87.85 -20.2 26.37 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.697 0.284 . . . . 0.0 111.717 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 97.24 -166.48 23.22 Favored Glycine 0 C--O 1.222 -0.633 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.84 117.01 3.66 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.589 2.193 . . . . 0.0 111.063 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.57 153.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.467 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 480' ' ' GLU . . . -147.88 123.95 10.75 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.926 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 480' ' ' GLU . 5.9 m -96.32 126.39 41.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.462 HD21 HD12 ' A' ' 444' ' ' LEU . 0.0 OUTLIER -134.97 173.43 11.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 121.04 0.448 . . . . 0.0 111.208 -177.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 476' ' ' SER . 1.7 tm? -116.52 107.58 14.93 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 475' ' ' PRO . 7.6 p -74.69 119.58 22.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.274 0.559 . . . . 0.0 112.063 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -124.39 -16.65 6.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 496' ' ' VAL . . . -69.21 -28.0 65.98 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.673 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . 0.486 ' HA3' ' OE2' ' A' ' 498' ' ' GLU . . . 175.01 -96.07 0.1 Allowed Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.103 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 501' ' ' LYS . 40.2 m -149.2 143.92 26.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.655 HD22 ' HE1' ' A' ' 462' ' ' MET . 0.5 OUTLIER -109.79 136.24 49.43 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 446' ' ' VAL . 25.7 ttpt -147.23 150.57 35.13 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 445' ' ' LYS . 34.1 m -69.69 131.04 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.167 0.508 . . . . 0.0 110.042 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.48 -10.46 61.18 Favored Glycine 0 N--CA 1.417 -2.586 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.415 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.518 ' OD2' ' HE2' ' A' ' 445' ' ' LYS . 17.2 m-20 -89.19 146.2 35.77 Favored Pre-proline 0 C--O 1.252 1.191 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.085 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 448' ' ' ASP . 3.8 Cg_exo -75.36 148.27 33.72 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.33 2.02 . . . . 0.0 111.702 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 12.9 pt -133.27 153.45 37.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.682 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.07 107.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.88 162.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . -39.85 108.7 0.1 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.263 0.483 . . . . 0.0 113.191 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 3.3 m 70.78 -25.34 0.16 Allowed 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 126.523 1.929 . . . . 0.0 115.198 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.422 HG21 ' CB ' ' A' ' 486' ' ' ASP . 89.1 m -119.6 132.82 55.8 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 120.955 -1.091 . . . . 0.0 112.295 -176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -111.46 165.44 11.98 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -169.8 -164.04 24.85 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -137.89 135.84 36.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 444' ' ' LEU . 38.6 t -69.99 118.48 14.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 120.905 0.383 . . . . 0.0 111.548 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -88.29 -54.86 3.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.149 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -133.19 146.37 51.45 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.655 ' HE1' HD22 ' A' ' 444' ' ' LEU . 49.6 tpp -115.54 116.69 28.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.24 132.13 60.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 479' ' ' VAL . 5.1 p30 -103.7 178.22 4.62 Favored 'General case' 0 C--N 1.283 -2.324 0 C-N-CA 118.523 -1.271 . . . . 0.0 110.945 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.27 -29.83 25.01 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.323 1.449 . . . . 0.0 112.985 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 47.6 t -78.52 -17.2 56.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.034 0.445 . . . . 0.0 110.494 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.74 56.69 Favored Glycine 0 CA--C 1.501 -0.814 0 O-C-N 122.013 -0.43 . . . . 0.0 112.157 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -92.08 149.19 21.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 120.722 0.296 . . . . 0.0 111.607 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -75.33 129.78 37.95 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.763 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 462' ' ' MET . 16.4 m -137.33 -176.07 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -111.54 -24.68 9.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.129 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -149.02 157.57 43.51 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 120.226 -0.589 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 479' ' ' VAL . . . -147.84 136.01 21.35 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 122.979 0.512 . . . . 0.0 110.189 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.0 167.86 38.48 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.482 ' HA ' HG13 ' A' ' 439' ' ' VAL . 38.6 Cg_endo -63.04 153.02 76.41 Favored 'Trans proline' 0 C--O 1.247 0.961 0 C-N-CA 123.02 2.48 . . . . 0.0 112.925 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 438' ' ' LEU . 21.1 m 71.61 21.63 4.33 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.649 1.18 . . . . 0.0 111.714 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 24.9 ttt -121.0 137.07 26.13 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.84 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 6.2 Cg_exo -78.61 126.84 7.66 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.84 2.36 . . . . 0.0 111.64 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 473' ' ' ALA . 13.4 m -143.78 155.93 16.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 122.516 0.326 . . . . 0.0 110.536 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 436' ' ' THR . 44.3 tt0 -116.11 115.43 26.05 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.1 pt -98.32 177.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.035 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' VAL . 2.0 p -152.44 166.68 31.2 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.91 20.35 24.1 Favored Glycine 0 C--N 1.294 -1.797 0 O-C-N 123.823 0.702 . . . . 0.0 114.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 43.3 tp -85.18 -33.37 22.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 7.6 t60 60.82 23.59 13.57 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.346 1.459 . . . . 0.0 110.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.422 ' CB ' HG21 ' A' ' 455' ' ' THR . 8.2 t70 -144.82 -179.91 6.9 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.18 112.49 56.48 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -78.19 166.2 24.88 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.961 1.774 . . . . 0.0 110.41 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 492' ' ' ASP . 5.5 tp-100 -120.09 132.81 55.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.785 0.802 . . . . 0.0 110.587 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.53 121.46 18.74 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.032 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.45 -0.25 59.76 Favored Glycine 0 C--N 1.309 -0.926 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 489' ' ' GLN . 3.4 t70 -80.28 -167.43 1.32 Allowed 'General case' 0 C--O 1.247 0.93 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . 0.494 ' HD3' ' N ' ' A' ' 493' ' ' ARG . 0.0 OUTLIER -137.76 129.71 28.76 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-O 121.385 0.612 . . . . 0.0 110.422 -172.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.33 158.95 29.9 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.715 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 26.8 ttt -118.4 123.23 44.75 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 441' ' ' ALA . 2.5 p -87.21 143.99 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -108.23 122.06 46.16 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.818 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.488 ' HG2' ' N ' ' A' ' 499' ' ' ASP . 0.0 OUTLIER -150.79 -162.86 1.64 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.488 ' N ' ' HG2' ' A' ' 498' ' ' GLU . 16.8 t70 -160.72 -63.61 0.06 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 165.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -61.81 -36.91 82.51 Favored 'General case' 0 C--O 1.188 -2.156 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.819 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 443' ' ' THR . 64.7 mttp -62.97 -45.32 93.0 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.297 0.57 . . . . 0.0 112.174 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -74.82 -27.51 60.32 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.75 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.13 31.75 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 500' ' ' GLU . 3.9 ptp180 -64.66 -23.22 67.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.87 -32.79 72.22 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.208 1.004 . . . . 0.0 109.028 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 60.6 mt -87.31 -44.89 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.564 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 162.87 -6.93 0.08 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 75.16 -28.77 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.457 2.303 . . . . 0.0 111.779 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -76.04 -28.03 57.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.361 1.077 . . . . 0.0 108.712 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -102.28 146.04 28.58 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . 68.19 27.64 6.7 Favored 'General case' 0 C--O 1.253 1.257 0 O-C-N 124.397 1.061 . . . . 0.0 110.156 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 513' ' ' ARG . 18.4 tt0 -81.89 161.42 23.14 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.878 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 512' ' ' GLN . 4.6 ptm180 -92.88 163.37 13.73 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--N 1.261 -3.242 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.125 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.538 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' SER . . . . . . . . . . . . . 12.5 p -151.35 32.92 0.57 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -93.53 -82.21 0.35 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.996 -0.44 . . . . 0.0 111.567 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -65.69 0.88 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.102 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 50.7 tp -97.82 72.34 2.25 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.21 1.005 . . . . 0.0 108.994 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -126.94 9.15 6.85 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.963 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -85.21 103.86 14.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.494 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 399' ' ' GLU . 84.5 mt -79.7 -35.97 38.22 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.869 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 86.4 mt 72.43 -35.85 0.34 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.09 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 397' ' ' LEU . 38.4 tt0 -66.19 111.32 3.37 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 170.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' MET . . . . . . . . . . . . . 24.4 mmt -96.8 145.65 25.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 15.8 tt -89.67 -22.01 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 98.8 mt -74.97 137.02 41.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.24 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 67.7 mt 70.69 -143.58 0.07 Allowed 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.642 1.214 . . . . 0.0 109.464 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 40.6 t 70.6 18.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 123.592 1.663 . . . . 0.0 108.142 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . . . . . . . . . 34.4 t -176.52 169.13 2.65 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.15 77.33 6.87 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.764 1.269 . . . . 0.0 109.403 175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 26.5 ttt -92.03 98.94 11.87 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.411 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -106.93 118.71 37.42 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.425 -174.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 410' ' ' LEU . 1.3 pt-20 -94.38 -88.21 0.25 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.152 0.501 . . . . 0.0 111.494 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' A' ' 409' ' ' GLU . 49.1 tp -131.91 79.95 1.89 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 411' ' ' LYS . 35.1 ttpt -126.04 112.53 15.99 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.08 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.67 -29.42 8.72 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -125.67 139.54 34.34 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.95 -29.07 49.67 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.02 102.67 13.21 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -53.88 109.7 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.346 1.058 . . . . 0.0 112.098 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 63.3 8.83 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.794 1.237 . . . . 0.0 113.19 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -98.24 -5.06 33.99 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.095 0.474 . . . . 0.0 111.436 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' VAL . . . . . . . . . . . . . 13.6 m -151.25 167.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -125.72 170.86 17.58 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.8 m -114.65 139.74 49.4 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.37 127.91 38.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.07 -37.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.83 154.96 26.97 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -146.58 139.13 25.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . 0.486 ' CD ' HG23 ' A' ' 434' ' ' VAL . 0.0 OUTLIER -156.99 176.85 12.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -100.41 150.09 22.98 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.88 119.48 32.76 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.551 ' HE2' ' N ' ' A' ' 429' ' ' LYS . 0.0 OUTLIER -50.85 -25.46 4.54 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -115.24 -36.28 1.23 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.119 -1.038 . . . . 0.0 113.646 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -90.08 -15.09 32.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 122.398 -0.472 . . . . 0.0 111.333 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 91.68 -144.93 17.45 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.02 116.42 4.14 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.388 2.059 . . . . 0.0 111.879 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.486 HG23 ' CD ' ' A' ' 426' ' ' LYS . 2.9 m -121.14 123.92 71.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 124.532 1.133 . . . . 0.0 108.943 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -130.18 125.22 34.45 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.175 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.11 122.2 40.96 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 494' ' ' PHE . 2.5 pp -132.3 173.18 11.54 Favored 'General case' 0 C--N 1.257 -3.417 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 476' ' ' SER . 4.5 tt -124.17 110.63 14.92 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 475' ' ' PRO . 7.2 p -69.12 121.63 18.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.806 0.812 . . . . 0.0 111.761 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -122.2 -16.03 7.55 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.655 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -82.0 -3.83 55.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.61 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 149.84 -103.56 0.25 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 119.943 -1.123 . . . . 0.0 112.04 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 39.8 m -142.51 130.44 21.77 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.478 ' CD1' HD11 ' A' ' 437' ' ' LEU . 2.9 tt -107.26 138.47 43.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.594 ' HE2' ' O ' ' A' ' 446' ' ' VAL . 1.1 ttpm? -145.94 151.94 38.63 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.866 0.757 . . . . 0.0 110.946 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . 0.594 ' O ' ' HE2' ' A' ' 445' ' ' LYS . 34.9 m -62.77 128.29 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.331 0.586 . . . . 0.0 111.123 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 103.43 -10.59 54.0 Favored Glycine 0 N--CA 1.428 -1.865 0 C-N-CA 119.845 -1.169 . . . . 0.0 114.219 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 445' ' ' LYS 0.254 2.2 p30 -101.17 149.58 36.4 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 118.904 1.352 . . . . 0.0 112.55 177.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 457' ' ' GLY . 73.2 Cg_endo -78.37 124.83 6.67 Favored 'Trans proline' 0 C--N 1.364 1.393 0 C-N-CA 122.881 2.387 . . . . 0.0 113.04 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.39 151.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.364 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.03 120.61 65.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.24 111.36 26.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.68 -113.83 6.23 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.235 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' THR . . . . . . . . . . . . . 17.5 p -104.06 2.92 32.68 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.889 0.376 . . . . 0.0 111.53 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.465 HG21 ' CB ' ' A' ' 486' ' ' ASP . 25.3 m -124.78 151.33 45.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.685 0.278 . . . . 0.0 110.692 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -127.56 144.34 51.08 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 449' ' ' PRO . . . -147.26 -164.36 11.12 Favored Glycine 0 C--N 1.287 -2.149 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' A' ' 483' ' ' GLY . 53.7 ttt180 -135.39 134.67 39.95 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.526 HG11 ' HE2' ' A' ' 462' ' ' MET . 38.5 t -66.67 121.58 16.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -86.88 -61.24 1.77 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.005 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ALA . . . . . . . . . . . . . . . -135.13 155.25 51.03 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 123.892 0.877 . . . . 0.0 109.091 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.526 ' HE2' HG11 ' A' ' 459' ' ' VAL . 36.4 tpp -123.68 117.83 25.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.27 132.01 70.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 468' ' ' ARG . 5.3 p30 -96.65 175.03 6.53 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.879 -1.128 . . . . 0.0 109.617 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.16 -27.35 61.83 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.53 0.732 . . . . 0.0 112.884 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 21.8 t -79.42 -11.03 59.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.206 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 96.55 6.0 58.69 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.134 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ARG . . . . . 0.494 ' HB2' HD21 ' A' ' 464' ' ' ASN . 9.6 mpt_? -87.75 130.79 34.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.809 0.338 . . . . 0.0 110.625 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.39 127.27 32.59 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 462' ' ' MET . 15.3 m -134.46 178.57 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -103.34 -35.4 8.42 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.647 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.65 162.16 33.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.905 0.383 . . . . 0.0 111.434 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 479' ' ' VAL . . . -129.65 129.49 44.36 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.213 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -87.25 163.99 34.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 439' ' ' VAL . 36.4 Cg_endo -65.26 152.37 82.36 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.402 2.068 . . . . 0.0 112.409 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.625 ' HA ' HD21 ' A' ' 438' ' ' LEU . 23.0 t 74.43 15.34 3.47 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.415 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 478' ' ' PRO . 42.1 ttm -113.14 134.81 21.77 Favored Pre-proline 0 C--O 1.242 0.671 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 477' ' ' MET . 5.9 Cg_exo -81.21 126.09 5.45 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.675 2.25 . . . . 0.0 110.882 173.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 473' ' ' ALA . 4.4 m -137.86 142.49 35.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.216 0.532 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -91.25 112.2 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.2 pt -101.47 167.37 2.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.17 0.51 . . . . 0.0 109.652 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.3 29.37 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 458' ' ' ARG . . . 94.27 12.87 55.67 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.512 177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 44.8 tp -75.05 -31.85 61.39 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 35.2 t60 61.73 20.52 11.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 111.499 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ASP . . . . . 0.465 ' CB ' HG21 ' A' ' 455' ' ' THR . 4.1 t70 -149.26 -179.54 7.13 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 488' ' ' PRO . 11.8 p -90.15 120.4 69.2 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-O 121.003 0.43 . . . . 0.0 110.369 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 487' ' ' VAL . 9.2 Cg_endo -88.01 172.05 5.49 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.064 1.843 . . . . 0.0 111.425 176.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -128.53 131.07 48.25 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.71 33.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 97.85 -0.4 59.21 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.383 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -89.36 -178.35 5.59 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 152.55 24.17 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' PHE . . . . . 0.647 ' CE1' ' HB2' ' A' ' 437' ' ' LEU . 50.6 p90 -141.59 154.54 45.49 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 56.0 ttp -126.26 121.41 32.6 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' VAL . . . . . . . . . . . . . 65.4 t -110.49 114.58 47.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.407 ' HD1' ' N ' ' A' ' 498' ' ' GLU . 0.3 OUTLIER -139.69 132.02 28.38 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' GLU . . . . . 0.407 ' N ' ' HD1' ' A' ' 497' ' ' PHE . 9.6 tp10 -67.0 141.37 57.6 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 123.724 0.64 . . . . 0.0 110.043 176.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -62.68 -61.21 2.58 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 125.242 1.417 . . . . 0.0 110.478 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.2 -28.72 70.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.376 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -68.77 -39.59 80.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.106 0.479 . . . . 0.0 111.374 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -80.24 -39.57 28.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.57 -52.44 61.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 508' ' ' GLU . 37.6 ttp180 -67.84 -15.79 63.79 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.389 0.676 . . . . 0.0 111.591 -174.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -80.95 -33.87 33.62 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.411 0.624 . . . . 0.0 109.375 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.83 -54.73 7.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.351 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -164.64 3.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.447 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 35.7 tt0 75.58 -39.99 0.4 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.869 2.068 . . . . 0.0 111.347 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -91.39 -32.03 15.81 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.615 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -99.02 132.68 44.15 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.128 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' ALA . . . . . . . . . . . . . . . -106.8 -179.09 3.84 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -164.45 107.05 0.89 Allowed 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -90.41 -37.31 14.05 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 128.593 2.757 . . . . 0.0 105.374 178.904 . . . . . . . . 0 0 . 1 stop_ save_